Import Date,ISID,Project,Protein,Modality,Control Type,Stress Condition,Temp. (°C),Time (Days),Well ID,Protein Conc (mg/mL),Sample Name,Notebook#,pH,Buffer,Arginine (mM),NaCl (mM),PS80 (%),Sucrose (%),Trehalose (%),Additional Excipient Name,Additional Excipient Unit,Additional Excipient Conc,CE-SDS NR - %Purity Sum,CE-SDS NR - Δ %Purity,CE-SDS NR - Abs (Δ %Purity),CE-SDS Red - %Purity Main Peak,CE-SDS Red - %Purity Sum,CE-SDS Red - Δ %Purity,CE-SDS Red - Abs (Δ %Purity),UV-Vis - A350-A500,cIEF - %Main,cIEF - %Acidic,cIEF - %Basic,cIEF - Δ %Main,cIEF - Δ %Acidic,cIEF - Δ %Basic,cIEF - Abs (Δ %Main),cIEF - Abs (Δ %Acidic),cIEF - Abs (Δ %Basic),DSF - Tm1 (°C),DSF - Tm2 (°C),FC - Initial - 0.22 μm conc. (cells/mL),FC - Initial - 0.45 μm conc. (cells/mL),FC - Initial - 0.88 μm conc. (cells/mL),FC - Initial - 1 μm conc. (cells/mL),FC - Initial - 1.35 μm conc. (cells/mL),FC - Initial - 2 μm conc. (cells/mL),FC - Initial - 5 μm conc. (cells/mL),FC - Initial - 10 μm conc. (cells/mL),FC - Initial - 25 μm conc. (cells/mL),FC - Stress - 0.22 μm conc. (cells/mL),FC - Stress - 0.45 μm conc. (cells/mL),FC - Stress - 0.88 μm conc. (cells/mL),FC - Stress - 1 μm conc. (cells/mL),FC - Stress - 1.35 μm conc. (cells/mL),FC - Stress - 2 μm conc. (cells/mL),FC - Stress - 5 μm conc. (cells/mL),FC - Stress - 10 μm conc. (cells/mL),FC - Stress - 25 μm conc. (cells/mL),AVG__2_UM,AVG__5_UM,AVG__25_UM,AVG_2_50_UM,AVG__100_UM,AVG_PARTICLE_COVERAGE____,RP-UPLC %Main,RP-UPLC %Pre-Peak,RP-UPLC %Post-Peak,RP-UPLC - Δ %Main,RP-UPLC - Δ %Pre-Peak,RP-UPLC - Δ %Post-Peak,RP-UPLC - Abs (Δ %Main),RP-UPLC - Abs (Δ %Pre-Peak),RP-UPLC - Abs (Δ %Post-Peak),UP-SEC - %Monomer,UP-SEC - %LMW,UP-SEC - %HMW,UP-SEC - Δ %Monomer,UP-SEC - Δ %LMW,UP-SEC - Δ %HMW,UP-SEC - Abs(Δ %Monomer),UP-SEC - Abs(Δ %LMW),UP-SEC - Abs(Δ %HMW),BATCH_BIOREG_ID,C_BIOREG_ID,FRAMEWORK,MERCK_NAME,PI,MW,IMPORTED_DATA_FILE_NAME,TARGETS,REAGENT_TYPE,Simplified Excipients,1st Excipient in Sample,2nd Excipient in Sample,#Conc for Excipient1,Origin of data
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,,,,,98.91,-0.79,,0.054,,,,,,,,,,59.8,61.8,7922,465,61,61,40,20,0,0,,569870,178327,39983,21528,5296,2224,20,20,,,,,,,,,,,,,,,,,78.5,7.48,14,-15.5,1.6,13.87,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,99.67,-0.02,,0.096,,,,,,,,,,62,63.4,16734,404,61,0,0,0,0,0,,887488,259555,27130,6004,121,20,0,0,,,,,,,,,,,,,,,,,92.1,6.46,1.47,-1.94,0.6,1.34,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,,,,,99.49,-0.21,,0.09,,,,,,,,,,62.6,67.6,16067,445,40,20,0,0,0,0,,889286,207321,13808,2163,20,0,0,0,,,,,,,,,,,,,,,,,93.2,5.56,1.26,-0.83,-0.3,1.13,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,,,,,97.03,-2.67,,0.057,,,,,,,,,,56.2,60.4,6386,505,61,40,20,20,0,0,,498903,114609,8651,4851,2082,1092,121,0,,,,,,,,,,,,,,,,,51.6,4.4,43.99,,-1.5,43.86,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,99.49,-0.21,,0.055,,,,,,,,,,62.2,64,8913,768,364,323,243,141,20,0,,103765,14916,3537,2041,546,202,40,20,,,,,,,,,,,,,,,,,81.6,5.86,12.56,-12.42,0,12.43,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,98.81,-0.88,,0.056,,,,,,,,,,59.6,62.8,6649,384,121,81,81,81,0,0,,56953,17886,4365,2082,707,263,0,0,,,,,,,,,,,,,,,,,82.8,4.45,12.81,-11.26,-1.4,12.68,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,99.28,-0.42,,0.061,,,,,,,,,,60.6,63,10105,364,61,40,20,20,0,0,,906987,17794,1456,789,121,20,0,0,,,,,,,,,,,,,,,,,73.6,5.5,20.9,-20.41,-0.4,20.77,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,100,0.31,,0.094,,,,,,,,,,63.2,64.6,15198,323,40,20,0,0,0,0,,433171,81702,3719,566,20,0,0,0,,,,,,,,,,,,,,,,,92.3,5.42,2.26,-1.69,-0.4,2.13,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,99.47,-0.22,,0.056,,,,,,,,,,61.6,63.8,6245,323,81,81,61,61,0,0,,123112,15968,4467,2870,606,303,40,20,,,,,,,,,,,,,,,,,89.3,4.26,6.41,-4.69,-1.6,6.28,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,B11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,99.17,-0.52,,0.059,,,,,,,,,,62.2,64,8690,445,141,81,20,20,0,0,,2000000,258955,4694,2266,607,182,20,20,,,,,,,,,,,,,,,,,86.2,4.47,9.3,-7.78,-1.4,9.17,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,50,0,0,0,,,,,,,,98.08,-1.62,,0.362,,,,,,,,,,57.4,59.2,10186,445,40,0,0,0,0,0,,4000000,4000000,3000000,3000000,1000000,77004,20,0,,,,,,,,,,,,,,,,,0,0,100,-94.01,-5.9,99.87,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,50,0,0,0,,,,,,,,99.65,-0.04,,0.178,,,,,,,,,,62.8,64.6,18957,647,61,0,0,0,0,0,,588908,416164,195137,109099,13178,4952,1011,0,,,,,,,,,,,,,,,,,89,9.04,2.01,-5.06,3.2,1.88,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,50,0,0,0,,,,,,,,99.6,-0.09,,0.107,,,,,,,,,,62,63.8,18331,808,0,0,0,0,0,0,,1000000,604704,202478,84957,1799,222,61,0,,,,,,,,,,,,,,,,,90,8.52,1.48,-4,2.7,1.35,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,50,0,0,0,,,,,,,,92.69,-7,,0.215,,,,,,,,,,56.6,58.8,14369,546,40,0,0,0,0,0,,3000000,3000000,2000000,2000000,202228,1597,20,0,,,,,,,,,,,,,,,,,16.1,18.56,65.29,,12.7,65.16,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,50,0,0,0,,,,,,,,99.24,-0.45,,0.423,,,,,,,,,,60,61.8,10368,889,101,40,0,0,0,0,,4000000,3000000,3000000,2000000,1000000,407079,141,20,,,,,,,,,,,,,,,,,88.7,8.45,2.89,-5.35,2.6,2.76,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0,0,0,,,,,,,,99.55,-0.15,,0.35,,,,,,,,,,60.6,61.8,2587,263,61,20,20,0,0,0,,1000000,580990,130832,46401,5742,3154,0,0,,,,,,,,,,,,,,,,,88.6,5.92,5.46,-5.38,0.1,5.33,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0,0,0,,,,,,,,98.09,-1.61,,0.338,,,,,,,,,,59.2,62,8266,222,20,0,0,0,0,0,,4000000,4000000,3000000,2000000,594094,8913,0,0,,,,,,,,,,,,,,,,,36.6,15.36,48.07,,9.5,47.94,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,50,0,0,0,,,,,,,,100,0.31,,0.145,,,,,,,,,,61.2,63.2,4749,303,20,20,0,0,0,0,,1000000,674854,222977,91426,2870,404,101,20,,,,,,,,,,,,,,,,,91,7.89,1.14,-3.04,2,1.01,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,50,0,0,0,,,,,,,,99.81,0.12,,0.239,,,,,,,,,,61.6,63,17603,505,61,20,0,0,0,0,,1000000,804665,295364,139161,6348,950,0,0,,,,,,,,,,,,,,,,,91.3,7.06,1.65,-2.73,1.2,1.52,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,C11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0,0,0,,,,,,,,100,0.31,,0.106,,,,,,,,,,62,64.2,243,20,0,0,0,0,0,0,,766134,460157,134797,48328,1354,323,61,20,,,,,,,,,,,,,,,,,95.1,4.47,0.46,1.06,-1.4,0.33,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,150,0,0,0,,,,,,,,96.32,-3.38,,0.357,,,,,,,,,,57.8,59.8,22817,748,61,0,0,0,0,0,,1000000,1000000,635052,451079,72987,7155,485,101,,,,,,,,,,,,,,,,,10.4,12.47,77.12,,6.6,76.99,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,150,0,0,0,,,,,,,,99.82,0.13,,0.269,,,,,,,,,,62.2,64,9337,525,20,20,0,0,0,0,,3000000,1000000,333804,149319,31263,11466,182,0,,,,,,,,,,,,,,,,,88.9,9.73,1.38,-5.12,3.9,1.25,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,150,0,0,0,,,,,,,,99.14,-0.55,,0.224,,,,,,,,,,63.2,64.6,12369,970,121,61,20,0,0,0,,4000000,2000000,798747,407753,67423,17730,384,0,,,,,,,,,,,,,,,,,86,12.44,1.56,-8,6.6,1.43,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,150,0,0,0,,,,,,,,90.07,-9.63,,0.555,,,,,,,,,,52.2,57.6,13743,748,81,20,0,0,0,0,,1000000,1000000,674495,439705,61224,12148,647,61,,,,,,,,,,,,,,,,,0,36.91,63.09,-94.01,31.1,62.96,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,150,0,0,0,,,,,,,,99.28,-0.42,,0.226,,,,,,,,,,60,63.2,17886,1900,162,61,0,0,0,0,,2000000,1000000,761375,528535,94960,6490,243,20,,,,,,,,,,,,,,,,,93.1,5.79,1.09,-0.89,-0.1,0.96,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0,0,0,,,,,,,,96.58,-3.11,,0.323,,,,,,,,,,59.8,56,7882,323,20,0,0,0,0,0,,3000000,3000000,2000000,1000000,142620,8146,263,0,,,,,,,,,,,,,,,,,0,0,100,-94.01,-5.9,99.87,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,150,0,0,0,,,,,,,,100,0.31,,0.192,,,,,,,,,,61.4,62.8,9923,505,61,0,0,0,0,0,,1000000,777896,331004,180734,19688,5599,323,20,,,,,,,,,,,,,,,,,91.5,7.92,0.62,-2.55,2.1,0.49,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,150,0,0,0,,,,,,,,98.92,-0.77,,0.23,,,,,,,,,,61.6,60,12672,1758,141,40,0,0,0,0,,2000000,1000000,399539,219969,14599,2608,162,0,,,,,,,,,,,,,,,,,90.5,7.61,1.9,-3.52,1.8,1.77,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0,0,0,,,,,,,,99.71,0.01,,0.263,,,,,,,,,,60.4,61.8,10954,1011,283,121,20,0,0,0,,2000000,1000000,431357,242050,19529,3477,121,20,,,,,,,,,,,,,,,,,91.6,7.9,0.48,-2.39,2.1,0.35,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50,10,D11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,150,0,0,0,,,,,,,,100,0.31,,0.159,,,,,,,,,,60,62.6,11277,869,121,81,20,20,0,0,,1000000,899317,413817,236170,28281,5822,243,20,,,,,,,,,,,,,,,,,92.7,6.82,0.5,-1.33,1,0.37,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,5,0,H02,1,,NB-ferguhei-5069961-0004,6,Water,0,0,0,0,0,,,,,,,,99.67,,,0.05,71.8,22.26,5.99,0,,,,,,57.2,63,161730,45516,9722,5336,1112,303,40,0,,602508,113377,25595,14738,4953.2,2304.7,323.5,40.4,,,,,,,,,,,,,,,,,94,5.85,0.13,6.13,-5.97,0,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,5,0,H03,1,,NB-ferguhei-5069961-0004,5.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.011,,,,,,,,,,61.4,62.6,895524,367092,115814,59413,13241,2951,182,61,,,,,,,,,,,,,,,,,,,,,,,,,,96.7,2.99,0.28,8.85,-8.83,-0.01,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E03,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,99.63,0.37,,0.055,,,,,,,,,,62,66,72617,3840,586,465,222,182,0,0,,1000000,622256,150721,25703,815,407,34,34,,,,,,,,,,,,,,,,,92.4,5.32,2.26,-2.56,2.58,-0.01,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E04,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,99.61,0.35,,0.055,,,,,,,,,,56.4,62.4,7922,465,61,61,40,20,0,0,,157067,55892,8436,1409,85,17,0,0,,,,,,,,,,,,,,,,,90.3,7.34,2.34,-4.67,4.6,0.07,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E05,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,99.6,0.33,,0.06,,,,,,,,,,61,63.6,16734,404,61,0,0,0,0,0,,41276,10523,2766,849,119,17,0,0,,,,,,,,,,,,,,,,,94.3,3.43,2.28,-0.68,0.69,0.01,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E06,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,99.65,0.39,,0.055,,,,,,,,,,62.8,67.6,16067,445,40,20,0,0,0,0,,258651,134426,45861,17991,1256,187,0,0,,,,,,,,,,,,,,,,,94,4.05,1.94,-0.97,1.31,-0.33,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E07,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,,,,,99.65,0.38,,0.055,,,,,,,,,,62,63.2,6386,505,61,40,20,20,0,0,,225466,117163,41464,15123,849,51,0,0,,,,,,,,,,,,,,,,,94,4.05,1.94,-0.97,1.31,-0.33,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E08,1,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,,,,,99.57,0.31,,0.054,,,,,,,,,,55.2,56.6,8913,768,364,323,243,141,20,0,,2000000,881709,106412,8575,441,204,0,0,,,,,,,,,,,,,,,,,93.5,3.51,2.99,-1.48,0.77,0.72,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E09,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,99.66,0.39,,0.054,,,,,,,,,,59.2,63.8,6649,384,121,81,81,81,0,0,,1000000,543933,82398,11749,170,34,0,0,,,,,,,,,,,,,,,,,94.4,3.3,2.27,-0.55,0.56,0,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,99.59,0.32,,0.054,,,,,,,,,,61.8,63.8,10105,364,61,40,20,20,0,0,,584357,175988,9812,2071,492,373,102,17,,,,,,,,,,,,,,,,,95.7,2.48,1.78,0.76,-0.26,-0.49,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45,10,E11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,99.47,0.21,,0.052,,,,,,,,,,61.8,63.2,15198,323,40,20,0,0,0,0,,217779,27515,3989,1765,509,289,34,17,,,,,,,,,,,,,,,,,95.9,2.3,1.83,0.88,-0.44,-0.44,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,,,,,99.14,-0.55,,0.053,,,,,,,,,,64,64.6,48870,3496,404,263,101,61,0,0,,2000000,598840,151782,68036,22503,8067,202,101,,,,,,,,,,,,,,,,,89.6,3.63,6.78,1.71,-8.19,6.49,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,99.12,-0.57,,0.078,,,,,,,,,,64.6,68.2,13197,505,61,40,20,0,0,0,,1000000,180714,8532,1355,61,40,0,0,,,,,,,,,,,,,,,,,95.3,4.57,0.17,7.38,-7.25,-0.12,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,,,,,99.18,-0.52,,0.075,,,,,,,,,,64,67.2,11075,445,81,61,20,20,0,0,,1000000,249255,13284,1597,20,20,0,0,,,,,,,,,,,,,,,,,95.7,4.06,0.27,7.79,-7.76,-0.02,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,,,,,98.22,-1.48,,0.059,,,,,,,,,,59.4,61.8,45857,3294,263,162,101,61,20,0,,2000000,658957,89197,31485,13225,5541,61,40,,,,,,,,,,,,,,,,,74.2,4.68,21.17,-13.73,-7.14,20.88,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,99.43,-0.26,,0.053,,,,,,,,,,65,66.6,62835,3456,222,81,81,81,0,0,,862200,80534,28691,18319,7865,3943,162,40,,,,,,,,,,,,,,,,,89.6,4.63,5.74,1.76,-7.19,5.45,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,99.5,-0.2,,0.054,,,,,,,,,,59.6,64.6,48101,3072,283,162,101,61,0,0,,1000000,481073,93202,47855,19004,6187,142,101,,,,,,,,,,,,,,,,,89.6,3.8,6.61,1.72,-8.02,6.32,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,99.25,-0.45,,0.059,,,,,,,,,,65.2,67,47434,2021,182,121,40,40,0,0,,466361,9077,2446,1435,505,222,61,40,,,,,,,,,,,,,,,,,87.2,4.51,8.33,-0.72,-7.31,8.04,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,99.67,-0.03,,0.09,,,,,,,,,,65.6,68.6,10792,121,40,20,20,20,20,0,,447701,91525,5195,970,61,0,0,0,,,,,,,,,,,,,,,,,95.5,3.89,0.63,7.6,-7.93,0.34,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,99.44,-0.25,,0.056,,,,,,,,,,65.4,68,48647,2526,263,121,40,20,20,20,,193675,48490,15483,10288,3578,1233,40,40,,,,,,,,,,,,,,,,,92.2,3.21,4.57,4.34,-8.61,4.28,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,E11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,99.2,-0.5,,0.058,,,,,,,,,,65.4,66.8,72617,3840,586,465,222,182,0,0,,3000000,112820,17643,8235,1841,486,20,0,,,,,,,,,,,,,,,,,91.2,3.23,5.56,3.34,-8.59,5.27,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,50,0,0,0,,,,,,,,99.48,-0.22,,0.352,,,,,,,,,,61.8,62.6,43109,546,40,20,0,0,0,0,,2000000,2000000,2000000,2000000,2000000,1000000,3173,0,,,,,,,,,,,,,,,,,59.5,15.87,24.6,,4.05,24.31,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,50,0,0,0,,,,,,,,99.62,-0.07,,0.102,,,,,,,,,,65,68,78762,4123,222,81,40,20,0,0,,1000000,775782,333255,174087,8835,465,40,0,,,,,,,,,,,,,,,,,93.5,5.85,0.63,5.65,-5.97,0.34,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,50,0,0,0,,,,,,,,99.43,-0.26,,0.075,,,,,,,,,,65,67.6,88079,5235,404,101,20,20,0,0,,1000000,320351,29661,5803,142,40,20,0,,,,,,,,,,,,,,,,,94.7,4.94,0.33,6.85,-6.88,0.04,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,50,0,0,0,,,,,,,,95.25,-4.45,,0.374,,,,,,,,,,56.6,58,16047,202,40,40,40,40,20,0,,2000000,2000000,2000000,2000000,1000000,1000000,40178,20.2,,,,,,,,,,,,,,,,,11.5,8.4,80.06,,-3.42,79.77,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,50,0,0,0,,,,,,,,99.47,-0.22,,0.287,,,,,,,,,,62.6,64,9681,344,40,40,0,0,0,0,,3000000,2000000,2000000,2000000,1000000,826104,183219,50436,,,,,,,,,,,,,,,,,93.5,4.81,1.72,5.59,-7.01,1.43,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0,0,0,,,,,,,,99.1,-0.59,,0.313,,,,,,,,,,52.8,61.2,7255,101,40,40,20,20,20,20,,3000000,3000000,3000000,2000000,2000000,273649,0,0,,,,,,,,,,,,,,,,,74.9,10.03,15.07,-12.98,-1.79,14.78,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,50,0,0,0,,,,,,,,90,-9.69,,0.082,,,,,,,,,,57.4,64.2,2930,162,81,61,40,20,0,0,,1000000,722818,246916,108692,3113,323.4,60.6,0,,,,,,,,,,,,,,,,,93.9,5.71,0.39,6.02,-6.11,0.1,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,50,0,0,0,,,,,,,,99.63,-0.06,,0.229,,,,,,,,,,60.2,65,65604,2264,61,40,40,20,0,0,,3000000,1000000,142434,46595,9545.5,3134.6,80.9,0,,,,,,,,,,,,,,,,,93.8,5.73,0.47,5.92,-6.09,0.18,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0,0,0,,,,,,,,99.49,-0.21,,0.293,,,,,,,,,,62.2,63.6,2668,263,20,20,0,0,0,0,,735295,271640,67253,33333,12836,5922.8,121.3,0,,,,,,,,,,,,,,,,,94.1,4.67,1.27,6.18,-7.15,0.98,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,F11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0,0,0,,,,,,,,99.62,-0.07,,0.095,,,,,,,,,,63.8,65.2,344,81,40,40,40,0,0,0,,706105,393931,103505,37210,1091.4,161.7,0,0,,,,,,,,,,,,,,,,,95.8,4.08,0.17,7.87,-7.74,-0.12,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,150,0,0,0,,,,,,,,98.45,-1.24,,0.391,,,,,,,,,,58,60.2,101903,5073,61,40,20,0,0,0,,3000000,3000000,2000000,1000000,273513,10349,141.5,0,,,,,,,,,,,,,,,,,0,0,0,,-11.82,-0.29,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,150,0,0,0,,,,,,,,0,-99.69,,0.211,,,,,,,,,,60.2,65,21342,728,20,0,0,0,0,0,,4000000,3000000,2000000,2000000,646859,124359,20.2,0,,,,,,,,,,,,,,,,,92.1,7.12,0.78,4.21,-4.7,0.49,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,150,0,0,0,,,,,,,,99.66,-0.03,,0.13,,,,,,,,,,64.2,65.6,21524,869,101,40,40,20,0,0,,4000000,2000000,580345,266708,37749,10251,283.1,0,,,,,,,,,,,,,,,,,92,7.6,0.38,4.14,-4.22,0.09,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,150,0,0,0,,,,,,,,93.59,-6.1,,0.543,,,,,,,,,,48.8,56.2,75366,2102,121,81,0,0,0,0,,2000000,2000000,1000000,863640,122999,12896,727.7,101.1,,,,,,,,,,,,,,,,,21.3,12.52,66.21,,0.7,65.92,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,150,0,0,0,,,,,,,,98.66,-1.03,,0.323,,,,,,,,,,56.4,62.8,56690,1334,81,61,20,20,0,0,,3000000,2000000,1000000,789485,142234,19770,404.3,20.2,,,,,,,,,,,,,,,,,91.2,8.1,0.74,3.28,-3.72,0.45,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0,0,0,,,,,,,,98.3,-1.39,,0.37,,,,,,,,,,54.2,60.4,28699,465,20,0,0,0,0,0,,4000000,3000000,2000000,2000000,185672,4931.8,141.5,0,,,,,,,,,,,,,,,,,24.7,18.31,0,,6.49,-0.29,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,150,0,0,0,,,,,,,,99.66,-0.03,,0.146,,,,,,,,,,64.2,68.4,32114,849,202,81,0,0,0,0,,2000000,1000000,441331,240963,22926,3537.9,363.9,0,,,,,,,,,,,,,,,,,89.1,10.58,0.35,1.19,-1.24,0.06,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,150,0,0,0,,,,,,,,100,0.31,,0.303,,,,,,,,,,64.2,63,29689,768,61,40,20,0,0,0,,3000000,1000000,600805,337546,34292,6348.9,60.7,0,,,,,,,,,,,,,,,,,85.3,13.96,0.74,-2.58,2.14,0.45,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0,0,0,,,,,,,,100,0.31,,0.28,,,,,,,,,,58.8,63.8,36560,829,61,40,0,0,0,0,,2000000,1000000,390941,218946,22930,5277.5,121.3,0,,,,,,,,,,,,,,,,,87.5,11.93,0.61,-0.42,0.11,0.32,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50,10,G11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,150,0,0,0,,,,,,,,99.53,-0.17,,0.114,,,,,,,,,,60.4,64.6,36500,869,40,0,0,0,0,0,,1000000,837125,368282,198351,12916,1313.9,101.1,0,,,,,,,,,,,,,,,,,89.6,10.3,0.06,1.76,-1.52,-0.23,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,5,0,H07,1,,NB-ferguhei-5069961-0004,6,Water,0,0,0,0,0,,,,,,,,99.69,,,0.011,76.4,17.9,5.7,0,,,,,,65.4,68.2,104510,21767,5336,2688,323,20,0,0,,484296,181207,43356,20961,4487.2,1253.2,40.4,40.4,,,,,,,,,,,,,,,,,87.9,11.82,0.29,0,0,0,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,5,0,H08,1,,NB-ferguhei-5069961-0004,5.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.011,,,,,,,,,,64.4,65.6,1000000,668219,281459,153576,32527,5782,303,20,,,,,,,,,,,,,,,,,,,,,,,,,,90.6,9.37,0.04,2.71,-2.45,-0.25,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D03,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,99.28,0.53,,0.054,,,,,,,,,,60.4,65,48870,3496,404,263,101,61,0,0,,1000000,368618,23941,1545,119,68,0,0,,,,,,,,,,,,,,,,,94.1,4.04,1.82,-1.33,1.01,0.32,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D04,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,98.63,-0.12,,0.055,,,,,,,,,,64.4,65.6,13197,505,61,40,20,0,0,0,,103890,34353,2240,204,51,17,0,0,,,,,,,,,,,,,,,,,92.9,5,2.06,-2.53,1.97,0.56,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D05,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,99.22,0.46,,0.057,,,,,,,,,,63.8,65.6,11075,445,81,61,20,20,0,0,,158218,47829,9114,3089,390,17,0,0,,,,,,,,,,,,,,,,,95.4,2.6,1.97,-0.03,-0.43,0.47,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D06,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,99.01,0.26,,0.056,,,,,,,,,,65,67.6,45857,3294,263,162,101,61,20,0,,180471,70810,17686,6433,679,85,0,0,,,,,,,,,,,,,,,,,95.4,2.7,1.95,-0.12,-0.33,0.45,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D07,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,,,,,99.16,0.41,,0.052,,,,,,,,,,63.8,67.2,62835,3456,222,81,81,81,0,0,,48099,15852,2682,560,51,34,17,17,,,,,,,,,,,,,,,,,95.5,2.61,1.88,0.05,-0.42,0.38,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D08,1,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,,,,,99.38,0.63,,0.053,,,,,,,,,,56.2,60.8,48101,3072,283,162,101,61,0,0,,2000000,738484,40397,1885,272,187,51,34,,,,,,,,,,,,,,,,,94.6,3.33,2.11,-0.92,0.3,0.61,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D09,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,98.75,-0.01,,0.054,,,,,,,,,,63.4,65.6,47434,2021,182,121,40,40,0,0,,2000000,1000000,219368,29221,255,68,0,0,,,,,,,,,,,,,,,,,94.6,2.42,2.94,-0.83,-0.61,1.44,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,98.72,-0.03,,0.053,,,,,,,,,,59.6,66.2,10792,121,40,20,20,20,20,0,,327887,90765,6858,679,102,51,17,17,,,,,,,,,,,,,,,,,95.1,2.67,2.2,-0.34,-0.36,0.7,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45,10,D11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,99.06,0.31,,0.053,,,,,,,,,,64.6,66.2,48647,2526,263,121,40,20,20,20,,518950,10663,764,289,51,17,0,0,,,,,,,,,,,,,,,,,95.9,2.17,1.98,0.38,-0.86,0.48,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,,,,,99,0.67,,0.044,,,,,,,,,,59.4,61.8,29854,655,67,17,0,0,0,0,,2000000,526696,24622,10528,3243,1053,17,0,,,,,,,,,,,,,,,,,81.9,1.72,16.36,-15.8,0.4,15.46,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,100,0.94,,0.044,,,,,,,,,,64.8,69.6,117961,2235,101,17,0,0,0,0,,1000000,460155,72377,30493,7793,2716,68,34,,,,,,,,,,,,,,,,,94.2,1.56,4.21,-3.53,0.2,3.31,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,,,,,100,0.78,,0.045,,,,,,,,,,65.2,70,141006,4185,50,17,0,0,0,0,,2000000,1000000,140414,47710,11885,4958,51,0,,,,,,,,,,,,,,,,,94.2,1.67,4.13,-3.55,0.3,3.23,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,,,,,97,-1.67,,0.047,,,,,,,,,,56,59.6,91493,8704,807,134,0,0,0,0,,824575,204573,19982,10390,3209,1375,51,17,,,,,,,,,,,,,,,,,30,3.14,66.89,,1.8,65.99,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,100,0.92,,0.045,,,,,,,,,,56.8,62.2,86873,2756,168,17,0,0,0,0,,201781,52906,5279,2631,967,611,170,85,,,,,,,,,,,,,,,,,86.4,1.94,11.7,-11.39,0.6,10.8,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,99,0.49,,0.044,,,,,,,,,,59.4,65.6,3638,748,162,81,40,0,0,0,,130995,37136,6738,3853,1494,645,34,17,,,,,,,,,,,,,,,,,80,1.88,18.09,-17.72,0.5,17.19,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,100,1.16,,0.047,,,,,,,,,,63.2,60.2,31690,445,0,0,0,0,0,0,,84624,27003,3955,1511,51,0,0,0,,,,,,,,,,,,,,,,,95.6,2.12,2.27,-2.14,0.8,1.37,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,100,1.11,,0.046,,,,,,,,,,63.4,69,7599,606,40,40,0,0,0,0,,84098,31501,9674,5584,1782,645,102,34,,,,,,,,,,,,,,,,,93.4,1.87,4.77,-4.4,0.5,3.87,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,100,0.95,,0.047,,,,,,,,,,62,62,30477,1637,344,162,40,0,0,0,,21232,3072,594,289,153,136,68,34,,,,,,,,,,,,,,,,,89.3,1.51,9.23,-8.49,0.2,8.33,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,B11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,100,0.94,,0.103,,,,,,,,,,62.6,65,31468,768,121,81,0,0,0,0,,3000000,2000000,2000000,1000000,193226,10474,68,0,,,,,,,,,,,,,,,,,95.8,2.05,2.17,-1.97,0.7,1.27,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,50,0,0,0,,,,,,,,99,0.55,,0.141,,,,,,,,,,58.4,65,43733,756,50,34,17,0,0,0,,3000000,2000000,994799,459346,73065,19382,1111,154,,,,,,,,,,,,,,,,,91.5,1.7,6.79,-6.23,0.3,5.89,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,50,0,0,0,,,,,,,,99,0.44,,0.045,,,,,,,,,,64.4,69.4,140303,7261,67,0,0,0,0,0,,662809,201890,19895,7962,1748,509,17,17,,,,,,,,,,,,,,,,,93.5,1.9,4.66,-4.3,0.5,3.76,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,50,0,0,0,,,,,,,,100,0.8,,0.047,,,,,,,,,,65.2,69.4,150157,8487,118,34,0,0,0,0,,2000000,1000000,244538,87540,15043,4975,68,34,,,,,,,,,,,,,,,,,93.6,1.95,4.48,-4.17,0.6,3.58,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,50,0,0,0,,,,,,,,93,-5.66,,0.27,,,,,,,,,,53.4,57.2,78490,2336,168,84,0,0,0,0,,3000000,1000000,267873,78689,9272,3464,51,0,,,,,,,,,,,,,,,,,0,0,100,,-1.4,99.1,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,50,0,0,0,,,,,,,,100,1.11,,0.072,,,,,,,,,,61.8,65.8,53397,2235,252,84,0,0,0,0,,132101,12305,1528,900,204,51,0,0,,,,,,,,,,,,,,,,,93.3,2.23,4.49,-4.48,0.9,3.59,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0,0,0,,,,,,,,99,0.5,,0.109,,,,,,,,,,57.8,58.8,8791,1314,263,61,0,0,0,0,,766086,434407,172374,87961,6297,458,17,0,,,,,,,,,,,,,,,,,94.6,1.65,3.76,-3.16,0.3,2.86,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,50,0,0,0,,,,,,,,100,1.16,,0.067,,,,,,,,,,62.8,65.6,20453,606,40,0,0,0,0,0,,155034,9488,153,51,17,0,0,0,,,,,,,,,,,,,,,,,96.5,1.5,2.02,-1.27,0.1,1.12,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,50,0,0,0,,,,,,,,98,-0.67,,0.046,,,,,,,,,,62.2,68,6245,1233,283,101,20,0,0,0,,90141,29464,7672,4549,1731,1018,221,136,,,,,,,,,,,,,,,,,91.5,1.79,6.73,-6.27,0.4,5.83,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0,0,0,,,,,,,,100,1.1,,0.079,,,,,,,,,,62.2,65.8,25141,3658,1011,445,61,40,0,0,,153558,12679,238,51,17,0,0,0,,,,,,,,,,,,,,,,,94.8,2.64,2.51,-2.91,1.3,1.61,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,C11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0,0,0,,,,,,,,100,1.11,,0.061,,,,,,,,,,63.2,65.4,26536,2001,384,182,40,20,0,0,,211958,6603,221,85,17,0,0,0,,,,,,,,,,,,,,,,,96.2,2.2,1.57,-1.52,0.8,0.67,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,150,0,0,0,,,,,,,,0,-98.73,,0.076,,,,,,,,,,56.8,61,24578,1159,151,84,0,0,0,0,,361053,183217,63618,31996,2054,153,51,34,,,,,,,,,,,,,,,,,100,0,0,2.25,-1.4,-0.9,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,150,0,0,0,,,,,,,,100,1.12,,0.046,,,,,,,,,,63.4,68.8,52105,1092,134,0,0,0,0,0,,960710,351451,40557,14889,3344,1341,68,68,,,,,,,,,,,,,,,,,93.2,1.88,4.94,-4.57,0.5,4.04,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,150,0,0,0,,,,,,,,100,0.96,,0.046,,,,,,,,,,63.2,64.6,48625,1630,134,34,0,0,0,0,,2000000,1000000,354808,160901,27572,7572,17,0,,,,,,,,,,,,,,,,,93.6,1.74,4.67,-4.16,0.4,3.77,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,150,0,0,0,,,,,,,,92,-6.81,,0.391,,,,,,,,,,51.8,52.6,32458,1378,235,67,0,0,0,0,,223729,161967,89563,58045,11762,1680,85,17,,,,,,,,,,,,,,,,,0,0,100,,-1.4,99.1,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,150,0,0,0,,,,,,,,100,1.1,,0.091,,,,,,,,,,60.8,66,25755,991,84,0,0,0,0,0,,2000000,557801,156909,73911,13790,5621,323,0,,,,,,,,,,,,,,,,,95.1,1.9,3.01,-2.66,0.5,2.11,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0,0,0,,,,,,,,100,1.27,,0.073,,,,,,,,,,57.6,61.2,10489,2829,950,303,121,61,0,0,,433300,148886,35800,14768,696,153,17,0,,,,,,,,,,,,,,,,,100,0,0,2.25,-1.4,-0.9,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,150,0,0,0,,,,,,,,100,1.15,,0.046,,,,,,,,,,62.2,67.4,7154,687,101,40,0,0,0,0,,22064,5872,1884,1273,560,339,85,34,,,,,,,,,,,,,,,,,92,2.08,5.97,-5.79,0.7,5.07,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,150,0,0,0,,,,,,,,100,1.1,,0.085,,,,,,,,,,61,67.2,6366,2041,303,121,0,0,0,0,,4000000,3000000,1000000,619327,16251,815,68,23,,,,,,,,,,,,,,,,,92.8,2.02,5.15,-4.92,0.7,4.25,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0,0,0,,,,,,,,100,1.08,,0.051,,,,,,,,,,61.6,66.2,13824,3779,1112,566,202,40,20,20,,2000000,32184,5387,3161,1733,1240,204,51,,,,,,,,,,,,,,,,,90.7,2.48,6.79,-7.02,1.1,5.89,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50,10,D11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,150,0,0,0,,,,,,,,100,1.11,,0.045,,,,,,,,,,59.4,64,8650,2324,889,445,101,20,0,0,,96490,32045,8402,4820,2088,1341,85,17,,,,,,,,,,,,,,,,,92.4,2.59,5.06,-5.4,1.2,4.16,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,5,0,H02,1,,NB-ferguhei-5069961-0004,6,Water,0,0,0,0,0,,,,,,,,100,,,0.039,69.1,26.71,4.17,0,,,,,,53.2,59.6,17199,3880,930,485,101,20,0,0,,374364,160270,18570,8606,1867,628,119,17,,,,,,,,,,,,,,,,,97.8,1.36,0.9,-1.19,0.3,0,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,,,,,99,0.74,,0.05,,,,,,,,,,59.8,64,68706,2033,218,84,0,0,0,0,,3000000,372924,39875,17451,4304,1847,59,39,,,,,,,,,,,,,,,,,40.7,0.46,58.87,,-0.6,58.87,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,100,0.79,,0.054,,,,,,,,,,64,65.4,81195,521,17,17,17,0,0,0,,286494,20675,492,153,0,0,0,0,,,,,,,,,,,,,,,,,97.2,1.55,1.23,-1.72,0.49,1.23,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,,,,,100,0.86,,0.06,,,,,,,,,,64.8,,113200,2033,17,0,0,0,0,0,,576640,194975,36411,12714,373,51,0,0,,,,,,,,,,,,,,,,,97.4,1.74,0.84,-1.52,0.68,0.84,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,,,,,97,-2.21,,0.051,,,,,,,,,,56.6,60,122812,1664,67,34,0,0,0,0,,1000000,130226,17677,10545,4551,2394,221,17,,,,,,,,,,,,,,,,,4,2.87,93.08,,1.81,93.08,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,100,0.82,,0.195,,,,,,,,,,62.2,,141619,0,0,0,0,0,0,0,,2000000,332103,94860,59481,25613,10480,272,0,,,,,,,,,,,,,,,,,84.8,1.37,13.83,-14.13,0.31,13.83,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,99,0.4,,0.046,,,,,,,,,,59.4,,13783,1718,707,485,141,81,40,0,,1000000,182729,21890,14333,5927,3142,170,34,,,,,,,,,,,,,,,,,46.6,0.58,52.8,-52.31,-0.48,52.8,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,100,0.8,,0.054,,,,,,,,,,46.4,62.8,29164,546,40,20,0,0,0,0,,193631,19553,2733,917,85,17,0,0,,,,,,,,,,,,,,,,,97.7,1.43,0.84,-1.22,0.37,0.84,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,50,0,0,0,,,,,,,,100,1.27,,0.111,,,,,,,,,,57.8,59.2,41566,1462,202,84,0,0,0,0,,180706,97744,36728,19722,2054,102,0,0,,,,,,,,,,,,,,,,,0,0,0,,-1.06,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,100,0.89,,0.055,,,,,,,,,,63.4,66,56105,1738,101,61,20,0,0,0,,181568,3768,255,153,34,0,0,0,,,,,,,,,,,,,,,,,97.9,1.4,0.74,-1.08,0.34,0.74,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,100,1.01,,0.058,,,,,,,,,,62,65.2,51638,2122,647,424,162,40,20,0,,6000000,2000000,2487,829,265,166,99,33,,,,,,,,,,,,,,,,,79.9,1.27,18.78,-19,0.21,18.78,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,E11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,98,-0.48,,0.27,,,,,,,,,,62.8,65,41210,647,61,61,40,20,0,0,,1000000,871036,549734,367152,123001,29095,34,0,,,,,,,,,,,,,,,,,97.7,4.07,0.27,-1.25,3.01,0.27,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,50,0,0,0,,,,,,,,100,0.84,,0.061,,,,,,,,,,62.6,65.2,117960,2487,34,0,0,0,0,0,,280730,21149,594,187,17,0,0,0,,,,,,,,,,,,,,,,,96.2,1.5,2.35,-2.79,0.44,2.35,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,50,0,0,0,,,,,,,,100,0.86,,0.056,,,,,,,,,,63,65.4,131992,4117,118,34,0,0,0,0,,378955,59716,5551,1630,204,51,0,0,,,,,,,,,,,,,,,,,96.7,1.73,1.56,-2.22,0.67,1.56,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,50,0,0,0,,,,,,,,95,-4.17,,0.352,,,,,,,,,,54.8,57.4,141797,5042,50,0,0,0,0,0,,869508,475883,219855,131451,20115,2920,51,0,,,,,,,,,,,,,,,,,13.7,18.24,151,-85.21,17.18,151,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,50,0,0,0,,,,,,,,100,1.27,,0.067,,,,,,,,,,61,62,152740,5412,134,34,0,0,0,0,,519983,71538,4465,1681,136,51,34,17,,,,,,,,,,,,,,,,,97.7,4.21,0.17,-1.23,3.15,0.17,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0,0,0,,,,,,,,100,1.27,,0.074,,,,,,,,,,57.8,59.2,22150,1253,303,222,61,61,0,0,,67279,23117,6467,3327,441,85,0,0,,,,,,,,,,,,,,,,,100,0,0,1.06,-1.06,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,50,0,0,0,,,,,,,,100,0.8,,0.064,,,,,,,,,,63.4,,42239,1192,81,20,0,0,0,0,,378855,8437,696,306,34,0,0,0,,,,,,,,,,,,,,,,,97.6,1.99,0.38,-1.3,0.93,0.38,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,50,0,0,0,,,,,,,,100,1.27,,0.069,,,,,,,,,,62.2,66.6,43392,2183,182,81,0,0,0,0,,366656,80508,7706,1867,68,0,0,0,,,,,,,,,,,,,,,,,97.7,1.56,0.74,-1.24,0.5,0.74,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0,0,0,,,,,,,,100,1.27,,0.07,,,,,,,,,,61.8,65.4,35267,2829,909,505,162,101,20,20,,459600,32050,1681,594,85,0,0,0,,,,,,,,,,,,,,,,,98,3.85,0.09,-0.92,2.79,0.09,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,F11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0,0,0,,,,,,,,100,0.88,,0.056,,,,,,,,,,62.6,65.2,29952,1637,303,121,0,0,0,0,,294678,8912,764,492,102,34,17,0,,,,,,,,,,,,,,,,,98,2.04,0,-0.98,0.98,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,150,0,0,0,,,,,,,,100,1.27,,0.123,,,,,,,,,,57,59,34844,722,50,17,0,0,0,0,,36626,14240,5533,3004,645,102,0,0,,,,,,,,,,,,,,,,,0,0,0,,-1.06,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G03,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,150,0,0,0,,,,,,,,100,0.88,,0.076,,,,,,,,,,63.6,66.8,67985,924,50,0,0,0,0,0,,1000000,512978,200464,112559,13839,985,51,0,,,,,,,,,,,,,,,,,96.8,1.85,1.33,-2.11,0.79,1.33,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G04,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,150,0,0,0,,,,,,,,100,0.84,,0.095,,,,,,,,,,63.4,64,64203,689,50,0,0,0,0,0,,3000000,1000000,273073,132798,15108,1561,34,0,,,,,,,,,,,,,,,,,96.6,1.85,1.57,-2.36,0.79,1.57,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,150,0,0,0,,,,,,,,93,-5.44,,0.513,,,,,,,,,,53.2,57.2,81916,1159,67,17,0,0,0,0,,61557,49372,34470,26578,9267,1969,85,34,,,,,,,,,,,,,,,,,0,0,100,,-1.06,100,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G06,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,150,0,0,0,,,,,,,,100,1.27,,0.073,,,,,,,,,,60,61.2,114492,1949,151,17,0,0,0,0,,845211,319038,58396,18554,611,85,0,0,,,,,,,,,,,,,,,,,97.3,2.75,0,-1.69,1.69,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G07,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0,0,0,,,,,,,,100,1.27,,0.067,,,,,,,,,,57.6,59,27102,728,61,20,0,0,0,0,,77042,4770,1392,832,34,0,0,0,,,,,,,,,,,,,,,,,100,0,0,1.06,-1.06,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G08,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,150,0,0,0,,,,,,,,100,1.27,,0.067,,,,,,,,,,62.6,65.2,32053,1192,81,0,0,0,0,0,,501124,150106,17891,4312,51,0,0,0,,,,,,,,,,,,,,,,,98.1,1.86,0,-0.8,0.8,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G09,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,150,0,0,0,,,,,,,,100,1.27,,0.067,,,,,,,,,,61.2,65.8,32478,1779,182,61,0,0,0,0,,671205,239024,50161,18316,611,102,34,0,,,,,,,,,,,,,,,,,97.6,2.43,0,-1.37,1.37,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0,0,0,,,,,,,,100,1.27,,0.063,,,,,,,,,,61.6,65.2,38945,1273,101,61,20,0,0,0,,667571,211343,29350,8165,119,17,0,0,,,,,,,,,,,,,,,,,97.8,2.2,0,-1.14,1.14,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50,10,G11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,150,0,0,0,,,,,,,,99,0.72,,0.059,,,,,,,,,,62.2,63.4,39107,1900,344,141,20,0,0,0,,457168,94971,7672,1613,170,68,34,0,,,,,,,,,,,,,,,,,97.5,2.55,0,-1.49,1.49,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,5,0,H07,1,,NB-ferguhei-5069961-0004,6,Water,0,0,0,0,0,,,,,,,,99,,,0.036,63.1,30.89,5.98,0,,,,,,54.8,62.4,143377,31974,8266,4103,768,101,0,0,,116448,25017,6568,3344,866,390,0,0,,,,,,,,,,,,,,,,,98.9,1.06,0,0,0,0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,5,0,H08,1,,NB-ferguhei-5069961-0004,5.5,Acetate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,64,62.2,68290,22171,8690,5174,1071,202,40,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C02,1,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,,,,,99.53,-0.02,,0.052,,,,,,,,,,60.8,63.8,68706,2033,218,84,0,0,0,0,,2000000,1000000,168516,20205,391,153,0,0,,,,,,,,,,,,,,,,,96.2,1.26,2.58,1.09,-1.71,0.63,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C03,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,99.52,-0.03,,0.053,,,,,,,,,,62.2,63.8,81195,521,17,17,17,0,0,0,,167625,44520,2274,221,0,0,0,0,,,,,,,,,,,,,,,,,95.8,1.42,2.76,0.74,-1.55,0.81,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C04,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,99.52,-0.03,,0.055,,,,,,,,,,62.6,64,113200,2033,17,0,0,0,0,0,,22658,5244,119,68,17,0,0,0,,,,,,,,,,,,,,,,,95.4,1.54,3.03,0.35,-1.43,1.08,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C05,1,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,99.57,0.03,,0.055,,,,,,,,,,61.6,67.2,122812,1664,67,34,0,0,0,0,,20383,8978,2359,747,85,68,34,0,,,,,,,,,,,,,,,,,96.4,1.26,2.34,1.32,-1.71,0.39,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C06,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,99.53,-0.01,,0.056,,,,,,,,,,62.2,65.2,141619,0,0,0,0,0,0,0,,104940,62730,23150,9114,645,17,0,0,,,,,,,,,,,,,,,,,97,0.85,2.19,1.88,-2.12,0.24,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C07,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,,,,,99.56,0.01,,0.054,,,,,,,,,,62.6,66.8,13783,1718,707,485,141,81,40,0,,122574,60795,15207,4090,102,17,17,17,,,,,,,,,,,,,,,,,96.8,0.95,2.23,1.74,-2.02,0.28,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C08,1,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,,,,,95.13,-4.42,,0.054,,,,,,,,,,56.2,60.8,29164,546,40,20,0,0,0,0,,1000000,251376,2920,458,119,85,17,17,,,,,,,,,,,,,,,,,92.5,1.21,6.26,-2.55,-1.76,4.31,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C09,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,98.03,-1.52,,0.053,,,,,,,,,,59.2,60.6,56105,1738,101,61,20,0,0,0,,521123,178913,19419,3191,136,102,17,0,,,,,,,,,,,,,,,,,95.4,1.3,3.35,0.27,-1.67,1.4,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C10,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,99.53,-0.02,,0.052,,,,,,,,,,61.4,62.8,51638,2122,647,424,162,40,20,0,,5431,713,136,102,51,34,34,0,,,,,,,,,,,,,,,,,94.9,2.02,3.04,-0.14,-0.95,1.09,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45,10,C11,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,99.54,-0.01,,0.055,,,,,,,,,,61.4,63.4,41210,647,61,61,40,20,0,0,,883564,5010,85,17,0,0,0,0,,,,,,,,,,,,,,,,,95.9,1.62,2.45,0.85,-1.35,0.5,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B02,1.32,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,100,0,,,98.61,4.6,,0.0423,37.7,51.2,11.1,-29.1,,,,,,64,66.8,21836,3512,791,339,85,36,3,1,,14142,916,158,67,19,7,2,0,,,,,,,,93.6,0.74,5.71,-3,0.7,2,,,,95.5,3.61,0.94,1,0,-0.4,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B03,1.29,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,98.53,-1.47,,,100,6,,0.0441,35.4,56.1,8.5,-31.4,,,,,,66.4,65.8,2867,823,259,160,57,30,3,1,,32115,4083,949,465,55,7,0,0,,,,,,,,96.3,0.8,2.95,0,0.8,0,,,,94.1,3.91,1.99,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B04,1.3,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,94.39,-5.61,,,100,6,,0.0445,31.4,61.1,7.5,-35.4,,,,,,68,69.4,90853,8961,1123,362,42,10,2,0,,106872,20664,3666,1432,70,7,0,0,,,,,,,,94.3,0.84,4.85,-2,0.8,1,,,,94,3.5,2.49,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B05,1.31,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,100,0,,,99.79,5.8,,0.0435,36.2,55.2,8.6,-30.6,,,,,,66.4,65.4,105993,28146,1847,310,30,9,0,0,,3227,207,38,22,8,5,1,0,,,,,,,,84,0.8,15.23,-13,0.8,12,,,,94.1,4.03,1.92,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B06,1.3,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,98.26,-1.74,,,94.72,0.7,,0.0427,30.8,61.7,7.5,-36,,,,,,66.6,70,73538,4680,229,107,15,2,0,0,,2454,241,53,28,6,1,0,0,,,,,,,,81.7,0.84,17.45,-15,0.8,14,,,,94,3.67,2.3,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B07,1.3,,NB-ferguhei-5069961-0004,6.8,Acetate,0,0,0,0,0,,,,50.84,-49.16,,,100,6,,0.0433,23.8,69.3,6.9,-43,,,,,,66.8,70.2,25536,862,202,99,18,6,1,0,,919,207,60,24,3,1,1,1,,,,,,,,81.3,0.81,17.91,-15,0.8,15,,,,93,4.6,2.36,-2,1,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B08,1.3,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,84.33,-15.67,,,99.49,5.5,,0.0457,42.2,37.8,20,-24.6,,,,,,62.4,59,3255,755,215,106,26,10,0,0,,2351,447,78,34,9,5,0,0,,,,,,,,95.1,0.66,4.19,-1,0.6,1,,,,92.3,6.42,1.33,-2,3,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B09,1.3,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,100,0,,,100,6,,0.0462,44.6,41.7,13.7,-22.2,,,,,,64.8,63.8,5580,1571,397,213,59,16,0,0,,3768,784,153,82,27,7,0,0,,,,,,,,94.5,0.75,4.71,-2,0.7,1,,,,93.7,4.75,1.53,-1,1,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B10,1.3,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,92.17,-7.83,,,100,6,,0.0532,40.7,49.7,9.6,-26.1,,,,,,63.6,64.8,9597,2465,745,373,97,26,0,0,,18812,567,128,71,7,0,0,0,,,,,,,,94.1,0.86,5.08,-3,0.8,2,,,,93.7,4.61,1.65,-1,1,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,B11,1.29,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,100,0,,,96.6,2.6,,0.0498,34.7,55.9,9.4,-32.1,,,,,,67.8,70,102949,10193,1863,787,152,48,7,5,,42644,2465,223,105,28,7,1,0,,,,,,,,94,0.9,5.08,-3,0.9,2,,,,94.2,4.24,1.56,-1,0,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C02,1.31,,NB-ferguhei-5069961-0004,5,Histidine,0,50,0,0,0,,,,98.32,-1.68,,,100,6,,0.043,35,30.45,34.55,-31.8,,,,,,62.6,64,19597,2155,955,602,207,89,5,0,,53714,6264,363,85,8,3,0,0,,,,,,,,86.3,0.73,13.01,-10,0.7,10,,,,94.3,4.11,1.64,0,0,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C03,1.3,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0,0,0,,,,90.56,-9.44,,,100,6,,0.0435,34.2,29.33,36.47,-32.6,,,,,,66.6,66.8,94843,6157,1096,676,213,70,4,1,,625,84,21,11,4,2,0,0,,,,,,,,85,0.79,14.25,-12,0.7,11,,,,93.5,4.52,2.03,-1,1,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C04,1.31,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0,0,0,,,,78,-22,,,100,6,,0.0454,32.5,29.65,37.85,-34.3,,,,,,67.6,69.6,94832,8935,1180,651,196,57,2,0,,1387,135,29,15,5,1,0,0,,,,,,,,85,0.8,14.21,-12,0.8,11,,,,93.3,4.39,2.36,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C05,1.29,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0,0,0,,,,99.54,-0.46,,,97.98,4,,0.044,36.2,54.8,9,-30.6,,,,,,66.8,67,73679,5542,1340,836,267,89,5,1,,813,152,55,35,13,7,2,0,,,,,,,,81.4,0.79,17.87,-15,0.7,14,,,,94.5,3.79,1.74,0,0,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C06,1.3,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0,0,0,,,,95.25,-4.75,,,100,6,,0.0438,24.6,63.4,12,-42.2,,,,,,66.8,69.8,60240,3701,1381,858,299,103,8,1,,983,125,24,12,3,2,0,0,,,,,,,,80,0.82,19.16,-17,0.8,16,,,,93.5,4.36,2.1,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C07,1.29,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0,0,0,,,,48.27,-51.73,,,100,6,,0.0443,23.9,68.4,7.7,-42.9,,,,,,67,68.2,19376,3067,1383,926,325,108,3,0,,599,73,18,10,6,4,1,1,,,,,,,,79.8,0.79,19.38,-17,0.7,16,,,,93.8,3.59,2.57,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C08,1.3,,NB-ferguhei-5069961-0004,5,Histidine,0,50,0,0,0,,,,57.19,-42.81,,,98.26,4.2,,0.0473,31.3,25.8,42.9,-35.5,,,,,,59.2,69.4,76078,3904,1520,917,277,93,1,0,,32526,883,94,41,7,3,1,1,,,,,,,,92.8,0.82,6.41,-4,0.8,3,,,,87.8,5.73,6.46,-7,2,5,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C09,1.29,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0,0,0,,,,65.39,-34.61,,,100,6,,0.0463,43.4,39.8,16.8,-23.4,,,,,,61.6,59.8,97941,8643,1844,1104,352,102,5,1,,26042,3399,97,30,6,2,0,0,,,,,,,,90.1,0.78,9.13,-6,0.7,6,,,,93.3,4.59,2.15,-1,1,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C10,1.29,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0,0,0,,,,91.3,-8.7,,,94.01,0,,0.0516,41.3,48,10.7,-25.5,,,,,,66,67.4,84628,6224,1686,1046,354,112,4,0,,8617,287,32,16,2,2,1,0,,,,,,,,85.2,0.81,13.96,-11,0.8,11,,,,94.4,3.8,1.77,0,0,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,C11,1.26,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0,0,0,,,,98.64,-1.36,,,99.97,5.9,,0.0511,38.2,51.5,10.3,-28.6,,,,,,66.8,68.4,77647,4896,1507,898,279,92,3,0,,3954,413,49,25,9,5,0,0,,,,,,,,83.3,0.81,15.89,-13,0.8,13,,,,94.7,3.58,1.7,0,0,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D02,1.32,,NB-ferguhei-5069961-0004,5,Histidine,0,150,0,0,0,,,,77.28,-22.72,,,100,6,,0.0426,,,,,,,,,,61.8,61.8,67914,3515,1026,676,197,76,2,0,,7355,140,18,12,2,1,0,0,,,,,,,,82,0.76,17.27,-15,0.7,14,,,,92.9,4.13,3.01,-2,0,2,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D03,1.3,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0,0,0,,,,39.97,-60.03,,,89.64,-4.4,,0.0431,,,,,,,,,,62.2,66.6,37780,2482,1034,637,211,81,7,2,,941,73,25,19,8,3,0,0,,,,,,,,78.8,0.81,20.37,-18,0.8,17,,,,93.4,4.33,2.31,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D04,1.3,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0,0,0,,,,68.17,-31.83,,,96.86,2.8,,0.0437,,,,,,,,,,67,68.2,12190,2774,1222,728,261,98,4,0,,529,72,16,8,2,2,0,0,,,,,,,,80,0.81,19.16,-17,0.8,16,,,,93.5,3.98,2.51,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D05,1.32,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0,0,0,,,,76.71,-23.29,,,98.63,4.6,,0.0435,,,,,,,,,,65.4,63.4,77056,3106,1336,856,309,101,2,0,,2890,133,27,16,6,5,1,0,,,,,,,,78.2,0.73,21.03,-18,0.7,18,,,,93.3,4.3,2.41,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D06,1.3,,NB-ferguhei-5069961-0004,6.2,Phosphate,0,150,0,0,0,,,,11.93,-88.07,,,99.84,5.8,,0.0428,,,,,,,,,,66.8,67.8,59324,3281,1406,925,360,146,9,1,,580,109,17,9,4,1,0,0,,,,,,,,76.3,0.73,22.95,-20,0.7,20,,,,93.9,3.88,2.22,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D07,1.31,,NB-ferguhei-5069961-0004,6.8,Phosphate,0,150,0,0,0,,,,100,0,,,100,6,,0.0419,,,,,,,,,,66.2,69.4,53944,3133,1279,805,269,101,2,1,,774,86,22,13,3,3,0,0,,,,,,,,76.9,0.75,22.36,-20,0.7,19,,,,93.7,3.83,2.51,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D08,1.3,,NB-ferguhei-5069961-0004,5,Phosphate,0,150,0,0,0,,,,1.72,-98.28,,,99.03,5,,0.0503,,,,,,,,,,56.8,56.8,128536,3971,1539,989,328,104,5,1,,14469,81,5,4,0,0,0,0,,,,,,,,91.1,1.1,7.82,-5,1.1,4,,,,67.5,6.73,25.78,-27,3,24,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D09,1.31,,NB-ferguhei-5069961-0004,5.6,Phosphate,0,150,0,0,0,,,,97.59,-2.41,,,100,6,,0.0465,,,,,,,,,,61.4,60.4,87756,3824,1617,963,313,96,2,0,,13144,231,9,5,2,1,0,0,,,,,,,,83.3,0.71,16.04,-13,0.7,13,,,,91.9,3.49,4.61,-3,0,3,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D10,1.3,,NB-ferguhei-5069961-0004,6.2,Phosphate,0,150,0,0,0,,,,100,0,,,98.52,4.5,,0.0522,,,,,,,,,,61.4,65.8,78794,3700,1553,970,326,122,7,0,,568,120,41,22,4,3,0,0,,,,,,,,78.1,0.77,21.15,-18,0.7,18,,,,94.6,3.1,2.29,0,-1,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,D11,1.32,,NB-ferguhei-5069961-0004,6.8,Phosphate,0,150,0,0,0,,,,100,0,,,100,6,,0.0524,,,,,,,,,,61.4,66.8,52427,3655,1471,916,285,98,6,1,,574,115,31,23,11,6,3,0,,,,,,,,76.9,0.77,22.37,-20,0.7,19,,,,94.1,3.75,2.14,-1,0,1,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,E02,1.26,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,100,0,,,99.96,5.94,,0.0441,34.8,56.8,8.4,-32,,,,,,64.8,66.4,133515,5796,1229,570,105,42,2,1,,4965,1777,828,551,191,100,12,5,,,,,,,,93.4,0.77,5.86,-3.2,0.72,2.47,,,,93.9,4.13,1.97,-0.81,0.23,0.59,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,E03,1.29,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,100,0,,,100,5.98,,0.0447,36.8,54.5,8.7,-30,,,,,,67.2,70,42251,992,292,180,53,23,2,0,,13193,645,143,76,20,9,0,0,,,,,,,,84.7,0.78,14.56,-11.9,0.73,11.17,,,,94.7,3.23,2.08,-0.03,-0.67,0.7,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,E04,1.3,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,100,0,,,99.9,5.88,,0.0463,44.7,32.46,23,-22.1,,,,,,62.8,62.4,151111,10033,576,283,70,26,4,0,,11942,1504,499,369,200,108,7,2,,,,,,,,95.5,0.68,3.82,-1.1,0.63,0.43,,,,94.1,4.24,1.7,-0.66,0.34,0.32,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,E05,1.28,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,96.35,-3.65,,,100,5.98,,0.0455,45.7,39.7,14.6,-21.1,,,,,,67.4,65,55553,2971,1051,576,167,60,4,1,,5834,1025,224,119,36,11,1,0,,,,,,,,95,0.72,4.24,-1.5,0.67,0.85,,,,94.2,4.02,1.75,-0.49,0.12,0.37,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50,10,E06,1.29,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,100,0,,,99.66,5.64,,0.0476,45.2,41,13.8,-21.6,,,,,,68,65.2,156600,13898,477,228,41,9,2,0,,19056,1928,445,276,110,47,5,2,,,,,,,,95.3,0.7,3.97,-1.2,0.65,0.58,,,,94.1,4.37,1.56,-0.65,0.47,0.18,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,5,0,H02,1.29028777,,NB-ferguhei-5069961-0004,6.5,Water,0,0,0,0,0,,,,83.91,-16.09,,,90.95,-3.1,,0.0383,66.9,26.2,6.9,0.1,,,,,,66.6,66,135418,2237,564,287,65,14,0,0,,135240,30973,6372,2618,430,85,10,2,,,,,,,,96.6,0.04,3.41,0,0,0,,,,94.8,3.54,1.62,0,0,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,-80,0,H03,1.270215827,,NB-ferguhei-5069961-0004,6.5,Histidine,0,0,0,0,0,,,,100,0,,,94.02,0,,0.04,66.8,25.5,7.7,0,,,,,,68.6,68.8,177759,16097,1085,471,67,8,0,0,,24101,4859,1080,460,33,3,0,0,,,,,,,,96.6,0.05,3.39,0,0,0,,,,94.7,3.9,1.38,0,0,0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,0,0,0,0,,,,81.18,-3.18,,,99.86,-0.09,,0.0425,41.8,48.04,10.16,-19.1,,,,,,64,,116439,7026.9,835.7,358.2,119.4,51.2,0,0,,1178887.7,4980.3,849.9,509.9,153,51,17,0,,,,,,,,98.6,1.15,0.22,0.3,-0.45,0.18,,,,96.6,1.48,1.94,-0.02,0.92,1.12,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,0,0,0,0,,,,82.82,-1.54,,,99.92,-0.03,,0.0439,43,48.2,8.79,-17.9,,,,,,66.4,,104017.2,4264,526.6,271.8,101.9,51,0,0,,1145917.1,6117.3,1461.3,662.7,186.9,51,17,0,,,,,,,,97.7,2.19,0.13,-0.7,0.59,0.09,,,,96.2,1.36,2.44,-0.02,0.8,1.62,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,0,0,0,0,,,,82.91,-1.45,,,99.92,-0.03,,0.0453,38.1,52.78,9.15,-22.9,,,,,,68,,19077.4,2189.5,746.8,526.2,237.6,220.6,186.7,186.7,,914232.3,4909.8,1019.3,475.7,135.9,51,0,0,,,,,,,,98.4,1.16,0.26,0.1,-0.44,0.22,,,,96.1,1.32,2.62,-0.03,0.76,1.8,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,0,0,0,0,,,,93.85,9.49,,,99.88,-0.07,,0.045,36.8,54.61,8.6,-24.1,,,,,,66.4,,11184.6,1765.1,441.3,186.7,67.9,17,0,0,,149026.4,6484.6,2020.1,1188.3,492.3,152.8,50.9,34,,,,,,,,98.5,1.3,0.19,0.2,-0.3,0.15,,,,95.7,1.08,3.18,-0.03,0.52,2.36,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,0,0,0,0,,,,94.48,10.12,,,99.89,-0.07,,0.0448,34.8,57.82,7.39,-26.1,,,,,,66.6,,14137.9,2138.5,339.4,220.6,84.9,50.9,17,0,,33928.2,6823,2376.2,1663.3,526.1,186.7,0,0,,,,,,,,98.2,1.66,0.17,-0.2,0.06,0.13,,,,95.6,1.18,3.21,-0.03,0.62,2.39,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,0,0,0,0,,,,91.32,6.96,,,99.88,-0.07,,0.0457,30.3,63.7,6.05,-30.7,,,,,,66.8,,15258.6,2579.9,577.1,356.4,135.8,67.9,33.9,33.9,,70811.4,8826,1714.3,831.7,237.6,84.9,33.9,0,,,,,,,,98.2,1.6,0.19,-0.1,0,0.15,,,,94.9,1.09,4.02,-0.04,0.53,3.2,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,0,0,0,0,,,,89.82,5.46,,,99.72,-0.23,,0.05,34,19.31,46.71,-27,,,,,,62.4,,11337.3,2528.8,424.3,118.8,33.9,0,0,0,,32977.8,3784.9,746.8,441.3,135.8,17,0,0,,,,,,,,98.4,1.48,0.12,0.1,-0.12,0.08,,,,96.5,1.22,2.33,-0.02,0.66,1.51,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,0,0,0,0,,,,89.19,4.83,,,99.81,-0.14,,0.0477,34.7,17.76,47.53,-26.2,,,,,,64.8,,10319,2053.6,560.1,373.4,186.7,84.9,0,0,,56725.9,3174.1,746.8,339.5,118.8,67.9,0,0,,,,,,,,98.1,1.87,0.07,-0.3,0.27,0.03,,,,97.2,1.08,1.69,-0.01,0.52,0.87,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,0,0,0,0,,,,83.05,-1.31,,,99.94,-0.01,,0.0503,33.9,18.75,47.32,-27,,,,,,63.6,,43585.4,2732.6,458.3,203.7,50.9,33.9,0,0,,54551.1,4260.2,814.7,492.2,118.8,33.9,0,0,,,,,,,,98.6,1.32,0.08,0.3,-0.28,0.04,,,,97.4,1.09,1.51,-0.01,0.53,0.69,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,B11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,0,0,0,0,,,,83.6,-0.76,,,99.91,-0.04,,0.0471,32,18.9,49.08,-28.9,,,,,,67.8,,208217.4,3208.3,560.2,254.6,67.9,50.9,17,0,,238501.7,6925.9,984.6,543.2,152.8,34,0,0,,,,,,,,98.6,1.33,0.07,0.3,-0.27,0.03,,,,97.3,1.08,1.59,-0.01,0.52,0.77,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,50,0,0,0,,,,88.41,4.04,,,99.83,-0.12,,0.0435,64.7,30.45,4.85,3.8,,,,,,62.6,,34970,2801,814.8,526.2,186.7,101.9,0,0,,201539.6,4023.3,1290.2,763.9,169.8,84.9,0,0,,,,,,,,98.4,1.51,0.12,0,-0.09,0.08,,,,93.9,1.42,4.7,-0.05,0.86,3.88,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,50,0,0,0,,,,87.98,3.62,,,99.9,-0.05,,0.0443,66.6,29.33,4.11,5.6,,,,,,66.6,,11965.2,2545.8,967.4,577,203.7,101.8,0,0,,137327.7,5465.9,1629.6,1154.3,305.5,118.8,33.9,17,,,,,,,,98.5,1.38,0.13,0.1,-0.22,0.09,,,,94.8,1.44,3.78,-0.04,0.88,2.96,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,50,0,0,0,,,,91.21,6.85,,,99.9,-0.05,,0.0459,65.8,29.65,4.54,4.9,,,,,,67.6,,8231.4,1476.6,305.5,254.6,118.8,33.9,0,0,,137193.5,3972.2,1273.1,848.8,237.7,101.9,0,0,,,,,,,,98.4,1.51,0.12,0,-0.09,0.08,,,,94.8,1.46,3.73,-0.04,0.9,2.91,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,50,0,0,0,,,,92.06,7.69,,,99.79,-0.16,,0.0461,28,66.81,5.19,-32.9,,,,,,66.8,,8214.4,1765.1,560.1,407.3,186.7,33.9,17,0,,179754.4,4006.2,1595.7,882.7,305.6,135.8,17,0,,,,,,,,97.4,2.4,0.16,-0.9,0.8,0.12,,,,94.7,1.33,3.96,-0.04,0.77,3.14,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,50,0,0,0,,,,91.88,7.52,,,99.86,-0.09,,0.0454,29.2,65.55,5.27,-31.8,,,,,,66.8,,7841.1,1748.1,594,407.3,118.8,33.9,0,0,,221559.4,5381.5,1935.3,1120.4,356.5,118.8,17,0,,,,,,,,96.9,1.3,0.17,-1.5,-0.3,0.13,,,,94.4,1.52,4.07,-0.04,0.96,3.25,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,50,0,0,0,,,,92.49,8.13,,,99.74,-0.21,,0.046,26.7,69.02,4.25,-34.2,,,,,,67,,7247,1663.2,390.4,271.6,84.9,84.9,0,0,,223646.7,2020.2,662.1,390.5,50.9,34,0,0,,,,,,,,97.4,2.49,0.16,-1,0.89,0.12,,,,94.2,1.27,4.53,-0.04,0.71,3.71,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,50,0,0,0,,,,92.25,7.88,,,99.48,-0.47,,0.0488,39.2,24.04,36.74,-21.7,,,,,,59.2,,8655.7,2342.1,746.8,577,288.5,67.9,17,0,,167019.2,4566.3,1476.8,848.8,152.8,84.9,0,0,,,,,,,,97.7,2.15,0.17,-0.7,0.55,0.13,,,,90.3,1.38,8.32,-0.08,0.82,7.5,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,50,0,0,0,,,,91.66,7.3,,,99.76,-0.19,,0.0482,41.6,22.9,35.53,-19.4,,,,,,61.6,,9266.7,2070.6,695.8,407.3,152.7,50.9,17,0,,83002.3,4226.5,1256.1,695.9,220.7,50.9,0,0,,,,,,,,98,1.91,0.11,-0.4,0.31,0.07,,,,95,1.08,3.9,-0.04,0.52,3.08,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,50,0,0,0,,,,83.88,-0.48,,,99.93,-0.02,,0.0524,38.9,23.52,37.63,-22.1,,,,,,66,,8214.5,3071.9,1120.2,916.5,458.2,220.6,50.9,17,,100402.7,4362.4,1714.4,1086.4,339.5,101.8,17,0,,,,,,,,97.9,2,0.08,-0.4,0.4,0.04,,,,96.3,1,2.67,-0.02,0.44,1.85,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,C11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,50,0,0,0,,,,88.24,3.87,,,99.89,-0.06,,0.0483,36,22.07,41.9,-24.9,,,,,,66.8,,607742.4,97945.7,458.8,339.9,203.9,169.9,0,0,,93816.1,7434.7,2172.7,1290,373.4,169.7,17,17,,,,,,,,97.9,2.02,0.07,-0.4,0.42,0.03,,,,96.6,0.98,2.47,-0.02,0.42,1.65,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,150,0,0,0,,,,97.56,13.2,,,100,0.05,,0.0427,,,,,,,,,,61.8,,27292.1,5128.9,1630.4,1120.9,424.6,203.8,67.9,67.9,,450004.3,32645.4,11787.7,6709.1,1189,288.7,67.9,34,,,,,,,,97.7,2.13,0.16,-0.6,0.53,0.12,,,,90.1,1.44,8.5,-0.09,0.88,7.68,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,150,0,0,0,,,,94.28,9.92,,,99.92,-0.03,,0.0453,,,,,,,,,,62.2,,16057.1,3564.5,1459.7,1154.2,865.7,712.9,577.1,577.1,,473302.5,10322.8,3158,1782.7,543.3,135.8,34,34,,,,,,,,97.2,2.66,0.13,-1.1,1.06,0.09,,,,93.3,1.42,5.29,-0.05,0.86,4.47,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,150,0,0,0,,,,96.66,12.3,,,99.92,-0.03,,0.0455,,,,,,,,,,67,,8282.4,1697.2,475.2,288.5,152.7,67.9,17,17,,448740.2,11859.5,2820.4,1716.1,611.7,407.8,288.8,237.9,,,,,,,,97.5,2.37,0.13,-0.8,0.77,0.09,,,,93.7,1.46,4.81,-0.05,0.9,3.99,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,150,0,0,0,,,,94.96,10.59,,,99.91,-0.04,,0.0453,,,,,,,,,,65.4,,11710.7,2189.4,594,390.4,118.8,33.9,0,0,,775194.9,3922.8,934,509.4,17,0,0,0,,,,,,,,97.5,2.38,0.18,-0.9,0.78,0.14,,,,93.3,1.35,5.34,-0.05,0.79,4.52,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,150,0,0,0,,,,94.57,10.2,,,99.89,-0.07,,0.0439,,,,,,,,,,66.8,,10675.5,1510.5,560.1,373.4,118.8,50.9,0,0,,911271.3,8803.7,2141.4,1257.7,305.9,119,0,0,,,,,,,,97,2.85,0.16,-1.4,1.25,0.12,,,,93.5,1.8,4.72,-0.05,1.24,3.9,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,150,0,0,0,,,,93.96,9.6,,,99.89,-0.07,,0.0438,,,,,,,,,,66.2,,9385.5,1951.8,628,373.4,67.9,33.9,0,0,,561308.9,2207.3,832,628.2,407.5,237.7,169.8,135.8,,,,,,,,96.9,2.97,0.16,-1.5,1.37,0.12,,,,93.5,1.7,4.81,-0.05,1.14,3.99,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,150,0,0,0,,,,93.58,9.22,,,99.36,-0.59,,0.0505,,,,,,,,,,56.8,,9725,2189.4,950.4,644.9,271.6,118.8,17,0,,943523.6,7115.4,2037.8,1358.5,339.6,169.8,0,0,,,,,,,,97.5,2.27,0.19,-0.8,0.67,0.15,,,,80.6,1.54,17.82,-0.18,0.98,17,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,150,0,0,0,,,,95.62,11.26,,,100,0.05,,0.0481,,,,,,,,,,61.4,,8536.9,2274.3,865.6,577,288.5,84.9,0,0,,370497.1,4312.4,1205.4,747,254.7,135.8,17,0,,,,,,,,97.8,2.13,0.11,-0.6,0.53,0.07,,,,92.3,1.14,6.53,-0.06,0.58,5.71,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,150,0,0,0,,,,97.25,12.89,,,99.92,-0.03,,0.0526,,,,,,,,,,64.6,,6873.7,1866.9,780.7,407.3,135.8,101.8,33.9,0,,201148.5,6620.6,2376.6,1409,543.2,118.8,17,0,,,,,,,,97.7,2.17,0.1,-0.6,0.57,0.06,,,,94.8,1.04,4.12,-0.04,0.48,3.3,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50,10,D11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,150,0,0,0,,,,94.32,9.96,,,99.92,-0.03,,0.0502,,,,,,,,,,66.8,,10149.2,2596.7,712.8,526.1,339.4,186.7,33.9,0,,174248.4,3922.4,1137.7,628.3,288.7,101.9,34,17,,,,,,,,97.9,2.03,0.1,-0.5,0.43,0.06,,,,95.4,1.01,3.62,-0.03,0.45,2.8,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,5,0,H02,1.232278481,,NB-ferguhei-5069961-0003,5.5,Acetate,0,0,0,0,0,,,,84.36,0,,,99.95,0,,0.0383,60.9,24.87,14.2,0,,,,,,66.6,,447194.5,50264,1022.7,750,545.4,511.3,477.2,477.2,,1083749.6,16347.3,2432.5,1462.9,527.3,255.2,221.1,221.1,,,,,,,,98.4,1.6,0.04,0,0,0,,,,98.6,0.56,0.82,0,0,0,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,0,0,0,0,,,,99.46,-0.54,,,99.88,-0.07,,0.0424,36.3,55.24,8.46,-25.4,,,,,,64.6,,12762.9,3224.7,1018.3,611,288.5,118.8,0,0,,283973,4346.1,1392.1,933.7,458.4,135.8,0,0,,,,,,,,96.4,2.59,0.97,-1.1,0.78,0.36,,,,97.4,1.43,1.19,-0.02,1.15,0.35,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,0,0,0,0,,,,99.46,-0.54,,,99.89,-0.06,,0.0435,38.4,53.4,8.17,-23.3,,,,,,67.8,,11999.3,3292.6,1154.1,628,254.6,33.9,17,0,,267006.9,4244.1,1171.4,730,305.6,101.9,0,0,,,,,,,,96.2,2.63,1.13,-1.3,0.82,0.52,,,,97.1,1.31,1.62,-0.02,1.03,0.78,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,0,0,0,0,,,,99.14,-0.86,,,99.87,-0.07,,0.0457,38.1,54.33,7.61,-23.6,,,,,,68,,11252.4,2817.3,780.7,458.2,118.8,67.9,0,0,,299660.4,3955.6,1052.6,407.4,186.7,67.9,17,0,,,,,,,,96.2,2.75,1.09,-1.4,0.94,0.48,,,,97.1,1.24,1.62,-0.02,0.96,0.78,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,0,0,0,0,,,,99.26,-0.74,,,99.86,-0.08,,0.0449,33.7,60.76,5.57,-28,,,,,,67,,8163.5,2291.2,797.7,509.2,169.7,50.9,17,17,,110063.5,2766.9,831.8,509.2,169.7,118.8,33.9,17,,,,,,,,96.1,2.76,1.1,-1.4,0.95,0.49,,,,97.4,1,1.56,-0.01,0.72,0.72,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,0,0,0,0,,,,99.79,-0.21,,,99.85,-0.1,,0.0441,31.9,62.5,5.56,-29.8,,,,,,65,,9283.7,2698.5,1035.3,695.9,169.7,67.9,0,0,,84632.9,2478.2,814.8,424.4,186.7,84.9,0,0,,,,,,,,95.9,2.92,1.2,-1.7,1.11,0.59,,,,97.2,1.11,1.68,-0.02,0.83,0.84,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,0,0,0,0,,,,100,0,,,99.81,-0.14,,0.0441,29.3,65.89,4.78,-32.4,,,,,,68.8,,8316.2,2138.5,577,339.4,101.8,50.9,0,0,,65110.8,2121.7,560.1,237.6,67.9,17,17,17,,,,,,,,95.6,3.12,1.26,-2,1.31,0.65,,,,97.3,1.09,1.65,-0.02,0.81,0.81,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,0,0,0,0,,,,99.5,-0.5,,,99.67,-0.28,,0.0481,36.4,18.77,44.81,-25.3,,,,,,61.4,,11642.7,4327.8,1697.2,1120.1,356.4,135.8,0,0,,149262.2,4583.3,1035.5,458.3,152.8,50.9,0,0,,,,,,,,96.6,2.47,0.91,-1,0.66,0.3,,,,97.5,1.21,1.3,-0.01,0.93,0.46,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,0,0,0,0,,,,99.64,-0.36,,,99.82,-0.12,,0.0476,36,17.82,46.17,-25.7,,,,,,65.4,,182003.4,6060,1833.3,1035.5,271.6,84.9,0,0,,295729,4719.4,1307.2,645.1,152.8,67.9,0,0,,,,,,,,96.7,2.34,0.97,-0.9,0.53,0.36,,,,97.9,0.98,1.11,-0.01,0.7,0.27,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,0,0,0,0,,,,99.86,-0.14,,,99.87,-0.08,,0.052,35.3,19.66,45,-26.4,,,,,,68,,12813.8,4463.6,2036.6,1374.7,509.2,203.7,17,0,,188600.1,6348.9,2359.6,1595.7,526.2,305.6,50.9,0,,,,,,,,96.3,2.4,1.29,-1.3,0.59,0.68,,,,98,0.96,1.07,-0.91,0.68,0.23,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,E11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,0,0,0,0,,,,96.73,-3.27,,,99.88,-0.07,,0.0469,34,20.13,45.88,-27.7,,,,,,68.8,,12576.2,4073.3,1222,729.8,339.4,152.7,0,0,,305333.7,6230.6,1477,797.9,152.8,67.9,17,0,,,,,,,,96.8,2.17,1.01,-0.8,0.36,0.4,,,,98,0.9,1.08,-0.85,0.62,0.24,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,50,0,0,0,,,,99.8,-0.2,,,99.78,-0.16,,0.0421,33.4,60.58,5.99,-28.3,,,,,,64.8,,89823.9,5280.8,2054.6,1477.3,645.2,373.6,17,0,,289068.4,8675.3,2886.1,1833.5,780.9,288.6,17,0,,,,,,,,96.4,2.72,0.9,-1.2,0.91,0.29,,,,97.1,1.36,1.52,-1.77,1.08,0.68,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,50,0,0,0,,,,99.8,-0.2,,,99.85,-0.1,,0.0433,33.7,60.36,5.98,-28,,,,,,67.2,,15597.7,4871.1,2053.7,1357.8,492.2,186.7,17,17,,223528.1,9133.3,2699.2,1629.7,611.1,220.7,67.9,50.9,,,,,,,,96.2,2.76,1.01,-1.4,0.95,0.4,,,,97,1.35,1.68,-1.91,1.07,0.84,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,50,0,0,0,,,,99.38,-0.62,,,99.85,-0.09,,0.0462,63,32.46,5,1.3,,,,,,62.8,,12185.9,3733.8,1476.6,933.5,407.3,169.7,17,0,,488781.8,5195.3,1069.6,713.1,305.6,135.8,17,0,,,,,,,,96.2,2.77,1.03,-1.4,0.96,0.42,,,,97.1,1.37,1.52,-1.77,1.09,0.68,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,50,0,0,0,,,,99.81,-0.19,,,99.85,-0.1,,0.0449,30.2,64.61,5.24,-31.5,,,,,,67.4,,12864.7,4293.9,1799,1069.2,475.2,67.9,0,0,,536908.5,4363.5,1001.7,611.2,237.7,101.9,17,17,,,,,,,,96.1,2.9,1.02,-1.5,1.09,0.41,,,,97.2,1.23,1.61,-1.72,0.95,0.77,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,50,0,0,0,,,,99.76,-0.24,,,99.82,-0.12,,0.045,30.8,64.48,4.71,-30.9,,,,,,68,,12712.1,4395.8,2138.5,1425.7,661.9,373.4,50.9,0,,117635,4040,2003,1442.9,729.9,339.5,33.9,0,,,,,,,,95.8,3.11,1.07,-1.8,1.3,0.46,,,,97,1.48,1.57,-1.92,1.2,0.73,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,50,0,0,0,,,,99.32,-0.68,,,99.82,-0.12,,0.0453,28.5,67.65,3.84,-33.2,,,,,,68.2,,15512.4,5872.3,2681.6,1680.2,763.7,254.6,0,0,,87161.9,3072.3,1357.9,1018.4,373.4,101.8,0,0,,,,,,,,95.6,3.27,1.1,-1.9,1.46,0.49,,,,97.1,1.26,1.63,-1.77,0.98,0.79,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,50,0,0,0,,,,99.19,-0.81,,,99.29,-0.66,,0.0499,37.7,24.34,37.93,-24,,,,,,59.6,,15105.2,5176.5,2070.6,1425.7,594,220.6,0,0,,263849.4,8725.9,2903,1646.7,475.3,237.7,17,0,,,,,,,,96.4,2.7,0.86,-1.1,0.89,0.25,,,,96.4,1.42,2.23,-2.53,1.14,1.39,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,50,0,0,0,,,,97.08,-2.92,,,99.72,-0.23,,0.0486,39,22.32,38.7,-22.7,,,,,,62.6,,13221.2,4599.4,2189.4,1493.5,746.8,373.4,50.9,0,,189991.7,8606.7,2631.2,1697.6,662.1,254.6,0,0,,,,,,,,96.5,2.58,0.92,-1.1,0.77,0.31,,,,97.6,1.02,1.42,-1.32,0.74,0.58,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,50,0,0,0,,,,99.85,-0.15,,,99.85,-0.09,,0.0523,37.1,23.61,39.31,-24.6,,,,,,66.4,,11710.6,4514.5,2019.7,1612.3,899.5,390.4,33.9,17,,95768.9,6263.5,2563.1,1816.2,628,237.6,50.9,33.9,,,,,,,,96.4,2.6,0.98,-1.2,0.79,0.37,,,,97.9,0.92,1.23,-1.02,0.64,0.39,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,F11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,50,0,0,0,,,,99.85,-0.15,,,99.85,-0.09,,0.0484,37.2,23.27,39.54,-24.5,,,,,,68.2,,29545.7,5756.3,2326.3,1681.1,594.3,356.6,0,0,,49409.1,3445.6,1374.8,933.5,543.1,305.5,17,0,,,,,,,,96.5,2.42,1.12,-1.1,0.61,0.51,,,,98,0.83,1.12,-0.84,0.55,0.28,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,150,0,0,0,,,,99.7,-0.3,,,99.73,-0.21,,0.0422,,,,,,,,,,63,,500871,61942.1,2531.4,1546,560.6,237.8,34,17,,636338.3,38186.8,3463.8,1850.8,645.2,356.6,101.9,17,,,,,,,,96.4,2.7,0.89,-1.2,0.89,0.28,,,,96.6,1.41,1.96,-2.25,1.13,1.12,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,150,0,0,0,,,,99.79,-0.21,,,99.83,-0.11,,0.0433,,,,,,,,,,65.8,,270493.5,6431,2024.6,1378.1,731.6,425.3,306.2,289.2,,2432216.3,28342.9,3995.5,2210.3,765.1,272,34,34,,,,,,,,96.5,2.7,0.78,-1.1,0.89,0.17,,,,97.1,1.29,1.64,-1.81,1.01,0.8,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,150,0,0,0,,,,99.78,-0.22,,,99.82,-0.12,,0.0437,,,,,,,,,,67.8,,31966.3,5469.3,2004.3,1477.7,832.3,509.6,322.7,305.7,,860421.8,10788.2,3194,1783.9,611.6,220.9,101.9,84.9,,,,,,,,96.1,2.95,1,-1.5,1.14,0.39,,,,97.1,1.31,1.55,-1.74,1.03,0.71,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,150,0,0,0,,,,99.8,-0.2,,,99.81,-0.14,,0.0449,,,,,,,,,,64.8,,40819.2,4448.7,1409.3,1069.7,441.5,237.7,34,0,,984927.2,6642.1,2242.3,1579.8,526.6,305.8,17,17,,,,,,,,96.2,2.86,0.97,-1.4,1.05,0.36,,,,97.2,1.23,1.58,-1.69,0.95,0.74,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,150,0,0,0,,,,98.04,-1.96,,,99.82,-0.13,,0.0438,,,,,,,,,,67.6,,26128.9,5942.3,2207.1,1545,865.9,356.5,169.8,169.8,,678407.8,6895,2598.4,1800.2,628.4,339.7,67.9,50.9,,,,,,,,96,2.96,1.03,-1.6,1.15,0.42,,,,97,1.58,1.47,-1.93,1.3,0.63,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,150,0,0,0,,,,98.83,-1.17,,,99.81,-0.13,,0.0434,,,,,,,,,,68.4,,32298.3,7841.2,3156.8,1816,831.6,441.3,67.9,50.9,,213224.4,6930.3,2089.3,1324.9,492.6,186.8,51,51,,,,,,,,95.9,2.99,1.08,-1.7,1.18,0.47,,,,96.8,1.69,1.56,-2.12,1.41,0.72,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,150,0,0,0,,,,96.02,-3.98,,,99.04,-0.91,,0.0484,,,,,,,,,,58.8,,38836,7179.9,2427.3,1799.2,865.7,373.4,17,0,,445846.6,7083.9,1698.8,985.3,288.8,169.9,68,68,,,,,,,,96.5,2.62,0.83,-1,0.81,0.22,,,,94.7,1.64,3.69,-4.21,1.36,2.85,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,150,0,0,0,,,,99.84,-0.16,,,99.83,-0.11,,0.0482,,,,,,,,,,62.4,,29811.8,6739.9,2190,1527.9,645.1,339.5,17,0,,264989.4,6285.4,1681.8,1155.2,526.6,271.8,101.9,84.9,,,,,,,,96.5,2.54,0.93,-1.1,0.73,0.32,,,,97.3,1.11,1.58,-1.57,0.83,0.74,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,150,0,0,0,,,,100,0,,,99.84,-0.11,,0.0525,,,,,,,,,,61.8,,46188.7,7166,2954.7,2037.7,849.1,475.5,118.9,67.9,,582971.3,5862.5,2141.1,1580.3,577.8,305.9,85,85,,,,,,,,96.8,2.38,0.81,-0.8,0.57,0.2,,,,97.9,0.91,1.24,-1.03,0.63,0.4,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50,10,G11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,150,0,0,0,,,,100,0,,,99.85,-0.09,,0.049,,,,,,,,,,67.4,,122653.7,7184,2734.3,1698.3,730.3,203.8,17,17,,332363.6,6730.6,1716.6,1138.8,509.9,339.9,85,68,,,,,,,,96.9,2.17,0.97,-0.7,0.36,0.36,,,,98.1,0.86,1.08,-0.82,0.58,0.24,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,5,0,H07,1.254620253,,NB-ferguhei-5069961-0003,5.5,Acetate,0,0,0,0,0,,,,100,0,,,99.95,0,,0.0377,61.7,28.04,10.27,0,,,,,,68.6,,370816.4,26832.6,560.4,186.8,101.9,84.9,50.9,34,,610050.8,9907.1,2570.4,1412.9,425.6,187.2,51.1,34,,,,,,,,97.6,1.81,0.61,0,0,0,,,,98.9,0.28,0.84,0,0,0,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B02,1.269,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,96,-4,,,99,-0.59,,0.036,,,,,,,,,,61.2,63.2,21435.7,7382.9,1171.1,390.4,84.9,33.9,33.9,0,,51496,5737,1714,1205,102,17,0,0,,,,,,,,73.3,0.61,26.1,4,-6,-2,,,,93.4,3.08,3.52,-4,2,2,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B03,1.27,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,97,-3,,,99,-0.55,,0.037,,,,,,,,,,68.2,66.2,24813.2,5787.5,1476.6,797.7,254.6,101.8,0,0,,55012,6671,1460,815,255,34,0,0,,,,,,,,73.9,0.62,25.49,5,-6,-3,,,,92.4,4.32,3.33,-5,3,1,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B04,1.27,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,97,-3,,,99,-0.67,,0.038,,,,,,,,,,67.8,64.6,17345.3,3784.7,1018.3,373.4,118.8,33.9,17,0,,48169,4549,475,221,102,51,0,0,,,,,,,,75.3,0.65,24.08,6,-6,-4,,,,90.9,5.05,4.04,-6,4,2,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B05,1.274,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,100,0,,,99,-1.24,,0.038,,,,,,,,,,65.2,67.8,108035.7,5533.3,1171.2,390.4,50.9,17,0,0,,22318,3276,594,305,68,34,17,17,,,,,,,,77.6,0.7,21.66,8,-6,-7,,,,92,2.23,5.76,-5,1,4,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B06,1.275,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,99,-1,,,100,-0.11,,0.038,,,,,,,,,,65,67.4,112686.7,7230.7,1748.3,729.9,50.9,33.9,0,0,,22064,5397,832,441,102,34,0,0,,,,,,,,79,0.7,20.34,10,-6,-8,,,,90.8,2.65,6.53,-6,2,5,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B07,1.284,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,99,-1,,,99,-0.53,,0.038,,,,,,,,,,66.2,68.2,133478,7977.4,1935,780.8,203.7,101.8,33.9,0,,35302,3717,543,272,102,51,0,0,,,,,,,,80.7,0.66,18.65,11,-6,-10,,,,90.1,2.95,6.91,-7,2,5,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B08,1.278,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,99,-1,,,99,-1.04,,0.04,,,,,,,,,,61.2,59.4,20977.4,5295.3,1510.5,797.7,203.7,101.8,50.9,33.9,,31399,7807,1680,883,238,85,0,0,,,,,,,,75.3,0.46,24.2,6,-6,-4,,,,91.3,2.79,5.9,-6,2,4,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B09,1.283,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,100,0,,,99,-0.46,,0.04,,,,,,,,,,63.4,65.2,23319.5,4548.5,1239,644.9,322.5,186.7,0,0,,66141,12067,2800,1494,339,85,34,0,,,,,,,,72.6,0.59,26.81,3,-6,-2,,,,94.1,2.04,3.81,-3,1,2,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B10,1.271,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,100,0,,,,,,0.045,,,,,,,,,,66,67.4,17633.9,4039.3,1018.3,458.2,118.8,50.9,0,0,,26103,5346,1171,577,204,68,0,0,,,,,,,,76.3,0.64,23.03,7,-6,-6,,,,94.6,1.96,3.4,-2,1,1,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,B11,1.253,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,100,0,,,,,,0.043,,,,,,,,,,65.2,68.2,72422.7,7756.5,1273,526.2,84.9,33.9,17,0,,39341,7094,1341,696,272,187,102,0,,,,,,,,75.1,0.67,24.24,6,-6,-4,,,,94.6,1.96,3.41,-2,1,1,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50,10,C02,1.262,,NB-ferguhei-5069961-0004,5.6,Keytruda,0,0,0,0,0,,,,100,0,,,99,-0.49,,0.042,,,,,,,,,,67.2,,462719.5,16908.9,1256.3,509.3,169.8,84.9,34,17,,165287,13222,917,407,68,51,0,0,,,,,,,,61.9,0.17,37.91,-7,-7,9,,,,93.5,2.19,4.27,-3,1,2,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,5,0,H02,1.264,,NB-ferguhei-5069961-0004,5,Water,0,0,0,0,0,,,,100,0,,,100,0,,0.033,,,,,,,,,,72.2,32,1479026.9,194724.6,44047.9,22355.2,6268.3,1800.6,203.8,17,,1424005,510962,39148,11503,1767,408,34,0,,,,,,,,69.4,6.84,28.57,0,0,0,,,,96.9,1.15,1.95,0,0,0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D02,1.271,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,99,0,,,99,-0.47,,0.036,,,,,,,,,,63,64.8,15478.4,2834.3,356.4,135.8,17,17,0,0,,22743,5431,849,373,68,34,0,0,,,,,,,,74.4,0.49,25.12,9,0,-1,,,,92.4,5.33,2.28,-3,4,-1,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D03,1.277,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,97,-2,,,99,-0.76,,0.038,,,,,,,,,,67.8,66.4,15902.7,4344.8,899.5,407.3,84.9,33.9,17,17,,69420,5533,747,306,119,68,0,0,,,,,,,,76.8,0.69,22.55,9,0,-4,,,,91.7,6.54,1.76,-4,5,-1,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D04,1.271,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,98,-2,,,99,-0.76,,0.038,,,,,,,,,,67.6,69.2,17158.6,4361.8,1052.3,424.3,67.9,17,0,0,,27291,5312,815,238,34,17,0,0,,,,,,,,72.6,0.62,26.79,4,0,1,,,,91.2,6.81,2,-4,5,-1,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D05,1.28,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,100,1,,,100,-0.01,,0.038,,,,,,,,,,68.2,66.2,14986.3,3530.2,644.9,254.6,67.9,17,0,0,,13781,3106,798,407,34,17,0,0,,,,,,,,76.7,0.69,22.61,9,0,-4,,,,93.1,4.15,2.8,-2,2,0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D06,1.258,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,99,0,,,100,0,,0.038,,,,,,,,,,68.2,66.2,63342.4,5193.7,1357.8,560.1,101.8,50.9,0,0,,12797,3310,747,322,51,0,0,0,,,,,,,,77.9,0.67,21.4,10,0,-5,,,,92.6,4.61,2.83,-3,3,0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D07,1.262,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,99,0,,,99,-0.82,,0.038,,,,,,,,,,68.6,67.2,97219,7994.1,1884,797.7,67.9,17,0,0,,15156,3836,662,289,34,0,0,0,,,,,,,,77.8,0.67,21.57,10,0,-5,,,,91.7,5.35,2.98,-4,4,0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D08,1.261,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,99,0,,,100,-0.28,,0.04,,,,,,,,,,60,62,40122.2,8554,1289.9,390.4,67.9,0,0,0,,20417,4090,577,238,34,0,0,0,,,,,,,,73,0.46,26.58,5,0,0,,,,92.4,5.04,2.59,-3,3,0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D11,1.253,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,100,1,,,100,-0.19,,0.044,,,,,,,,,,68.6,72.8,194929.6,10983.1,2138.9,899.7,203.7,67.9,17,17,,36762,9284,1765,866,221,68,17,0,,,,,,,,73.6,0.66,25.77,5,0,-1,,,,94.9,3.42,1.71,0,2,-1,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D09,1.28,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,100,1,,,100,0,,0.041,,,,,,,,,,63.4,65,618556.1,111889.1,6688.6,1986.2,288.6,84.9,17,0,,832729,14723,1817,645,85,17,0,0,,,,,,,,73.5,0.59,25.96,5,0,0,,,,94.4,3.65,1.96,-1,2,-1,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,D10,1.26,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,100,1,,,100,-0.12,,0.046,,,,,,,,,,66.2,68.8,22742.6,4073.3,848.6,373.4,67.9,33.9,0,0,,243535,9303,1409,713,119,34,0,0,,,,,,,,72.2,0.67,27.17,4,0,1,,,,94.5,3.63,1.85,-1,2,-1,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50,10,E02,1.274,,NB-ferguhei-5069961-0004,5.6,Keytruda,0,0,0,0,0,,,,100,1,,,100,-0.02,,0.041,,,,,,,,,,,,310232.8,25687.1,3261.9,2208.5,1647.9,1495,1342.1,1308.1,,118026,29311,2767,815,102,51,17,0,,,,,,,,74.8,0.66,24.56,7,0,-2,,,,93.1,3.74,3.18,-2,2,0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,5,0,H07,1.29,,NB-ferguhei-5069961-0004,5,Water,0,0,0,0,0,,,,99,0,,,100,0,,0.04,,,,,,,,,,68.8,66.4,712740.2,85197.1,10467,4876.7,1427.3,679.7,186.9,34,,2304548,1148691,178789,53031,8507,2258,662,51,,,,,,,,68.1,0.83,26.27,0,0,0,,,,95.2,1.81,2.97,0,0,0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F02,1.271,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,99,-1,,,99,-0.6,,0.035,,,,,,,,,,63.8,61.6,65585.5,4296.5,475.5,152.8,0,0,0,0,,128105,5663,884,357,85,34,17,0,,,,,,,,72.1,0.5,27.42,3,-4,1,,,,92.9,4.98,2.15,0,3,-3,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F03,1.284,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,98,-2,,,99,-0.64,,0.036,,,,,,,,,,69,67.4,16821.1,4566,594.1,305.5,84.9,33.9,0,0,,265423,5993,1171,611,119,17,17,17,,,,,,,,72.5,0.64,26.83,3,-4,1,,,,92.8,5.86,1.39,0,4,-4,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F04,1.279,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,98,-2,,,99,-0.76,,0.038,,,,,,,,,,68,69.2,212460.1,42566.8,765,255,85,34,17,17,,39257,8062,1324,611,85,34,17,0,,,,,,,,76.3,0.67,22.99,7,-4,-3,,,,91.8,6.47,1.71,-1,5,-4,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F05,1.287,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,100,0,,,100,-0.14,,0.037,,,,,,,,,,67.8,66.6,134559.2,3005.3,713.1,237.7,34,34,17,0,,16734,4158,1035,577,136,34,0,0,,,,,,,,77.3,0.7,22.03,8,-4,-4,,,,94,3.86,2.12,1,2,-3,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F06,1.274,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,97,-3,,,100,-0.16,,0.039,,,,,,,,,,68.4,69.8,94608.2,3192.1,628.2,339.6,34,34,34,34,,21673,4124,747,255,51,17,0,0,,,,,,,,77.6,0.7,21.66,8,-4,-4,,,,93,4.47,2.5,0,3,-3,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F07,1.298,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,98,-2,,,99,-0.81,,0.039,,,,,,,,,,69.2,67.6,267391.1,7559.2,1647.7,951.3,186.9,101.9,84.9,67.9,,15377,3581,560,187,34,17,0,0,,,,,,,,75,0.68,24.29,5,-4,-2,,,,92.4,4.9,2.7,-1,3,-3,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F08,1.275,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,99,-1,,,99,-0.45,,0.04,,,,,,,,,,62.4,59,124648.7,5612.5,1105.5,357.2,119.1,85,85,85,,26799,5771,1120,611,170,68,0,0,,,,,,,,72.3,0.46,27.24,3,-4,1,,,,92.9,4.82,2.3,0,3,-3,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F09,1.291,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,100,0,,,99,-0.47,,0.041,,,,,,,,,,68.8,64.8,203951.7,9086.8,2564.7,1613.5,730.3,356.7,101.9,51,,82097,11762,3310,1765,560,119,0,0,,,,,,,,69.7,0.62,29.64,0,-4,4,,,,94.8,3.64,1.54,2,2,-4,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F10,1.273,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,99,-1,,,100,-0.12,,0.047,,,,,,,,,,68,66,246033.4,4076.2,1070,475.6,101.9,51,34,34,,30227,6551,1494,730,272,51,0,0,,,,,,,,69.4,0.67,29.9,0,-4,4,,,,95,3.43,1.58,2,2,-4,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F11,1.274,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,100,0,,,100,-0.31,,0.043,,,,,,,,,,69.2,63.2,607302.2,9484.6,2362.6,1240.8,238,119,17,17,,52653,9390,2004,1104,238,85,17,0,,,,,,,,76.1,0.67,23.2,7,-4,-3,,,,95.1,3.3,1.63,2,2,-4,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50,10,F12,1.265,,NB-ferguhei-5069961-0004,5.6,Keytruda,0,0,0,0,0,,,,100,0,,,99,-0.51,,0.041,,,,,,,,,,,,562446,20809.3,2907.2,1309.1,595,408,306,306,,140743,22655,1769,561,119,119,34,34,,,,,,,,75.9,0.61,23.46,6,-4,-3,,,,93.5,3.66,2.81,0,2,-2,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,5,0,H11,1.245,,NB-ferguhei-5069961-0004,5,Water,0,0,0,0,0,,,,100,0,,,100,0,,0.039,,,,,,,,,,68.8,65.4,1086701.7,201200.2,32528.3,15270.5,4722.1,1868.5,254.8,17,,1932969,693765,63280,15497,2039,561,221,85,,,,,,,,69.6,4.33,26.1,0,0,0,,,,93.1,1.68,5.26,0,0,0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G02,1.211,,NB-ferguhei-5069961-0004,5,Acetate,0,0,0,0,0,,,,99.3,-1,,,99.6,-0.33,,0.037,,,,,,,,,,60,61.4,19263.2,3937.5,458.2,237.6,135.8,101.8,33.9,33.9,,207018.9,3955.3,560.2,254.6,84.9,34,17,0,,,,,,,,82.7,0.91,16.39,5,1,-5,,,,86.6,4.64,8.81,-9,1,8,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G03,1.231,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,99.1,-1,,,99.7,-0.26,,0.037,,,,,,,,,,61.8,63,20213.7,3224.7,424.3,220.6,67.9,17,17,0,,233303.6,3276.4,407.4,237.7,50.9,17,0,0,,,,,,,,86.6,0.92,12.52,8,1,-9,,,,86.4,5.01,8.6,-9,2,8,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G04,1.225,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,98.8,-1,,,99.7,-0.24,,0.039,,,,,,,,,,62.4,60,15716.1,2002.7,322.5,169.7,118.8,67.9,33.9,33.9,,518162.2,6553.9,899.9,356.6,135.8,67.9,0,0,,,,,,,,83.8,1.01,15.21,6,1,-7,,,,83.4,5.7,10.93,-12,3,10,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G05,1.245,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0,0,0,,,,100,0,,,99.9,-0.09,,0.046,,,,,,,,,,60.4,58.8,2494.9,475.2,152.7,101.8,33.9,33.9,0,0,,6664942.8,95217,534.5,213.8,71.3,35.6,0,0,,,,,,,,82.6,1.1,16.34,4,1,-6,,,,39.1,2.26,58.69,-57,-1,58,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G06,1.247,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,91.7,-8,,,99.9,-0.04,,0.056,,,,,,,,,,57.6,61.2,74899.3,3954.6,203.7,152.8,84.9,33.9,33.9,17,,7396183.4,326119.3,38.9,38.9,38.9,38.9,0,0,,,,,,,,80.7,1.29,18.05,2,1,-4,,,,24.5,2.65,72.83,-71,-1,72,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G07,1.02,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,96.2,-4,,,99.8,-0.14,,0.053,,,,,,,,,,60,58,152535.2,30619.1,1391.8,101.8,0,0,0,0,,4110626.4,312.8,0,0,0,0,0,0,,,,,,,,78.6,2.61,18.78,0,3,-3,,,,34,4.21,61.84,-62,1,61,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G08,1.234,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,99.1,-1,,,99.6,-0.43,,0.041,,,,,,,,,,61.6,59.8,14680.8,2460.9,339.4,203.7,135.8,50.9,33.9,17,,126412.1,3581.7,543.2,271.6,67.9,17,0,0,,,,,,,,84.6,0.71,14.7,6,1,-7,,,,82.3,4.17,13.53,-13,1,13,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G09,1.248,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,99.5,0,,,99.8,-0.18,,0.041,,,,,,,,,,61.2,56.6,14052.8,2308.2,712.8,475.2,237.6,220.6,0,0,,66757,3326.8,678.9,271.6,50.9,0,0,0,,,,,,,,85.3,0.81,13.86,7,1,-8,,,,89.4,3.95,6.67,-6,1,6,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G10,1.235,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,99.4,-1,,,99.9,-0.06,,0.048,,,,,,,,,,62.6,60.2,13628.5,1934.8,560.1,288.5,118.8,50.9,0,0,,89946.2,3513.7,611.1,288.6,67.9,17,17,0,,,,,,,,81.3,0.89,17.86,3,1,-4,,,,90.7,2.53,6.82,-5,-1,6,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G11,1.231,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,99.4,-1,,,99.7,-0.26,,0.045,,,,,,,,,,61.4,62.8,1126363.6,6726,696.4,288.7,118.9,51,17,0,,2252640.2,13657.8,1121.2,441.7,169.9,84.9,17,0,,,,,,,,81.1,0.88,17.98,3,1,-4,,,,89.2,2.52,8.25,-7,-1,7,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50,10,G12,1.273,,NB-ferguhei-5069961-0004,5.6,Keytruda,0,0,0,0,0,,,,99.2,-1,,,99.7,-0.27,,0.041,,,,,,,,,,,,299342.6,24680.7,662,339.5,186.7,118.8,0,0,,762364.8,82254.9,2665.4,848.9,101.9,50.9,34,17,,,,,,,,79.2,0.54,20.31,1,1,-2,,,,92.3,3.77,3.97,-4,1,3,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,5,0,H12,1.23,,NB-ferguhei-5069961-0004,5,Water,0,0,0,0,0,,,,100,0,,,100,0,,0.031,,,,,,,,,,62.8,61.6,26408.7,3988.5,865.6,509.2,186.7,101.8,0,0,,114272.7,7519.7,1748.4,1018.5,390.4,220.7,33.9,0,,,,,,,,78.2,0,21.84,0,0,0,,,,95.8,3.18,1.03,0,0,0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E02,1,DAB013887_E02,NB-jarvcass-5073893-0001,5,Acetate,0,0,0,0,0,,,,98.7,,,47.29,98.3,,,0.0523,25.08,69.8,5.13,-28.52,30.67,-2.14,28.52,30.67,2.14,68,77.8,7128.2,950.4,84.9,50.9,0,0,0,0,,8757.5,1578.4,203.7,101.8,50.9,0,0,0,,,,,,,,81.03,3.32,15.65,,,,,,,98.09,0.47,1.45,-1.24,0.47,0.78,1.24,0.47,0.78,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E03,1,DAB013887_E03,NB-jarvcass-5073893-0001,5.5,Acetate,0,0,0,0,0,,,,97.3,,,49.91,98.63,,,0.0539,23.87,69.08,7.05,-29.73,29.95,-0.22,29.73,29.95,0.22,69.8,77.8,73951.1,1391.8,186.7,33.9,0,0,0,0,,12678,1968.7,424.3,186.7,84.9,33.9,17,0,,,,,,,,81.32,3.16,15.52,,,,,,,97.96,0.67,1.37,-1.37,0.67,0.7,1.37,0.67,0.7,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E04,1,DAB013887_E04,NB-jarvcass-5073893-0001,6,Acetate,0,0,0,0,0,,,,96.3,,,50.26,97.42,,,0.0544,27.02,68,4.98,-26.58,28.87,-2.29,26.58,28.87,2.29,71.2,77.5,73204.5,1951.9,305.5,118.8,0,0,0,0,,27341.9,4276.9,712.8,220.6,17,17,0,0,,,,,,,,80.1,3.84,16.06,,,,,,,98.15,0.61,1.24,-1.18,0.61,0.57,1.18,0.61,0.57,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E05,1,DAB013887_E05,NB-jarvcass-5073893-0001,5.5,Citrate,0,0,0,0,0,,,,96.1,,,49.05,98.91,,,0.0553,23.79,71.86,4.35,-29.81,32.73,-2.92,29.81,32.73,2.92,69.2,78,49746.2,5125.7,492.2,203.7,0,0,0,0,,13815.2,1255.9,220.6,118.8,33.9,17,0,0,,,,,,,,80.27,3.12,16.61,,,,,,,97.66,0.92,1.42,-1.67,0.92,0.75,1.67,0.92,0.75,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E06,1,DAB013887_E06,NB-jarvcass-5073893-0001,6,Citrate,0,0,0,0,0,,,,95.7,,,49.86,98.21,,,0.0536,21.37,74.49,4.14,-32.23,35.36,-3.13,32.23,35.36,3.13,69.7,76.5,55805.3,2834.4,424.3,169.7,50.9,17,0,0,,5685.6,1188,237.6,152.7,101.8,67.9,33.9,0,,,,,,,,78.84,3.55,17.61,,,,,,,98.03,0.34,1.63,-1.3,0.34,0.96,1.3,0.34,0.96,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E07,1,DAB013887_E07,NB-jarvcass-5073893-0001,6.5,Citrate,0,0,0,0,0,,,,93.1,,,45.38,93.21,,,0.0552,18.35,77.72,3.93,-35.25,38.59,-3.34,35.25,38.59,3.34,70,75,132476.5,10727.1,1680.4,594.1,84.9,17,0,0,,11235.4,3818.7,644.9,254.6,50.9,0,0,0,,,,,,,,79.72,3.3,16.98,,,,,,,97.75,0.41,1.84,-1.58,0.41,1.17,1.58,0.41,1.17,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E08,1,DAB013887_E08,NB-jarvcass-5073893-0001,5,Histidine,0,0,0,0,0,,,,96.6,,,45.46,94.37,,,0.0573,29.6,61.86,8.54,-24,22.73,1.27,24,22.73,1.27,62.3,73.8,5804.4,1001.3,135.8,50.9,0,0,0,0,,8010.7,1374.7,220.6,118.8,33.9,33.9,0,0,,,,,,,,80.25,4.63,15.12,,,,,,,96.87,0.53,2.6,-2.46,0.53,1.93,2.46,0.53,1.93,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E09,1,DAB013887_E09,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0,0,0,,,,98.2,,,46.63,96.59,,,0.0561,32.57,60.49,6.94,-21.03,21.36,-0.33,21.03,21.36,0.33,65.8,76.3,76683,3156.9,424.3,135.8,0,0,0,0,,20162.9,3479.3,339.4,152.7,33.9,33.9,17,0,,,,,,,,80.98,3.48,15.54,,,,,,,98.63,0.15,1.23,-0.7,0.15,0.56,0.7,0.15,0.56,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E10,1,DAB013887_E10,NB-jarvcass-5073893-0001,6,Histidine,0,0,0,0,0,,,,97.6,,,50,99.6,,,0.0612,33.17,60.64,6.19,-20.43,21.51,-1.08,20.43,21.51,1.08,68.7,77.9,81248.7,3411.5,441.3,169.7,0,0,0,0,,31703.7,5125.6,611,254.6,84.9,33.9,0,0,,,,,,,,80.45,3.93,15.62,,,,,,,98.8,0.15,1.05,-0.53,0.15,0.38,0.53,0.15,0.38,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,E11,1,DAB013887_E11,NB-jarvcass-5073893-0001,6.5,Histidine,0,0,0,0,0,,,,97.2,,,48.98,98.24,,,0.0645,31.92,61.51,6.57,-21.68,22.38,-0.7,21.68,22.38,0.7,70.9,78,87953.7,8164,1120.2,712.9,220.6,101.8,0,0,,43534.2,8265.6,1595.4,967.4,339.4,101.8,17,17,,,,,,,,81.21,3.31,15.48,,,,,,,98.86,0.17,0.97,-0.47,0.17,0.3,0.47,0.17,0.3,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F02,1,DAB013887_F02,NB-jarvcass-5073893-0001,5,Acetate,0,75,0,0,0,,,,93.5,,,47.45,99.18,,,0.0528,18.76,76.26,4.98,-34.84,37.13,-2.29,34.84,37.13,2.29,64.2,75.4,8061.7,1340.8,254.6,84.9,17,17,0,0,,10522.6,2359.1,475.2,322.5,152.7,67.9,0,0,,,,,,,,79.3,4.11,16.59,,,,,,,96.21,0.64,3.16,-3.12,0.64,2.49,3.12,0.64,2.49,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F03,1,DAB013887_F03,NB-jarvcass-5073893-0001,5.5,Acetate,0,75,0,0,0,,,,94.7,,,47.67,98.57,,,0.0532,18.93,76.9,4.17,-34.67,37.77,-3.1,34.67,37.77,3.1,67.4,76.7,4243,763.7,135.8,50.9,17,17,0,0,,8519.9,1289.9,237.6,67.9,33.9,0,0,0,,,,,,,,79.14,3.96,16.9,,,,,,,97.84,0.73,1.43,-1.49,0.73,0.76,1.49,0.73,0.76,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F04,1,DAB013887_F04,NB-jarvcass-5073893-0001,6,Acetate,0,75,0,0,0,,,,96.4,,,48.15,98.77,,,0.0547,20.49,75.98,3.53,-33.11,36.85,-3.74,33.11,36.85,3.74,69.5,76.6,4429.7,712.8,118.8,67.9,17,17,0,0,,4412.7,865.6,118.8,84.9,17,0,0,0,,,,,,,,78.63,4.15,17.23,,,,,,,97.88,0.78,1.34,-1.45,0.78,0.67,1.45,0.78,0.67,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F05,1,DAB013887_F05,NB-jarvcass-5073893-0001,5.5,Citrate,0,75,0,0,0,,,,96.6,,,48.86,98.5,,,0.0551,19.83,76.18,3.99,-33.77,37.05,-3.28,33.77,37.05,3.28,67.9,76.6,13357,3275.6,712.8,339.4,118.8,33.9,0,0,,6619,763.7,186.7,84.9,17,17,0,0,,,,,,,,78.51,3.67,17.82,,,,,,,98.02,0.55,1.43,-1.31,0.55,0.76,1.31,0.55,0.76,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F06,1,DAB013887_F06,NB-jarvcass-5073893-0001,6,Citrate,0,75,0,0,0,,,,92.2,,,50.32,97.26,,,0.0542,19.73,76.78,3.49,-33.87,37.65,-3.78,33.87,37.65,3.78,70.3,76.3,5566.8,1748.1,492.2,186.7,0,0,0,0,,3530.2,814.7,203.7,84.9,33.9,33.9,0,0,,,,,,,,78.47,3.59,17.93,,,,,,,97.65,0.79,1.56,-1.68,0.79,0.89,1.68,0.79,0.89,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F07,1,DAB013887_F07,NB-jarvcass-5073893-0001,6.5,Citrate,0,75,0,0,0,,,,91.9,,,47.03,95.94,,,0.0557,17.2,79.25,3.56,-36.4,40.12,-3.71,36.4,40.12,3.71,69.9,75.3,15139,5532.9,1765.1,933.5,254.6,67.9,0,0,,3360.4,831.6,305.5,186.7,33.9,0,0,0,,,,,,,,78.79,3.46,17.75,,,,,,,97.59,0.75,1.65,-1.74,0.75,0.98,1.74,0.75,0.98,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F08,1,DAB013887_F08,NB-jarvcass-5073893-0001,5,Histidine,0,75,0,0,0,,,,83.4,,,42.72,95.94,,,0.0585,21.48,70.88,7.65,-32.12,31.75,0.38,32.12,31.75,0.38,59.1,70.3,7077.3,1442.6,254.6,118.8,17,0,0,0,,11048.8,2257.3,678.9,424.3,118.8,33.9,17,0,,,,,,,,77.55,6.11,16.34,,,,,,,85.65,1.33,13.02,-13.68,1.33,12.35,13.68,1.33,12.35,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F09,1,DAB013887_F09,NB-jarvcass-5073893-0001,5.5,Histidine,0,75,0,0,0,,,,91.6,,,46.99,99.12,,,0.0582,23.61,70.85,5.53,-29.99,31.72,-1.74,29.99,31.72,1.74,63.3,74,10098.3,1951.8,356.4,186.7,33.9,17,0,0,,19908.1,3139.8,543.1,220.6,101.8,33.9,0,0,,,,,,,,79.27,4.14,16.58,,,,,,,98.17,0.32,1.51,-1.16,0.32,0.84,1.16,0.32,0.84,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F10,1,DAB013887_F10,NB-jarvcass-5073893-0001,6,Histidine,0,75,0,0,0,,,,94.3,,,47.75,99.46,,,0.062,24.56,70.99,4.45,-29.04,31.86,-2.82,29.04,31.86,2.82,66.8,76.4,18686.1,2206.4,322.5,135.8,33.9,17,0,0,,20994.5,3241.7,628,509.2,254.6,118.8,0,0,,,,,,,,79.77,3.41,16.82,,,,,,,98.59,0.22,1.19,-0.74,0.22,0.52,0.74,0.22,0.52,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,F11,1,DAB013887_F11,NB-jarvcass-5073893-0001,6.5,Histidine,0,75,0,0,0,,,,93.5,,,48.6,99.33,,,0.0642,23.7,71.01,5.29,-29.9,31.88,-1.98,29.9,31.88,1.98,69.3,77.2,18873,3530.2,644.9,339.4,84.9,33.9,0,0,,13119.3,2783.4,560.1,322.5,84.9,33.9,0,0,,,,,,,,79.59,3.54,16.87,,,,,,,98.61,0.25,1.14,-0.72,0.25,0.47,0.72,0.25,0.47,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50,10,G02,1,DAB013887_G02,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.02,7,0,,,,97.7,,,50.13,99.74,,,0.0562,32.14,61.18,6.68,-21.46,22.05,-0.59,21.46,22.05,0.59,67.7,78.1,34522.5,814.7,67.9,67.9,17,17,0,0,,252999.8,3056,322.6,169.8,84.9,67.9,17,0,,,,,,,,80.68,3.43,15.89,,,,,,,98.57,0.32,1.11,-0.76,0.32,0.44,0.76,0.32,0.44,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,PS80,-,PS80,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,5,10,H07,1,DAB013887_H07,NB-jarvcass-5073893-0001,5,Acetate,0,0,0,0,0,,,,99.4,,,50.45,100,,,0.0472,53.6,39.13,7.27,0,0,0,0,0,0,,,34097,5312.3,729.8,458.2,169.7,67.9,0,0,,34843.6,4921.9,695.9,288.5,50.9,0,0,0,,,,,,,,83.02,2.44,14.53,,,,,,,99.33,0,0.67,0,0,0,0,0,0,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,5,10,H08,1,DAB013887_H08,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0,7,0,,,,96.4,,,50.49,99.75,,,0.0494,55.05,37.57,7.38,1.45,-1.56,0.11,1.45,-1.56,0.11,,,70166.6,6178.2,1035.4,577.1,220.6,101.8,33.9,0,,207154.9,11304.9,2614,1544.7,339.5,118.8,17,0,,,,,,,,83.44,2.06,14.51,,,,,,,99.21,0,0.79,-0.12,0,0.12,0.12,0,0.12,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B02,1,DAB014071_B02,NB-jarvcass-5073893-0001,5,Acetate,0,0,0,0,0,,,,97.3,,,87.74,99.73,,,0.0527,,,,,,,,,,70,76.2,13000.5,1408.7,118.8,50.9,17,0,0,0,,27732.5,3699.9,577.1,288.5,118.8,33.9,0,0,,,,,,,,,,,,,,,,,97.27,1.67,1.06,0.6,1.35,-1.95,0.6,1.35,1.95,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B03,1,DAB014071_B03,NB-jarvcass-5073893-0001,5.5,Acetate,0,0,0,0,0,,,,97.8,,,86.09,99.47,,,0.0538,,,,,,,,,,70.6,75.2,15817.8,2087.5,118.8,50.9,17,17,17,17,,142195.3,49899,10251.4,5108.7,1544.5,577.1,101.8,50.9,,,,,,,,,,,,,,,,,94.98,1.73,3.3,-1.69,1.41,0.29,1.69,1.41,0.29,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B04,1,DAB014071_B04,NB-jarvcass-5073893-0001,6,Acetate,0,0,0,0,0,,,,97.8,,,85.58,98.53,,,0.0549,,,,,,,,,,70.9,75.6,26425.6,4192.1,984.4,712.8,475.2,271.6,67.9,33.9,,172046.7,11457.3,1408.8,628,118.8,33.9,0,0,,,,,,,,,,,,,,,,,94.86,1.54,3.6,-1.81,1.22,0.59,1.81,1.22,0.59,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B05,1,DAB014071_B05,NB-jarvcass-5073893-0001,5.5,Citrate,0,0,0,0,0,,,,97,,,58.37,99.23,,,0.0541,,,,,,,,,,69.7,78,148986.5,16955.7,611,186.7,17,0,0,0,,14494,4073.3,644.9,237.6,67.9,17,0,0,,,,,,,,,,,,,,,,,94.14,1.47,4.39,-2.53,1.15,1.38,2.53,1.15,1.38,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B06,1,DAB014071_B06,NB-jarvcass-5073893-0001,6,Citrate,0,0,0,0,0,,,,95.9,,,56.59,97.82,,,0.054,,,,,,,,,,69.9,77.5,171681.3,20588.2,1035.3,203.7,0,0,0,0,,144458.8,4769.5,220.7,67.9,0,0,0,0,,,,,,,,,,,,,,,,,94.01,1.4,4.59,-2.66,1.08,1.58,2.66,1.08,1.58,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B07,1,DAB014071_B07,NB-jarvcass-5073893-0001,6.5,Citrate,0,0,0,0,0,,,,95.5,,,55.08,95.85,,,0.0547,,,,,,,,,,69.6,77.6,160449.8,15734.4,763.8,67.9,0,0,0,0,,134188.9,4345.1,135.8,33.9,0,0,0,0,,,,,,,,,,,,,,,,,93.13,1.4,5.47,-3.54,1.08,2.46,3.54,1.08,2.46,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B08,1,DAB014071_B08,NB-jarvcass-5073893-0001,5,Histidine,0,0,0,0,0,,,,97.6,,,47.48,97.39,,,0.0564,,,,,,,,,,61.8,68.2,17175.7,1239,101.8,33.9,17,17,0,0,,34538.2,9131,1306.9,628,186.7,67.9,0,0,,,,,,,,,,,,,,,,,94.7,2.12,3.18,-1.97,1.8,0.17,1.97,1.8,0.17,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B09,1,DAB014071_B09,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0,0,0,,,,98.6,,,53.69,99.23,,,0.0566,,,,,,,,,,69.5,77,25661.7,2444,135.8,84.9,0,0,0,0,,42939.4,10336,1222,543.1,118.8,33.9,0,0,,,,,,,,,,,,,,,,,95.25,1.74,3.01,-1.42,1.42,0,1.42,1.42,0,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B10,1,DAB014071_B10,NB-jarvcass-5073893-0001,6,Histidine,0,0,0,0,0,,,,99.2,,,56.12,99.49,,,0.0595,,,,,,,,,,70.3,77.1,69622.7,2512,101.8,50.9,50.9,50.9,0,0,,52749.7,9691.1,1069.3,237.6,33.9,0,0,0,,,,,,,,,,,,,,,,,94.11,2.81,3.07,-2.56,2.49,0.06,2.56,2.49,0.06,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B11,1,DAB014071_B11,NB-jarvcass-5073893-0001,6.5,Histidine,0,0,0,0,0,,,,96.5,,,55.19,99.43,,,0.0622,,,,,,,,,,71.2,77,47318.7,5091.7,526.1,254.6,84.9,50.9,0,0,,128296,26579.1,4463.8,2138.6,458.3,169.7,0,0,,,,,,,,,,,,,,,,,92.71,3.94,3.35,-3.96,3.62,0.34,3.96,3.62,0.34,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C02,1,DAB014071_C02,NB-jarvcass-5073893-0001,5,Acetate,0,75,0,0,0,,,,97.1,,,55.62,99.57,,,0.0526,,,,,,,,,,67.2,74,16802.4,644.9,118.8,84.9,67.9,50.9,0,0,,44585.9,7976.9,1171.1,678.9,135.8,84.9,0,0,,,,,,,,,,,,,,,,,92.5,1.56,5.94,-4.17,1.24,2.93,4.17,1.24,2.93,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C03,1,DAB014071_C03,NB-jarvcass-5073893-0001,5.5,Acetate,0,75,0,0,0,,,,93.4,,,49.81,89.98,,,0.0528,,,,,,,,,,69,74.2,16870.4,763.8,67.9,50.9,17,17,0,0,,42684.8,5736.6,1052.3,526.1,135.8,50.9,0,0,,,,,,,,,,,,,,,,,94.02,1.48,4.5,-2.65,1.16,1.49,2.65,1.16,1.49,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C04,1,DAB014071_C04,NB-jarvcass-5073893-0001,6,Acetate,0,75,0,0,0,,,,93.8,,,49.35,88.94,,,0.054,,,,,,,,,,69.8,74,71154.1,1086.3,322.5,152.8,67.9,33.9,0,0,,34911.8,4124.2,780.7,288.5,50.9,0,0,0,,,,,,,,,,,,,,,,,93.94,1.55,4.52,-2.73,1.23,1.51,2.73,1.23,1.51,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C05,1,DAB014071_C05,NB-jarvcass-5073893-0001,5.5,Citrate,0,75,0,0,0,,,,95.3,,,55.98,99.09,,,0.0547,,,,,,,,,,69.1,73.9,137051.3,1188.2,101.8,17,17,17,0,0,,31398.2,3343.5,644.9,288.5,118.8,101.8,67.9,33.9,,,,,,,,,,,,,,,,,94.2,1.06,4.75,-2.47,0.74,1.74,2.47,0.74,1.74,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C06,1,DAB014071_C06,NB-jarvcass-5073893-0001,6,Citrate,0,75,0,0,0,,,,90.8,,,55.49,98.5,,,0.0543,,,,,,,,,,70,77.7,53040.6,1086.3,67.9,17,17,0,0,0,,4209,1527.5,475.2,271.6,67.9,17,0,0,,,,,,,,,,,,,,,,,94,1.25,4.75,-2.67,0.93,1.74,2.67,0.93,1.74,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C07,1,DAB014071_C07,NB-jarvcass-5073893-0001,6.5,Citrate,0,75,0,0,0,,,,91.2,,,54.39,95.86,,,0.0555,,,,,,,,,,70,77.2,96547.8,1408.8,237.6,84.9,17,0,0,0,,5380.1,1459.6,288.5,118.8,0,0,0,0,,,,,,,,,,,,,,,,,93.49,1.22,5.29,-3.18,0.9,2.28,3.18,0.9,2.28,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C08,1,DAB014071_C08,NB-jarvcass-5073893-0001,5,Histidine,0,75,0,0,0,,,,93.8,,,44.29,89.28,,,0.0581,,,,,,,,,,60.7,66.1,594690.9,1341.4,237.7,84.9,17,0,0,0,,60710.4,6381.6,1357.8,661.9,135.8,84.9,0,0,,,,,,,,,,,,,,,,,85.05,1.87,13.08,-11.62,1.55,10.07,11.62,1.55,10.07,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C09,1,DAB014071_C09,NB-jarvcass-5073893-0001,5.5,Histidine,0,75,0,0,0,,,,94.5,,,54.12,99.52,,,0.0571,,,,,,,,,,66.6,68.9,499211.1,899.9,0,0,0,0,0,0,,44653.5,6415.4,1120.2,373.4,84.9,33.9,0,0,,,,,,,,,,,,,,,,,92.65,1.18,6.17,-4.02,0.86,3.16,4.02,0.86,3.16,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C10,1,DAB014071_C10,NB-jarvcass-5073893-0001,6,Histidine,0,75,0,0,0,,,,91.1,,,55.27,100,,,0.0605,,,,,,,,,,68.4,75.3,487176.2,1154.6,118.9,0,0,0,0,0,,47793.6,5719.6,814.7,390.4,84.9,17,0,0,,,,,,,,,,,,,,,,,94.16,0.95,4.89,-2.51,0.63,1.88,2.51,0.63,1.88,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C11,1,DAB014071_C11,NB-jarvcass-5073893-0001,6.5,Histidine,0,75,0,0,0,,,,82.8,,,55.64,100,,,0.0657,,,,,,,,,,69.9,75,448766.9,1901.7,186.8,84.9,0,0,0,0,,27426.9,3394.4,695.9,305.5,67.9,17,0,0,,,,,,,,,,,,,,,,,91.65,4.05,4.29,-5.02,3.73,1.28,5.02,3.73,1.28,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50,10,D02,1,DAB014071_D02,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.02,7,0,,,,99.1,,,54.53,99.65,,,0.0571,,,,,,,,,,70.8,78.5,96698.5,1256,271.6,135.8,17,0,0,0,,289552.2,8164.8,1086.4,424.4,152.8,50.9,17,0,,,,,,,,,,,,,,,,,95.52,0.89,3.59,-1.15,0.57,0.58,1.15,0.57,0.58,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,PS80,-,PS80,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,5,10,H02,1,DAB014071_H02,NB-jarvcass-5073893-0001,5,Acetate,0,0,0,0,0,,,,99.3,,,58.16,99.63,,,0.0478,,,,,,,,,,,,752340.7,11921.2,1783.1,849.1,169.8,101.9,34,17,,88052.4,14341.6,1629.3,611,118.8,33.9,0,0,,,,,,,,,,,,,,,,,96.67,0.32,3.01,0,0,0,0,0,0,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,5,10,H03,1,DAB014071_H03,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0,7,0,,,,95.8,,,54.51,99.25,,,0.0494,,,,,,,,,,,,293182.9,12409,2953.7,1510.8,288.6,50.9,0,0,,114483,7858.5,1714.3,814.7,237.6,152.8,33.9,17,,,,,,,,,,,,,,,,,97.39,0.31,2.3,0.72,-0.01,-0.71,0.72,0.01,0.71,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B02,1,DAB014072_B02,NB-jarvcass-5073893-0001,5,Acetate,0,0,0,0,0,,,,93.6,,,45.57,98.73,,,0.0529,23.73,71.26,5.01,-22.01,24.94,-2.93,22.01,24.94,2.93,68.2,77.8,6143.8,1374.7,322.5,169.7,50.9,17,0,0,,19195.3,2477.9,356.4,169.7,17,0,0,0,,,,,,,,89.22,2.52,8.26,,,,,,,95.21,0.93,3.86,-3.11,0.93,2.18,3.11,0.93,2.18,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B03,1,DAB014072_B03,NB-jarvcass-5073893-0001,5.5,Acetate,0,0,0,0,0,,,,95.5,,,45.98,98.45,,,0.0542,24.19,70.92,4.88,-21.55,24.6,-3.06,21.55,24.6,3.06,69.3,76.8,8163.5,1171.1,203.7,135.8,33.9,0,0,0,,33163.8,2817.4,373.4,220.6,33.9,0,0,0,,,,,,,,88.76,2.5,8.75,,,,,,,96.73,0.84,2.43,-1.59,0.84,0.75,1.59,0.84,0.75,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B04,1,DAB014072_B04,NB-jarvcass-5073893-0001,6,Acetate,0,0,0,0,0,,,,94.5,,,45.75,98.16,,,0.0573,25.05,70.24,4.71,-20.69,23.92,-3.23,20.69,23.92,3.23,69.6,76.5,119271.6,2732.7,339.5,84.9,0,0,0,0,,16445.9,2953.1,441.3,152.7,50.9,17,0,0,,,,,,,,88.42,2.46,9.12,,,,,,,97.36,0.82,1.82,-0.96,0.82,0.14,0.96,0.82,0.14,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B05,1,DAB014072_B05,NB-jarvcass-5073893-0001,5.5,Citrate,0,0,0,0,0,,,,94.4,,,45.45,98.27,,,0.055,21.67,74.17,4.16,-24.07,27.85,-3.78,24.07,27.85,3.78,67.9,77.9,144916,10862.8,882.6,305.5,101.8,67.9,0,0,,6211.7,1035.3,254.6,152.7,33.9,17,0,0,,,,,,,,88.69,1.64,9.67,,,,,,,96.13,0.34,3.53,-2.19,0.34,1.85,2.19,0.34,1.85,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B06,1,DAB014072_B06,NB-jarvcass-5073893-0001,6,Citrate,0,0,0,0,0,,,,87.4,,,44.61,97.07,,,0.055,17.68,78.77,3.55,-28.06,32.45,-4.39,28.06,32.45,4.39,68.9,76.5,168306.3,11151.4,848.7,390.4,186.7,50.9,17,0,,460445.5,26891.3,1867.5,713,152.8,34,17,0,,,,,,,,86.92,2.13,10.95,,,,,,,96.04,1.06,2.9,-2.28,1.06,1.22,2.28,1.06,1.22,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B07,1,DAB014072_B07,NB-jarvcass-5073893-0001,6.5,Citrate,0,0,0,0,0,,,,90.3,,,41.57,93.62,,,0.0546,15.87,80.53,3.6,-29.87,34.21,-4.34,29.87,34.21,4.34,69,75.9,257591.1,31265.3,1850.1,882.6,101.8,50.9,0,0,,12762.9,5465,1272.9,373.4,33.9,33.9,0,0,,,,,,,,87.54,1.93,10.53,,,,,,,96.75,0.65,2.6,-1.57,0.65,0.92,1.57,0.65,0.92,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B08,1,DAB014072_B08,NB-jarvcass-5073893-0001,5,Histidine,0,0,0,0,0,,,,87.5,,,43.25,92.14,,,0.0583,27.52,64.65,7.83,-18.22,18.33,-0.11,18.22,18.33,0.11,63,71,76765.6,30567.1,11948.5,8316.4,3207.8,1374.8,203.7,33.9,,92924.9,39648,15343.2,10149.6,4192.2,1289.9,118.8,0,,,,,,,,89.14,2.67,8.2,,,,,,,94.84,0.89,4.26,-3.48,0.89,2.58,3.48,0.89,2.58,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B09,1,DAB014072_B09,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0,0,0,,,,97.9,,,44.12,98.65,,,0.0584,28.14,64.84,7.02,-17.6,18.52,-0.92,17.6,18.52,0.92,66.7,75.3,174507.5,5482.5,712.9,322.5,50.9,17,0,0,,27562.5,4871,763.7,356.4,118.8,33.9,0,0,,,,,,,,89.68,2.09,8.23,,,,,,,95.67,0.45,3.88,-2.65,0.45,2.2,2.65,0.45,2.2,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B10,1,DAB014072_B10,NB-jarvcass-5073893-0001,6,Histidine,0,0,0,0,0,,,,95.9,,,44.96,98.03,,,0.0628,29.59,64.08,6.33,-16.15,17.76,-1.61,16.15,17.76,1.61,68.8,76.4,116230,4141.4,424.3,305.5,186.7,101.8,17,17,,462533.9,10135.5,1680.8,1120.5,577.2,169.8,34,0,,,,,,,,90.03,1.96,8.01,,,,,,,97.64,0.39,1.96,-0.68,0.39,0.28,0.68,0.39,0.28,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,B11,1,DAB014072_B11,NB-jarvcass-5073893-0001,6.5,Histidine,0,0,0,0,0,,,,97.2,,,45.47,98.74,,,0.0638,27.61,66.13,6.26,-18.13,19.81,-1.68,18.13,19.81,1.68,70.4,76.9,57197.5,7281.2,916.5,373.4,33.9,17,0,0,,111168.4,43160.5,19535.1,13934.2,6551.3,3394.5,356.4,67.9,,,,,,,,89.88,2.05,8.07,,,,,,,97.85,0.46,1.69,-0.47,0.46,0.01,0.47,0.46,0.01,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C02,1,DAB014072_C02,NB-jarvcass-5073893-0001,5,Acetate,0,75,0,0,0,,,,92.6,,,45.17,98.76,,,0.0529,17.57,77.02,5.42,-28.17,30.7,-2.52,28.17,30.7,2.52,64.5,76.2,6822.7,1086.2,237.6,118.8,50.9,17,0,0,,9809.8,1765.1,407.3,203.7,50.9,17,0,0,,,,,,,,87.65,2.36,9.98,,,,,,,90.14,0.96,8.9,-8.18,0.96,7.22,8.18,0.96,7.22,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C03,1,DAB014072_C03,NB-jarvcass-5073893-0001,5.5,Acetate,0,75,0,0,0,,,,92.1,,,45.73,99.12,,,0.0542,18.39,77.82,3.79,-27.35,31.5,-4.15,27.35,31.5,4.15,67.2,77.4,5329.2,356.4,84.9,17,0,0,0,0,,8112.6,1731.1,152.7,84.9,67.9,17,0,0,,,,,,,,88.34,2.41,9.25,,,,,,,92.8,1.01,6.19,-5.52,1.01,4.51,5.52,1.01,4.51,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C04,1,DAB014072_C04,NB-jarvcass-5073893-0001,6,Acetate,0,75,0,0,0,,,,95,,,44.95,98.84,,,0.0561,18.56,77.74,3.69,-27.18,31.42,-4.25,27.18,31.42,4.25,68.4,76.4,8163.5,933.5,152.7,84.9,0,0,0,0,,6042,814.7,84.9,33.9,17,0,0,0,,,,,,,,88.17,2.45,9.38,,,,,,,95.22,1.09,3.69,-3.1,1.09,2.01,3.1,1.09,2.01,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C05,1,DAB014072_C05,NB-jarvcass-5073893-0001,5.5,Citrate,0,75,0,0,0,,,,96.9,,,46.01,99.31,,,0.0556,18.05,78.3,3.65,-27.69,31.98,-4.29,27.69,31.98,4.29,67.3,77.8,15325.7,3920.5,509.2,186.7,17,17,0,0,,9826.7,1595.4,203.7,101.8,50.9,17,0,0,,,,,,,,87.48,1.97,10.55,,,,,,,94.36,0.78,4.86,-3.96,0.78,3.18,3.96,0.78,3.18,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C06,1,DAB014072_C06,NB-jarvcass-5073893-0001,6,Citrate,0,75,0,0,0,,,,94.6,,,45.53,98.08,,,0.0555,16.7,80.07,3.23,-29.04,33.75,-4.71,29.04,33.75,4.71,68.9,75.7,8231.4,1748.1,373.4,169.7,33.9,17,17,0,,3699.9,729.8,237.6,135.8,67.9,17,0,0,,,,,,,,86.92,2.51,10.57,,,,,,,95,1.62,3.38,-3.32,1.62,1.7,3.32,1.62,1.7,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C07,1,DAB014072_C07,NB-jarvcass-5073893-0001,6.5,Citrate,0,75,0,0,0,,,,93.6,,,44,97.21,,,0.056,15.14,81.89,2.97,-30.6,35.57,-4.97,30.6,35.57,4.97,69.2,75.7,18584.3,6025,1646.3,899.5,152.7,67.9,0,0,,1883.9,458.2,271.5,186.7,33.9,33.9,0,0,,,,,,,,86.85,2.19,10.96,,,,,,,96.51,1.05,2.44,-1.81,1.05,0.76,1.81,1.05,0.76,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C08,1,DAB014072_C08,NB-jarvcass-5073893-0001,5,Histidine,0,75,0,0,0,,,,95.8,,,42.05,96.62,,,0.0592,20,72.58,7.42,-25.74,26.26,-0.52,25.74,26.26,0.52,59.8,73.4,10879,1069.2,67.9,33.9,17,17,0,0,,14833.5,3682.9,1069.2,628,220.6,50.9,0,0,,,,,,,,85.81,3.03,11.16,,,,,,,81.95,1.59,16.45,-16.37,1.59,14.77,16.37,1.59,14.77,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C09,1,DAB014072_C09,NB-jarvcass-5073893-0001,5.5,Histidine,0,75,0,0,0,,,,96.9,,,45.2,98.9,,,0.0582,21.3,73.17,5.52,-24.44,26.85,-2.42,24.44,26.85,2.42,63.8,76.8,20519.2,2511.9,322.5,203.7,33.9,17,0,0,,18160.1,3122.9,492.2,254.6,50.9,33.9,0,0,,,,,,,,88.11,2.08,9.81,,,,,,,91.94,0.71,7.35,-6.38,0.71,5.67,6.38,0.71,5.67,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C10,1,DAB014072_C10,NB-jarvcass-5073893-0001,6,Histidine,0,75,0,0,0,,,,94.1,,,46.37,99.23,,,0.0647,21.52,73.87,4.61,-24.22,27.55,-3.33,24.22,27.55,3.33,66.7,76.1,154489.9,10642.2,712.9,322.5,101.8,33.9,0,0,,72642.8,10149.6,2783.5,1646.3,678.9,356.4,33.9,0,,,,,,,,89.47,1.8,8.73,,,,,,,95.4,0.53,4.08,-2.92,0.53,2.4,2.92,0.53,2.4,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,C11,1,DAB014072_C11,NB-jarvcass-5073893-0001,6.5,Histidine,0,75,0,0,0,,,,95.3,,,45.77,97.85,,,0.0705,21.13,74.59,4.28,-24.61,28.27,-3.66,24.61,28.27,3.66,68.4,76.5,83861.5,8299.6,1306.9,729.8,169.7,67.9,33.9,0,,6636,1442.6,492.2,390.4,186.7,84.9,0,0,,,,,,,,89.07,1.79,9.14,,,,,,,97.2,0.56,2.24,-1.12,0.56,0.56,1.12,0.56,0.56,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50,10,D02,1,DAB014072_D02,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.02,7,0,,,,88.9,,,42.92,96.46,,,0.057,27.87,65.33,6.8,-17.87,19.01,-1.14,17.87,19.01,1.14,68.4,77.1,42178,1188.1,169.7,118.8,67.9,50.9,17,17,,31364.7,1782.1,339.4,254.6,84.9,67.9,17,0,,,,,,,,89.39,1.95,8.65,,,,,,,96.6,0.37,3.03,-1.72,0.37,1.35,1.72,0.37,1.35,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,PS80,-,PS80,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,5,10,H02,1,DAB014072_H02,NB-jarvcass-5073893-0001,5,Acetate,0,0,0,0,0,,,,94.3,,,45.8,99.6,,,0.048,45.74,46.32,7.94,0,0,0,0,0,0,,,53920.6,9911.7,1374.7,763.7,67.9,50.9,0,0,,63119.9,9911.8,1629.3,661.9,50.9,33.9,0,0,,,,,,,,90.73,1.23,8.04,,,,,,,98.32,0,1.68,0,0,0,0,0,0,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,5,10,H03,1,DAB014072_H03,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0,7,0,,,,96.9,,,46.07,96.69,,,0.052,46.52,45.48,8.01,0.78,-0.84,0.07,0.78,-0.84,0.07,,,101703,12356.4,1425.7,492.2,33.9,17,0,0,,107151.2,10744,2053.7,1035.4,237.6,118.8,17,0,,,,,,,,90.7,1.19,8.11,,,,,,,98.14,0,1.86,-0.18,0,0.18,0.18,0,0.18,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E02,1,DAB014074_E02,NB-jarvcass-5073893-0001,5,Acetate,0,0,0,0,0,,,,,,,,,,,0.052,,,,,,,,,,,,10980.8,2240.3,101.8,67.9,17,17,0,0,,5617.7,1272.9,118.8,50.9,50.9,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E03,1,DAB014074_E03,NB-jarvcass-5073893-0001,5.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.054,,,,,,,,,,,,5668.6,712.8,101.8,17,0,0,0,0,,7196.1,1561.4,220.6,101.8,67.9,50.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E04,1,DAB014074_E04,NB-jarvcass-5073893-0001,6,Acetate,0,0,0,0,0,,,,,,,,,,,0.054,,,,,,,,,,,,5668.6,899.5,67.9,33.9,17,0,0,0,,7009.4,1289.9,271.6,101.8,33.9,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E05,1,DAB014074_E05,NB-jarvcass-5073893-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0543,,,,,,,,,,,,8129.6,780.7,84.9,33.9,17,17,0,0,,1510.5,526.1,169.7,84.9,33.9,17,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E06,1,DAB014074_E06,NB-jarvcass-5073893-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,0.0543,,,,,,,,,,,,20095,933.5,84.9,33.9,33.9,0,0,0,,1782,254.6,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E07,1,DAB014074_E07,NB-jarvcass-5073893-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0544,,,,,,,,,,,,53632.8,2308.2,135.8,67.9,0,0,0,0,,3004,695.8,67.9,17,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E08,1,DAB014074_E08,NB-jarvcass-5073893-0001,5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0569,,,,,,,,,,,,5431,1137.1,339.4,169.7,0,0,0,0,,6143.8,1697.2,339.4,220.6,50.9,33.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E09,1,DAB014074_E09,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0572,,,,,,,,,,,,7739.2,1629.3,135.8,50.9,0,0,0,0,,9606.2,2240.3,186.7,101.8,50.9,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E10,1,DAB014074_E10,NB-jarvcass-5073893-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,0.0607,,,,,,,,,,,,11439.1,1833,135.8,84.9,33.9,17,0,0,,14222.5,3088.9,373.4,169.7,33.9,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,E11,1,DAB014074_E11,NB-jarvcass-5073893-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0634,,,,,,,,,,,,19280.4,3428.4,390.4,135.8,17,0,0,0,,22216.4,5091.6,644.9,322.5,152.7,67.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F02,1,DAB014074_F02,NB-jarvcass-5073893-0001,5,Acetate,0,75,0,0,0,,,,,,,,,,,0.0518,,,,,,,,,,,,6076,678.9,67.9,17,0,0,0,0,,8129.5,1629.3,237.6,118.8,50.9,17,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F03,1,DAB014074_F03,NB-jarvcass-5073893-0001,5.5,Acetate,0,75,0,0,0,,,,,,,,,,,0.0531,,,,,,,,,,,,10624.5,356.4,101.8,33.9,17,17,0,0,,8519.9,1306.8,305.5,237.6,135.8,101.8,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F04,1,DAB014074_F04,NB-jarvcass-5073893-0001,6,Acetate,0,75,0,0,0,,,,,,,,,,,0.0539,,,,,,,,,,,,11490,373.4,33.9,17,17,17,0,0,,14511.2,424.3,17,17,17,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F05,1,DAB014074_F05,NB-jarvcass-5073893-0001,5.5,Citrate,0,75,0,0,0,,,,,,,,,,,0.0536,,,,,,,,,,,,3309.6,746.8,118.8,33.9,0,0,0,0,,5295.2,594,152.7,135.8,118.8,118.8,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F06,1,DAB014074_F06,NB-jarvcass-5073893-0001,6,Citrate,0,75,0,0,0,,,,,,,,,,,0.0538,,,,,,,,,,,,2681.6,661.9,135.8,33.9,17,0,0,0,,2121.5,237.6,33.9,17,17,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F07,1,DAB014074_F07,NB-jarvcass-5073893-0001,6.5,Citrate,0,75,0,0,0,,,,,,,,,,,0.054,,,,,,,,,,,,3801.7,1306.8,339.4,135.8,50.9,33.9,0,0,,1120.1,220.6,33.9,33.9,17,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F08,1,DAB014074_F08,NB-jarvcass-5073893-0001,5,Histidine,0,75,0,0,0,,,,,,,,,,,0.057,,,,,,,,,,,,6619.1,1086.2,169.7,101.8,17,0,0,0,,9521.2,2002.7,356.4,271.6,67.9,33.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F09,1,DAB014074_F09,NB-jarvcass-5073893-0001,5.5,Histidine,0,75,0,0,0,,,,,,,,,,,0.0581,,,,,,,,,,,,4361.8,797.7,101.8,50.9,17,17,0,0,,18754,6483.3,2172.4,1510.5,865.6,509.2,135.8,50.9,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F10,1,DAB014074_F10,NB-jarvcass-5073893-0001,6,Histidine,0,75,0,0,0,,,,,,,,,,,0.0607,,,,,,,,,,,,3716.8,746.8,101.8,33.9,17,17,0,0,,7382.8,1306.8,152.7,84.9,50.9,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,F11,1,DAB014074_F11,NB-jarvcass-5073893-0001,6.5,Histidine,0,75,0,0,0,,,,,,,,,,,0.0627,,,,,,,,,,,,6636,1442.6,407.3,237.6,84.9,67.9,17,17,,6771.8,1731.1,254.6,169.7,17,17,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50,10,G02,1,DAB014074_G02,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.02,7,0,,,,,,,,,,,0.0555,,,,,,,,,,,,10641.6,169.7,33.9,0,0,0,0,0,,16106.5,780.7,67.9,50.9,17,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,PS80,-,PS80,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,5,10,H07,1,DAB014074_H07,NB-jarvcass-5073893-0001,5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0462,,,,,,,,,,,,8214.4,1222,118.8,50.9,17,0,0,0,,18686.1,2613.7,339.4,101.8,50.9,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,5,10,H08,1,DAB014074_H08,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0,7,0,,,,,,,,,,,0.0487,,,,,,,,,,,,35472.8,2359.2,797.7,492.2,152.8,101.8,0,0,,37967.2,3411.4,1222,644.9,186.7,135.8,17,0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,N/A,-,-,0,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B02,1.3819,DNB_547B02,NB-munselle-5020702-0004,4.5,Acetate,0,0,0,0,0,,,,99.5,0.1,0.1,63.11,99.81,-0.1,0.1,0.0404,,,,-16.65,11.17,5.48,16.65,11.17,5.48,62.8,,44637.4,6381.6,1544.5,780.7,271.6,135.8,0,0,,9538.2,1731.1,135.8,67.9,0,0,0,0,,,,,,,,82.34,13.44,4.22,-8.71,7.98,0.73,8.71,7.98,0.73,90.71,9.29,0,-0.03,0.03,0,0.03,0.03,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B03,1.3786,DNB_547B03,NB-munselle-5020702-0004,5,Acetate,0,0,0,0,0,,,,99.5,0,0,63.41,99.92,0,0,0.0414,,,,-14.17,10.62,3.55,14.17,10.62,3.55,64.2,,11557.9,4412.7,1629.3,1001.3,373.4,135.8,0,0,,12151.9,1985.7,203.7,50.9,33.9,17,0,0,,,,,,,,82.59,13.16,4.26,-8.46,7.7,0.77,8.46,7.7,0.77,90.7,9.3,0,-0.04,0.04,0,0.04,0.04,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B04,1.3856,DNB_547B04,NB-munselle-5020702-0004,5.6,Acetate,0,0,0,0,0,,,,88.5,-10.9,10.9,63.28,99.88,-0.1,0.1,0.0431,,,,-16.42,12.42,4,16.42,12.42,4,63.2,,13611.5,6313.6,1629.3,882.5,271.6,84.9,17,17,,96219.6,3768,220.6,101.8,17,0,0,0,,,,,,,,83.08,12.66,4.26,-7.97,7.2,0.77,7.97,7.2,0.77,90.64,9.36,0,-0.1,0.1,0,0.1,0.1,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B05,1.3739,DNB_547B05,NB-munselle-5020702-0004,6.2,Acetate,0,0,0,0,0,,,,89.2,-10.2,10.2,63.45,99.93,0,0,0.0426,,,,-18.32,13.17,5.15,18.32,13.17,5.15,62.4,,30176.3,9657.1,1425.7,865.6,305.5,169.7,17,0,,25084.7,3615.1,288.5,33.9,0,0,0,0,,,,,,,,82.89,12.82,4.29,-8.16,7.36,0.8,8.16,7.36,0.8,90.65,9.35,0,-0.09,0.09,0,0.09,0.09,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B06,1.3812,DNB_547B06,NB-munselle-5020702-0004,5.6,Citrate,0,0,0,0,0,,,,,,,63.43,99.92,0,0,0.0415,,,,-19.53,15.98,3.55,19.53,15.98,3.55,60,,15546.4,4022.4,1272.9,729.8,254.6,135.8,0,0,,38849.2,4514.6,661.9,288.5,0,0,0,0,,,,,,,,82.21,13.32,4.47,-8.84,7.86,0.98,8.84,7.86,0.98,91.04,8.96,0,0.3,-0.3,0,0.3,0.3,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B07,1.3697,DNB_547B07,NB-munselle-5020702-0004,6.2,Citrate,0,0,0,0,0,,,,,,,63.42,99.93,0,0,0.0425,,,,-21.48,17.7,3.77,21.48,17.7,3.77,59.6,,17379.3,6347.5,1408.7,780.7,237.6,118.8,0,0,,38051.7,6687.1,1035.3,441.3,203.7,33.9,0,0,,,,,,,,80.53,14.88,4.59,-10.52,9.42,1.1,10.52,9.42,1.1,91.47,8.53,0,0.73,-0.73,0,0.73,0.73,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B08,1.3952,DNB_547B08,NB-munselle-5020702-0004,5,Histidine,0,0,0,0,0,,,,99.4,0,0,63.29,99.81,-0.1,0.1,0.0435,,,,-13.43,9.13,4.29,13.43,9.13,4.29,62.2,,11931.3,5465,1340.8,831.6,373.4,169.7,0,0,,14782.6,2274.2,254.6,101.8,50.9,0,0,0,,,,,,,,82.96,13.05,3.99,-8.09,7.59,0.5,8.09,7.59,0.5,90.64,9.36,0,-0.1,0.1,0,0.1,0.1,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B09,1.3623,DNB_547B09,NB-munselle-5020702-0004,5.6,Histidine,0,0,0,0,0,,,,99.4,0,0,63.34,99.81,-0.1,0.1,0.0432,,,,-12.78,9.39,3.39,12.78,9.39,3.39,63.6,,16547.6,8961.2,1934.8,899.5,237.6,67.9,0,0,,13339.9,1900.9,271.6,67.9,0,0,0,0,,,,,,,,83.87,12.37,3.76,-7.18,6.91,0.27,7.18,6.91,0.27,90.48,9.52,0,-0.26,0.26,0,0.26,0.26,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B10,1.3733,DNB_547B10,NB-munselle-5020702-0004,6.2,Histidine,0,0,0,0,0,,,,99.4,-0.1,0.1,63.33,99.9,0,0,0.0433,,,,-14.82,11.13,3.69,14.82,11.13,3.69,64.8,,53445.3,17175.8,2647.7,1374.7,475.2,254.6,33.9,33.9,,40377,3598.1,390.4,186.7,101.8,50.9,0,0,,,,,,,,84.22,11.85,3.93,-6.83,6.39,0.44,6.83,6.39,0.44,90.73,9.27,0,-0.01,0.01,0,0.01,0.01,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B11,1.3339,DNB_547B11,NB-munselle-5020702-0004,6.8,Histidine,0,0,0,0,0,,,,96.6,-2.8,2.8,63.4,99.93,0,0,0.0424,,,,-17.39,14.32,3.06,17.39,14.32,3.06,63.4,,30821.2,18126.1,2834.3,1340.8,407.3,169.7,17,0,,45502.3,5838.4,1001.4,543.1,135.8,50.9,33.9,0,,,,,,,,82.37,13.74,3.89,-8.68,8.28,0.4,8.68,8.28,0.4,90.69,9.31,0,-0.05,0.05,0,0.05,0.05,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C02,1.2963,DNB_547C02,NB-munselle-5020702-0004,4.5,Acetate,0,50,0,0,0,,,,98.1,-1.4,1.4,62.99,99.88,-0.1,0.1,0.0406,,,,-18.42,13.53,4.89,18.42,13.53,4.89,,,5431,1035.3,101.8,67.9,0,0,0,0,,35913.1,6687,1561.4,933.5,288.5,118.8,33.9,33.9,,,,,,,,79.14,17.17,3.69,-11.91,11.71,0.2,11.91,11.71,0.2,90.18,9.82,0,-0.56,0.56,0,0.56,0.56,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C03,1.3525,DNB_547C03,NB-munselle-5020702-0004,5,Acetate,0,50,0,0,0,,,,98.2,-1.2,1.2,63.38,99.87,-0.1,0.1,0.0428,,,,-17.83,13.02,4.81,17.83,13.02,4.81,59,,7552.5,1357.8,135.8,101.8,50.9,0,0,0,,12627.1,2104.5,271.6,135.8,33.9,17,0,0,,,,,,,,81.02,15.12,3.85,-10.03,9.66,0.36,10.03,9.66,0.36,90.39,9.61,0,-0.35,0.35,0,0.35,0.35,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C04,1.3989,DNB_547C04,NB-munselle-5020702-0004,5.6,Acetate,0,50,0,0,0,,,,90.1,-9.4,9.4,63.49,99.89,0,0,0.0443,,,,-17.58,12.45,5.13,17.58,12.45,5.13,60.8,,6398.4,1476.6,169.7,84.9,17,17,0,0,,14884.4,2393,339.4,186.7,33.9,17,0,0,,,,,,,,82.24,14.08,3.68,-8.81,8.62,0.19,8.81,8.62,0.19,90.82,9.18,0,0.08,-0.08,0,0.08,0.08,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C05,1.3774,DNB_547C05,NB-munselle-5020702-0004,6.2,Acetate,0,50,0,0,0,,,,90.9,-8.5,8.5,63.74,99.93,0,0,0.0448,,,,-17.2,12.77,4.44,17.2,12.77,4.44,60.2,,10539.5,4005.4,220.6,152.7,17,0,0,0,,13356.9,1816,356.4,169.7,50.9,50.9,50.9,33.9,,,,,,,,83.51,12.77,3.73,-7.54,7.31,0.24,7.54,7.31,0.24,91.02,8.98,0,0.28,-0.28,0,0.28,0.28,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C06,1.4014,DNB_547C06,NB-munselle-5020702-0004,5.6,Citrate,0,50,0,0,0,,,,94,-5.5,5.5,63.64,99.91,0,0,0.0431,,,,-21.09,17,4.09,21.09,17,4.09,59.6,,12525.3,3699.9,322.5,220.6,67.9,17,0,0,,25899.6,5414.1,1103.2,543.1,84.9,17,0,0,,,,,,,,81.87,14.37,3.76,-9.18,8.91,0.27,9.18,8.91,0.27,91.48,8.52,0,0.74,-0.74,0,0.74,0.74,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C07,1.3925,DNB_547C07,NB-munselle-5020702-0004,6.2,Citrate,0,50,0,0,0,,,,89.3,-10.1,10.1,63.82,99.93,0,0,0.0442,,,,-22.54,18.5,4.05,22.54,18.5,4.05,60,,14494.1,4226,628,322.5,101.8,67.9,0,0,,17583,3055,509.2,237.6,118.8,101.8,17,0,,,,,,,,82.26,13.7,4.04,-8.79,8.24,0.55,8.79,8.24,0.55,91.45,8.47,0.08,0.71,-0.79,0.08,0.71,0.79,0.08,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C08,1.3743,DNB_547C08,NB-munselle-5020702-0004,5,Histidine,0,50,0,0,0,,,,99.4,-0.1,0.1,63.16,99.81,-0.1,0.1,0.0436,,,,-14.82,10.79,4.03,14.82,10.79,4.03,56,,7009.4,1799,356.4,220.6,67.9,17,0,0,,18805,3275.6,339.4,135.8,33.9,0,0,0,,,,,,,,80.73,15.97,3.3,-10.32,10.51,-0.19,10.32,10.51,0.19,90.44,9.56,0,-0.3,0.3,0,0.3,0.3,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C09,1.3743,DNB_547C09,NB-munselle-5020702-0004,5.6,Histidine,0,50,0,0,0,,,,98.6,-0.9,0.9,63.46,99.81,-0.1,0.1,0.0433,,,,-12.85,9.37,3.48,12.85,9.37,3.48,59,,11829.5,3852.6,509.2,288.5,67.9,33.9,0,0,,16140.3,3139.8,577,271.6,67.9,33.9,0,0,,,,,,,,81.85,14.46,3.7,-9.2,9,0.21,9.2,9,0.21,90.88,9.12,0,0.14,-0.14,0,0.14,0.14,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C10,1.356,DNB_547C10,NB-munselle-5020702-0004,6.2,Histidine,0,50,0,0,0,,,,99.3,-0.2,0.2,63.88,99.92,0,0,0.044,,,,-13.73,10.03,3.7,13.73,10.03,3.7,,,11812.4,5193.4,644.9,322.5,152.7,67.9,17,0,,14290.4,2376.1,220.6,67.9,33.9,17,17,17,,,,,,,,83.16,12.67,4.17,-7.89,7.21,0.68,7.89,7.21,0.68,90.97,8.92,0.11,0.23,-0.34,0.11,0.23,0.34,0.11,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C11,1.3295,DNB_547C11,NB-munselle-5020702-0004,6.8,Histidine,0,50,0,0,0,,,,97.8,-1.7,1.7,63.82,99.93,0,0,0.0423,,,,-16.82,13.21,3.61,16.82,13.21,3.61,61.4,,13577.5,4107.2,882.5,526.1,152.7,101.8,17,17,,27376.1,7009.5,1748.1,950.4,203.7,33.9,0,0,,,,,,,,82,13.78,4.21,-9.05,8.32,0.72,9.05,8.32,0.72,90.92,8.64,0.44,0.18,-0.62,0.44,0.18,0.62,0.44,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D02,1.4113,DNB_547D02,NB-munselle-5020702-0004,4.5,Acetate,0,150,0,0,0,,,,97.9,-1.5,1.5,62.49,99.44,-0.5,0.5,0.0427,,,,,,,,,,55,,345313.9,8776.3,899.7,288.6,17,17,17,17,,40597.4,4905,916.5,373.4,101.8,50.9,17,17,,,,,,,,76.79,19.61,3.6,-14.26,14.15,0.11,14.26,14.15,0.11,79.54,7.48,12.98,-11.2,-1.78,12.98,11.2,1.78,12.98,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D03,1.4213,DNB_547D03,NB-munselle-5020702-0004,5,Acetate,0,150,0,0,0,,,,98.6,-0.9,0.9,63.63,99.87,-0.1,0.1,0.043,,,,,,,,,,56.6,,13730.3,1968.7,475.2,220.6,67.9,17,0,0,,17498.1,2681.6,458.2,220.6,33.9,17,0,0,,,,,,,,79.64,16.49,3.88,-11.41,11.03,0.39,11.41,11.03,0.39,90.84,8.7,0.46,0.1,-0.56,0.46,0.1,0.56,0.46,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D04,1.3951,DNB_547D04,NB-munselle-5020702-0004,5.6,Acetate,0,150,0,0,0,,,,86,-13.4,13.4,64.12,99.87,-0.1,0.1,0.0432,,,,,,,,,,59.6,,8740.6,1849.9,475.2,288.5,101.8,33.9,0,0,,12389.5,1765.1,203.7,84.9,0,0,0,0,,,,,,,,81.03,14.14,4.83,-10.02,8.68,1.34,10.02,8.68,1.34,90.7,9.17,0.13,-0.04,-0.09,0.13,0.04,0.09,0.13,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D05,1.4015,DNB_547D05,NB-munselle-5020702-0004,6.2,Acetate,0,150,0,0,0,,,,82.7,-16.8,16.8,64.26,99.93,0,0,0.0429,,,,,,,,,,61.2,,9707.9,2562.8,441.3,237.6,84.9,33.9,0,0,,17040,2749.5,577.1,288.5,33.9,0,0,0,,,,,,,,81.51,13.53,4.95,-9.54,8.07,1.46,9.54,8.07,1.46,91.23,8.57,0.2,0.49,-0.69,0.2,0.49,0.69,0.2,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D06,1.3895,DNB_547D06,NB-munselle-5020702-0004,5.6,Citrate,0,150,0,0,0,,,,97.1,-2.3,2.3,64.11,100,0.1,0.1,0.0417,,,,,,,,,,59.4,,20705.8,4972.8,1018.3,644.9,169.7,50.9,0,0,,59149.2,9657.4,1340.8,729.8,220.6,84.9,17,0,,,,,,,,81.24,14.59,4.18,-9.81,9.13,0.69,9.81,9.13,0.69,90.91,8.93,0.16,0.17,-0.33,0.16,0.17,0.33,0.16,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D07,1.3902,DNB_547D07,NB-munselle-5020702-0004,6.2,Citrate,0,150,0,0,0,,,,94.6,-4.8,4.8,64.37,100,0.1,0.1,0.0419,,,,,,,,,,61.8,,10318.9,2325.2,339.4,237.6,84.9,17,0,0,,24813.2,3649,678.9,441.3,169.7,101.8,17,0,,,,,,,,79.85,15.96,4.19,-11.2,10.5,0.7,11.2,10.5,0.7,91.03,8.76,0.2,0.29,-0.5,0.2,0.29,0.5,0.2,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D08,1.4019,DNB_547D08,NB-munselle-5020702-0004,5,Histidine,0,150,0,0,0,,,,98,-1.4,1.4,63.27,99.83,-0.1,0.1,0.0435,,,,,,,,,,53.4,,18194.1,4192.1,1239,644.9,220.6,101.8,33.9,0,,30821.4,5227.4,984.4,526.1,135.8,33.9,17,0,,,,,,,,78.24,18.04,3.72,-12.81,12.58,0.23,12.81,12.58,0.23,88.92,8.24,2.85,-1.82,-1.02,2.85,1.82,1.02,2.85,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D09,1.3899,DNB_547D09,NB-munselle-5020702-0004,5.6,Histidine,0,150,0,0,0,,,,98.4,-1.1,1.1,63.95,99.91,0,0,0.0433,,,,,,,,,,56.6,,15563.2,3411.4,882.5,424.3,169.7,118.8,17,17,,12134.9,2291.2,475.2,237.6,135.8,50.9,0,0,,,,,,,,80.8,15.27,3.93,-10.25,9.81,0.44,10.25,9.81,0.44,90.44,9.38,0.18,-0.3,0.12,0.18,0.3,0.12,0.18,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D10,1.4039,DNB_547D10,NB-munselle-5020702-0004,6.2,Histidine,0,150,0,0,0,,,,98.4,-1,1,64.25,99.91,0,0,0.0445,,,,,,,,,,60.6,,17684.8,5804.4,1816,1052.3,441.3,237.6,67.9,33.9,,20553.2,3716.9,475.2,305.5,50.9,17,0,0,,,,,,,,83.23,12.38,4.39,-7.82,6.92,0.9,7.82,6.92,0.9,90.21,9.55,0.24,-0.53,0.29,0.24,0.53,0.29,0.24,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D11,1.3673,DNB_547D11,NB-munselle-5020702-0004,6.8,Histidine,0,150,0,0,0,,,,98,-1.4,1.4,64.38,99.95,0,0,0.0427,,,,,,,,,,61.4,,16242.2,3632,1205,797.7,271.6,101.8,0,0,,16377.9,3122.8,611,254.6,50.9,33.9,0,0,,,,,,,,80.56,15.5,3.94,-10.49,10.04,0.45,10.49,10.04,0.45,90.01,9.89,0.1,-0.73,0.63,0.1,0.73,0.63,0.1,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,,5,12,H02,1.3916,DNB_547H02,NB-munselle-5020702-0004,5.2,Acetate,0,0,0,0,0,,,,99.5,0,0,64.08,99.93,0,0,0.0386,,,,0,0,0,0,0,0,66,,7858,2817.3,560.1,373.4,67.9,50.9,0,0,,11388.1,5431,322.5,169.7,0,0,0,0,,,,,,,,91.05,5.46,3.49,0,0,0,0,0,0,90.74,9.26,0,0,0,0,0,0,0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E02,1.4024,DNB_553E02,NB-munselle-5020702-0004,4.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0405,,,,-16.26,11.19,5.08,16.26,11.19,5.08,63.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.62,15.93,1.45,-12.49,12.54,-0.05,12.49,12.54,0.05,90.94,9.06,0,-0.39,0.39,0,0.39,0.39,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E03,1.4073,DNB_553E03,NB-munselle-5020702-0004,5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0422,,,,-16.13,11.09,5.04,16.13,11.09,5.04,63,,,,,,,,,,,,,,,,,,,,,,,,,,84.57,14.17,1.27,-10.54,10.78,-0.23,10.54,10.78,0.23,90.55,9.45,0,-0.78,0.78,0,0.78,0.78,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E04,1.4024,DNB_553E04,NB-munselle-5020702-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,,,,0.0429,,,,-15.98,11.34,4.64,15.98,11.34,4.64,64,,,,,,,,,,,,,,,,,,,,,,,,,,84.65,13.93,1.42,-10.46,10.54,-0.08,10.46,10.54,0.08,90.96,9.04,0,-0.37,0.37,0,0.37,0.37,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E05,1.4042,DNB_553E05,NB-munselle-5020702-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,,,,0.0423,,,,-16.59,11.54,5.05,16.59,11.54,5.05,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,85.69,12.83,1.49,-9.42,9.44,-0.01,9.42,9.44,0.01,91.13,8.87,0,-0.2,0.2,0,0.2,0.2,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E06,1.4021,DNB_553E06,NB-munselle-5020702-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,,,,0.0412,,,,-18.14,15.18,2.96,18.14,15.18,2.96,60,,,,,,,,,,,,,,,,,,,,,,,,,,83.16,15.48,1.36,-11.95,12.09,-0.14,11.95,12.09,0.14,90.97,8.74,0.29,-0.36,0.07,0.29,0.36,0.07,0.29,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E07,1.3873,DNB_553E07,NB-munselle-5020702-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,,,,0.0429,,,,-20.49,16.75,3.74,20.49,16.75,3.74,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.82,14.74,1.44,-11.29,11.35,-0.06,11.29,11.35,0.06,91.14,8.62,0.24,-0.19,-0.05,0.24,0.19,0.05,0.24,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E08,1.4036,DNB_553E08,NB-munselle-5020702-0004,5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0431,,,,-11.24,7.23,4.02,11.24,7.23,4.02,62.6,,,,,,,,,,,,,,,,,,,,,,,,,,84.51,14.07,1.42,-10.6,10.68,-0.08,10.6,10.68,0.08,90.12,9.88,0,-1.21,1.21,0,1.21,1.21,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E09,1.397,DNB_553E09,NB-munselle-5020702-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,,,,0.044,,,,-10.21,6.69,3.52,10.21,6.69,3.52,62.8,,,,,,,,,,,,,,,,,,,,,,,,,,84.52,14.29,1.19,-10.59,10.9,-0.31,10.59,10.9,0.31,89.78,10.22,0,-1.55,1.55,0,1.55,1.55,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E10,1.3954,DNB_553E10,NB-munselle-5020702-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,,,,0.0436,,,,-12.18,8.4,3.78,12.18,8.4,3.78,63.8,,,,,,,,,,,,,,,,,,,,,,,,,,86.45,12.4,1.14,-8.66,9.01,-0.36,8.66,9.01,0.36,89.65,10.35,0,-1.68,1.68,0,1.68,1.68,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E11,1.3726,DNB_553E11,NB-munselle-5020702-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,,,,0.0429,,,,-15.44,11.94,3.5,15.44,11.94,3.5,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.63,15.08,1.29,-11.48,11.69,-0.21,11.48,11.69,0.21,89.21,10.69,0.1,-2.12,2.02,0.1,2.12,2.02,0.1,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F02,1.3845,DNB_553F02,NB-munselle-5020702-0004,4.5,Acetate,0,50,0,0,0,,,,,,,,,,,0.0412,,,,-16.88,12.5,4.39,16.88,12.5,4.39,54.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.59,17.04,1.36,-13.52,13.65,-0.14,13.52,13.65,0.14,89.86,10.14,0,-1.47,1.47,0,1.47,1.47,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F03,1.3852,DNB_553F03,NB-munselle-5020702-0004,5,Acetate,0,50,0,0,0,,,,,,,,,,,0.0418,,,,-17.15,12.79,4.36,17.15,12.79,4.36,59.4,,,,,,,,,,,,,,,,,,,,,,,,,,82.6,16.07,1.33,-12.51,12.68,-0.17,12.51,12.68,0.17,90.11,9.89,0,-1.22,1.22,0,1.22,1.22,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F04,1.3861,DNB_553F04,NB-munselle-5020702-0004,5.6,Acetate,0,50,0,0,0,,,,,,,,,,,0.0431,,,,-15.65,11.61,4.04,15.65,11.61,4.04,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.88,14.78,1.35,-11.23,11.39,-0.15,11.23,11.39,0.15,90.68,9.32,0,-0.65,0.65,0,0.65,0.65,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F05,1.3812,DNB_553F05,NB-munselle-5020702-0004,6.2,Acetate,0,50,0,0,0,,,,,,,,,,,0.0434,,,,-15.99,11.94,4.05,15.99,11.94,4.05,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,84.14,14.28,1.58,-10.97,10.89,0.08,10.97,10.89,0.08,90.7,9.3,0,-0.63,0.63,0,0.63,0.63,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F06,1.3868,DNB_553F06,NB-munselle-5020702-0004,5.6,Citrate,0,50,0,0,0,,,,,,,,,,,0.0438,,,,-18.66,15.9,2.77,18.66,15.9,2.77,60.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.65,15.87,1.48,-12.46,12.48,-0.02,12.46,12.48,0.02,89.95,10.05,0,-1.38,1.38,0,1.38,1.38,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F07,1.3557,DNB_553F07,NB-munselle-5020702-0004,6.2,Citrate,0,50,0,0,0,,,,,,,,,,,0.0447,,,,-19.83,16.42,3.41,19.83,16.42,3.41,62,,,,,,,,,,,,,,,,,,,,,,,,,,82.19,16.06,1.75,-12.92,12.67,0.25,12.92,12.67,0.25,90.58,9.42,0,-0.75,0.75,0,0.75,0.75,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F08,1.3896,DNB_553F08,NB-munselle-5020702-0004,5,Histidine,0,50,0,0,0,,,,,,,,,,,0.0448,,,,-12.67,8.75,3.92,12.67,8.75,3.92,57.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.8,14.88,1.32,-11.31,11.49,-0.18,11.31,11.49,0.18,89.33,10.67,0,-2,2,0,2,2,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F09,1.3626,DNB_553F09,NB-munselle-5020702-0004,5.6,Histidine,0,50,0,0,0,,,,,,,,,,,0.0433,,,,-10.06,6.54,3.52,10.06,6.54,3.52,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.31,15.33,1.36,-11.8,11.94,-0.14,11.8,11.94,0.14,89.35,10.65,0,-1.98,1.98,0,1.98,1.98,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F10,1.3398,DNB_553F10,NB-munselle-5020702-0004,6.2,Histidine,0,50,0,0,0,,,,,,,,,,,0.046,,,,-11.29,7.77,3.52,11.29,7.77,3.52,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,85.81,12.7,1.49,-9.3,9.31,-0.01,9.3,9.31,0.01,89.85,10.15,0,-1.48,1.48,0,1.48,1.48,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F11,1.3639,DNB_553F11,NB-munselle-5020702-0004,6.8,Histidine,0,50,0,0,0,,,,,,,,,,,0.0401,,,,-16.59,12.87,3.72,16.59,12.87,3.72,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,82.8,15.73,1.47,-12.31,12.34,-0.03,12.31,12.34,0.03,90.09,9.66,0.25,-1.24,0.99,0.25,1.24,0.99,0.25,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G02,1.3572,DNB_553G02,NB-munselle-5020702-0004,4.5,Acetate,0,150,0,0,0,,,,,,,,,,,0.041,,,,,,,,,,51.2,,,,,,,,,,,,,,,,,,,,,,,,,,81.47,17.09,1.44,-13.64,13.7,-0.06,13.64,13.7,0.06,73.29,7.28,19.43,-18.04,-1.39,19.43,18.04,1.39,19.43,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G03,1.4033,DNB_553G03,NB-munselle-5020702-0004,5,Acetate,0,150,0,0,0,,,,,,,,,,,0.0421,,,,,,,,,,56.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.8,15.81,1.39,-12.31,12.42,-0.11,12.31,12.42,0.11,90.25,9.2,0.54,-1.08,0.53,0.54,1.08,0.53,0.54,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G04,1.3967,DNB_553G04,NB-munselle-5020702-0004,5.6,Acetate,0,150,0,0,0,,,,,,,,,,,0.0429,,,,,,,,,,59.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.97,14.65,1.38,-11.14,11.26,-0.12,11.14,11.26,0.12,90.8,9.2,0,-0.53,0.53,0,0.53,0.53,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G05,1.3835,DNB_553G05,NB-munselle-5020702-0004,6.2,Acetate,0,150,0,0,0,,,,,,,,,,,0.0443,,,,,,,,,,61.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.75,14.86,1.39,-11.36,11.47,-0.11,11.36,11.47,0.11,90.59,9.41,0,-0.74,0.74,0,0.74,0.74,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G06,1.4021,DNB_553G06,NB-munselle-5020702-0004,5.6,Citrate,0,150,0,0,0,,,,,,,,,,,0.0418,,,,,,,,,,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.08,15.39,1.53,-12.03,12,0.03,12.03,12,0.03,90.41,9.59,0,-0.92,0.92,0,0.92,0.92,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G07,1.4081,DNB_553G07,NB-munselle-5020702-0004,6.2,Citrate,0,150,0,0,0,,,,,,,,,,,0.0427,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,82.69,15.88,1.43,-12.42,12.49,-0.07,12.42,12.49,0.07,90.57,9.27,0.16,-0.76,0.6,0.16,0.76,0.6,0.16,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G08,1.4082,DNB_553G08,NB-munselle-5020702-0004,5,Histidine,0,150,0,0,0,,,,,,,,,,,0.0444,,,,,,,,,,54.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.57,16.17,1.26,-12.54,12.78,-0.24,12.54,12.78,0.24,88.22,8.58,3.2,-3.11,-0.09,3.2,3.11,0.09,3.2,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G09,1.4007,DNB_553G09,NB-munselle-5020702-0004,5.6,Histidine,0,150,0,0,0,,,,,,,,,,,0.0435,,,,,,,,,,57.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.72,14.87,1.41,-11.39,11.48,-0.09,11.39,11.48,0.09,89.5,10.36,0.14,-1.83,1.69,0.14,1.83,1.69,0.14,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G10,1.3998,DNB_553G10,NB-munselle-5020702-0004,6.2,Histidine,0,150,0,0,0,,,,,,,,,,,0.0435,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.36,12.15,1.5,-8.75,8.76,0,8.75,8.76,0,89.97,10.03,0,-1.36,1.36,0,1.36,1.36,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G11,1.3356,DNB_553G11,NB-munselle-5020702-0004,6.8,Histidine,0,150,0,0,0,,,,,,,,,,,0.0423,,,,,,,,,,62,,,,,,,,,,,,,,,,,,,,,,,,,,82.74,15.62,1.64,-12.37,12.23,0.14,12.37,12.23,0.14,89.15,10.85,0,-2.18,2.18,0,2.18,2.18,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,,5,12,H07,1.4108,DNB_553H07,NB-munselle-5020702-0004,5.2,Acetate,0,0,0,0,0,,,,,,,,,,,0.0414,,,,0,0,0,0,0,0,66.2,,,,,,,,,,,,,,,,,,,,,,,,,,95.11,3.39,1.5,0,0,0,0,0,0,91.33,8.67,0,0,0,0,0,0,0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B02,1.4011,DNB_557B02,NB-munselle-5020702-0004,4.5,Acetate,0,0,0,0,0,,,,100,0,0,63.63,99.69,-0.3,0.3,0.0413,,,,-16.04,11.44,4.61,16.04,11.44,4.61,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.81,15.12,1.07,-8.42,8.9,-0.48,8.42,8.9,0.48,89.57,10.43,0,-0.3,0.3,0,0.3,0.3,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B03,1.4385,DNB_557B03,NB-munselle-5020702-0004,5,Acetate,0,0,0,0,0,,,,100,0,0,64.07,99.51,-0.5,0.5,0.0419,,,,-16.27,12,4.28,16.27,12,4.28,64.2,,,,,,,,,,,,,,,,,,,,,,,,,,84.38,14.39,1.23,-7.85,8.17,-0.32,7.85,8.17,0.32,90.07,9.93,0,0.2,-0.2,0,0.2,0.2,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B04,1.4419,DNB_557B04,NB-munselle-5020702-0004,5.6,Acetate,0,0,0,0,0,,,,100,0,0,64.41,99.56,-0.4,0.4,0.0431,,,,-17.29,12.75,4.55,17.29,12.75,4.55,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,84.42,14.42,1.15,-7.81,8.2,-0.4,7.81,8.2,0.4,89.91,10.09,0,0.04,-0.04,0,0.04,0.04,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B08,1.449,DNB_557B08,NB-munselle-5020702-0004,5,Histidine,0,0,0,0,0,,,,100,0,0,64.25,99.21,-0.8,0.8,0.0441,,,,-14.63,10.89,3.75,14.63,10.89,3.75,60.6,,,,,,,,,,,,,,,,,,,,,,,,,,84.79,14.12,1.1,-7.44,7.9,-0.45,7.44,7.9,0.45,89.14,10.86,0,-0.73,0.73,0,0.73,0.73,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B05,1.436,DNB_557B05,NB-munselle-5020702-0004,6.2,Acetate,0,0,0,0,0,,,,98.9,-1.1,1.1,64.54,99.6,-0.4,0.4,0.0435,,,,-18.02,13.42,4.61,18.02,13.42,4.61,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,85.77,13.13,1.1,-6.46,6.91,-0.45,6.46,6.91,0.45,89.73,10.27,0,-0.14,0.14,0,0.14,0.14,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B06,1.4457,DNB_557B06,NB-munselle-5020702-0004,5.6,Citrate,0,0,0,0,0,,,,100,0,0,64.52,99.5,-0.5,0.5,0.0423,,,,-19.67,16.78,2.9,19.67,16.78,2.9,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.68,15.07,1.25,-8.55,8.85,-0.3,8.55,8.85,0.3,89.67,10.33,0,-0.2,0.2,0,0.2,0.2,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B07,1.4392,DNB_557B07,NB-munselle-5020702-0004,6.2,Citrate,0,0,0,0,0,,,,,,,64.63,99.61,-0.4,0.4,0.0431,,,,-23.26,19.92,3.35,23.26,19.92,3.35,60.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.32,15.45,1.23,-8.91,9.23,-0.32,8.91,9.23,0.32,90.04,9.96,0,0.17,-0.17,0,0.17,0.17,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B09,1.4496,DNB_557B09,NB-munselle-5020702-0004,5.6,Histidine,0,0,0,0,0,,,,100,0,0,64.21,99.34,-0.7,0.7,0.0432,,,,-13.63,10.22,3.42,13.63,10.22,3.42,63.8,,,,,,,,,,,,,,,,,,,,,,,,,,85.4,13.59,1.02,-6.83,7.37,-0.53,6.83,7.37,0.53,88.9,11.1,0,-0.97,0.97,0,0.97,0.97,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B10,1.419,DNB_557B10,NB-munselle-5020702-0004,6.2,Histidine,0,0,0,0,0,,,,100,0,0,64.59,99.73,-0.3,0.3,0.0434,,,,-16.96,13.28,3.69,16.96,13.28,3.69,,,,,,,,,,,,,,,,,,,,,,,,,,,85.95,12.77,1.27,-6.28,6.55,-0.28,6.28,6.55,0.28,89.09,10.91,0,-0.78,0.78,0,0.78,0.78,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,B11,1.4032,DNB_557B11,NB-munselle-5020702-0004,6.8,Histidine,0,0,0,0,0,,,,100,0,0,64.52,99.58,-0.4,0.4,0.0417,,,,-21.64,18.34,3.31,21.64,18.34,3.31,63.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.01,15.65,1.34,-9.22,9.43,-0.21,9.22,9.43,0.21,89.06,10.94,0,-0.81,0.81,0,0.81,0.81,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C02,1.415,DNB_557C02,NB-munselle-5020702-0004,4.5,Acetate,0,50,0,0,0,,,,100,0,0,63.92,99.12,-0.9,0.9,0.041,,,,-18.71,14.04,4.68,18.71,14.04,4.68,54.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.47,17.31,1.22,-10.76,11.09,-0.33,10.76,11.09,0.33,89.05,10.95,0,-0.82,0.82,0,0.82,0.82,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C03,1.4324,DNB_557C03,NB-munselle-5020702-0004,5,Acetate,0,50,0,0,0,,,,100,0,0,64.44,99.57,-0.4,0.4,0.0428,,,,-17.29,13.19,4.12,17.29,13.19,4.12,58.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.48,15.34,1.19,-8.75,9.12,-0.36,8.75,9.12,0.36,89.08,10.92,0,-0.79,0.79,0,0.79,0.79,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C04,1.4462,DNB_557C04,NB-munselle-5020702-0004,5.6,Acetate,0,50,0,0,0,,,,100,0,0,64.95,99.75,-0.2,0.2,0.0442,,,,-17.27,12.94,4.34,17.27,12.94,4.34,58.4,,,,,,,,,,,,,,,,,,,,,,,,,,84.64,14.18,1.18,-7.59,7.96,-0.37,7.59,7.96,0.37,89.84,10.16,0,-0.03,0.03,0,0.03,0.03,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C05,1.4186,DNB_557C05,NB-munselle-5020702-0004,6.2,Acetate,0,50,0,0,0,,,,100,0,0,65.28,99.76,-0.2,0.2,0.0441,,,,-17.7,13.65,4.05,17.7,13.65,4.05,60,,,,,,,,,,,,,,,,,,,,,,,,,,84.85,13.5,1.65,-7.38,7.28,0.1,7.38,7.28,0.1,89.49,10.51,0,-0.38,0.38,0,0.38,0.38,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C06,1.3988,DNB_557C06,NB-munselle-5020702-0004,5.6,Citrate,0,50,0,0,0,,,,100,0,0,64.96,99.74,-0.3,0.3,0.0432,,,,-21.32,18.37,2.97,21.32,18.37,2.97,60.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.22,15.25,1.54,-9.01,9.03,-0.01,9.01,9.03,0.01,89.78,10.22,0,-0.09,0.09,0,0.09,0.09,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C07,1.4279,DNB_557C07,NB-munselle-5020702-0004,6.2,Citrate,0,50,0,0,0,,,,100,0,0,65.34,99.75,-0.2,0.2,0.0449,,,,-22.03,18.47,3.57,22.03,18.47,3.57,59.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.31,14.97,1.73,-8.92,8.75,0.18,8.92,8.75,0.18,89.84,10.03,0.13,-0.03,-0.1,0.13,0.03,0.1,0.13,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C08,1.4484,DNB_557C08,NB-munselle-5020702-0004,5,Histidine,0,50,0,0,0,,,,100,0,0,64.47,99.31,-0.7,0.7,0.044,,,,-14.59,10.07,4.53,14.59,10.07,4.53,,,,,,,,,,,,,,,,,,,,,,,,,,,83.61,15.01,1.38,-8.62,8.79,-0.17,8.62,8.79,0.17,89.11,10.89,0,-0.76,0.76,0,0.76,0.76,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C09,1.4349,DNB_557C09,NB-munselle-5020702-0004,5.6,Histidine,0,50,0,0,0,,,,100,0,0,65.01,99.7,-0.3,0.3,0.0438,,,,-14.12,9.98,4.15,14.12,9.98,4.15,58.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.8,14.89,1.31,-8.43,8.67,-0.24,8.43,8.67,0.24,89.55,10.45,0,-0.32,0.32,0,0.32,0.32,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C10,1.4193,DNB_557C10,NB-munselle-5020702-0004,6.2,Histidine,0,50,0,0,0,,,,100,0,0,65.14,99.39,-0.6,0.6,0.0426,,,,-14.87,11.32,3.56,14.87,11.32,3.56,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,85.21,13.27,1.53,-7.02,7.05,-0.02,7.02,7.05,0.02,89.4,10.6,0,-0.47,0.47,0,0.47,0.47,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,C11,1.4143,DNB_557C11,NB-munselle-5020702-0004,6.8,Histidine,0,50,0,0,0,,,,100,0,0,65.36,99.75,-0.2,0.2,0.0429,,,,-19.21,15.6,3.61,19.21,15.6,3.61,60.4,,,,,,,,,,,,,,,,,,,,,,,,,,82.7,15.5,1.8,-9.53,9.28,0.25,9.53,9.28,0.25,89.83,10.17,0,-0.04,0.04,0,0.04,0.04,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D02,1.3719,DNB_557D02,NB-munselle-5020702-0004,4.5,Acetate,0,150,0,0,0,,,,100,0,0,64.66,99.7,-0.3,0.3,0.0421,,,,,,,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,78.45,20.11,1.44,-13.78,13.89,-0.11,13.78,13.89,0.11,67.94,8.1,23.96,-21.93,-2.03,23.96,21.93,2.03,23.96,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D03,1.4196,DNB_557D03,NB-munselle-5020702-0004,5,Acetate,0,150,0,0,0,,,,100,0,0,65.48,99.75,-0.2,0.2,0.0421,,,,,,,,,,56.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.82,16.72,1.47,-10.41,10.5,-0.08,10.41,10.5,0.08,88.97,10.18,0.85,-0.9,0.05,0.85,0.9,0.05,0.85,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D04,1.4378,DNB_557D04,NB-munselle-5020702-0004,5.6,Acetate,0,150,0,0,0,,,,100,0,0,65.98,99.76,-0.2,0.2,0.0436,,,,,,,,,,60.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.51,15.13,1.36,-8.72,8.91,-0.19,8.72,8.91,0.19,89.72,10.28,0,-0.15,0.15,0,0.15,0.15,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D05,1.4079,DNB_557D05,NB-munselle-5020702-0004,6.2,Acetate,0,150,0,0,0,,,,100,0,0,65.21,98.28,-1.7,1.7,0.043,,,,,,,,,,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,85.12,13.14,1.73,-7.11,6.92,0.18,7.11,6.92,0.18,89.84,10.16,0,-0.03,0.03,0,0.03,0.03,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D06,1.4209,DNB_557D06,NB-munselle-5020702-0004,5.6,Citrate,0,150,0,0,0,,,,100,0,0,66.01,99.75,-0.2,0.2,0.0422,,,,,,,,,,58.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.24,15.44,1.33,-8.99,9.22,-0.22,8.99,9.22,0.22,89.69,10.31,0,-0.18,0.18,0,0.18,0.18,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D07,1.4257,DNB_557D07,NB-munselle-5020702-0004,6.2,Citrate,0,150,0,0,0,,,,100,0,0,66.27,99.77,-0.2,0.2,0.0423,,,,,,,,,,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.45,15.94,1.6,-9.78,9.72,0.05,9.78,9.72,0.05,89.35,10.65,0,-0.52,0.52,0,0.52,0.52,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D08,1.4138,DNB_557D08,NB-munselle-5020702-0004,5,Histidine,0,150,0,0,0,,,,100,0,0,65.21,99.68,-0.3,0.3,0.0438,,,,,,,,,,53.8,,,,,,,,,,,,,,,,,,,,,,,,,,80.15,18.22,1.63,-12.08,12,0.08,12.08,12,0.08,85.28,10.06,4.66,-4.59,-0.07,4.66,4.59,0.07,4.66,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D09,1.4041,DNB_557D09,NB-munselle-5020702-0004,5.6,Histidine,0,150,0,0,0,,,,100,0,0,65.88,99.71,-0.3,0.3,0.0444,,,,,,,,,,57,,,,,,,,,,,,,,,,,,,,,,,,,,82.46,15.83,1.71,-9.77,9.61,0.16,9.77,9.61,0.16,88.94,11.06,0,-0.93,0.93,0,0.93,0.93,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D10,1.429,DNB_557D10,NB-munselle-5020702-0004,6.2,Histidine,0,150,0,0,0,,,,100,0,0,66.07,99.74,-0.3,0.3,0.0442,,,,,,,,,,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.97,14.02,2.01,-8.26,7.8,0.46,8.26,7.8,0.46,88.55,11.45,0,-1.32,1.32,0,1.32,1.32,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,D11,1.4353,DNB_557D11,NB-munselle-5020702-0004,6.8,Histidine,0,150,0,0,0,,,,100,0,0,66.23,99.76,-0.2,0.2,0.0435,,,,,,,,,,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.01,15.37,1.63,-9.22,9.15,0.08,9.22,9.15,0.08,89.27,10.73,0,-0.6,0.6,0,0.6,0.6,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,,5,12,H02,1.4247,DNB_557H02,NB-munselle-5020702-0004,5.2,Acetate,0,0,0,0,0,,,,100,0,0,69.47,100,0,0,0.0391,,,,0,0,0,0,0,0,64.4,,,,,,,,,,,,,,,,,,,,,,,,,,92.23,6.22,1.55,0,0,0,0,0,0,89.87,10.13,0,0,0,0,0,0,0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E02,1.4611,DNB_558E02,NB-munselle-5020702-0004,4.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0408,,,,-13.16,9.24,3.92,13.16,9.24,3.92,63.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.74,14.33,2.93,-9.67,9.31,0.36,9.67,9.31,0.36,89.51,10.49,0,-0.66,0.66,0,0.66,0.66,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E03,1.4479,DNB_558E03,NB-munselle-5020702-0004,5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0433,,,,-13.19,9.27,3.92,13.19,9.27,3.92,63.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.07,13.94,2.99,-9.34,8.92,0.42,9.34,8.92,0.42,89.74,10.26,0,-0.43,0.43,0,0.43,0.43,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E04,1.4579,DNB_558E04,NB-munselle-5020702-0004,5.6,Acetate,0,0,0,0,0,,,,,,,,,,,0.0425,,,,-13.86,10.11,3.74,13.86,10.11,3.74,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.33,13.63,3.05,-9.08,8.61,0.48,9.08,8.61,0.48,89.62,10.38,0,-0.55,0.55,0,0.55,0.55,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E05,1.4371,DNB_558E05,NB-munselle-5020702-0004,6.2,Acetate,0,0,0,0,0,,,,,,,,,,,0.0477,,,,-14.65,10.81,3.84,14.65,10.81,3.84,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.09,13.94,2.97,-9.32,8.92,0.4,9.32,8.92,0.4,89.91,10.09,0,-0.26,0.26,0,0.26,0.26,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E06,1.4275,DNB_558E06,NB-munselle-5020702-0004,5.6,Citrate,0,0,0,0,0,,,,,,,,,,,0.0416,,,,-17.52,14.74,2.79,17.52,14.74,2.79,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.55,14.17,3.28,-9.86,9.15,0.71,9.86,9.15,0.71,89.77,10.23,0,-0.4,0.4,0,0.4,0.4,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E07,1.429,DNB_558E07,NB-munselle-5020702-0004,6.2,Citrate,0,0,0,0,0,,,,,,,,,,,0.0437,,,,-18.59,15.85,2.74,18.59,15.85,2.74,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,80.83,16.04,3.12,-11.58,11.02,0.55,11.58,11.02,0.55,90.07,9.82,0.11,-0.1,-0.01,0.11,0.1,0.01,0.11,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E08,1.4505,DNB_558E08,NB-munselle-5020702-0004,5,Histidine,0,0,0,0,0,,,,,,,,,,,0.043,,,,-12,7.54,4.46,12,7.54,4.46,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.23,13.91,2.85,-9.18,8.89,0.28,9.18,8.89,0.28,88.94,11.06,0,-1.23,1.23,0,1.23,1.23,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E09,1.457,DNB_558E09,NB-munselle-5020702-0004,5.6,Histidine,0,0,0,0,0,,,,,,,,,,,0.0434,,,,-12.33,8.57,3.76,12.33,8.57,3.76,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,82.66,14.11,3.23,-9.75,9.09,0.66,9.75,9.09,0.66,89.14,10.86,0,-1.03,1.03,0,1.03,1.03,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E10,1.4413,DNB_558E10,NB-munselle-5020702-0004,6.2,Histidine,0,0,0,0,0,,,,,,,,,,,0.0444,,,,-13.18,9.78,3.39,13.18,9.78,3.39,64.6,,,,,,,,,,,,,,,,,,,,,,,,,,84.35,12.37,3.29,-8.06,7.35,0.72,8.06,7.35,0.72,89.32,10.68,0,-0.85,0.85,0,0.85,0.85,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,E11,1.4425,DNB_558E11,NB-munselle-5020702-0004,6.8,Histidine,0,0,0,0,0,,,,,,,,,,,0.0433,,,,-17.59,14.42,3.17,17.59,14.42,3.17,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.51,15.38,3.11,-10.9,10.36,0.54,10.9,10.36,0.54,89.55,10.45,0,-0.62,0.62,0,0.62,0.62,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F02,1.4487,DNB_558F02,NB-munselle-5020702-0004,4.5,Acetate,0,50,0,0,0,,,,,,,,,,,0.0415,,,,-15.02,9.68,5.34,15.02,9.68,5.34,56.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.55,15.32,3.13,-10.86,10.3,0.56,10.86,10.3,0.56,89.61,10.39,0,-0.56,0.56,0,0.56,0.56,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F03,1.4621,DNB_558F03,NB-munselle-5020702-0004,5,Acetate,0,50,0,0,0,,,,,,,,,,,0.0423,,,,-14.5,10.59,3.9,14.5,10.59,3.9,59.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.29,15.59,3.12,-11.12,10.57,0.55,11.12,10.57,0.55,89.36,10.64,0,-0.81,0.81,0,0.81,0.81,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F04,1.44,DNB_558F04,NB-munselle-5020702-0004,5.6,Acetate,0,50,0,0,0,,,,,,,,,,,0.0435,,,,-13.8,10.01,3.79,13.8,10.01,3.79,60,,,,,,,,,,,,,,,,,,,,,,,,,,82.83,13.97,3.2,-9.58,8.95,0.63,9.58,8.95,0.63,89.74,10.26,0,-0.43,0.43,0,0.43,0.43,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F05,1.4627,DNB_558F05,NB-munselle-5020702-0004,6.2,Acetate,0,50,0,0,0,,,,,,,,,,,0.0435,,,,-14.41,10.61,3.8,14.41,10.61,3.8,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.92,13.68,3.4,-9.49,8.66,0.83,9.49,8.66,0.83,89.92,10.08,0,-0.25,0.25,0,0.25,0.25,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F06,1.4535,DNB_558F06,NB-munselle-5020702-0004,5.6,Citrate,0,50,0,0,0,,,,,,,,,,,0.0442,,,,-16.2,13.99,2.2,16.2,13.99,2.2,59.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.78,14.73,3.48,-10.63,9.71,0.91,10.63,9.71,0.91,89.93,9.98,0.1,-0.24,0.15,0.1,0.24,0.15,0.1,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F07,1.4575,DNB_558F07,NB-munselle-5020702-0004,6.2,Citrate,0,50,0,0,0,,,,,,,,,,,0.0444,,,,-17.54,14.38,3.16,17.54,14.38,3.16,61.6,,,,,,,,,,,,,,,,,,,,,,,,,,80.77,15.93,3.29,-11.64,10.91,0.72,11.64,10.91,0.72,90.27,9.58,0.15,0.1,-0.25,0.15,0.1,0.25,0.15,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F08,1.4558,DNB_558F08,NB-munselle-5020702-0004,5,Histidine,0,50,0,0,0,,,,,,,,,,,0.0443,,,,-13.25,8.68,4.57,13.25,8.68,4.57,56.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.78,14.87,3.35,-10.63,9.85,0.78,10.63,9.85,0.78,89.08,10.92,0,-1.09,1.09,0,1.09,1.09,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F09,1.4481,DNB_558F09,NB-munselle-5020702-0004,5.6,Histidine,0,50,0,0,0,,,,,,,,,,,0.0441,,,,-11.93,8.05,3.88,11.93,8.05,3.88,58.8,,,,,,,,,,,,,,,,,,,,,,,,,,82.45,14.41,3.15,-9.96,9.39,0.58,9.96,9.39,0.58,88.95,11.05,0,-1.22,1.22,0,1.22,1.22,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F10,1.4519,DNB_558F10,NB-munselle-5020702-0004,6.2,Histidine,0,50,0,0,0,,,,,,,,,,,0.0445,,,,-11.98,8.16,3.82,11.98,8.16,3.82,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.12,13.55,3.33,-9.29,8.53,0.76,9.29,8.53,0.76,89.57,10.43,0,-0.6,0.6,0,0.6,0.6,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,F11,1.4148,DNB_558F11,NB-munselle-5020702-0004,6.8,Histidine,0,50,0,0,0,,,,,,,,,,,0.0434,,,,-15.56,11.99,3.57,15.56,11.99,3.57,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,80.97,15.91,3.12,-11.44,10.89,0.55,11.44,10.89,0.55,89.53,10.47,0,-0.64,0.64,0,0.64,0.64,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G02,1.4621,DNB_558G02,NB-munselle-5020702-0004,4.5,Acetate,0,150,0,0,0,,,,,,,,,,,0.0413,,,,,,,,,,51.8,,,,,,,,,,,,,,,,,,,,,,,,,,81.52,15.04,3.44,-10.89,10.02,0.87,10.89,10.02,0.87,75.96,8.12,15.93,-14.21,-1.71,15.93,14.21,1.71,15.93,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G03,1.4431,DNB_558G03,NB-munselle-5020702-0004,5,Acetate,0,150,0,0,0,,,,,,,,,,,0.0417,,,,,,,,,,56.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.14,14.39,3.47,-10.27,9.37,0.9,10.27,9.37,0.9,89.64,10.1,0.25,-0.53,0.27,0.25,0.53,0.27,0.25,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G04,1.4693,DNB_558G04,NB-munselle-5020702-0004,5.6,Acetate,0,150,0,0,0,,,,,,,,,,,0.0426,,,,,,,,,,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.88,13.99,3.13,-9.53,8.97,0.56,9.53,8.97,0.56,89.97,9.99,0.03,-0.2,0.16,0.03,0.2,0.16,0.03,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G05,1.4468,DNB_558G05,NB-munselle-5020702-0004,6.2,Acetate,0,150,0,0,0,,,,,,,,,,,0.0434,,,,,,,,,,60.8,,,,,,,,,,,,,,,,,,,,,,,,,,82.48,14,3.52,-9.93,8.98,0.95,9.93,8.98,0.95,90.1,9.9,0,-0.07,0.07,0,0.07,0.07,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G06,1.4608,DNB_558G06,NB-munselle-5020702-0004,5.6,Citrate,0,150,0,0,0,,,,,,,,,,,0.042,,,,,,,,,,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.93,14.64,3.43,-10.48,9.62,0.86,10.48,9.62,0.86,90.15,9.85,0,-0.02,0.02,0,0.02,0.02,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G07,1.4506,DNB_558G07,NB-munselle-5020702-0004,6.2,Citrate,0,150,0,0,0,,,,,,,,,,,0.0429,,,,,,,,,,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.39,15.27,3.33,-11.02,10.25,0.76,11.02,10.25,0.76,90.02,9.98,0,-0.15,0.15,0,0.15,0.15,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G08,1.443,DNB_558G08,NB-munselle-5020702-0004,5,Histidine,0,150,0,0,0,,,,,,,,,,,0.0438,,,,,,,,,,54,,,,,,,,,,,,,,,,,,,,,,,,,,81.94,14.87,3.2,-10.47,9.85,0.63,10.47,9.85,0.63,86.13,11.64,2.24,-4.04,1.81,2.24,4.04,1.81,2.24,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G09,1.4587,DNB_558G09,NB-munselle-5020702-0004,5.6,Histidine,0,150,0,0,0,,,,,,,,,,,0.0435,,,,,,,,,,55.8,,,,,,,,,,,,,,,,,,,,,,,,,,82.84,14.42,2.74,-9.57,9.4,0.17,9.57,9.4,0.17,86.97,13.03,0,-3.2,3.2,0,3.2,3.2,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G10,1.4352,DNB_558G10,NB-munselle-5020702-0004,6.2,Histidine,0,150,0,0,0,,,,,,,,,,,0.0435,,,,,,,,,,59.8,,,,,,,,,,,,,,,,,,,,,,,,,,85.66,11.46,2.88,-6.75,6.44,0.31,6.75,6.44,0.31,86.78,13.08,0.14,-3.39,3.25,0.14,3.39,3.25,0.14,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40,12,G11,1.4426,DNB_558G11,NB-munselle-5020702-0004,6.8,Histidine,0,150,0,0,0,,,,,,,,,,,0.0426,,,,,,,,,,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.98,14.91,3.11,-10.43,9.89,0.54,10.43,9.89,0.54,86.84,13.02,0.14,-3.33,3.19,0.14,3.33,3.19,0.14,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,,5,12,H07,1.4322,DNB_558H07,NB-munselle-5020702-0004,5.2,Acetate,0,0,0,0,0,,,,,,,,,,,0.0388,,,,0,0,0,0,0,0,65.2,,,,,,,,,,,,,,,,,,,,,,,,,,92.41,5.02,2.57,0,0,0,0,0,0,90.17,9.83,0,0,0,0,0,0,0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,0,0,0,0,,,,100,0,,,99,-0.5,,0.0537,60.1,30.9,9,-19.2,,,,,,53.6,55.6,5957.1,1493.5,288.5,152.7,84.9,33.9,0,0,,7552.5,2223.3,390.4,186.7,50.9,0,0,0,,,,,,,,91.6,5.55,2.83,-3,2,1,,,,87.6,9.41,3,-5,4,2,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B03,1,,NB-munselle-5020702-0007,5,Acetate,0,0,0,0,0,,,,100,0,,,99,-0.3,,0.056,62.2,32.2,5.6,-17.1,,,,,,54.8,56.6,10658.4,1714.2,135.8,101.8,33.9,0,0,0,,8231.4,1951.8,288.5,186.7,67.9,17,17,17,,,,,,,,91.9,5.21,2.92,-3,2,1,,,,84.9,9.37,5.72,-8,4,4,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,0,0,0,0,,,,98,-2,,,99,-0.3,,0.0586,59.8,35.1,5.1,-19.5,,,,,,56,54.6,22963.6,1425.7,135.8,33.9,17,0,0,0,,28615.7,2783.5,322.5,169.7,33.9,17,0,0,,,,,,,,92.1,4.84,3.11,-2,2,1,,,,85.4,8.03,6.54,-7,2,5,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B05,1,,NB-munselle-5020702-0007,6.2,Acetate,0,0,0,0,0,,,,96,-4,,,100,0,,0.0604,58.5,35.8,5.7,-20.8,,,,,,56.6,49.6,77672,2376.3,220.7,50.9,17,0,0,0,,137357.5,4854.7,882.7,271.6,50.9,33.9,0,0,,,,,,,,91.8,4.68,3.53,-3,2,1,,,,86.8,8.13,5.12,-6,3,4,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B06,1,,NB-munselle-5020702-0007,5.6,Citrate,0,0,0,0,0,,,,97,-3,,,99.7,0,,0.0706,60.3,35.5,4.2,-19,,,,,,54.6,48.6,290078.2,3501.9,442,272,102,51,51,34,,4557712.9,41364.3,5170.5,2006.5,565.9,385.9,102.9,25.7,,,,,,,,91.3,5.45,3.29,-3,2,1,,,,79.9,8.13,11.95,-13,3,10,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B07,1,,NB-munselle-5020702-0007,6.2,Citrate,0,0,0,0,0,,,,93,-7,,,99.8,0.1,,0.063,56.6,38,5.4,-22.7,,,,,,57.8,52.8,330599.4,3785.9,696.1,288.6,169.8,152.8,50.9,50.9,,1114791.7,26321.9,4907.8,2547.3,1001.9,713.2,50.9,17,,,,,,,,91.5,4.76,3.79,-3,2,1,,,,86,7.44,6.61,-7,2,5,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B08,1,,NB-munselle-5020702-0007,5,Histidine,0,0,0,0,0,,,,100,0,,,99.4,-0.3,,0.0568,65,29.4,5.6,-14.3,,,,,,54.8,52.8,12983.6,3055,492.2,152.7,33.9,33.9,0,0,,14222.5,4158.1,678.9,356.4,84.9,67.9,0,0,,,,,,,,91.9,5.32,2.79,-3,2,0,,,,85.2,8.61,6.2,-8,3,5,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B09,1,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0,0,0,,,,100,0,,,99.4,-0.3,,0.0581,62.9,31.9,5.2,-16.4,,,,,,54.6,56.6,19518.1,2800.4,390.4,118.8,17,17,0,0,,21028.3,5159.5,865.6,373.4,152.7,33.9,0,0,,,,,,,,92.5,4.92,2.63,-2,2,0,,,,84.2,8.19,7.61,-9,3,6,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B10,1,,NB-munselle-5020702-0007,6.2,Histidine,0,0,0,0,0,,,,100,0,,,99.6,-0.1,,0.0604,61.2,33.8,5,-18.1,,,,,,56,54.8,149515.5,2716,458.3,152.8,50.9,17,0,0,,109093.4,3870.1,645,288.6,50.9,33.9,17,17,,,,,,,,92.2,4.73,3.08,-2,2,1,,,,87.2,8.18,4.62,-6,3,3,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,B11,1,,NB-munselle-5020702-0007,6.8,Histidine,0,0,0,0,0,,,,97,-3,,,99.7,0,,0.0604,56,39.1,4.9,-23.3,,,,,,58.2,50.2,631835.1,1647,135.8,50.9,34,0,0,0,,747407.9,10969.1,1833.8,696.2,220.7,169.8,17,17,,,,,,,,92,4.75,3.21,-2,2,1,,,,88,8.06,3.91,-5,2,2,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,50,0,0,0,,,,97,-3,,,98.9,-0.8,,0.061,14.4,83.7,1.9,-64.9,,,,,,48,46,20332.5,1799,203.7,84.9,33.9,0,0,0,,54347,6398.8,1561.5,848.6,288.5,101.8,0,0,,,,,,,,81.3,13.62,5.13,-13,10,3,,,,42.1,5.77,52.17,-51,0,51,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C03,1,,NB-munselle-5020702-0007,5,Acetate,0,50,0,0,0,,,,98,-2,,,99.5,-0.3,,0.0602,45.1,50.3,4.6,-34.2,,,,,,50,44.2,42855.1,1816,203.7,33.9,17,17,0,0,,195031.1,5992.3,662,288.6,17,0,0,0,,,,,,,,89.1,7.55,3.33,-5,4,1,,,,72.2,6.74,21.08,-21,1,20,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,50,0,0,0,,,,99,-1,,,99.8,0.1,,0.0636,55.5,39.5,5,-23.8,,,,,,53,43.6,96646.9,3649.3,475.3,237.6,135.8,67.9,0,0,,992805.7,12277.6,1613.2,594.4,50.9,0,0,0,,,,,,,,91.1,5.41,3.48,-3,2,1,,,,79.6,5.76,14.67,-13,0,13,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C05,1,,NB-munselle-5020702-0007,6.2,Acetate,0,50,0,0,0,,,,100,0,,,99.8,0.1,,0.0637,54.8,39.5,5.7,-24.5,,,,,,54.2,46,191667.1,3617,1256.6,984.9,611.3,407.5,135.8,17,,1281924,25728.8,3787.1,1188.8,186.8,101.9,0,0,,,,,,,,91.5,4.93,3.57,-3,2,1,,,,79.9,5.78,14.36,-13,0,13,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C06,1,,NB-munselle-5020702-0007,5.6,Citrate,0,50,0,0,0,,,,91,-9,,,99.7,0,,0.0684,53.9,41.6,4.5,-25.4,,,,,,53.6,46,158386,10281.5,4622.4,3619.8,2566.1,2073.3,407.9,203.9,,3320574.5,50459.2,11259.5,4567.3,814.2,516.3,39.7,19.9,,,,,,,,90.5,5.8,3.69,-4,3,1,,,,76,5.7,18.29,-17,0,17,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C07,1,,NB-munselle-5020702-0007,6.2,Citrate,0,50,0,0,0,,,,90,-10,,,100,0.3,,0.0637,53,39.4,7.6,-26.3,,,,,,56.4,49.2,208019.4,17501.1,5845.1,3817.2,2044.9,1533.7,562.4,289.7,,729985.4,21479.1,3565.7,1307.4,356.6,288.7,17,0,,,,,,,,91.3,5.12,3.57,-3,2,1,,,,85.3,5.38,9.17,-8,0,8,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C08,1,,NB-munselle-5020702-0007,5,Histidine,0,50,0,0,0,,,,98,-2,,,99,-0.7,,0.0612,29.6,67.3,3.1,-49.7,,,,,,48,49.4,39528.7,1900.9,271.6,186.7,135.8,118.8,0,0,,108599.3,5295.9,577.1,220.7,17,0,0,0,,,,,,,,86.2,10.79,3.03,-8,8,1,,,,49.9,6.96,43.17,-43,1,42,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C09,1,,NB-munselle-5020702-0007,5.6,Histidine,0,50,0,0,0,,,,99,-1,,,99.3,-0.4,,0.062,56.5,38.6,4.9,-22.8,,,,,,51,45.4,85919,2308.4,492.2,288.5,186.7,135.8,0,0,,504030.6,16010.4,3191.9,1426.2,322.6,169.8,0,0,,,,,,,,91.1,5.96,2.99,-3,3,1,,,,78.8,5.84,15.39,-14,0,14,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C10,1,,NB-munselle-5020702-0007,6.2,Histidine,0,50,0,0,0,,,,99,-1,,,99.7,0,,0.0641,57.5,37.4,5.1,-21.8,,,,,,54,45.4,248444.9,3327.3,1086.5,730,305.6,101.9,17,0,,1251707.8,14809.1,3243.7,1715.3,475.5,169.8,0,0,,,,,,,,92.1,5.08,2.85,-2,2,1,,,,80.7,5.48,13.79,-12,0,12,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,C11,1,,NB-munselle-5020702-0007,6.8,Histidine,0,50,0,0,0,,,,99,-1,,,99.7,0,,0.0624,57.3,37.5,5.2,-22,,,,,,55.4,49.6,407812.4,6912.6,2632.6,2004.2,1070,747.3,322.7,203.8,,986449.5,54473.5,10561.9,4448.9,832,322.6,34,0,,,,,,,,92.5,4.67,2.84,-2,2,1,,,,88,5.81,6.19,-5,0,5,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,150,0,0,0,,,,97,-3,,,98.7,-1,,0.0623,,,,,,,,,,42.8,40.4,62747.1,4616.5,1748.2,1256,848.6,594,0,0,,911993.2,94800.8,28645.7,15791.6,3973.4,1103.7,0,0,,,,,,,,79.2,16.27,4.55,-15,13,2,,,,4.5,2.48,92.98,-88,-3,91,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D03,1,,NB-munselle-5020702-0007,5,Acetate,0,150,0,0,0,,,,97,-3,,,99.2,-0.5,,0.0694,,,,,,,,,,45.8,47,109320.6,13917.9,7375.3,6559.6,4843.2,3806.6,475.8,85,,2751439.2,73198.4,18478.3,10157.9,2109.9,1003.9,119.1,85.1,,,,,,,,82.5,12.6,4.9,-12,9,3,,,,9.5,2.69,87.81,-83,-3,86,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,150,0,0,0,,,,98,-2,,,100,0.3,,0.0664,,,,,,,,,,51,45.4,118628.6,12424.7,6857.3,6110.5,4820.5,3937.9,254.6,84.9,,2456025,49813.8,11832.9,7412.6,4403.3,3502.3,170,51,,,,,,,,90.4,6.47,3.14,-4,3,1,,,,71.7,4.29,23.99,-21,-1,22,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D05,1,,NB-munselle-5020702-0007,6.2,Acetate,0,150,0,0,0,,,,99,-1,,,100,0.3,,0.066,,,,,,,,,,53.8,47.6,154048,27195,14271,11849.8,8797.9,7024.7,613.8,153.5,,2132237.1,51046.4,13972.7,8567.2,5490.5,4470.6,238,102,,,,,,,,91.3,5.38,3.3,-3,2,1,,,,79,4.4,16.61,-14,-1,15,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D06,1,,NB-munselle-5020702-0007,5.6,Citrate,0,150,0,0,0,,,,80,-20,,,100,0.3,,0.0669,,,,,,,,,,51.4,52,111726.6,9849.2,5426.4,4831.1,3929.5,3334.1,442.3,187.1,,2907557,51397.9,12787.5,8324.3,5490.5,4516.4,194.8,124,,,,,,,,90.1,6.76,3.13,-4,4,1,,,,68.6,4.27,27.1,-24,-1,26,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D07,1,,NB-munselle-5020702-0007,6.2,Citrate,0,150,0,0,0,,,,99,-1,,,100,0.3,,0.0617,,,,,,,,,,55,49,118386.7,8809,1697.3,1035.4,543.1,407.4,50.9,33.9,,786741.3,39533.5,10019.5,6617.3,4048.6,3249.1,340.2,102.1,,,,,,,,91.9,4.94,3.15,-3,2,1,,,,83.2,4.12,12.7,-10,-2,11,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D08,1,,NB-munselle-5020702-0007,5,Histidine,0,150,0,0,0,,,,98,-2,,,97,-2.8,,0.0671,,,,,,,,,,45.2,44.2,99613.7,5295.5,1867,1425.7,984.4,814.7,101.8,50.9,,2158469.7,173778.9,37470.1,17359.2,3159.3,1053.1,51,17,,,,,,,,80.7,14.2,5.07,-14,11,3,,,,6,1.32,92.72,-87,-4,91,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D09,1,,NB-munselle-5020702-0007,5.6,Histidine,0,150,0,0,0,,,,98,-2,,,99.6,-0.1,,0.0677,,,,,,,,,,49.4,42.4,142817.6,10577.8,4829.7,4217.5,3656.3,3027.1,561.2,255.1,,2685153.5,65538.8,16919.8,11585.7,7083.9,5266.2,118.9,84.9,,,,,,,,89,8.05,3,-6,5,1,,,,55.2,4.27,40.5,-38,-1,39,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D10,1,,NB-munselle-5020702-0007,6.2,Histidine,0,150,0,0,0,,,,98,-2,,,100,0.3,,0.0666,,,,,,,,,,53.6,48.2,141561.3,14305.6,5216,4162.6,2990.3,2599.5,322.8,169.9,,1541421.7,39894.2,10139.1,6504.7,4636.5,3838.3,441.6,135.9,,,,,,,,92.2,4.85,2.93,-2,2,1,,,,80.5,4.18,15.34,-12,-1,14,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40,12,D11,1,,NB-munselle-5020702-0007,6.8,Histidine,0,150,0,0,0,,,,98,-2,,,100,0.3,,0.0603,,,,,,,,,,55,47,107171.2,5805,1459.7,797.8,492.2,322.5,50.9,17,,300250.9,26659.1,5929.9,3279.3,1750.1,1138.4,186.9,85,,,,,,,,92.4,4.85,2.76,-2,2,0,,,,90,4.87,5.12,-3,-1,4,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,5,0,H02,1,,NB-munselle-5020702-0007,5.2,Acetate,0,0,0,0,0,,,,100,,,,99.7,,,0.0527,79.3,16.7,4,0,,,,,,57.4,56.6,40410.5,20824.7,509.2,135.8,17,17,0,0,,31483.1,8638.7,1289.9,543.1,33.9,33.9,17,0,,,,,,,,94.5,3.17,2.31,0,0,0,,,,92.9,5.63,1.5,0,-6.33,0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,-80,0,H03,1,,NB-munselle-5020702-0007,5.5,Frozen,0,0,0,0,0,,,,99,,,,,,,0.057,70.7,25.8,3.5,-8.6,,,,,,56.2,61.4,357667.8,127879.1,14818,6161.4,1273,509.2,17,17,,357667.8,127879.1,14818,6161.4,1273,509.2,17,17,,,,,,,,93.9,3.18,2.89,0,0,0,,,,91.5,7.02,1.53,-1.42,,0.03,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,0,0,0,0,,,,100,1,,,99.2,-0.5,,0.0532,54.4,38.3,7.3,-29.9,,,,,,54.2,51.6,28479.1,2749.5,526.1,373.4,50.9,0,0,0,,12168.9,3207.7,678.9,424.3,101.8,33.9,0,0,,,,,,,,90.3,6.24,3.42,-4,3,1,,,,86.9,6.71,6.44,-6,0,5,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E03,1,,NB-munselle-5020702-0007,5,Acetate,0,0,0,0,0,,,,100,1,,,99.3,-0.5,,0.0555,54.2,39.8,6,-30.1,,,,,,54.2,49.6,92703.8,6093.1,526.1,203.7,101.8,67.9,0,0,,41157.4,7315,1714.2,916.5,203.7,101.8,0,0,,,,,,,,90.9,5.57,3.55,-4,3,1,,,,85.6,6.45,8,-7,0,7,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,0,0,0,0,,,,97,-2,,,99.4,-0.3,,0.0566,54.5,40,5.5,-29.8,,,,,,54.4,51.4,104703.1,8112.8,746.8,356.4,152.8,33.9,0,0,,51714.4,8112.7,1476.6,678.9,84.9,0,0,0,,,,,,,,91,5.24,3.75,-4,2,1,,,,83.5,5.88,10.65,-9,0,9,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E05,1,,NB-munselle-5020702-0007,6.2,Acetate,0,0,0,0,0,,,,97,-2,,,100,0.3,,0.058,52.3,42.1,5.6,-32,,,,,,54.2,49.4,129317.8,8707.2,577.1,288.5,84.9,50.9,17,0,,80026.1,9776.3,2206.4,950.5,84.9,0,0,0,,,,,,,,91.2,4.91,3.91,-3,2,1,,,,78.5,5.89,15.56,-14,0,14,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E06,1,,NB-munselle-5020702-0007,5.6,Citrate,0,0,0,0,0,,,,97,-2,,,99.3,-0.4,,0.0714,40.8,55.1,4.1,-43.5,,,,,,50.8,45.6,343996.5,30101.8,5730.4,3752.1,2438.8,2097.7,869.8,579.9,,4539343.5,120262.7,10729.6,3152.8,432.2,152.6,0,0,,,,,,,,90.1,6.57,3.31,-4,4,1,,,,62.2,5.63,32.17,-30,-1,31,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E07,1,,NB-munselle-5020702-0007,6.2,Citrate,0,0,0,0,0,,,,96,-3,,,99.8,0.1,,0.0653,47.9,47.7,4.4,-36.4,,,,,,54.4,49.4,369594,33964.2,5388.7,3144.8,1716.9,1410.9,442,272,,2508716.8,68800.6,7374.5,1920.1,373.8,271.9,135.9,51,,,,,,,,90.4,5.49,4.1,-4,3,2,,,,71.6,5.53,22.88,-21,-1,22,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E08,1,,NB-munselle-5020702-0007,5,Histidine,0,0,0,0,0,,,,100,1,,,99.2,-0.5,,0.0554,64.9,28.7,6.4,-19.4,,,,,,52,50.2,112578.7,7162.4,848.6,356.4,101.8,33.9,0,0,,34521.3,5566.9,1069.2,526.1,67.9,17,0,0,,,,,,,,91.4,5.66,2.96,-3,3,0,,,,86.3,6.89,6.78,-6,1,6,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E09,1,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0,0,0,,,,100,1,,,99.3,-0.4,,0.0564,63,31.1,5.9,-21.3,,,,,,54.6,53.4,117705.8,9267.1,882.6,322.5,118.8,33.9,0,0,,38441.7,6296.6,1306.8,560.1,135.8,17,0,0,,,,,,,,92.1,4.95,2.95,-3,2,0,,,,85.1,6.55,8.35,-7,0,7,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E10,1,,NB-munselle-5020702-0007,6.2,Histidine,0,0,0,0,0,,,,100,1,,,99.7,0,,0.0584,55.8,39.3,4.9,-28.5,,,,,,54.2,55.8,181953.3,13748.3,1595.5,899.6,492.2,203.7,33.9,0,,73490.9,10760.6,2053.7,1086.2,407.3,186.7,17,0,,,,,,,,92.2,4.42,3.41,-2,2,1,,,,79.9,6.38,13.73,-13,0,12,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,E11,1,,NB-munselle-5020702-0007,6.8,Histidine,0,0,0,0,0,,,,98,-1,,,99.7,0,,0.0586,50.2,45.4,4.4,-34.1,,,,,,54.4,50.6,315913.5,10813.4,1035.5,560.2,203.7,101.9,0,0,,454341.5,33920.3,6926.7,3429.4,764,356.5,34,0,,,,,,,,91.9,4.7,3.37,-3,2,1,,,,80.2,4.01,15.82,-12,-2,15,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,50,0,0,0,,,,94,-5,,,98,-1.7,,0.0559,9.3,88.9,1.8,-75,,,,,,45.6,43.4,78787,2800.5,441.3,254.6,84.9,33.9,17,17,,65428.8,10998.2,1867,611,237.6,84.9,17,0,,,,,,,,74.5,20.34,5.16,-20,18,3,,,,19.5,3.32,77.23,-73,-3,76,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F03,1,,NB-munselle-5020702-0007,5,Acetate,0,50,0,0,0,,,,96,-3,,,98.9,-0.8,,0.0582,32.1,65.8,2.1,-52.2,,,,,,48.8,50,155355.6,8452.6,1459.7,831.7,390.4,288.5,17,0,,347115.4,40773.2,5805.3,1816.3,67.9,17,0,0,,,,,,,,82.8,12.35,4.9,-12,10,2,,,,53.8,5.04,41.19,-39,-1,40,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,50,0,0,0,,,,98,-2,,,99.3,-0.4,,0.0606,53.5,43.2,3.3,-30.8,,,,,,51,45.8,216908.8,15334.6,4432.3,2649.2,1154.8,679.3,169.8,50.9,,694463.7,88386.9,17962.6,7266.5,696.1,186.8,0,0,,,,,,,,90,6.84,3.17,-5,4,1,,,,76.8,4.91,18.32,-16,-1,17,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F05,1,,NB-munselle-5020702-0007,6.2,Acetate,0,50,0,0,0,,,,98,-1,,,99.7,0,,0.0608,51.9,46,2.1,-32.4,,,,,,51.8,45.2,211687.8,14742,5027.6,3544.9,2113.3,1448.6,460.2,153.4,,954814.3,55032.9,8880.7,3124.4,271.7,101.9,0,0,,,,,,,,91.8,5.1,3.08,-3,2,1,,,,77.6,3.23,19.19,-15,-3,18,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F06,1,,NB-munselle-5020702-0007,5.6,Citrate,0,50,0,0,0,,,,97,-2,,,99.2,-0.5,,0.0663,45.2,52,2.8,-39.1,,,,,,50.8,50.2,317552.8,33331.4,9279.6,6260.3,2644,1654.6,494.7,375.3,,2697652.6,118178.5,14082.2,3924,407.7,220.8,17,0,,,,,,,,88.7,7.85,3.48,-6,5,1,,,,62.3,4.6,33.13,-30,-2,32,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F07,1,,NB-munselle-5020702-0007,6.2,Citrate,0,50,0,0,0,,,,98,-1,,,100,0.3,,0.0635,48.8,47.1,4.1,-35.5,,,,,,54,48.4,344400.1,49599.6,15180.1,9551.5,4605.2,3121.3,716.4,443.5,,1690621.2,85462.6,13366.3,5112.1,900.1,628.4,118.9,34,,,,,,,,91,5.03,4,-4,2,1,,,,74.3,4.08,21.63,-18,-2,20,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F08,1,,NB-munselle-5020702-0007,5,Histidine,0,50,0,0,0,,,,96,-3,,,98.3,-1.4,,0.0593,18.6,78.2,3.2,-65.7,,,,,,46.2,39.8,186337,15062.5,2971.7,1952.9,815.1,492.5,84.9,0,,318457.4,36393.2,4549.1,1442.8,67.9,50.9,0,0,,,,,,,,78.1,17.36,4.52,-16,15,2,,,,31.4,2.78,65.83,-61,-4,65,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F09,1,,NB-munselle-5020702-0007,5.6,Histidine,0,50,0,0,0,,,,98,-2,,,99,-0.7,,0.06,59.6,35.4,5,-24.7,,,,,,49.6,54,193373,13026.3,3413.7,2089,1137.9,781.2,220.8,101.9,,548202.1,69722.1,12070.2,5126.9,458.4,220.7,34,0,,,,,,,,86.1,8.52,5.36,-8,6,3,,,,72.1,5.53,22.33,-20,-1,21,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F10,1,,NB-munselle-5020702-0007,6.2,Histidine,0,50,0,0,0,,,,96,-4,,,99.4,-0.3,,0.062,55.2,39.9,4.9,-29.1,,,,,,51.8,45,226353.9,19361.4,5150.6,3348.7,1546.9,917.9,374,221,,926110.1,56238,10188,4856.3,815,390.5,17,0,,,,,,,,91.6,4.94,3.46,-3,2,1,,,,76.2,5.1,18.74,-16,-1,17,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,F11,1,,NB-munselle-5020702-0007,6.8,Histidine,0,50,0,0,0,,,,99,-1,,,100,0.3,,0.0623,47.7,46.9,5.4,-36.6,,,,,,53.4,49.2,247743.5,9357.5,2751.2,1749.2,849.1,560.4,152.8,67.9,,1741782.7,50529.5,6861.8,2547.7,339.7,169.8,17,0,,,,,,,,92.3,4.06,3.68,-2,1,1,,,,73.6,3.56,22.83,-19,-3,22,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,150,0,0,0,,,,95,-4,,,98,-1.7,,0.0591,,,,,,,,,,40.6,39.2,139552.6,4367.9,1444.6,1002.8,509.9,322.9,68,34,,512246.5,40286.4,6366.4,2512.6,679.1,339.5,17,0,,,,,,,,73.2,20.21,6.55,-21,17,4,,,,4.5,1.46,94.03,-88,-5,93,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G03,1,,NB-munselle-5020702-0007,5,Acetate,0,150,0,0,0,,,,96,-3,,,98.6,-1.1,,0.0633,,,,,,,,,,45.2,48.8,234137.1,11852,3209.2,1901.8,764.1,492.4,118.9,50.9,,1837575.7,128130.3,17901.6,6556,1121,628.4,0,0,,,,,,,,76.2,17.41,6.44,-18,15,4,,,,7.6,1.49,91.14,-85,-5,90,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,150,0,0,0,,,,98,-1,,,99.5,-0.2,,0.0639,,,,,,,,,,49.6,50.8,297850.3,36042.3,9494.7,5146.5,1851.4,1104,271.8,101.9,,1979338.3,158071.9,24525.2,9052.6,1885.2,968.1,0,0,,,,,,,,85,9.5,5.53,-10,7,3,,,,56.4,2.68,40.89,-36,-4,40,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G05,1,,NB-munselle-5020702-0007,6.2,Acetate,0,150,0,0,0,,,,99,0,,,100,0.3,,0.0619,,,,,,,,,,51,52.6,172265.8,4299,645.7,407.8,305.9,237.9,102,68,,1503229.2,123328.8,19343.4,6674.2,815.2,577.4,34,0,,,,,,,,90.6,5.97,3.46,-4,3,1,,,,78.8,2.78,18.46,-14,-4,17,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G06,1,,NB-munselle-5020702-0007,5.6,Citrate,0,150,0,0,0,,,,99,-1,,,99.1,-0.6,,0.0655,,,,,,,,,,50,45.4,278588,23333.2,6135,4078.6,2022.3,1325.6,373.9,220.9,,2802579.8,168707.5,22727.6,7100.3,373.7,152.9,0,0,,,,,,,,84.2,10.01,5.77,-10,7,3,,,,48.3,2.82,48.88,-44,-4,48,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G07,1,,NB-munselle-5020702-0007,6.2,Citrate,0,150,0,0,0,,,,100,1,,,100,0.3,,0.0602,,,,,,,,,,53,48.4,316938.1,50812.8,15463.3,10189.8,4388.9,2721.8,578.4,221.1,,1159070.5,108709,18865.3,7980.8,2343.3,1664.1,0,0,,,,,,,,91.4,5,3.6,-3,2,1,,,,81.1,2.94,15.97,-11,-3,15,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G08,1,,NB-munselle-5020702-0007,5,Histidine,0,150,0,0,0,,,,97,-3,,,98.2,-1.5,,0.0637,,,,,,,,,,44.2,42.8,314256.7,46279.3,16418.9,10378.8,3556,1922.6,476.4,170.1,,1510100,126894.6,20345.3,7676.2,1511.5,815.2,0,0,,,,,,,,74.7,19.07,6.25,-20,16,4,,,,6.1,1.41,92.51,-86,-5,91,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G09,1,,NB-munselle-5020702-0007,5.6,Histidine,0,150,0,0,0,,,,98,-2,,,98.9,-0.9,,0.0665,,,,,,,,,,48.2,41,329321.4,38417.1,11068.8,6760.5,3627.2,2264.8,834.4,476.8,,2489197.8,176066,26584,9444.5,1274,611.5,101.9,17,,,,,,,,81.5,12.75,5.74,-13,10,3,,,,32.9,2.46,64.65,-60,-4,63,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G10,1,,NB-munselle-5020702-0007,6.2,Histidine,0,150,0,0,0,,,,99,-1,,,100,0.3,,0.0632,,,,,,,,,,51.4,45.8,285203.1,25689.8,5416.4,3446.8,1528.1,1188.6,322.6,118.9,,1361951.1,119995.8,20038.9,7506.1,1528.4,1188.8,84.9,17,,,,,,,,91.3,5.09,3.63,-3,2,1,,,,80.3,3.04,16.63,-12,-3,15,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40,12,G11,1,,NB-munselle-5020702-0007,6.8,Histidine,0,150,0,0,0,,,,99,-1,,,100,0.3,,0.0595,,,,,,,,,,53.6,49.6,211631.4,13731.9,2359.4,1273,475.3,288.6,84.9,17,,1117470.2,84821.5,14383.1,5892.5,1528.3,1239.6,34,0,,,,,,,,91.8,4.96,3.25,-3,2,1,,,,78.8,2.96,18.27,-14,-3,17,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,5,0,H07,1,,NB-munselle-5020702-0007,5.2,Acetate,0,0,0,0,0,,,,99,,,,99.7,,,0.0538,84.3,13.8,1.9,0,,,,,,54.6,53.2,165063,10862.8,712.9,322.5,67.9,17,0,0,,125140.4,15360.4,2223.4,1018.4,339.5,169.7,17,0,,,,,,,,94.6,2.83,2.56,0,0,0,,,,92.4,6.33,1.26,0,-6.33,0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,-80,0,H08,1,,NB-munselle-5020702-0007,5.5,Frozen,0,0,0,0,0,,,,100,,,,99.7,,,0.056,71.9,24.8,3.3,-12.4,,,,,,56.2,54,515894.9,112253.7,20590.3,8657.1,1137.3,237.6,0,0,,515894.9,112253.7,20590.3,8657.1,1137.3,237.6,0,0,,,,,,,,94.7,2.89,2.4,0,0,0,,,,94.2,5.29,0.54,1.76,,-0.72,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_10FM1000_0.02%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%10FM1000,0.02%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7929894,6124338.7,10582,7929894,0,1.2,,,,,,,,,,98.96,0,1.04,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_10FM1000_0.02%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%10FM1000,0.02%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9451058,2832010.7,2645.3,9449735.3,0,1.3,,,,,,,,,,98.96,0,1.04,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_10FM1000_0.02%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%10FM1000,0.02%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33419312.3,17489418,0,33419312.3,0,3.3,,,,,,,,,,98.97,0,1.03,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_10FM1000_0.02%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%10FM1000,0.02%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,131468254,50216931.3,1322.7,131468254,0,11.4,,,,,,,,,,98.94,0,1.06,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_10FM1000_0.02%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%10FM1000,0.02%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4762,476.3,13.3,4762,0,0.4,,,,,,,,,,98.96,0,1.04,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_10FM1000_2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%10FM1000,2%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2378307,1452381,3968.3,2378307,0,1.3,,,,,,,,,,99,0,1,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_10FM1000_2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%10FM1000,2%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,654761.7,39682.7,1322.7,654761.7,0,0.3,,,,,,,,,,98.9,0,1.1,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_10FM1000_2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%10FM1000,2%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3874338.7,1973545,3968,3871693,0,0.5,,,,,,,,,,98.77,0,1.23,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_10FM1000_2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%10FM1000,2%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11972222,6937831,1322.7,11970899.3,0,1.4,,,,,,,,,,98.75,0,1.25,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_10FM1000_2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%10FM1000,2%10FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,316865,25476.3,145.3,316825.3,13.3,2.9,,,,,,,,,,98.73,0,1.27,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_14FM1000_0.02%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%14FM1000,0.02%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5693122,3001322.7,3968.3,5693122,0,0.9,,,,,,,,,,99.03,0,0.97,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_14FM1000_0.02%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%14FM1000,0.02%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9875661.3,6915344,0,9875661.3,0,1.3,,,,,,,,,,99.09,0,0.91,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_14FM1000_0.02%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%14FM1000,0.02%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14006613.7,7121693.3,1322.7,14006613.7,0,1.5,,,,,,,,,,99.01,0,0.99,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_14FM1000_0.02%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%14FM1000,0.02%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50968254.3,27732804.3,0,50968254.3,0,5.8,,,,,,,,,,99.09,0,0.91,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_14FM1000_0.02%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%14FM1000,0.02%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2963,635,26.3,2950,0,1.2,,,,,,,,,,99.06,0,0.94,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_14FM1000_2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%14FM1000,2%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,490740.7,30423.7,0,490740.7,0,0.4,,,,,,,,,,98.51,0,1.49,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_14FM1000_2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%14FM1000,2%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,152116.3,21164.3,3968.3,150793.7,0,0.4,,,,,,,,,,98.5,0,1.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_14FM1000_2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%14FM1000,2%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,236772.3,41005,1322.7,236772.3,0,1.1,,,,,,,,,,98.55,0,1.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_14FM1000_2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%14FM1000,2%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3890211.7,1585979,1322.7,3890211.7,0,0.7,,,,,,,,,,98.45,0,1.55,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_14FM1000_2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%14FM1000,2%14FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,234127,78042.3,11905,231481.3,0,0.6,,,,,,,,,,98.59,0,1.41,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_18FM1000_0.02%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%18FM1000,0.02%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2451058.3,448412.7,2645.7,2448413,1322.7,0.6,,,,,,,,,,99,0,1,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_18FM1000_0.02%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%18FM1000,0.02%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26585978.7,9494709,2645.7,26585978.7,0,2.9,,,,,,,,,,98.95,0,1.05,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_18FM1000_0.02%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%18FM1000,0.02%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14009259,7994709,5291,14009259,0,1.6,,,,,,,,,,98.93,0,1.07,0,0,0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_18FM1000_0.02%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%18FM1000,0.02%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63904762,25937830.7,6614,63902116.3,0,5.2,,,,,,,,,,98.89,0,1.11,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_18FM1000_0.02%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%18FM1000,0.02%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7169,1587.3,79.3,7143,13.3,0.3,,,,,,,,,,99.13,0,0.87,0.1,0,-0.2,0.1,0,0.2,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_18FM1000_2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%18FM1000,2%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3174603,67460.3,2645.3,3171957.7,0,1.4,,,,,,,,,,93.01,0,6.99,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_18FM1000_2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%18FM1000,2%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10813492,675926,6614,10812169.3,0,0.8,,,,,,,,,,92.55,0,7.45,-0.6,0,0.6,0.6,0,0.6,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_18FM1000_2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%18FM1000,2%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8981481.3,850529.3,0,8981481.3,0,0.7,,,,,,,,,,92.06,0,7.94,-1.1,0,1.1,1.1,0,1.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_18FM1000_2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%18FM1000,2%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,34526455,7760582,0,34526455,0,2.2,,,,,,,,,,92.65,0,7.35,-0.5,0,0.5,0.5,0,0.5,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_18FM1000_2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,2%18FM1000,2%18FM1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,82301.7,14140,26.7,82301.7,0,1.5,,,,,,,,,,95.5,0,4.5,2.3,0,-2.3,2.3,0,2.3,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_Brij58_0.0075%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.0075%Brij58,0.0075%Brij58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35632275,6906084.7,1322.7,35632275,0,3,,,,,,,,,,99.4,0,0.6,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_Brij58_0.0075%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.0075%Brij58,0.0075%Brij58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37082010.7,10238095,1322.7,37082010.7,0,3,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_Brij58_0.0075%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.0075%Brij58,0.0075%Brij58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14346560.7,7439153.3,1322.7,14346560.7,0,2.3,,,,,,,,,,99.44,0,0.56,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_Brij58_0.0075%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.0075%Brij58,0.0075%Brij58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,124780423.3,41841269.7,3968.3,124779100.7,1322.7,10.7,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_Brij58_0.0075%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.0075%Brij58,0.0075%Brij58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2553,859.7,26.3,2553,0,0.9,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,10,MK-1248_HPbCD_0.4%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1878.3,648,39.7,1878.3,0,0.7,,,,,,,,,,99.3,0,0.7,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,10,MK-1248_HPbCD_0.4%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8359.7,1627,79.3,8346.3,13.3,0.9,,,,,,,,,,99.3,0,0.7,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,10,MK-1248_HPbCD_0.4%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12248.7,2381,66.3,12235.7,0,0.9,,,,,,,,,,99.27,0,0.73,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,10,MK-1248_HPbCD_0.4%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5397,992,26.7,5383.7,0,0.9,,,,,,,,,,99.3,0,0.7,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_HPbCD_0.4%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35929894.3,6645502.7,2645.3,35928571.7,0,2.8,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_HPbCD_0.4%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31490740.7,9419312,1322.7,31490740.7,0,2.3,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_HPbCD_0.4%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42026455,20243386.3,1322.7,42026455,0,4.3,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_HPbCD_0.4%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86423280.3,13425925.7,11905,86420635,0,6.8,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_HPbCD_0.4%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPbCD,0.4%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1323,317.3,0,1323,0,0.8,,,,,,,,,,99.55,0,0.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,10,MK-1248_HPgCD_0.4%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6468,1547.7,79.7,6455,0,0.7,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,10,MK-1248_HPgCD_0.4%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10119,4709,357,10106,0,0.9,,,,,,,,,,99.44,0,0.56,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,10,MK-1248_HPgCD_0.4%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17460.3,7381,185.3,17434,0,1,,,,,,,,,,99.36,0,0.63,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,10,MK-1248_HPgCD_0.4%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3373,1177,26.3,3346.7,0,0.6,,,,,,,,,,99.45,0,0.55,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_HPgCD_0.4%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22060846.7,1076719.7,0,22060846.7,0,1.7,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_HPgCD_0.4%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,40357143,10527778,0,40357143,0,3.2,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_HPgCD_0.4%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,81076719.3,23912698.3,0,81076719.3,0,6.1,,,,,,,,,,99.57,0,0.43,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_HPgCD_0.4%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,128591269.7,36044973.7,0,128591269.7,0,9.8,,,,,,,,,,99.59,0,0.41,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_HPgCD_0.4%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%HPgCD,0.4%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2473.3,886.3,26.3,2460.3,0,0.6,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,10,MK-1248_MoNi_0.02%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%MoNi,0.02%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3597.7,978.7,0,3597.7,0,0.6,,,,,,,,,,99.41,0,0.59,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,10,MK-1248_MoNi_0.02%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%MoNi,0.02%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2222.3,608.3,53,2195.7,13.3,33.8,,,,,,,,,,99.34,0,0.66,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,10,MK-1248_MoNi_0.02%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%MoNi,0.02%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9536.7,2777.7,224.7,9444.7,26.7,0.9,,,,,,,,,,99.12,0,0.88,-0.2,0,0.2,0.2,0,0.2,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,10,MK-1248_MoNi_0.02%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%MoNi,0.02%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11799,2949.7,66,11759.3,13.3,0.7,,,,,,,,,,99.45,0,0.55,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,10,MK-1248_MoNi_0.05%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1679.7,423.3,53,1666.3,0,0.7,,,,,,,,,,99.43,0,0.58,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,10,MK-1248_MoNi_0.05%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1944.3,489.3,26.7,1918.3,0,0.6,,,,,,,,,,99.42,0,0.58,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,10,MK-1248_MoNi_0.05%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,912.7,212,39.7,899.3,13.3,0.7,,,,,,,,,,99.42,0,0.58,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,10,MK-1248_MoNi_0.05%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16389,1917.7,13.3,16375.7,0,0.8,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_MoNi_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7247354.7,510582,5291.3,7246032,0,0.6,,,,,,,,,,99.57,0,0.43,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_MoNi_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16740740.7,7921957.7,5291,16740740.7,0,1.9,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_MoNi_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,62666666.7,25095238.3,2645.3,62664021.3,1322.7,5.4,,,,,,,,,,99.53,0,0.47,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_MoNi_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,168138889,67374338.7,2645.7,168138889,0,18.4,,,,,,,,,,99.55,0,0.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_MoNi_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12037,1547.7,39.7,12037,0,1.1,,,,,,,,,,99.45,0,0.55,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,10,MK-1248_MoNi_0.2%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6785.7,1349.3,66.3,6772.7,13.3,0.8,,,,,,,,,,99.47,0,0.53,0,0,0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,10,MK-1248_MoNi_0.2%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3029.3,846.3,53,3029.3,0,0.8,,,,,,,,,,99.47,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,10,MK-1248_MoNi_0.2%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4365,1031.7,198.3,4338.3,0,0.9,,,,,,,,,,99.46,0,0.54,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,10,MK-1248_MoNi_0.2%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64616.7,10013,26.7,64616.7,0,1.1,,,,,,,,,,99.67,0,0.33,0.2,0,-0.1,0.2,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_MoNi_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19993386.3,7181217,2645.3,19993386.3,0,2,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_MoNi_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,56821428.7,26665344,13227.7,56817460.3,1322.7,5.5,,,,,,,,,,99.52,0,0.48,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_MoNi_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13208994.3,1853174.3,3968.3,13207671.7,1322.7,1.3,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_MoNi_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63746031.3,13968254,11905,63743386,0,5,,,,,,,,,,99.56,0,0.44,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_MoNi_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,62460.3,16150.7,158.7,62447,13.3,0.7,,,,,,,,,,99.44,0,0.56,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_MoNi_1%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19300264.3,1656084.7,9259.3,19296296.3,1322.7,1.7,,,,,,,,,,99.52,0,0.48,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_MoNi_1%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17265873,2624339,1322.7,17264550.3,0,1.7,,,,,,,,,,99.56,0,0.44,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_MoNi_1%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30805555.3,8171957.7,3968.3,30804232.7,1322.7,2.6,,,,,,,,,,99.53,0,0.47,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_MoNi_1%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,106395502.7,30689153.7,1322.7,106395502.7,0,8.4,,,,,,,,,,99.58,0,0.42,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_MoNi_1%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,198069,71362.3,383.3,198029,13.3,2.4,,,,,,,,,,99.51,0,0.49,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_None_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17443121.7,5867725,2645.3,17441799,0,1.3,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_None_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,72849206.7,16550264.3,1322.7,72849206.7,0,5.1,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_None_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,59112434,23961640.3,0,59112434,0,5,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_None_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,126984127,28555555.7,5291,126984127,0,10.3,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_None_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,846.7,145.3,0,846.7,0,0.1,,,,,,,,,,99.51,0,0.49,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,10,MK-1248_PO188_0.02%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%PO188,0.02%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1256.7,331,52.7,1243.3,0,0.5,,,,,,,,,,94.76,4.29,0.95,-0.2,0.2,0,0.2,0.2,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,10,MK-1248_PO188_0.02%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%PO188,0.02%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1084.7,357.3,13.3,1084.7,0,0.6,,,,,,,,,,95.06,4.03,0.91,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,10,MK-1248_PO188_0.02%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%PO188,0.02%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1283,317.3,0,1283,0,0.7,,,,,,,,,,95.2,3.8,1,0.2,-0.3,0,0.2,0.3,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,10,MK-1248_PO188_0.02%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%PO188,0.02%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2989.3,1587.3,53,2989.3,0,0.6,,,,,,,,,,94.8,4.18,1.02,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_PO188_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PO188,0.05%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7305555.7,503968.7,0,7305555.7,0,0.5,,,,,,,,,,99.51,0,0.49,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_PO188_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PO188,0.05%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7414021.3,563492,0,7414021.3,0,0.5,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_PO188_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PO188,0.05%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32537037,8870370.3,1322.7,32535714.3,1322.7,2.1,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_PO188_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PO188,0.05%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94997354.7,35998677.3,0,94997354.7,0,7.5,,,,,,,,,,99.55,0,0.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_PO188_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PO188,0.05%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,754,344,13.3,740.7,0,0.1,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_PO188_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PO188,0.2%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1615079.7,216931.3,0,1615079.7,0,0.7,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_PO188_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PO188,0.2%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9328042.3,1283068.7,1322.7,9328042.3,0,1.1,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_PO188_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PO188,0.2%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60267195.7,25007936.3,1322.7,60267195.7,0,4.7,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_PO188_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PO188,0.2%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41404761.7,12166666.7,1322.7,41403439,0,3.4,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_PO188_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PO188,0.2%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1971,516,0,1971,0,1,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_PS20_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4785714,182539.7,1322.7,4784391.3,0,0.6,,,,,,,,,,99.4,0,1.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_PS20_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13287037,7730159,5291,13285714.3,0,2.1,,,,,,,,,,99.39,0,1.48,0,0,0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_PS20_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37440476.3,21914021.3,1322.7,37440476.3,0,3.7,,,,,,,,,,99.44,0,1.41,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_PS20_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46907407.3,15698413,0,46907407.3,0,3.7,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_PS20_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57015873,12400793.7,3968.3,57013227.7,1322.7,3.6,,,,,,,,,,99.42,0,1.44,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_PS20_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,462.7,185,39.7,436.3,0,0.3,,,,,,,,,,99.41,0,1.36,0,0,-0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_PS20_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13797619,5712963,1322.7,13797619,0,1.6,,,,,,,,,,99.45,0,0.55,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_PS20_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10007936.7,3609788.3,0,10007936.7,0,0.8,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_PS20_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,27386243.3,9837301.3,1322.7,27386243.3,0,35.5,,,,,,,,,,99.45,0,0.55,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_PS20_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,701,171.7,13.3,688,13.3,0.6,,,,,,,,,,99.49,0,0.51,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_PS80_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0.05,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15855820,4682539.7,0,15855820,0,1.4,,,,,,,,,,99.47,0,1.46,0,0,0,0,0,0,,,,,,,,,,PS80 0.05%,PS80 0.05%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_PS80_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0.05,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51289682.3,15136243.7,0,51289682.3,0,3.6,,,,,,,,,,99.46,0,1.44,0,0,0,0,0,0,,,,,,,,,,PS80 0.05%,PS80 0.05%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_PS80_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0.05,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35572751.3,17949735.3,0,35572751.3,0,3,,,,,,,,,,99.41,0,1.57,0,0,0.1,0,0,0.1,,,,,,,,,,PS80 0.05%,PS80 0.05%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_PS80_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0.05,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,53452381,29846560.7,9259,53448412.7,2645.7,5.3,,,,,,,,,,99.39,0,1.56,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,PS80 0.05%,PS80 0.05%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_PS80_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0.05,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1600.3,503,0,1600.3,0,0.1,,,,,,,,,,99.54,0,1.35,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,PS80 0.05%,PS80 0.05%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_PS80_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0.2,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5690476.3,1113756.3,2645.3,5689153.3,1322.7,0.4,,,,,,,,,,96.52,0,3.48,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,PS80 0.2%,PS80 0.2%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_PS80_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0.2,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57833333.7,18673280.3,1322.7,57833333.7,0,4,,,,,,,,,,96.68,0,3.32,0.4,0,-0.4,0.4,0,0.4,,,,,,,,,,PS80 0.2%,PS80 0.2%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_PS80_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0.2,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33298941.7,4329365.3,0,33298941.7,0,1.9,,,,,,,,,,96.06,0,3.94,-0.2,0,0.2,0.2,0,0.2,,,,,,,,,,PS80 0.2%,PS80 0.2%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_PS80_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0.2,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,38398148,10387566,0,38398148,0,3.2,,,,,,,,,,94.83,0,5.17,-1.5,0,1.5,1.5,0,1.5,,,,,,,,,,PS80 0.2%,PS80 0.2%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_PS80_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0.2,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6111.3,1336,0,6111.3,0,0.2,,,,,,,,,,97.43,0,2.57,1.1,0,-1.1,1.1,0,1.1,,,,,,,,,,PS80 0.2%,PS80 0.2%,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,10,MK-1248_SBEbCD_0.4%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16137.3,8029,3161,14920.7,158.7,2.2,,,,,,,,,,99.3,0,0.7,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,10,MK-1248_SBEbCD_0.4%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,56613.7,38783,18545.3,48307,1005.3,10.4,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,10,MK-1248_SBEbCD_0.4%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46560.7,32566,17394.3,37222,1521,12.8,,,,,,,,,,98.8,0,1.2,-0.4,0,0.4,0.4,0,0.4,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,10,MK-1248_SBEbCD_0.4%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16468.3,4153.3,66,16468.3,0,0.7,,,,,,,,,,99.4,0,0.6,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_SBEbCD_0.4%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21521164,6279100.7,1322.7,21519841.3,0,1.8,,,,,,,,,,99.53,0,0.47,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_SBEbCD_0.4%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19338624.3,1949735.3,0,19338624.3,0,1.8,,,,,,,,,,99.55,0,0.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_SBEbCD_0.4%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70000000,31879629.3,0,70000000,0,6.6,,,,,,,,,,99.49,0,0.51,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_SBEbCD_0.4%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,112743386,39267195.7,5291,112743386,0,9.7,,,,,,,,,,99.45,0,0.55,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_SBEbCD_0.4%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%SBebCD,0.4%SBebCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14457.7,2645.3,26.3,14457.7,0,0.8,,,,,,,,,,99.49,0,0.51,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,10,MK-1248_gCD_0.4%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51402,18280.7,5357,50158.7,145.7,3,,,,,,,,,,99.36,0,0.64,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,10,MK-1248_gCD_0.4%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,103981.3,43068.7,9749,101124.3,291,5.5,,,,,,,,,,99.32,0,0.68,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,10,MK-1248_gCD_0.4%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,139232.7,64166.7,19378.3,131415.3,939,12.9,,,,,,,,,,99.22,0,0.78,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,10,MK-1248_gCD_0.4%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,142182.3,9365,13.3,142182.3,0,2.3,,,,,,,,,,99.44,0,0.56,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-1248_gCD_0.4%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11919312,2411376,1322.7,11919312,0,1.5,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-1248_gCD_0.4%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23009259.3,9665344,0,23009259.3,0,2.7,,,,,,,,,,99.52,0,0.48,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-1248_gCD_0.4%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,68074074,13468254,2645.3,68071428.7,0,4.9,,,,,,,,,,99.46,0,0.54,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-1248_gCD_0.4%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,106145502.7,31929894,10582,106140211.7,0,8.6,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-1248_gCD_0.4%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.4%gCD,0.4%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,152262,7407.7,26.7,152262,0,2.2,,,,,,,,,,99.52,0,0.48,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-4166_MoNi_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,675926,91270,0,675926,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-4166_MoNi_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91270,8597.7,661.3,91270,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-4166_MoNi_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2279100.7,162037,1322.7,2277777.7,661.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-4166_MoNi_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5333333.3,314153.3,1984,5332672,0,1.4,,,,,,,,,,99.29,0,0.71,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-4166_MoNi_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9999.7,1283,39.7,9986.3,0,0.7,,,,,,,,,,99.53,0,0.47,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-4166_MoNi_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,536375.7,26455.3,0,536375.7,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-4166_MoNi_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,875661.3,64814.7,3968,874338.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-4166_MoNi_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5791666.7,333333,1322.7,5791005.3,661.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-4166_MoNi_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6200396.7,535053,5291,6199074,0,2,,,,,,,,,,99.26,0,0.74,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-4166_MoNi_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57301.7,9008,105.7,57301.7,0,1.3,,,,,,,,,,99.43,0,0.57,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-4166_MoNi_1%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,630290.7,155423.3,1322.7,630290.7,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-4166_MoNi_1%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,609788.3,94576.7,3306.7,609127,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-4166_MoNi_1%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2898809.7,259920.7,5291,2898148.3,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-4166_MoNi_1%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4199735.7,206349.3,661.3,4199074.3,0,2.5,,,,,,,,,,99.33,0,0.67,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-4166_MoNi_1%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,251746,75211.3,211.7,251706.3,0,3.2,,,,,,,,,,99.48,0,0.52,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-4166_PS20_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,258598,31084.7,1322.7,258598,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-4166_PS20_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,242724.7,37037,1322.7,242724.7,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-4166_PS20_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1048280.3,76719.3,661.3,1048280.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-4166_PS20_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2165343.7,98545,3306.7,2164021,0,0.7,,,,,,,,,,99.78,0,0.22,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-4166_PS20_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5833.3,1270,0,5833.3,0,0.9,,,,,,,,,,99.86,0,0.14,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-4166_PS20_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,214947,31746,5952.3,214947,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-4166_PS20_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,378968.3,28439.3,2645.3,378307,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-4166_PS20_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,324074,43650.7,661.3,324074,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-4166_PS20_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6164682.7,161375.3,3968,6164682.7,0,1.8,,,,,,,,,,99.42,0,0.58,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-4166_PS20_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3465.7,859.7,0,3465.7,0,1,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,10,MK-7110_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4285.7,952.3,13.3,4285.7,0,0.8,,,,,,,,,,99,0,1,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,10,MK-7110_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,635,132.3,13.3,635,0,0.7,,,,,,,,,,99.01,0,0.99,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,10,MK-7110_MoNi_0.02%_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%MoNi,0.02%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11944.3,1772.7,13.3,11944.3,0,0.8,,,,,,,,,,99.18,0,0.82,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,10,MK-7110_MoNi_0.02%_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%MoNi,0.02%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7169.3,806.7,26.3,7169.3,0,0.8,,,,,,,,,,99.22,0,0.78,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,10,MK-7110_MoNi_0.05%_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19775,2076.7,66,19761.7,13.3,1,,,,,,,,,,99.19,0,0.81,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,10,MK-7110_MoNi_0.05%_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16151,1653.3,0,16151,0,1.1,,,,,,,,,,99.22,0,0.78,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-7110_MoNi_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,106878.3,28968.7,1190.3,106349.3,132.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-7110_MoNi_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,66269.7,11640,397,66137.3,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-7110_MoNi_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,103439,14947.3,1454.7,102778,264.7,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-7110_MoNi_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1100264.7,171560.7,661.3,1100000.3,132.3,1.7,,,,,,,,,,99.15,0,0.85,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-7110_MoNi_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20741,3664,159,20687.7,13.3,29.2,,,,,,,,,,99.29,0,0.71,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-7110_MoNi_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,77248.7,9127,793.7,77248.7,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-7110_MoNi_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99735.3,16666.7,1190.7,99338.7,132.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-7110_MoNi_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100661.3,13492,264.7,100396.7,0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-7110_MoNi_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,367592.7,37963,793.7,367460.3,0,1.1,,,,,,,,,,99.16,0,0.84,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-7110_MoNi_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%MoNi,0.2%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64920.7,9285.7,0,64920.7,0,1.3,,,,,,,,,,99.2,0,0.8,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-7110_MoNi_1%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,335582,49470.7,661.3,335582,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-7110_MoNi_1%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,362830.7,45105.7,1058,362698.3,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-7110_MoNi_1%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,49867.7,16799,2381,49603,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-7110_MoNi_1%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,364947.3,42857,1587,364550.3,0,1.2,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-7110_MoNi_1%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,253320,80846.7,39.7,253320,0,3.2,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,10,MK-7110_PS20_0.02%_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%PS20,0.02%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1031.7,277.3,26.7,1031.7,0,0.8,,,,,,,,,,99.1,0,0.9,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,10,MK-7110_PS20_0.02%_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%PS20,0.02%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1309.3,277.7,0,1309.3,0,0.9,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-7110_PS20_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14021,4894.3,925.7,13756.3,132.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-7110_PS20_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,357,53,13.3,357,0,0.5,,,,,,,,,,99.24,0,0.76,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-7110_PS20_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20635,7010.3,1322.7,19709.3,264.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-7110_PS20_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16666.7,4894.3,1058,16402.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-7110_PS20_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.05%PS20,0.05%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,69312,13227.7,1190.7,69312,0,1,,,,,,,,,,99.18,0,0.82,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,10,MK-7110_PS20_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17592.7,4894.3,1455,17460.3,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,10,MK-7110_PS20_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21693,9127,2248.7,21296.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,10,MK-7110_PS20_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,462698.3,60317.3,1455,462433.7,132.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,10,MK-7110_PS20_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,29233,7143,1058.3,28836,132.3,1,,,,,,,,,,99.21,0,0.79,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,10,MK-7110_PS20_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.2%PS20,0.2%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,992,225,0,992,0,0.9,,,,,,,,,,99.27,0,0.73,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,10,MK-7110_PS80_0.02%_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%PS80,0.02%PS80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,833.3,251.3,13.3,833.3,0,0.7,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/13/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,10,MK-7110_PS80_0.02%_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,0.02%PS80,0.02%PS80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,886.3,158.7,13.3,873,0,33.8,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,VLS-231_1%HPgCD_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%HPgCD,1%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.38,0.15,10.47,0.2,-0.1,-0.1,0.2,0.1,0.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,0.5,,5,VLS-231_1%HPgCD_t0.5,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%HPgCD,1%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.95,0.36,10.69,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,VLS-231_1%gCD_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%gCD,1%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.09,0.15,10.76,0.1,-0.1,0,0.1,0.1,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,0.5,,5,VLS-231_1%gCD_t0.5,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%gCD,1%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.84,0.32,10.85,-0.1,0.1,0,0.1,0.1,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,VLS-231_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.7,0.05,8.25,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,0.5,,5,VLS-231_t0.5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.96,0,8.04,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,VLS-231_t2,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.26,0.39,8.35,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,4,,5,VLS-231_t4,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.5,1.22,8.28,-1.3,1.2,0.1,1.3,1.2,0.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,VLS-231_w/o_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,w/o,w/o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.16,0.16,10.68,0,-0.1,0,0,0.1,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000141_005,ADC,MULTIPLE CONTROL,Stir,25,0.5,,5,VLS-231_w/o_t0.5,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,w/o,w/o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.08,0.3,10.61,0,0.1,0,0,0.1,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_002%PO188_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.02%PO188,0.02%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_002%PO188_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.02%PO188,0.02%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.12,0.39,4.49,-4.9,0.4,4.5,4.9,0.4,4.5,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_002%PS20_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.02%PS20,0.02%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.22,0,2.78,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_002%PS20_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.02%PS20,0.02%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.71,0.13,3.16,-0.5,0.1,0.4,0.5,0.1,0.4,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_002%PS80_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.02%PS80,0.02%PS80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.09,0,2.91,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_002%PS80_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.02%PS80,0.02%PS80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,0,2.9,0,-2.9,2.9,0,2.9,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_005%MoNi_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.31,0,2.69,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_005%MoNi_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.05%MoNi,0.05%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.41,0.28,3.31,-0.9,0.3,0.6,0.9,0.3,0.6,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_05%MoNi_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.5%MoNi,0.5%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.24,0,2.76,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_05%MoNi_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,0.5%MoNi,0.5%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.92,0.05,3.03,-0.3,0,0.3,0.3,0,0.3,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_1%HPbCD_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%HPbCD,1%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.13,0,2.87,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_1%HPbCD_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%HPbCD,1%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.56,0.17,3.27,-0.6,0.2,0.4,0.6,0.2,0.4,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_1%HPgCD_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%HPgCD,1%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.06,0,2.94,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_1%HPgCD_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%HPgCD,1%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.56,0.15,3.29,-0.5,0.2,0.4,0.5,0.2,0.4,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_1%MoNi_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.9,0,3.1,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_1%MoNi_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.35,0.23,3.42,-0.6,0.2,0.3,0.6,0.2,0.3,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_1%SBEbCD_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%SBEbCD,1%SBEbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.13,0,2.87,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_1%SBEbCD_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%SBEbCD,1%SBEbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.13,0.47,3.41,-1,0.5,0.5,1,0.5,0.5,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_1%gCD_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%gCD,1%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.1,0,2.9,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_1%gCD_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,1%gCD,1%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.12,0.5,3.37,-1,0.5,0.5,1,0.5,0.5,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.37,0,2.63,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0.5,,5,Trop2-CPT-L3_t0.5,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.91,0,3.09,-0.2,0,0.2,0.2,0,0.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.75,0.1,3.15,-0.4,0.1,0.3,0.4,0.1,0.3,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,4,,5,Trop2-CPT-L3_t4,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.65,0.2,4.15,-1.5,0.2,1.3,1.5,0.2,1.3,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,0,,5,Trop2-CPT-L3_w/o_t0,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,w/o,w/o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.54,0,3.46,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Stir,25,2,,5,Trop2-CPT-L3_w/o_t2,NB-knoxbrow-5090913-0001,6.5,10 mM Histidine,0,0,0,9,0,w/o,w/o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.22,0.4,3.38,-0.3,0.4,-0.1,0.3,0.4,0.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,0,,5,MK-1697_002%PO188_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,0,0,0.02%PO188,0.02%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,2,,5,MK-1697_002%PO188_t2,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,0,0,0.02%PO188,0.02%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,0,,5,MK-1697_002%PS20_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,0,0,0.02%PS20,0.02%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,2,,5,MK-1697_002%PS20_t2,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,0,0,0.02%PS20,0.02%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,0,,5,MK-1697_002%PS80_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,0,0,0.02%PS80,0.02%PS80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,2,,5,MK-1697_002%PS80_t2,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,0,0,0.02%PS80,0.02%PS80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,0,,5,MK-1697_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,0.5,,5,MK-1697_t0.5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,2,,5,MK-1697_t2,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,4,,5,MK-1697_t4,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,0,,5,MK-1697_w/o_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,0,0,w/o,w/o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Surfactant,,ADC,,Stir,25,2,,5,MK-1697_w/o_t2,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,0,0,w/o,w/o,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DAB015692_013,ADC,MULTIPLE CONTROL,Thermal Stress,40,14,,9.8,Anti-MMAE_Fab_2w40C,NB-ramapa-5085300-0002,6,Histidine,0,0,0.02,9,0,,,,99.3,0.2,0.2,47.95,77.3,-1.5,1.5,,8.427,14.037,18.621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.65,0,2.35,-0.2,0,0.2,0.2,0,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DAB015692_013,ADC,MULTIPLE CONTROL,Thermal Stress,5,0,,9.8,Anti-MMAE_Fab_T0,NB-ramapa-5085300-0002,6,Histidine,0,0,0.02,9,0,,,,99.1,0,0,48.02,78.82,0,0,,8.448,14.063,18.641,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.84,0,2.16,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000141_007,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,5,VLS231_0.2%Pyr_0.2x,NB-ramapa-5085300-0002,6,Histidine,0,0,0,0,0, 0.2%Pyridoxine , 0.2%Pyridoxine ,,81,0.2,0.2,43.62,82.6,-14.2,14.2,,10.1,5.85,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,44.15,0,55.85,-48.1,0,48.1,48.1,0,48.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000141_007,ADC,MULTIPLE CONTROL,Light stress 0.2 x,-80,0,,5,VLS231_CT,NB-ramapa-5085300-0002,6,Histidine,0,0,0,0,0,,,,80.8,0,0,62.45,96.81,0,0,,6.686,12.475,16.837,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.25,0,7.75,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000141_007,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,5,VLS231_Start_0.2x,NB-ramapa-5085300-0002,6,Histidine,0,0,0,0,0,,,,65.9,-14.9,14.9,42.58,79.17,-17.6,17.6,,10.1,5.85,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,43.06,0,56.94,-49.2,0,49.2,49.2,0,49.2,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000492_005,ADC,MULTIPLE CONTROL,Thermal Stress,25,14,,20.3,D64_2w25C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9,0,,,,97.2,,,64.9,98.32,,,,8.796,14.449,18.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.19,0.22,6.59,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000492_005,ADC,MULTIPLE CONTROL,Thermal Stress,40,14,,20.3,D64_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.3,,,62.93,97.47,,,,8.8,14.453,18.989,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,84.73,0.67,14.61,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000674_005,ADC,MULTIPLE CONTROL,Thermal Stress,25,14,,21.1,D63_2w25C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9,0,,,,91.6,,,60.38,95.18,,,,8.587,14.149,18.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.59,0.07,3.34,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000674_005,ADC,MULTIPLE CONTROL,Thermal Stress,40,14,,21.1,D63_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9,0,,,,92.8,,,61.52,96.94,,,,8.569,14.156,18.894,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.63,0.58,3.78,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Thermal Stress,25,14,,21.6,D62_2w25C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.8,,,66.42,99.22,,,,8.785,14.419,18.966,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0.11,0.95,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Thermal Stress,40,14,,21.6,D62_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.5,,,65.38,98.75,,,,8.792,14.424,18.984,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.06,0.64,2.31,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,1.61,Trop2-Trabectedin_0.2%Pyr_0.2x,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0,9,0,  0.2%Pyridoxine ,  0.2%Pyridoxine ,,68.9,,,50.43,88.28,,,,10.1,5.85,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,76.78,0,23.22,-0.6,-1.1,1.7,0.6,1.1,1.7,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Thermal Stress,40,14,,1.61,Trop2-Trabectedin_0.5%MoNi_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0,9,0,  0.5%MoNi ,  0.5%MoNi ,,56.6,-33.6,33.6,55.34,86.73,-10.8,10.8,,10.1,5.85,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,77.38,0.91,21.72,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Thermal Stress,40,14,,1.61,Trop2-Trabectedin_1%SBEbCD_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0,9,0, 1%SBebCD, 1%SBebCD,,66.6,-23.6,23.6,54.95,88.52,-9,9,,10.1,5.85,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60.45,1.29,38.26,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Thermal Stress,40,14,,1.61,Trop2-Trabectedin_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0,9,0,,,,57.8,-32.4,32.4,54.85,87.98,-9.5,9.5,,10.1,5.85,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,73.93,0.94,25.13,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,1.61,Trop2-Trabectedin_Start_0.2x,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0,9,0,,,,85.8,,,66.93,94.74,,,,8.876,14.537,19.075,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,76.89,2.51,20.6,-0.5,1.4,-0.9,0.5,1.4,0.9,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,1.61,Trop2-Trabectedin_Start_CT,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0,9,0,,,,89.7,,,70.06,96.93,,,,8.884,14.546,19.082,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,77.05,2.67,20.28,-0.4,1.6,-1.2,0.4,1.6,1.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Thermal Stress,-80,0,,1.61,Trop2-Trabectedin_T0,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0,9,0,,,,90.2,0,0,70.44,97.47,0,0,,8.869,14.533,19.067,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,77.4,1.09,21.51,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_10FM1000_0.02%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7929894,6124338.7,10582,7929894,0,1.2,,,,,,,,,,98.96,0,1.04,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_10FM1000_0.02%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9451058,2832010.7,2645.3,9449735.3,0,1.3,,,,,,,,,,98.96,0,1.04,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_10FM1000_0.02%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33419312.3,17489418,0,33419312.3,0,3.3,,,,,,,,,,98.97,0,1.03,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_10FM1000_0.02%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,131468254,50216931.3,1322.7,131468254,0,11.4,,,,,,,,,,98.94,0,1.06,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_10FM1000_0.02%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4762,476.3,13.3,4762,0,0.4,,,,,,,,,,98.96,0,1.04,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_10FM1000_2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2378307,1452381,3968.3,2378307,0,1.3,,,,,,,,,,99,0,1,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_10FM1000_2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,654761.7,39682.7,1322.7,654761.7,0,0.3,,,,,,,,,,98.9,0,1.1,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_10FM1000_2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3874338.7,1973545,3968,3871693,0,0.5,,,,,,,,,,98.77,0,1.23,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_10FM1000_2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11972222,6937831,1322.7,11970899.3,0,1.4,,,,,,,,,,98.75,0,1.25,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_10FM1000_2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,316865,25476.3,145.3,316825.3,13.3,2.9,,,,,,,,,,98.73,0,1.27,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_14FM1000_0.02%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5693122,3001322.7,3968.3,5693122,0,0.9,,,,,,,,,,99.03,0,0.97,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_14FM1000_0.02%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9875661.3,6915344,0,9875661.3,0,1.3,,,,,,,,,,99.09,0,0.91,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_14FM1000_0.02%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14006613.7,7121693.3,1322.7,14006613.7,0,1.5,,,,,,,,,,99.01,0,0.99,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_14FM1000_0.02%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50968254.3,27732804.3,0,50968254.3,0,5.8,,,,,,,,,,99.09,0,0.91,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_14FM1000_0.02%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2963,635,26.3,2950,0,1.2,,,,,,,,,,99.06,0,0.94,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_14FM1000_2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,490740.7,30423.7,0,490740.7,0,0.4,,,,,,,,,,98.51,0,1.49,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_14FM1000_2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,152116.3,21164.3,3968.3,150793.7,0,0.4,,,,,,,,,,98.5,0,1.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_14FM1000_2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,236772.3,41005,1322.7,236772.3,0,1.1,,,,,,,,,,98.55,0,1.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_14FM1000_2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3890211.7,1585979,1322.7,3890211.7,0,0.7,,,,,,,,,,98.45,0,1.55,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_14FM1000_2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,234127,78042.3,11905,231481.3,0,0.6,,,,,,,,,,98.59,0,1.41,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_18FM1000_0.02%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2451058.3,448412.7,2645.7,2448413,1322.7,0.6,,,,,,,,,,99,0,1,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_18FM1000_0.02%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26585978.7,9494709,2645.7,26585978.7,0,2.9,,,,,,,,,,98.95,0,1.05,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_18FM1000_0.02%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14009259,7994709,5291,14009259,0,1.6,,,,,,,,,,98.93,0,1.07,0,0,0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_18FM1000_0.02%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63904762,25937830.7,6614,63902116.3,0,5.2,,,,,,,,,,98.89,0,1.11,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_18FM1000_0.02%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7169,1587.3,79.3,7143,13.3,0.3,,,,,,,,,,99.13,0,0.87,0.1,0,-0.2,0.1,0,0.2,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_18FM1000_2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3174603,67460.3,2645.3,3171957.7,0,1.4,,,,,,,,,,93.01,0,6.99,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_18FM1000_2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10813492,675926,6614,10812169.3,0,0.8,,,,,,,,,,92.55,0,7.45,-0.6,0,0.6,0.6,0,0.6,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_18FM1000_2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8981481.3,850529.3,0,8981481.3,0,0.7,,,,,,,,,,92.06,0,7.94,-1.1,0,1.1,1.1,0,1.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_18FM1000_2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,34526455,7760582,0,34526455,0,2.2,,,,,,,,,,92.65,0,7.35,-0.5,0,0.5,0.5,0,0.5,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_18FM1000_2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,82301.7,14140,26.7,82301.7,0,1.5,,,,,,,,,,95.5,0,4.5,2.3,0,-2.3,2.3,0,2.3,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_Brij58_0.0075%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35632275,6906084.7,1322.7,35632275,0,3,,,,,,,,,,99.4,0,0.6,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_Brij58_0.0075%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37082010.7,10238095,1322.7,37082010.7,0,3,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_Brij58_0.0075%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14346560.7,7439153.3,1322.7,14346560.7,0,2.3,,,,,,,,,,99.44,0,0.56,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_Brij58_0.0075%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,124780423.3,41841269.7,3968.3,124779100.7,1322.7,10.7,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_Brij58_0.0075%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2553,859.7,26.3,2553,0,0.9,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,,MK-1248_HPbCD_0.4%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1878.3,648,39.7,1878.3,0,0.7,,,,,,,,,,99.3,0,0.7,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,,MK-1248_HPbCD_0.4%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8359.7,1627,79.3,8346.3,13.3,0.9,,,,,,,,,,99.3,0,0.7,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,,MK-1248_HPbCD_0.4%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12248.7,2381,66.3,12235.7,0,0.9,,,,,,,,,,99.27,0,0.73,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,,MK-1248_HPbCD_0.4%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5397,992,26.7,5383.7,0,0.9,,,,,,,,,,99.3,0,0.7,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_HPbCD_0.4%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35929894.3,6645502.7,2645.3,35928571.7,0,2.8,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_HPbCD_0.4%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31490740.7,9419312,1322.7,31490740.7,0,2.3,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_HPbCD_0.4%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42026455,20243386.3,1322.7,42026455,0,4.3,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_HPbCD_0.4%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86423280.3,13425925.7,11905,86420635,0,6.8,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_HPbCD_0.4%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1323,317.3,0,1323,0,0.8,,,,,,,,,,99.55,0,0.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,,MK-1248_HPgCD_0.4%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6468,1547.7,79.7,6455,0,0.7,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,,MK-1248_HPgCD_0.4%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10119,4709,357,10106,0,0.9,,,,,,,,,,99.44,0,0.56,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,,MK-1248_HPgCD_0.4%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17460.3,7381,185.3,17434,0,1,,,,,,,,,,99.36,0,0.63,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,,MK-1248_HPgCD_0.4%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3373,1177,26.3,3346.7,0,0.6,,,,,,,,,,99.45,0,0.55,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_HPgCD_0.4%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22060846.7,1076719.7,0,22060846.7,0,1.7,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_HPgCD_0.4%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,40357143,10527778,0,40357143,0,3.2,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_HPgCD_0.4%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,81076719.3,23912698.3,0,81076719.3,0,6.1,,,,,,,,,,99.57,0,0.43,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_HPgCD_0.4%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,128591269.7,36044973.7,0,128591269.7,0,9.8,,,,,,,,,,99.59,0,0.41,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_HPgCD_0.4%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2473.3,886.3,26.3,2460.3,0,0.6,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,,MK-1248_MoNi_0.02%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3597.7,978.7,0,3597.7,0,0.6,,,,,,,,,,99.41,0,0.59,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,,MK-1248_MoNi_0.02%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2222.3,608.3,53,2195.7,13.3,33.8,,,,,,,,,,99.34,0,0.66,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,,MK-1248_MoNi_0.02%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9536.7,2777.7,224.7,9444.7,26.7,0.9,,,,,,,,,,99.12,0,0.88,-0.2,0,0.2,0.2,0,0.2,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,,MK-1248_MoNi_0.02%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11799,2949.7,66,11759.3,13.3,0.7,,,,,,,,,,99.45,0,0.55,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,,MK-1248_MoNi_0.05%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1679.7,423.3,53,1666.3,0,0.7,,,,,,,,,,99.43,0,0.58,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,,MK-1248_MoNi_0.05%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1944.3,489.3,26.7,1918.3,0,0.6,,,,,,,,,,99.42,0,0.58,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,,MK-1248_MoNi_0.05%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,912.7,212,39.7,899.3,13.3,0.7,,,,,,,,,,99.42,0,0.58,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,,MK-1248_MoNi_0.05%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16389,1917.7,13.3,16375.7,0,0.8,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_MoNi_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7247354.7,510582,5291.3,7246032,0,0.6,,,,,,,,,,99.57,0,0.43,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_MoNi_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16740740.7,7921957.7,5291,16740740.7,0,1.9,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_MoNi_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,62666666.7,25095238.3,2645.3,62664021.3,1322.7,5.4,,,,,,,,,,99.53,0,0.47,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_MoNi_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,168138889,67374338.7,2645.7,168138889,0,18.4,,,,,,,,,,99.55,0,0.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_MoNi_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12037,1547.7,39.7,12037,0,1.1,,,,,,,,,,99.45,0,0.55,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,,MK-1248_MoNi_0.2%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6785.7,1349.3,66.3,6772.7,13.3,0.8,,,,,,,,,,99.47,0,0.53,0,0,0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,,MK-1248_MoNi_0.2%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3029.3,846.3,53,3029.3,0,0.8,,,,,,,,,,99.47,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,,MK-1248_MoNi_0.2%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4365,1031.7,198.3,4338.3,0,0.9,,,,,,,,,,99.46,0,0.54,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,,MK-1248_MoNi_0.2%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64616.7,10013,26.7,64616.7,0,1.1,,,,,,,,,,99.67,0,0.33,0.2,0,-0.1,0.2,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_MoNi_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19993386.3,7181217,2645.3,19993386.3,0,2,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_MoNi_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,56821428.7,26665344,13227.7,56817460.3,1322.7,5.5,,,,,,,,,,99.52,0,0.48,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_MoNi_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13208994.3,1853174.3,3968.3,13207671.7,1322.7,1.3,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_MoNi_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63746031.3,13968254,11905,63743386,0,5,,,,,,,,,,99.56,0,0.44,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_MoNi_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,62460.3,16150.7,158.7,62447,13.3,0.7,,,,,,,,,,99.44,0,0.56,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_MoNi_1%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19300264.3,1656084.7,9259.3,19296296.3,1322.7,1.7,,,,,,,,,,99.52,0,0.48,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_MoNi_1%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17265873,2624339,1322.7,17264550.3,0,1.7,,,,,,,,,,99.56,0,0.44,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_MoNi_1%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30805555.3,8171957.7,3968.3,30804232.7,1322.7,2.6,,,,,,,,,,99.53,0,0.47,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_MoNi_1%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,106395502.7,30689153.7,1322.7,106395502.7,0,8.4,,,,,,,,,,99.58,0,0.42,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_MoNi_1%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,198069,71362.3,383.3,198029,13.3,2.4,,,,,,,,,,99.51,0,0.49,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_None_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17443121.7,5867725,2645.3,17441799,0,1.3,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_None_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,72849206.7,16550264.3,1322.7,72849206.7,0,5.1,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_None_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,59112434,23961640.3,0,59112434,0,5,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_None_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,126984127,28555555.7,5291,126984127,0,10.3,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_None_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,846.7,145.3,0,846.7,0,0.1,,,,,,,,,,99.51,0,0.49,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,,MK-1248_PO188_0.02%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1256.7,331,52.7,1243.3,0,0.5,,,,,,,,,,94.76,4.29,0.95,-0.2,0.2,0,0.2,0.2,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,,MK-1248_PO188_0.02%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1084.7,357.3,13.3,1084.7,0,0.6,,,,,,,,,,95.06,4.03,0.91,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,,MK-1248_PO188_0.02%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1283,317.3,0,1283,0,0.7,,,,,,,,,,95.2,3.8,1,0.2,-0.3,0,0.2,0.3,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,,MK-1248_PO188_0.02%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2989.3,1587.3,53,2989.3,0,0.6,,,,,,,,,,94.8,4.18,1.02,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_PO188_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7305555.7,503968.7,0,7305555.7,0,0.5,,,,,,,,,,99.51,0,0.49,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_PO188_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7414021.3,563492,0,7414021.3,0,0.5,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_PO188_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32537037,8870370.3,1322.7,32535714.3,1322.7,2.1,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_PO188_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94997354.7,35998677.3,0,94997354.7,0,7.5,,,,,,,,,,99.55,0,0.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_PO188_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,754,344,13.3,740.7,0,0.1,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_PO188_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1615079.7,216931.3,0,1615079.7,0,0.7,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_PO188_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9328042.3,1283068.7,1322.7,9328042.3,0,1.1,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_PO188_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60267195.7,25007936.3,1322.7,60267195.7,0,4.7,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_PO188_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41404761.7,12166666.7,1322.7,41403439,0,3.4,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_PO188_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1971,516,0,1971,0,1,,,,,,,,,,100,0,0,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_PS20_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4785714,182539.7,1322.7,4784391.3,0,0.6,,,,,,,,,,99.4,0,1.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_PS20_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13287037,7730159,5291,13285714.3,0,2.1,,,,,,,,,,99.39,0,1.48,0,0,0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_PS20_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37440476.3,21914021.3,1322.7,37440476.3,0,3.7,,,,,,,,,,99.44,0,1.41,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_PS20_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57015873,12400793.7,3968.3,57013227.7,1322.7,3.6,,,,,,,,,,99.42,0,1.44,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_PS20_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,462.7,185,39.7,436.3,0,0.3,,,,,,,,,,99.41,0,1.36,0,0,-0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_PS20_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13797619,5712963,1322.7,13797619,0,1.6,,,,,,,,,,99.45,0,0.55,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_PS20_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46907407.3,15698413,0,46907407.3,0,3.7,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_PS20_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10007936.7,3609788.3,0,10007936.7,0,0.8,,,,,,,,,,99.48,0,0.52,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_PS20_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,27386243.3,9837301.3,1322.7,27386243.3,0,35.5,,,,,,,,,,99.45,0,0.55,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_PS20_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,701,171.7,13.3,688,13.3,0.6,,,,,,,,,,99.49,0,0.51,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_PS80_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15855820,4682539.7,0,15855820,0,1.4,,,,,,,,,,99.47,0,1.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_PS80_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51289682.3,15136243.7,0,51289682.3,0,3.6,,,,,,,,,,99.46,0,1.44,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_PS80_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35572751.3,17949735.3,0,35572751.3,0,3,,,,,,,,,,99.41,0,1.57,0,0,0.1,0,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_PS80_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,53452381,29846560.7,9259,53448412.7,2645.7,5.3,,,,,,,,,,99.39,0,1.56,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_PS80_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1600.3,503,0,1600.3,0,0.1,,,,,,,,,,99.54,0,1.35,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_PS80_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5690476.3,1113756.3,2645.3,5689153.3,1322.7,0.4,,,,,,,,,,96.52,0,3.48,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_PS80_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57833333.7,18673280.3,1322.7,57833333.7,0,4,,,,,,,,,,96.68,0,3.32,0.4,0,-0.4,0.4,0,0.4,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_PS80_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33298941.7,4329365.3,0,33298941.7,0,1.9,,,,,,,,,,96.06,0,3.94,-0.2,0,0.2,0.2,0,0.2,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_PS80_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,38398148,10387566,0,38398148,0,3.2,,,,,,,,,,94.83,0,5.17,-1.5,0,1.5,1.5,0,1.5,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_PS80_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6111.3,1336,0,6111.3,0,0.2,,,,,,,,,,97.43,0,2.57,1.1,0,-1.1,1.1,0,1.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,,MK-1248_SBEbCD_0.4%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16137.3,8029,3161,14920.7,158.7,2.2,,,,,,,,,,99.3,0,0.7,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,,MK-1248_SBEbCD_0.4%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,56613.7,38783,18545.3,48307,1005.3,10.4,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,,MK-1248_SBEbCD_0.4%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46560.7,32566,17394.3,37222,1521,12.8,,,,,,,,,,98.8,0,1.2,-0.4,0,0.4,0.4,0,0.4,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,,MK-1248_SBEbCD_0.4%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16468.3,4153.3,66,16468.3,0,0.7,,,,,,,,,,99.4,0,0.6,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_SBEbCD_0.4%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21521164,6279100.7,1322.7,21519841.3,0,1.8,,,,,,,,,,99.53,0,0.47,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_SBEbCD_0.4%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19338624.3,1949735.3,0,19338624.3,0,1.8,,,,,,,,,,99.55,0,0.45,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_SBEbCD_0.4%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70000000,31879629.3,0,70000000,0,6.6,,,,,,,,,,99.49,0,0.51,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_SBEbCD_0.4%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,112743386,39267195.7,5291,112743386,0,9.7,,,,,,,,,,99.45,0,0.55,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_SBEbCD_0.4%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14457.7,2645.3,26.3,14457.7,0,0.8,,,,,,,,,,99.49,0,0.51,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.04,,,MK-1248_gCD_0.4%_GF_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51402,18280.7,5357,50158.7,145.7,3,,,,,,,,,,99.36,0,0.64,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.08,,,MK-1248_gCD_0.4%_GF_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,103981.3,43068.7,9749,101124.3,291,5.5,,,,,,,,,,99.32,0,0.68,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,25,0.16,,,MK-1248_gCD_0.4%_GF_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,139232.7,64166.7,19378.3,131415.3,939,12.9,,,,,,,,,,99.22,0,0.78,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,G-Force,5,0,,,MK-1248_gCD_0.4%_GF_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,142182.3,9365,13.3,142182.3,0,2.3,,,,,,,,,,99.44,0,0.56,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-1248_gCD_0.4%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11919312,2411376,1322.7,11919312,0,1.5,,,,,,,,,,99.5,0,0.5,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-1248_gCD_0.4%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23009259.3,9665344,0,23009259.3,0,2.7,,,,,,,,,,99.52,0,0.48,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-1248_gCD_0.4%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,68074074,13468254,2645.3,68071428.7,0,4.9,,,,,,,,,,99.46,0,0.54,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-1248_gCD_0.4%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,106145502.7,31929894,10582,106140211.7,0,8.6,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-1248,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-1248_gCD_0.4%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,152262,7407.7,26.7,152262,0,2.2,,,,,,,,,,99.52,0,0.48,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,2,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-4166_MoNi_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,675926,91270,0,675926,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-4166_MoNi_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91270,8597.7,661.3,91270,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-4166_MoNi_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2279100.7,162037,1322.7,2277777.7,661.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-4166_MoNi_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5333333.3,314153.3,1984,5332672,0,1.4,,,,,,,,,,99.29,0,0.71,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-4166_MoNi_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9999.7,1283,39.7,9986.3,0,0.7,,,,,,,,,,99.53,0,0.47,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-4166_MoNi_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,536375.7,26455.3,0,536375.7,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-4166_MoNi_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,875661.3,64814.7,3968,874338.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-4166_MoNi_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5791666.7,333333,1322.7,5791005.3,661.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-4166_MoNi_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6200396.7,535053,5291,6199074,0,2,,,,,,,,,,99.26,0,0.74,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-4166_MoNi_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57301.7,9008,105.7,57301.7,0,1.3,,,,,,,,,,99.43,0,0.57,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-4166_MoNi_1%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,630290.7,155423.3,1322.7,630290.7,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-4166_MoNi_1%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,609788.3,94576.7,3306.7,609127,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-4166_MoNi_1%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2898809.7,259920.7,5291,2898148.3,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-4166_MoNi_1%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4199735.7,206349.3,661.3,4199074.3,0,2.5,,,,,,,,,,99.33,0,0.67,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-4166_MoNi_1%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,251746,75211.3,211.7,251706.3,0,3.2,,,,,,,,,,99.48,0,0.52,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-4166_PS20_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,258598,31084.7,1322.7,258598,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-4166_PS20_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,242724.7,37037,1322.7,242724.7,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-4166_PS20_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1048280.3,76719.3,661.3,1048280.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-4166_PS20_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2165343.7,98545,3306.7,2164021,0,0.7,,,,,,,,,,99.78,0,0.22,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-4166_PS20_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5833.3,1270,0,5833.3,0,0.9,,,,,,,,,,99.86,0,0.14,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-4166_PS20_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,214947,31746,5952.3,214947,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-4166_PS20_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,378968.3,28439.3,2645.3,378307,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-4166_PS20_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,324074,43650.7,661.3,324074,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-4166_PS20_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6164682.7,161375.3,3968,6164682.7,0,1.8,,,,,,,,,,99.42,0,0.58,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-4166,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-4166_PS20_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3465.7,859.7,0,3465.7,0,1,,,,,,,,,,99.47,0,0.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,,MK-7110_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4285.7,952.3,13.3,4285.7,0,0.8,,,,,,,,,,99,0,1,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,,MK-7110_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,635,132.3,13.3,635,0,0.7,,,,,,,,,,99.01,0,0.99,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,,MK-7110_MoNi_0.02%_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11944.3,1772.7,13.3,11944.3,0,0.8,,,,,,,,,,99.18,0,0.82,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,,MK-7110_MoNi_0.02%_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7169.3,806.7,26.3,7169.3,0,0.8,,,,,,,,,,99.22,0,0.78,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,,MK-7110_MoNi_0.05%_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19775,2076.7,66,19761.7,13.3,1,,,,,,,,,,99.19,0,0.81,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,,MK-7110_MoNi_0.05%_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16151,1653.3,0,16151,0,1.1,,,,,,,,,,99.22,0,0.78,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-7110_MoNi_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,106878.3,28968.7,1190.3,106349.3,132.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-7110_MoNi_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,66269.7,11640,397,66137.3,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-7110_MoNi_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,103439,14947.3,1454.7,102778,264.7,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-7110_MoNi_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1100264.7,171560.7,661.3,1100000.3,132.3,1.7,,,,,,,,,,99.15,0,0.85,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-7110_MoNi_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20741,3664,159,20687.7,13.3,29.2,,,,,,,,,,99.29,0,0.71,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-7110_MoNi_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,77248.7,9127,793.7,77248.7,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-7110_MoNi_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99735.3,16666.7,1190.7,99338.7,132.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-7110_MoNi_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100661.3,13492,264.7,100396.7,0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-7110_MoNi_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,367592.7,37963,793.7,367460.3,0,1.1,,,,,,,,,,99.16,0,0.84,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-7110_MoNi_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64920.7,9285.7,0,64920.7,0,1.3,,,,,,,,,,99.2,0,0.8,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-7110_MoNi_1%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,335582,49470.7,661.3,335582,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-7110_MoNi_1%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,362830.7,45105.7,1058,362698.3,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-7110_MoNi_1%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,49867.7,16799,2381,49603,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-7110_MoNi_1%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,364947.3,42857,1587,364550.3,0,1.2,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-7110_MoNi_1%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,253320,80846.7,39.7,253320,0,3.2,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,,MK-7110_PS20_0.02%_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1031.7,277.3,26.7,1031.7,0,0.8,,,,,,,,,,99.1,0,0.9,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,,MK-7110_PS20_0.02%_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1309.3,277.7,0,1309.3,0,0.9,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-7110_PS20_0.05%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14021,4894.3,925.7,13756.3,132.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-7110_PS20_0.05%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20635,7010.3,1322.7,19709.3,264.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-7110_PS20_0.05%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16666.7,4894.3,1058,16402.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-7110_PS20_0.05%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,69312,13227.7,1190.7,69312,0,1,,,,,,,,,,99.18,0,0.82,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-7110_PS20_0.05%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,357,53,13.3,357,0,0.5,,,,,,,,,,99.24,0,0.76,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.02,,,MK-7110_PS20_0.2%_ST_0.5H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17592.7,4894.3,1455,17460.3,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.04,,,MK-7110_PS20_0.2%_ST_1H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21693,9127,2248.7,21296.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.08,,,MK-7110_PS20_0.2%_ST_2H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,462698.3,60317.3,1455,462433.7,132.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,25,0.16,,,MK-7110_PS20_0.2%_ST_4H,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,29233,7143,1058.3,28836,132.3,1,,,,,,,,,,99.21,0,0.79,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Stirring,5,0,,,MK-7110_PS20_0.2%_ST_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,992,225,0,992,0,0.9,,,,,,,,,,99.27,0,0.73,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,-80,0.2,,,MK-7110_PS80_0.02%_FT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,833.3,251.3,13.3,833.3,0,0.7,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
11/17/2023,ramapa,Surfactant,MK-7110,mAb,MULTIPLE CONTROL,Freeze Thaw,5,0,,,MK-7110_PS80_0.02%_FT_CT,NB-ramapa-5085300-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,886.3,158.7,13.3,873,0,33.8,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B02,1.03,,NB-ferguhei-5069961-0003,4.5,Acetate,0,0,0,0,0,,,,100,0,,,100,2.383,,0.04,50.7,33.07,16.23,11.5,,,,,,74,72.2,34097.1,8129.7,2698.6,2002.7,1255.9,1001.4,560.1,339.4,,21520.6,2477.9,339.4,169.7,67.9,17,0,0,,,,,,,,91.2,6.06,2.77,-4.7,5.76,-1.1,,,,90.3,9.63,0.1,-3,3,0,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B03,1.01,,NB-ferguhei-5069961-0003,5.6,Acetate,0,0,0,0,0,,,,100,0,,,97,-0.369,,0.041,41.9,38.01,20.13,2.7,,,,,,70,72.2,22895.4,1917.8,169.7,84.9,67.9,33.9,17,0,,25967.3,2528.8,169.7,135.8,67.9,0,0,0,,,,,,,,93.4,3.37,3.23,-2.4,3.08,-0.6,,,,91.4,8.41,0.23,-1.9,1.8,0.13,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B04,1.03,,NB-ferguhei-5069961-0003,6.2,Acetate,0,0,0,0,0,,,,100,0,,,97,-0.439,,0.042,45,40.96,14.08,5.8,,,,,,71.4,73.4,21418.9,1850,305.5,169.7,33.9,17,0,0,,29701.5,3343.5,271.6,101.8,50.9,0,0,0,,,,,,,,94,2.52,3.46,-1.8,2.22,-0.4,,,,91.4,8.35,0.28,-1.9,1.7,0.18,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B05,1.04,,NB-ferguhei-5069961-0003,5,Histidine,0,0,0,0,0,,,,100,0,,,97,-0.53,,0.043,10.5,48.59,40.94,-28.7,,,,,,68.6,76.6,21809.1,2376.1,577,407.3,203.7,67.9,0,0,,19857.3,2460.9,373.4,254.6,67.9,17,0,0,,,,,,,,95.2,1.8,3.03,-0.7,1.5,-0.8,,,,91.4,8.38,0.19,-1.8,1.7,0.09,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B06,1.03,,NB-ferguhei-5069961-0003,5.6,Histidine,0,0,0,0,0,,,,100,0,,,97.2,-0.417,,0.042,9.3,51.1,39.61,-29.9,,,,,,70.6,76.8,22861.4,2240.3,322.5,203.7,152.7,67.9,17,0,,25085.1,2783.5,441.3,169.7,33.9,0,0,0,,,,,,,,95.4,1.44,3.2,-0.5,1.15,-0.7,,,,91.7,8.18,0.17,-1.6,1.5,0.07,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B07,1.04,,NB-ferguhei-5069961-0003,6.2,Histidine,0,0,0,0,0,,,,100,0,,,97.1,-0.559,,0.042,9.3,52.17,38.51,-29.9,,,,,,69,70.8,19993.1,1850,288.5,152.7,67.9,33.9,0,0,,26544.4,2732.5,288.5,67.9,17,17,0,0,,,,,,,,95.5,1.17,3.31,-0.3,0.88,-0.5,,,,91.7,8.04,0.22,-1.5,1.4,0.12,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B08,1.04,,NB-ferguhei-5069961-0003,6.8,Histidine,0,0,0,0,0,,,,100,0,,,96.3,-1.27,,0.044,10.4,50.82,38.76,-28.8,,,,,,64.2,61.2,25033.8,3852.7,1086.2,831.6,509.2,339.4,67.9,33.9,,30668.9,3122.9,84.9,50.9,33.9,0,0,0,,,,,,,,95.6,0.99,3.4,-0.2,0.7,-0.5,,,,91.7,7.93,0.37,-1.5,1.3,0.27,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B09,1.04,,NB-ferguhei-5069961-0003,6.2,Citrate,0,0,0,0,0,,,,100,0,,,100,2.383,,0.043,33.4,48.89,17.68,-5.8,,,,,,62.8,64.4,23608.2,2647.6,441.3,186.7,67.9,33.9,0,0,,27919.3,2189.4,220.6,169.7,67.9,17,0,0,,,,,,,,95,1.02,4.03,-0.9,0.73,0.2,,,,92.5,7.18,0.32,-0.7,0.5,0.22,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B10,1.03,,NB-ferguhei-5069961-0003,6.8,Citrate,0,0,0,0,0,,,,100,0,,,100,2.383,,0.042,34,51.86,14.13,-5.2,,,,,,60.6,,34691.3,7688.4,1391.7,611,186.7,101.8,0,0,,42346.3,6313.8,543.1,220.6,33.9,17,0,0,,,,,,,,95.1,0.95,3.91,-0.7,0.66,0,,,,92.6,7.06,0.38,-0.7,0.4,0.28,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,B11,1.02,,NB-ferguhei-5069961-0003,7.4,Phosphate,0,0,0,0,0,,,,99.8,-0.243,,,96.6,-1.053,,0.043,23.7,65.2,11.09,-15.5,,,,,,62.6,65.4,25033.9,2511.9,373.4,271.6,135.8,101.8,17,0,,70045.1,8520.1,746.8,424.3,203.7,84.9,0,0,,,,,,,,91.3,2.55,6.17,-4.6,2.26,2.3,,,,87.6,9.13,3.3,-5.7,2.5,3.2,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C02,1.03,,NB-ferguhei-5069961-0003,4.5,Acetate,0,50,0,0,0,,,,100,0,,,100,2.383,,0.041,46,43.48,10.5,6.8,,,,,,65.6,63.8,28004.2,4972.9,1408.7,933.5,390.4,152.8,17,0,,29786.1,5974.2,1374.7,797.7,254.6,84.9,17,0,,,,,,,,95.1,1.64,3.31,-0.8,1.34,-0.6,,,,86.2,9.08,4.68,-7,2.4,4.58,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C03,1.03,,NB-ferguhei-5069961-0003,5.6,Acetate,0,50,0,0,0,,,,100,0,,,97.7,0.111,,0.042,46.1,41.8,12.1,6.9,,,,,,64.4,59.2,23896.8,3055,763.7,526.1,169.7,50.9,17,0,,65242,12797.2,3479.3,1714.2,543.1,152.8,0,0,,,,,,,,95.9,0.73,3.4,0,0.44,-0.5,,,,91.5,8.24,0.31,-1.8,1.6,0.21,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C04,1.02,,NB-ferguhei-5069961-0003,6.2,Acetate,0,50,0,0,0,,,,100,0,,,97.9,0.292,,0.043,47.6,48.84,3.61,8.4,,,,,,61,62,25033.8,3241.7,967.4,644.9,356.4,203.7,67.9,33.9,,33231.6,5736.6,1001.4,509.2,237.6,84.9,0,0,,,,,,,,95.7,0.7,3.6,-0.1,0.41,-0.3,,,,90.9,8.83,0.27,-2.3,2.2,0.17,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C05,1.03,,NB-ferguhei-5069961-0003,5,Histidine,0,50,0,0,0,,,,100,0,,,98,0.354,,0.044,0,65.24,34.76,-39.2,,,,,,55,60.6,22776.6,3088.9,729.8,356.4,169.7,101.8,17,0,,54718.6,10777.4,2393.1,1103.2,322.5,118.8,17,17,,,,,,,,95.4,1.27,3.32,-0.4,0.98,-0.5,,,,89.4,8.83,1.82,-3.9,2.2,1.72,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C06,1.03,,NB-ferguhei-5069961-0003,5.6,Histidine,0,50,0,0,0,,,,100,0,,,98.1,0.435,,0.043,0,66.19,33.81,-39.2,,,,,,58.4,59.6,27206.3,3309.6,814.7,560.1,220.6,67.9,17,17,,62068.4,9759.2,1782.1,780.7,135.8,33.9,0,0,,,,,,,,96.3,0.54,3.19,0.4,0.25,-0.7,,,,91.3,8.37,0.38,-2,1.7,0.28,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C07,1.02,,NB-ferguhei-5069961-0003,6.2,Histidine,0,50,0,0,0,,,,100,0,,,97.3,-0.281,,0.044,0,65.13,34.87,-39.2,,,,,,56.8,27.2,22980.2,2511.9,695.9,441.3,237.6,169.7,67.9,33.9,,49542,10539.8,1917.9,865.6,169.7,50.9,0,0,,,,,,,,96,0.6,3.37,0.2,0.3,-0.5,,,,91.1,8.69,0.24,-2.2,2,0.14,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C08,1.03,,NB-ferguhei-5069961-0003,6.8,Histidine,0,50,0,0,0,,,,100,0,,,97.4,-0.193,,0.046,0,64.92,35.08,-39.2,,,,,,54.6,56.6,23845.7,2800.4,661.9,475.2,237.6,169.7,50.9,17,,58537.7,8282.5,1612.4,814.7,152.8,101.8,17,0,,,,,,,,96.1,0.65,3.28,0.2,0.36,-0.6,,,,91.4,8.34,0.24,-1.8,1.7,0.14,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C09,1.03,,NB-ferguhei-5069961-0003,6.2,Citrate,0,50,0,0,0,,,,99.9,-0.063,,,97.6,-0.059,,0.043,41.1,9.25,49.65,1.9,,,,,,61.4,57.6,26374.7,3632,678.9,441.3,220.6,135.8,33.9,17,,41191.6,6738,1374.8,678.9,152.8,101.8,33.9,17,,,,,,,,94.2,1.53,4.28,-1.6,1.23,0.4,,,,92.9,6.81,0.27,-0.3,0.1,0.17,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C10,1.04,,NB-ferguhei-5069961-0003,6.8,Citrate,0,50,0,0,0,,,,100,0,,,97.7,0.123,,0.043,39.8,53.46,6.73,0.6,,,,,,62,55.8,28139.6,4701.3,1171.1,712.8,220.6,118.8,17,0,,32043.3,4786.1,661.9,356.4,135.8,67.9,33.9,0,,,,,,,,94.6,1.51,3.94,-1.3,1.21,0.1,,,,92.4,7.28,0.31,-0.8,0.6,0.21,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,C11,1.02,,NB-ferguhei-5069961-0003,7.4,Phosphate,0,50,0,0,0,,,,99.9,-0.098,,,97.5,-0.114,,0.043,26.5,65.13,8.35,-12.7,,,,,,54.8,47.8,27019.6,3835.7,712.8,424.3,101.8,67.9,33.9,0,,94096.3,16819.9,2562.9,1239,237.6,67.9,0,0,,,,,,,,92.4,2.22,5.43,-3.5,1.92,1.6,,,,89,9.07,1.89,-4.2,2.4,1.79,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D02,1.05,,NB-ferguhei-5069961-0003,4.5,Acetate,0,150,0,0,0,,,,100,0,,,98.2,0.621,,0.04,,,,,,,,,,52.2,59.4,29904.9,3649,356.4,220.6,67.9,67.9,17,17,,106912.2,13374.6,2817.5,1544.5,526.2,135.8,0,0,,,,,,,,94.9,1.27,3.79,-0.9,0.98,-0.1,,,,44.8,7.76,47.46,-48.5,1.1,47.36,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D03,1.05,,NB-ferguhei-5069961-0003,5.6,Acetate,0,150,0,0,0,,,,100,0,,,98.2,0.571,,0.045,,,,,,,,,,61.6,57.8,36252.7,5465.1,492.2,339.4,152.7,84.9,0,0,,85425,16769.3,3038.2,1595.5,441.3,186.7,17,0,,,,,,,,96.1,0.43,3.49,0.2,0.14,-0.4,,,,91.1,8.53,0.42,-2.2,1.9,0.32,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D04,1.02,,NB-ferguhei-5069961-0003,6.2,Acetate,0,150,0,0,0,,,,100,0,,,98.2,0.618,,0.043,,,,,,,,,,61.4,53.6,24881.1,3088.9,831.6,543.1,254.6,135.8,33.9,0,,66856.4,14376.1,1985.8,1069.3,271.6,220.6,50.9,0,,,,,,,,95.8,0.61,3.57,0,0.32,-0.3,,,,91.2,8.52,0.25,-2,1.9,0.15,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D05,1.03,,NB-ferguhei-5069961-0003,5,Histidine,0,150,0,0,0,,,,100,0,,,100,2.383,,0.044,,,,,,,,,,61.2,55.2,24728.5,3122.9,695.9,407.3,152.7,101.8,50.9,0,,69909.7,13326.7,2614.4,1137.4,169.8,34,0,0,,,,,,,,95.7,1.09,3.22,-0.2,0.8,-0.6,,,,83.1,8.75,8.13,-10.1,2.1,8.03,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D06,1.02,,NB-ferguhei-5069961-0003,5.6,Histidine,0,150,0,0,0,,,,100,0,,,100,2.383,,0.044,,,,,,,,,,60.2,58.4,25407.2,2851.3,424.3,271.6,152.7,84.9,0,0,,51952.1,9521.4,1816,899.5,288.5,101.8,17,0,,,,,,,,96.3,0.43,3.28,0.4,0.14,-0.6,,,,91.5,8.06,0.49,-1.8,1.4,0.39,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D07,1.03,,NB-ferguhei-5069961-0003,6.2,Histidine,0,150,0,0,0,,,,100,0,,,100,2.383,,0.042,,,,,,,,,,57.4,55,22029.8,2308.2,407.3,288.5,169.7,101.8,0,0,,56789.4,9810,1917.9,1137.1,288.5,101.8,50.9,33.9,,,,,,,,96.3,0.49,3.25,0.4,0.19,-0.6,,,,91.8,8.03,0.2,-1.5,1.4,0.1,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D08,1.03,,NB-ferguhei-5069961-0003,6.8,Histidine,0,150,0,0,0,,,,100,0,,,100,2.383,,0.042,,,,,,,,,,46.2,48.8,25373.3,2970.1,611,356.4,118.8,33.9,0,0,,58589.4,12220.3,2274.3,1188.1,407.3,271.6,0,0,,,,,,,,96.2,0.49,3.34,0.3,0.19,-0.5,,,,91.8,7.98,0.21,-1.4,1.3,0.11,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D09,1.01,,NB-ferguhei-5069961-0003,6.2,Citrate,0,150,0,0,0,,,,100,0,,,100,2.383,,0.045,,,,,,,,,,61.4,60.2,24507.8,2613.7,492.2,305.5,118.8,84.9,0,0,,66278.2,9351.9,1120.2,661.9,169.7,101.8,33.9,17,,,,,,,,94.7,1.75,3.58,-1.2,1.46,-0.3,,,,91.4,8.35,0.25,-1.8,1.7,0.15,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D10,1.04,,NB-ferguhei-5069961-0003,6.8,Citrate,0,150,0,0,0,,,,100,0,,,100,2.383,,0.044,,,,,,,,,,61.2,56.2,34131.1,5566.9,865.6,492.2,118.8,50.9,0,0,,91007.1,16107,526.2,271.6,50.9,0,0,0,,,,,,,,94.9,1.16,3.95,-1,0.87,0.1,,,,91.8,7.94,0.24,-1.4,1.3,0.14,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37,14,D11,1.02,,NB-ferguhei-5069961-0003,7.4,Phosphate,0,150,0,0,0,,,,100,0,,,100,2.368,,0.045,,,,,,,,,,51,46.8,26527.3,3920.5,424.3,203.7,33.9,33.9,0,0,,153563.8,26378.1,4365.2,2276,611.5,186.8,17,0,,,,,,,,93.5,1.83,4.69,-2.4,1.53,0.8,,,,90.6,8.53,0.91,-2.7,1.9,0.81,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,5,0,H02,1.05,,NB-ferguhei-5069961-0003,6,Water,0,0,0,0,0,,,,100,,,,97.4,,,0.04,39.7,30.52,29.8,0,,,,,,64,39.6,,,,,,,,,,1467261,628843.1,104286.2,44412.5,9548.5,3601.9,373.8,68,,,,,,,,95.3,0.89,3.8,0,0,0,,,,93.5,6.36,0.13,0,0,0,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,5,0,H03,1.03,,NB-ferguhei-5069961-0003,4,Bulk Dialysis,0,0,0,0,0,,,,100,,,,97.6,,,0.044,39.2,29.52,31.29,0,,,,,,65,,31602,4769.2,831.6,577.1,220.6,118.8,17,0,,2594567,1461923.6,206691.7,97656.3,17900.8,4178,883.2,169.8,,,,,,,,95.8,0.29,3.86,0,0,0,,,,93.2,6.66,0.1,0,0,0,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E02,0.97,,NB-ferguhei-5069961-0003,4.3,Acetate,0,0,0,0,0,,,,98.1,23.196,,,62.1,1.724,,0.039,18.8,18.48,62.74,-10.8,,,,,,56.4,49.8,77936.6,35862.4,5651.8,1646.3,322.5,101.8,17,0,,12847.7,4582.4,1374.7,780.7,271.6,118.8,17,17,,,,,,,,78.9,15.97,5.1,-16.9,15.68,1.2,,,,90.5,9.26,0.19,-1.97,2.02,-0.06,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E03,0.98,,NB-ferguhei-5069961-0003,4.7,Acetate,0,0,0,0,0,,,,98.2,23.336,,,61.8,1.42,,0.042,9.5,29.49,61,-20,,,,,,61.4,60.8,1189351.8,508616.2,188417.9,111814.8,31799.1,7775.8,84.9,0,,307798.2,46815.6,2987.5,950.6,237.6,84.9,0,0,,,,,,,,78.7,15.94,5.33,-17.1,15.65,1.5,,,,90.8,8.97,0.23,-1.71,1.73,-0.02,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E04,0.98,,NB-ferguhei-5069961-0003,4.85,Acetate,0,0,0,0,0,,,,98.1,23.229,,,62.2,1.818,,0.042,4.5,81.15,14.39,-25.1,,,,,,61.2,62,999216.1,304238.4,61424.9,25907.8,5483.8,2037.3,50.9,0,,525447.7,99154.8,8657.6,1765.5,101.9,34,0,0,,,,,,,,78.2,16.65,5.18,-17.7,16.36,1.3,,,,90.5,9.26,0.24,-2.01,2.02,-0.01,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E05,0.98,,NB-ferguhei-5069961-0003,3.9,Histidine,0,0,0,0,0,,,,79.4,4.445,,,59.8,-0.58,,0.043,15.6,33.16,51.24,-13.9,,,,,,62.2,56.2,55397.1,13000.7,1306.9,644.9,203.7,50.9,0,0,,29803.1,4972.8,186.7,101.8,17,0,0,0,,,,,,,,79.4,16.33,4.32,-16.5,16.04,0.5,,,,90.8,9.06,0.13,-1.7,1.82,-0.12,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E06,0.97,,NB-ferguhei-5069961-0003,4.4,Histidine,0,0,0,0,0,,,,62.2,-12.725,,,59.8,-0.617,,0.041,2.7,28.76,68.58,-26.9,,,,,,55.6,60.4,259135,67147.3,13612.8,6534.8,865.7,186.7,0,0,,10352.9,2987.1,441.3,220.6,33.9,0,0,0,,,,,,,,77.6,18.06,4.33,-18.2,17.77,0.5,,,,91.3,8.48,0.21,-1.2,1.24,-0.04,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E07,0.96,,NB-ferguhei-5069961-0003,4.9,Histidine,0,0,0,0,0,,,,73.4,-1.491,,,58.9,-1.499,,0.041,1.4,28.68,69.9,-28.1,,,,,,58.4,59.6,1283423.1,520616,179300.3,102452.4,25978.2,6842.6,152.8,34,,670142.5,110332.3,6722.8,1392.1,203.7,84.9,34,0,,,,,,,,76.5,19.3,4.21,-19.4,19.01,0.3,,,,91.5,8.3,0.24,-1.06,1.06,-0.01,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E08,0.98,,NB-ferguhei-5069961-0003,5.4,Histidine,0,0,0,0,0,,,,73.4,-1.464,,,63.3,2.837,,0.043,3.5,22.55,73.97,-26.1,,,,,,57.6,59,1483065.7,622797.2,210915.7,120535.4,32651,8846.2,186.8,17,,1286032.6,281969.7,13110.1,1800.1,237.7,67.9,0,0,,,,,,,,74.3,21.05,4.61,-21.5,20.76,0.7,,,,91.3,8.5,0.26,-1.26,1.26,0.01,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E09,0.93,,NB-ferguhei-5069961-0003,5.5,Citrate,0,0,0,0,0,,,,78.4,3.534,,,62.3,1.885,,0.051,25.8,41.86,32.37,-3.8,,,,,,55.2,44.6,510009.8,317364.3,131864.5,65448.5,15394.7,6432.8,220.7,33.9,,79904.5,30821.3,4616.4,1154.1,67.9,50.9,0,0,,,,,,,,75.7,18.61,5.68,-20.1,18.32,1.8,,,,78.1,21.71,0.2,-14.42,14.47,-0.05,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E10,0.94,,NB-ferguhei-5069961-0003,5.63,Citrate,0,0,0,0,0,,,,75.4,0.481,,,60.2,-0.223,,0.041,3.1,85.22,11.68,-26.4,,,,,,54.6,45.8,518534.5,332812.6,141167,69268.1,15123.2,5991.6,271.6,33.9,,53310,19263.6,3275.7,984.4,67.9,0,0,0,,,,,,,,75.9,0,24.06,-19.9,-0.29,20.2,,,,77.7,22.06,0.21,-14.78,14.82,-0.04,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,E11,1.07,,NB-ferguhei-5069961-0003,6,Phosphate,0,0,0,0,0,,,,80.8,5.94,,,64.5,4.041,,0.21,28.2,42.34,29.42,-1.3,,,,,,57.6,53.6,1704557.1,876610,477765,361150.8,160896.3,57475.1,2139.4,526.4,,3458767.8,3198934.5,407340.4,3737.9,1505.5,1107.5,34.6,17.3,,,,,,,,73,18.42,8.57,-22.8,18.13,4.7,,,,89.3,10.44,0.29,-3.24,3.2,0.04,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F02,0.99,,NB-ferguhei-5069961-0003,4.3,Acetate,0,50,0,0,0,,,,80.3,5.438,,,69.9,9.46,,0.04,5.1,76.52,18.42,-24.5,,,,,,57.2,59,34928.5,8740.6,1917.8,1188,441.3,203.7,17,0,,3816899.2,688218.4,1015.6,406.3,81.3,40.6,20.3,20.3,,,,,,,,78.1,15.9,6.02,-17.8,15.61,2.2,,,,85.2,14.57,0.23,-7.31,7.33,-0.02,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F03,0.98,,NB-ferguhei-5069961-0003,4.7,Acetate,0,50,0,0,0,,,,81.8,6.921,,,69.4,9.019,,0.042,6.2,81.37,12.46,-23.4,,,,,,55.2,56.6,1051858.7,305920.5,100649.2,58219.6,12700,2360,34,0,,2919489.6,66087.1,2005.2,492.8,51,0,0,0,,,,,,,,75.6,19.89,4.56,-20.3,19.6,0.7,,,,89.3,10.59,0.16,-3.26,3.35,-0.09,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F04,1,,NB-ferguhei-5069961-0003,4.85,Acetate,0,50,0,0,0,,,,82.7,7.747,,,69,8.579,,0.044,0,81.68,18.32,-29.5,,,,,,47.2,54.2,1254079.7,410097,136517.9,80484.4,17743.9,3599.7,50.9,0,,690470.3,43124.7,1969.5,458.4,67.9,34,0,0,,,,,,,,75.2,20.14,4.66,-20.6,19.85,0.8,,,,89.6,10.22,0.17,-2.9,2.98,-0.08,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F05,0.98,,NB-ferguhei-5069961-0003,3.9,Histidine,0,50,0,0,0,,,,80.8,5.909,,,69.8,9.374,,0.043,0,42.37,57.63,-29.5,,,,,,48.8,56.6,31228.5,8316.3,2019.7,1188,373.4,152.7,0,0,,1017046.6,7370.5,1069.9,492.5,101.9,67.9,0,0,,,,,,,,81.8,14.03,4.16,-14,13.74,0.3,,,,79.5,20.26,0.24,-13.01,13.02,-0.01,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F06,0.98,,NB-ferguhei-5069961-0003,4.4,Histidine,0,50,0,0,0,,,,82.1,7.188,,,69.9,9.459,,0.043,0,43.7,56.3,-29.5,,,,,,49.2,42.6,47216.3,10386.9,2002.7,967.4,322.5,135.8,17,0,,710208.3,7624.6,984.9,492.5,118.9,50.9,17,0,,,,,,,,77.4,18.65,3.95,-18.4,18.36,0.1,,,,86.7,13.08,0.19,-5.78,5.84,-0.06,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F07,1,,NB-ferguhei-5069961-0003,4.9,Histidine,0,50,0,0,0,,,,82.1,7.175,,,69.1,8.646,,0.044,0,81.69,18.31,-29.5,,,,,,48.8,,1234955.7,370444.2,115320.3,67524.8,15722.4,4125.9,34,17,,1110585.8,91545.5,4601.9,934,84.9,50.9,0,0,,,,,,,,74.5,21.43,4.05,-21.3,21.14,0.2,,,,90.2,9.64,0.16,-2.3,2.4,-0.09,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F08,0.98,,NB-ferguhei-5069961-0003,5.4,Histidine,0,50,0,0,0,,,,73,-1.948,,,66.1,5.637,,0.047,0,44.97,55.03,-29.5,,,,,,45.6,39.2,1432110.5,496281.1,150483.9,89336,26184.4,7403.6,203.8,34,,1979828.5,330497.9,15454.9,3158.9,135.9,34,17,0,,,,,,,,73.9,21.9,4.18,-21.9,21.61,0.3,,,,91,8.79,0.19,-1.5,1.55,-0.06,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F09,0.96,,NB-ferguhei-5069961-0003,5.5,Citrate,0,50,0,0,0,,,,85.7,10.833,,,69,8.571,,0.055,1.8,85.94,12.24,-27.7,,,,,,48.6,40.4,669631.5,385338.1,146941.8,67012.4,13069.8,4175.5,50.9,0,,1121495,135610.5,5009.4,832.1,50.9,17,0,0,,,,,,,,76.4,18.55,5.06,-19.5,18.26,1.2,,,,78.2,21.61,0.17,-14.3,14.37,-0.08,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F10,0.94,,NB-ferguhei-5069961-0003,5.63,Citrate,0,50,0,0,0,,,,84.1,9.155,,,70.4,9.994,,0.045,6.7,91.01,2.31,-22.9,,,,,,48.6,49.8,779124.6,342107.3,93569,38873.9,8759.4,3004.7,50.9,17,,121490.2,30533.8,3258.7,628,84.9,0,0,0,,,,,,,,75.6,18.87,5.5,-20.2,18.58,1.6,,,,79.3,20.51,0.2,-13.22,13.27,-0.05,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,F11,0.97,,NB-ferguhei-5069961-0003,6,Phosphate,0,50,0,0,0,,,,98.4,23.542,,,69,8.617,,0.071,4.3,90.9,4.77,-25.2,,,,,,42.8,44.6,1648463.5,816251.6,412930.9,293228.5,114065.4,42040.2,2428,475.4,,3344684.3,2377714,305826.4,24686.1,764,101.9,17,0,,,,,,,,78,16.51,5.49,-17.8,16.22,1.6,,,,90.7,9.09,0.25,-1.85,1.85,0,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G02,1,,NB-ferguhei-5069961-0003,4.3,Acetate,0,150,0,0,0,,,,96.2,21.261,,,97.7,37.236,,0.07,,,,,,,,,,34.6,45.6,1696816.4,671465.5,224235,134659.9,33435.7,7318.8,67.9,34,,7639647.6,2600399.7,14874.1,4750.4,2647.7,1907.9,0,0,,,,,,,,80.8,12.59,6.6,-15,12.3,2.7,,,,58.6,40.45,0.97,-33.93,33.21,0.72,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G03,1.13,,NB-ferguhei-5069961-0003,4.7,Acetate,0,150,0,0,0,,,,93,18.054,,,95.1,34.711,,0.281,,,,,,,,,,50.2,49,1660890,617296,186124.4,107521.2,27185.9,6673.4,135.8,17,,5215629.4,4436026.2,2589025.6,1316045.8,1567.9,52.3,0,0,,,,,,,,78.3,14.24,7.45,-17.5,13.95,3.6,,,,81.9,17.59,0.47,-10.57,10.35,0.22,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G04,1.13,,NB-ferguhei-5069961-0003,4.85,Acetate,0,150,0,0,0,,,,93.7,18.82,,,94.2,33.785,,0.299,,,,,,,,,,50.6,42.6,1665799.8,650568.5,209831.8,120920.3,31125.8,7131.9,50.9,0,,4611928.9,4007740.5,2595850.1,1585997.4,11573.3,231,23.1,0,,,,,,,,78.6,14.75,6.69,-17.3,14.46,2.8,,,,80.4,19.16,0.4,-12.07,11.92,0.15,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G05,1,,NB-ferguhei-5069961-0003,3.9,Histidine,0,150,0,0,0,,,,97.1,22.158,,,76.4,15.941,,0.05,,,,,,,,,,49.4,,1401474.6,414736.6,118445.2,65633.1,12413.4,1969.8,0,0,,4393396.7,38017.2,1467.9,298.6,99.5,24.9,24.9,0,,,,,,,,82.5,13.18,4.28,-13.3,12.89,0.4,,,,47,51.95,1.03,-45.49,44.71,0.78,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G06,1.02,,NB-ferguhei-5069961-0003,4.4,Histidine,0,150,0,0,0,,,,97.2,22.266,,,75.1,14.683,,0.07,,,,,,,,,,50.2,42.6,1594773.3,514467.7,123628.5,64429.5,14995,4143.6,84.9,0,,7673035.7,2307252.3,5726,2627.7,1529.5,1176.6,0,0,,,,,,,,83.2,12.89,3.93,-12.7,12.6,0.1,,,,66.5,32.62,0.87,-25.99,25.38,0.62,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G07,1.1,,NB-ferguhei-5069961-0003,4.9,Histidine,0,150,0,0,0,,,,98.5,23.588,,,83.4,22.983,,0.284,,,,,,,,,,49.8,,1552668.3,543559.6,161913.2,97419.6,31346.8,8982.9,152.8,0,,4243233.9,3407752.6,1806411.6,618217.4,149.2,0,0,0,,,,,,,,79.2,16.85,4,-16.7,16.56,0.1,,,,86.3,13.43,0.28,-6.22,6.19,0.03,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G08,0.97,,NB-ferguhei-5069961-0003,5.4,Histidine,0,150,0,0,0,,,,100,25.094,,,74.7,14.289,,0.057,,,,,,,,,,36.8,38.8,1079370.2,262719.3,44013,21904.6,9712.7,4907.3,237.7,50.9,,3146695.6,1489089.5,108455.8,15078.9,373.6,135.8,17,0,,,,,,,,75.6,20.45,3.98,-20.3,20.16,0.1,,,,91.6,8.19,0.17,-0.87,0.95,-0.08,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G09,0.93,,NB-ferguhei-5069961-0003,5.5,Citrate,0,150,0,0,0,,,,99.1,24.204,,,99.7,39.299,,0.055,,,,,,,,,,44.6,43,1200514.3,291655.4,43826.4,18797.3,6537.5,2530.1,67.9,0,,2587820.6,706516.6,23133.3,5622,2598.7,1477.7,509.5,84.9,,,,,,,,75.3,20.3,4.42,-20.6,20.01,0.6,,,,76.4,23.47,0.16,-16.14,16.23,-0.09,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G10,0.96,,NB-ferguhei-5069961-0003,5.63,Citrate,0,150,0,0,0,,,,98.9,23.95,,,100,39.581,,0.045,,,,,,,,,,38.8,45,1219411.6,293734.7,44421.9,18237.4,5943.3,2869.8,84.9,34,,1323444.2,180283.6,8610,1613.3,560.4,169.8,84.9,0,,,,,,,,76.1,19.09,4.81,-19.7,18.8,0.9,,,,79.4,20.45,0.17,-13.13,13.21,-0.08,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37,14,G11,0.95,,NB-ferguhei-5069961-0003,6,Phosphate,0,150,0,0,0,,,,98.6,23.657,,,100,39.581,,0.042,,,,,,,,,,36,,564203.4,250155.4,128599.9,95414.5,50058.2,23391.1,1408.9,152.8,,1289321.8,188070.7,15352.7,6555.5,2870.1,1732.3,407.6,152.8,,,,,,,,78.5,16.19,5.29,-17.3,15.9,1.4,,,,92.1,7.7,0.23,-0.45,0.46,-0.02,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,5,0,H07,0.98,,NB-ferguhei-5069961-0003,6,Water,0,0,0,0,0,,,,77,,,,68.3,,,0.063,26.3,54.85,18.9,0,,,,,,48.2,45.4,,,,,,,,,,86777.8,66818.7,37643.9,22606.7,5108.6,780.7,17,0,,,,,,,,91.1,4.26,4.6,0,0,0,,,,88.8,10.77,0.39,0,0,0,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,5,0,H08,0.96,,NB-ferguhei-5069961-0003,4,Bulk Dialysis,0,0,0,0,0,,,,74.9,,,,60.4,,,0.038,29.5,50.45,20.01,0,,,,,,57.2,,2042605.8,1063809.4,333702.2,193117.4,51445.9,13396.3,390.5,84.9,,1182951.5,295050.2,25214.3,6214.4,1273.5,594.3,17,0,,,,,,,,93.9,3.18,2.92,0,0,0,,,,92.5,7.24,0.25,0,0,0,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B02,0.96,,NB-ferguhei-5069961-0003,4.6,Acetate,0,0,0,0,0,,,,100,0.515,,,99,1.291,,0.04,2.5,51.25,46.21,-16.6,,,,,,38.4,39.6,7705.3,1968.7,712.8,407.3,101.8,50.9,0,0,,41259.2,16259.3,5431.1,3428.4,1510.5,763.7,118.8,0,,,,,,,,76.2,19.58,4.25,-13.2,12.16,1.1,,,,88.7,10.99,0.32,0.3,0.7,-1.04,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B03,0.97,,NB-ferguhei-5069961-0003,5.1,Acetate,0,0,0,0,0,,,,92.3,-7.181,,,98,0.762,,0.041,11.2,57.49,31.34,-8,,,,,,46.2,,12067.1,2562.8,560.1,322.5,101.8,17,0,0,,551189.6,54242.9,17113.3,10373.2,3514.3,1443.1,322.6,50.9,,,,,,,,77.1,18.54,4.32,-12.3,11.12,1.1,,,,89.8,9.85,0.32,1.5,-0.4,-1.04,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B04,0.97,,NB-ferguhei-5069961-0003,5.2,Acetate,0,0,0,0,0,,,,98.8,-0.657,,,98,0.713,,0.042,9.3,54.18,36.54,-9.9,,,,,,49.8,,161460.3,6671.6,899.7,526.3,186.7,84.9,17,0,,339280.4,167951.4,76227.3,47780,20826.3,12390.6,1714.3,729.9,,,,,,,,75,20.36,4.66,-14.4,12.94,1.5,,,,89.6,10.04,0.36,1.3,-0.3,-1,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B05,0.99,,NB-ferguhei-5069961-0003,4.2,Histidine,0,0,0,0,0,,,,100,0.515,,,99,1.324,,0.044,0,28.77,71.23,-19.2,,,,,,48.6,,1783538.9,117449.1,2840.1,1462.6,391.2,136.1,0,0,,66633,20689.2,4972.9,2834.4,1306.9,780.7,101.8,17,,,,,,,,79.5,16.91,3.64,-10,9.49,0.5,,,,89.1,10.66,0.26,0.7,0.4,-1.1,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B06,0.98,,NB-ferguhei-5069961-0003,4.7,Histidine,0,0,0,0,0,,,,100,0.515,,,99,1.34,,0.042,0,28.81,71.19,-19.2,,,,,,50.2,,930205.3,33019.6,1664.6,730.4,220.8,101.9,17,0,,175672.8,44843.2,9929.3,5499.3,1748.2,814.7,135.8,33.9,,,,,,,,77.7,18.48,3.81,-11.7,11.06,0.6,,,,88.9,10.78,0.29,0.6,0.5,-1.07,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B07,0.98,,NB-ferguhei-5069961-0003,5.4,Histidine,0,0,0,0,0,,,,100,0.515,,,98.9,1.17,,0.045,0,33.28,66.72,-19.2,,,,,,50.4,57,2169366.2,818990.8,63016.3,7607.5,390.6,135.8,34,17,,2750265.7,1554034.4,438654.3,173485.5,38048.6,18031.1,831.9,169.8,,,,,,,,79.9,16.25,3.89,-9.5,8.83,0.7,,,,89.7,9.81,0.47,1.4,-0.5,-0.89,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B08,1,,NB-ferguhei-5069961-0003,6,Histidine,0,0,0,0,0,,,,99.1,-0.383,,,98.8,1.128,,0.07,0,37.42,62.58,-19.2,,,,,,60,57,3098323.7,1836297.7,537513.9,171616,14312.6,1188.5,0,0,,2645642.9,2507215,1883186.3,1576883.1,740273.6,197407.4,2104.6,458.3,,,,,,,,78.7,17.26,4.06,-10.7,9.84,0.9,,,,90.4,8.8,0.76,2.1,-1.5,-0.6,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B09,0.93,,NB-ferguhei-5069961-0003,5.9,Citrate,0,0,0,0,0,,,,95.8,-3.64,,,98.1,0.419,,0.067,26,55.97,18.05,6.8,,,,,,61.6,60.4,1567895.4,906724.4,440356.1,204752.4,50479.2,20986.3,17,0,,2378153.1,2284259.9,2098527.1,1994840.7,1616772.8,1131114.6,419260.7,21114.1,,,,,,,,73.2,22.68,4.15,-16.2,15.26,1,,,,72.9,26.19,0.89,-15.4,15.9,-0.47,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B10,0.92,,NB-ferguhei-5069961-0003,6.1,Citrate,0,0,0,0,0,,,,94.7,-4.781,,,98.5,0.804,,0.056,28.1,54.11,17.8,8.9,,,,,,61.2,57.6,1975605.1,609378.5,304060.8,156845.8,43653.2,17563.2,34,17,,1842639.4,1661026.7,1414831.1,1316862,1026604.2,693692.7,232786.8,21589.8,,,,,,,,72.2,23.69,4.15,-17.2,16.27,1,,,,72,27.07,0.96,-16.4,16.8,-0.4,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,B11,0.84,,NB-ferguhei-5069961-0003,6.7,Phosphate,0,0,0,0,0,,,,92.8,-6.671,,,97.6,-0.055,,0.039,23.6,62.23,14.21,4.4,,,,,,51,53.4,331974.4,127999.8,40431.7,20012.2,6772.6,3513.6,50.9,17,,1044207.6,729556.8,520168.6,431032.3,263606.7,146020,39416.2,5211.4,,,,,,,,63.8,32.45,3.79,-25.6,25.03,0.6,,,,81.4,16.57,2.09,-7,6.3,0.73,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C05,0.99,,NB-ferguhei-5069961-0003,4.2,Histidine,0,50,0,0,0,,,,97.9,-1.595,,,96.1,-1.562,,0.047,0,59.49,40.51,-19.2,,,,,,41.2,50.4,1227151.1,9257.9,1494.8,815.4,271.8,84.9,17,0,,82842.8,18873.4,3122.9,1731.2,458.3,169.7,17,0,,,,,,,,79,16.6,4.37,-10.4,9.18,1.2,,,,67.9,31.15,1,-20.5,20.9,-0.36,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C02,0.99,,NB-ferguhei-5069961-0003,4.6,Acetate,0,50,0,0,0,,,,97.9,-1.634,,,96.7,-0.956,,0.044,22.4,62.86,14.74,3.3,,,,,,59.8,58.2,2331562.3,101895.4,12558.5,5743.9,951.7,254.9,0,0,,942749.5,214276.7,57763,31784.9,12021.2,5501.2,458.4,152.8,,,,,,,,70.3,24.99,4.76,-19.2,17.57,1.6,,,,79,20.32,0.7,-9.4,10,-0.66,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C03,0.98,,NB-ferguhei-5069961-0003,5.1,Acetate,0,50,0,0,0,,,,98.8,-0.708,,,98.3,0.65,,0.043,21.6,67.66,10.73,2.5,,,,,,61.8,56.2,1406435.3,13251.1,2106.6,883.4,186.9,68,17,0,,115805.5,26494.6,6432.7,3513.4,1120.2,577.1,33.9,17,,,,,,,,74.3,21.6,4.13,-15.1,14.18,0.9,,,,89.1,10.52,0.34,0.8,0.2,-1.02,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C04,0.97,,NB-ferguhei-5069961-0003,5.2,Acetate,0,50,0,0,0,,,,98.8,-0.649,,,98.9,1.225,,0.046,25.7,64.42,9.89,6.5,,,,,,60.4,55.4,1856159,25322.1,3110,1376.6,254.9,85,17,17,,1002960.1,303594.4,116201.6,78322.3,34449.6,18370.8,2886.4,1137.6,,,,,,,,73.2,22.62,4.17,-16.2,15.2,1,,,,,,,,,,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C06,1.01,,NB-ferguhei-5069961-0003,4.7,Histidine,0,50,0,0,0,,,,99.3,-0.158,,,98.3,0.576,,0.045,13,40.28,46.72,-6.2,,,,,,50.2,36.2,905685.8,9918.6,1851.2,1019,407.6,186.8,34,17,,92042.6,24457.6,6347.8,3309.7,831.7,390.4,0,0,,,,,,,,70.5,25.54,3.94,-18.9,18.12,0.8,,,,87.3,12.27,0.44,-1.1,2,-0.92,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C07,1,,NB-ferguhei-5069961-0003,5.4,Histidine,0,50,0,0,0,,,,100,0.515,,,98.8,1.132,,0.058,6.1,39.02,54.87,-13,,,,,,46.6,,1257179.4,580909.3,248861.7,92796.7,15485.9,6129.8,34,0,,2945070.1,1903889,956265,629384,175213.7,34105.6,899.8,339.5,,,,,,,,79.2,16.83,4.02,-10.3,9.41,0.8,,,,91.2,8.39,0.39,2.9,-1.9,-0.97,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C08,0.98,,NB-ferguhei-5069961-0003,6,Histidine,0,50,0,0,0,,,,98.1,-1.341,,,98.8,1.127,,0.059,4.5,43.68,51.8,-14.6,,,,,,43.8,42,1257103.8,234686.8,113768,48866.9,10038.4,3193.2,17,0,,2006027.1,1641085,1233741.8,1054343.1,711671,452239.6,39668.4,6127.6,,,,,,,,78.5,17.56,3.92,-10.9,10.14,0.7,,,,91,8.2,0.8,2.7,-2.1,-0.56,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C09,0.95,,NB-ferguhei-5069961-0003,5.9,Citrate,0,50,0,0,0,,,,97.3,-2.186,,,98.9,1.197,,0.062,25.7,64.56,9.74,6.6,,,,,,52,46.8,1498354.5,269058.7,133680,49667.1,10242.6,4314.5,17,17,,1711007.4,1504073.9,1245063.4,1108250.7,685913.7,333103.3,54911.8,7044.3,,,,,,,,74.6,20.99,4.37,-14.8,13.57,1.2,,,,76.4,22.84,0.78,-12,12.6,-0.58,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C10,0.96,,NB-ferguhei-5069961-0003,6.1,Citrate,0,50,0,0,0,,,,96.2,-3.247,,,98.7,1.032,,0.052,25,67.38,7.6,5.9,,,,,,54.6,47.8,142840.8,69129.1,16140.9,6059.2,967.4,305.5,50.9,50.9,,1393148.8,1195206.5,978288.2,856742.6,491970.1,213659.5,34897,5125.9,,,,,,,,74.2,21.07,4.7,-15.2,13.65,1.5,,,,76.7,22.39,0.93,-11.7,12.1,-0.43,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,C11,0.91,,NB-ferguhei-5069961-0003,6.7,Phosphate,0,50,0,0,0,,,,93.4,-6.127,,,97.8,0.069,,0.042,31,57.27,11.7,11.9,,,,,,35.8,38,1423646.4,246796.9,110770.7,40388.3,8118.4,3566.7,17,0,,759222.9,538240.5,365922.1,296668.8,155039.1,71459.9,13443.3,984.5,,,,,,,,72.2,24.47,3.29,-17.2,17.05,0.1,,,,87.1,11.35,1.52,-1.2,1.1,0.16,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D02,1.11,,NB-ferguhei-5069961-0003,4.6,Acetate,0,150,0,0,0,,,,95.2,-4.292,,,92.1,-5.603,,0.315,,,,,,,,,,45.8,38.4,6620635.3,5513472.2,913795.8,8453.4,331.5,33.2,0,0,,1615626.6,1599078.7,1568749.6,1549961.4,1465830.7,1195821.3,3479.3,271.6,,,,,,,,77,16.27,6.76,-12.4,8.85,3.6,,,,54.3,41.22,4.47,-34,30.9,3.11,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D03,0.96,,NB-ferguhei-5069961-0003,5.1,Acetate,0,150,0,0,0,,,,97,-2.483,,,96.1,-1.54,,0.24,,,,,,,,,,48.4,54.6,3806598.5,1949293.1,817760.9,361394.6,29111.8,1138.6,0,0,,1517855.3,1494315.2,1450934.8,1425205.2,1327701.2,1176684.5,773464.2,93261,,,,,,,,68.5,27.46,4.01,-20.9,20.04,0.8,,,,83.3,16.06,0.62,-5,5.8,-0.74,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D04,0.92,,NB-ferguhei-5069961-0003,5.2,Acetate,0,150,0,0,0,,,,98,-1.456,,,97.8,0.109,,0.136,,,,,,,,,,53.4,47,3009294.1,1972699.5,905053,383962.9,21799.1,424.4,0,0,,2543977.3,2432300.3,2240684.4,2123169,1700544.7,1141277.4,412559.8,28224.7,,,,,,,,72,24.25,3.77,-17.4,16.83,0.6,,,,84.8,14.65,0.52,-3.5,4.4,-0.84,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D05,1.07,,NB-ferguhei-5069961-0003,4.2,Histidine,0,150,0,0,0,,,,100,0.515,,,94.1,-3.615,,0.146,,,,,,,,,,52.8,51.6,2033641.5,1965836,1740914.9,1606542.7,865857.9,136086.4,33.9,0,,7086858.3,4406772.8,704200,214546.7,10420.4,2283.9,392.6,0,,,,,,,,79.6,15.33,5.1,-9.8,7.91,1.9,,,,70.8,23.75,5.51,-17.6,13.5,4.15,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D06,1.09,,NB-ferguhei-5069961-0003,4.7,Histidine,0,150,0,0,0,,,,97.2,-2.331,,,92.1,-5.567,,0.372,,,,,,,,,,51.8,35.6,3636390.9,578406.1,3929.4,742.9,117.3,58.6,0,0,,1364812.3,1356886.3,1339286.2,1329255.7,1286723.6,1182107.5,15410.7,84.9,,,,,,,,67.2,28.38,4.45,-22.2,20.96,1.3,,,,72.1,26.42,1.47,-16.2,16.1,0.11,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D07,0.96,,NB-ferguhei-5069961-0003,5.4,Histidine,0,150,0,0,0,,,,100,0.515,,,99.1,1.456,,0.053,,,,,,,,,,49.4,41.2,1910831.6,368527.2,217138.4,95490.6,19108.3,7524.4,34,17,,2685459,2080023.9,1353695.2,1041276.5,450931.8,181068.7,29366.2,1935.1,,,,,,,,80.8,15.41,3.75,-8.6,7.99,0.6,,,,93.1,6.34,0.55,4.8,-4,-0.81,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D08,0.97,,NB-ferguhei-5069961-0003,6,Histidine,0,150,0,0,0,,,,98.2,-1.264,,,98.5,0.806,,0.06,,,,,,,,,,,,2948272.1,456682,212696.5,85644,13222.4,3878.8,17.2,17.2,,1916417.6,1646717.4,1283490.4,1084724.6,600286.2,296841.6,37852.1,3768.2,,,,,,,,79.3,16.37,4.29,-10.1,8.95,1.1,,,,93.3,5.8,0.91,4.9,-4.5,-0.45,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D09,0.96,,NB-ferguhei-5069961-0003,5.9,Citrate,0,150,0,0,0,,,,96.9,-2.562,,,99.5,1.814,,0.051,,,,,,,,,,45.4,38.4,1978950.4,329629.7,193239.4,83396.8,18530.7,8220.8,17,0,,1604471.9,1269933.2,921560.1,744886.7,366349.4,159936.2,21863.5,2257.6,,,,,,,,73.3,21.98,4.68,-16.1,14.56,1.5,,,,76.2,23.14,0.68,-12.2,12.9,-0.68,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D10,0.96,,NB-ferguhei-5069961-0003,6.1,Citrate,0,150,0,0,0,,,,96.1,-3.353,,,98.9,1.227,,0.053,,,,,,,,,,47.2,41.6,2014433.7,324525.1,181873.3,81262.9,19092.7,7966.6,101.9,17,,1588485,1334649.3,1041212.1,866154.7,414227.3,158116.9,15752.3,2020,,,,,,,,73.8,21.72,4.48,-15.6,14.3,1.3,,,,76.5,22.67,0.84,-11.9,12.4,-0.52,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37,14,D11,0.93,,NB-ferguhei-5069961-0003,6.7,Phosphate,0,150,0,0,0,,,,94.9,-4.615,,,98.8,1.072,,0.05,,,,,,,,,,,,82417.2,33061.9,8282.5,3411.4,865.6,339.4,0,0,,1071097,898849.7,727026.8,634826.6,377491.1,158991,22727.5,1578.5,,,,,,,,76.6,20.26,3.13,-12.8,12.84,-0.1,,,,89,9.65,1.36,0.6,-0.6,0,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,5,0,H11,0.96,,NB-ferguhei-5069961-0003,6,Water,0,0,0,0,0,,,,97,,,,95.9,,,0.054,21.7,63.23,15.03,0,,,,,,59.8,46,,,,,,,,,,2401967.6,1752672.5,1057748.5,780614,385791.7,209336.1,14734.3,2868.8,,,,,,,,89.4,7.42,3.18,0,0,0,,,,88.3,10.29,1.36,0,0,0,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,5,0,H12,0.96,,NB-ferguhei-5069961-0003,4,Bulk Dialysis,0,0,0,0,0,,,,99.5,,,,97.7,,,0.037,19.2,64.93,15.92,0,,,,,,54,,4724870.3,173011.4,5720.2,2522.1,780,338,78,0,,1104399.2,450341,21631.6,7657.6,1103.7,305.6,34,34,,,,,,,,0,0,0,0,0,0,,,,0,0,0,0,0,0,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E02,1,,NB-ferguhei-5069961-0004,4.5,Acetate,0,0,0,0,0,,,,94.8,-4.2,,,91,-8.3,,0.0533,,,,,,,,,,47,45.6,57414,9917.1,2428.3,1494.4,441.5,186.8,17,17,,769578.3,43179.8,8456,5077,2190.4,1171.6,322.6,135.8,,,,,,,,79.9,2.56,17.58,-16,2,14,,,,41.5,14.45,44.01,-45,1,44,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E03,1,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0,0,0,,,,93.9,-5.11,,,92,-6.6,,0.0544,,,,,,,,,,61.8,50.8,69240.6,10527,3175.1,2105.4,305.6,220.7,50.9,34,,1631024.5,15065.1,2836.4,1732.4,679.4,288.7,0,0,,,,,,,,85.5,2.13,12.42,-10,2,9,,,,54.6,13.32,32.07,-31,0,32,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E04,1,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0,0,0,,,,89.8,-9.17,,,90,-8.7,,0.0605,,,,,,,,,,59.4,50,91298.2,11580,3956.2,2546.9,305.6,169.8,34,0,,4030529.7,20853.8,2662.2,1517.9,700.6,280.2,23.4,23.4,,,,,,,,85.7,2.72,11.61,-10,2,8,,,,39.1,13.24,47.64,-47,0,47,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E05,1,,NB-ferguhei-5069961-0004,5,Histidine,0,0,0,0,0,,,,98.3,-0.71,,,99,-0.2,,0.0484,,,,,,,,,,62.6,58.4,172344.4,11519.1,1817.9,1240.3,390.8,169.9,0,0,,58113.5,13442.2,3343.6,2036.7,797.7,356.4,84.9,33.9,,,,,,,,89.6,2.08,8.3,-6,2,4,,,,73.8,14.34,11.9,-12,1,11,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E06,1,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0,0,0,,,,98.7,-0.27,,,98.9,0,,0.0501,,,,,,,,,,62.6,58.6,163275,8153.6,1630.7,1036.2,322.7,135.9,51,17,,88037.8,15020.9,4124.4,2461.1,848.6,237.6,33.9,17,,,,,,,,90.8,1.86,7.31,-5,2,3,,,,69.8,12.86,17.36,-16,-1,17,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E07,1,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0,0,0,,,,96,-3.05,,,98.6,-0.3,,0.0556,,,,,,,,,,63.2,58.8,46263.6,4393,669.2,377.5,171.6,103,51.5,51.5,,795502.7,37357.9,6232,3328.2,1171.7,662.3,84.9,34,,,,,,,,89,2.48,8.54,-7,2,5,,,,58.6,18.48,22.88,-27,5,22,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E08,1,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0,0,0,,,,92.2,-6.83,,,93,-5.9,,0.0671,,,,,,,,,,61,53.8,101279.1,13631.8,2784.1,1426,271.6,118.8,34,17,,4352726,30700.8,7463.7,4453.4,1617.1,646.9,124.4,0,,,,,,,,87.5,3.28,9.18,-8,3,5,,,,29.3,11.76,58.93,-57,-2,59,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E09,1,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0,0,0,,,,85.2,-13.84,,,88,-10.9,,0.0666,,,,,,,,,,59.4,51.4,55116.8,4757.7,721.4,395,154.6,85.9,34.4,17.2,,5698114.5,60054.9,5211.4,3474.3,1116.7,527.3,93.1,31,,,,,,,,83.4,3.7,12.8,-12,3,9,,,,17.9,8.8,73.35,-68,-5,73,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50,10,E10,1,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0,0,0,,,,79.4,-19.63,,,83.8,-15.1,,0.067,,,,,,,,,,58.2,51.6,250406.7,22962.7,3025,1839.1,515.6,309.4,34.4,17.2,,5348160.8,98127.6,9947.3,4534.8,1404.3,585.1,58.5,0,,,,,,,,82.1,3.28,14.61,-14,3,11,,,,12.7,8.42,78.85,-73,-5,78,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,5,0,H08,1,,NB-ferguhei-5069961-0004,6,Water,0,0,0,0,0,,,,99,0,,,98.9,0,,0.03899,,,,,,,,,,53,44.4,242517.9,74272.1,21745.7,15115.5,4792.3,2851.3,34.4,0,,911773,361384.8,8149.6,4380.4,1494.1,696.1,118.8,0,,,,,,,,89.7,0.15,10.18,0,0,0,,,,86.1,13.53,0.42,0,0,0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,0,0,0,0,,,,0,0,,,0,0,,0.0732,0,0,100,0,,,,,,,,327408.3,73602.4,12204.8,5381,1001.5,322.5,17,0,,528696.7,118397.4,26416.2,14345.5,4295.2,1816.5,169.8,50.9,,,,,,,,43.2,50.55,6.22,-47,51,-3,,,,67.3,24.42,8.32,-21,16,5,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B03,1,,NB-munselle-5020702-0007,5,Acetate,0,0,0,0,0,,,,0,0,,,0,0,,0.0803,0,0,100,0,,,,,,,,359801.9,80020.1,13478.1,6026.1,950.6,254.6,33.9,0,,459887.2,126112.1,31421.9,17332.1,4872,1952.2,135.8,34,,,,,,,,33,62.24,4.78,-58,62,-5,,,,64.5,31.24,4.25,-24,23,1,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,0,0,0,0,,,,0,0,,,0,0,,0.0961,0,0,100,0,,,,,,,,354778.9,77813.7,14174.2,6433.6,1103.4,339.5,84.9,34,,300579.9,54914.8,6094.1,2733,492.3,203.7,17,17,,,,,,,,18.5,77.72,3.76,-72,78,-6,,,,51.2,45.16,3.64,-37,37,0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B05,1,,NB-munselle-5020702-0007,4.5,Citrate,0,0,0,0,0,,,,0,0,,,0,0,,0.0782,0,0,100,0,,,,,,,,347481.9,78102.8,13987.5,6518.5,1256.2,288.6,50.9,0,,265682.6,42860.2,6637,3208.2,780.8,237.6,17,0,,,,,,,,48.1,44.94,6.99,-43,45,-2,,,,11.7,6.49,81.84,-77,-2,78,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B06,1,,NB-munselle-5020702-0007,5,Citrate,0,0,0,0,0,,,,0,0,,,0,0,,0.0862,0,0,100,0,,,,,,,,342519.1,76217.2,13749.7,6535.3,1171.3,509.2,67.9,50.9,,253527.2,39753.7,5279,2495.2,560.1,220.7,0,0,,,,,,,,33,62.02,4.96,-58,62,-4,,,,41.8,14.48,43.72,-47,6,40,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B07,1,,NB-munselle-5020702-0007,5.6,Citrate,0,0,0,0,0,,,,0,0,,,0,0,,0.1047,0,0,100,0,,,,,,,,361175.6,80634.7,14157.8,5907.6,950.6,373.5,34,17,,311676.8,56187,6314.7,2495.3,492.3,135.8,0,0,,,,,,,,11.8,84.79,3.41,-79,85,-6,,,,45.5,32.64,21.89,-43,25,19,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B08,1,,NB-munselle-5020702-0007,6.2,Citrate,0,0,0,0,0,,,,0,0,,,0,0,,0.1419,0,0,100,0,,,,,,,,370225.4,85554.2,15209.6,6993.7,1459.9,475.3,101.9,17,,714124.9,106570.3,9626.5,2920.2,322.6,84.9,17,0,,,,,,,,2.2,95.19,2.63,-88,95,-7,,,,22.8,74.17,3.08,-66,66,0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B09,1,,NB-munselle-5020702-0007,5,Histidine,0,0,0,0,0,,,,0,0,,,0,0,,0.075,0,0,100,0,,,,,,,,378083.1,87866.3,15821.4,7520.2,1782.5,730,135.8,50.9,,246075.1,43267.3,5143.2,2206.6,475.3,135.8,0,0,,,,,,,,43.7,50.95,5.39,-47,51,-4,,,,65.1,24.97,9.88,-23,17,7,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B10,1,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0,0,0,,,,0,0,,,0,0,,0.0844,0,0,100,0,,,,,,,,378017.8,87947.8,16041.4,7621.8,1833.3,831.8,220.7,84.9,,254179.5,45526.2,6043,2580.2,594.1,254.6,33.9,0,,,,,,,,28.3,67.31,4.36,-62,67,-5,,,,60.7,34.51,4.81,-28,26,1,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,B11,1,,NB-munselle-5020702-0007,6.2,Histidine,0,0,0,0,0,,,,0,0,,,0,0,,0.115,0,0,100,0,,,,,,,,352581.3,79815,14683.1,6535.3,1680.5,611.1,101.8,17,,558681.8,107142.4,12868.6,5602.4,1578.9,662.1,17,17,,,,,,,,8.3,89.16,2.51,-82,89,-7,,,,33.1,64.09,2.8,-55,56,-1,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,0,0,0,0,,,,0,0,,,0,0,,0.0828,0,0,100,0,,,,,,,,284222.5,69171.5,11950.1,5245.1,1052.4,475.3,67.9,33.9,,251132.8,55233.9,8928.4,4311.4,1188.2,356.5,50.9,0,,,,,,,,43.5,50.8,5.75,-47,51,-4,,,,71.5,19.82,8.67,-17,12,5,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C03,1,,NB-munselle-5020702-0007,5,Acetate,0,0,0,0,0,,,,0,0,,,0,0,,0.0921,0,0,100,0,,,,,,,,289257.9,68321.3,12425.1,5618.5,1290,475.3,50.9,0,,273049.4,58086.2,7791.2,3377.9,594.1,169.7,0,0,,,,,,,,34.5,60.15,5.38,-56,60,-4,,,,67.1,28.11,4.76,-21,20,1,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,0,0,0,0,,,,0,0,,,0,0,,0.1076,0,0,100,0,,,,,,,,294425.6,71361.5,13443.9,6297.6,1222.2,475.3,17,0,,262010.7,60410.5,7740.1,2936.5,628,169.7,0,0,,,,,,,,19.7,76.79,3.47,-71,77,-6,,,,53.4,42.61,4.05,-35,35,1,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C05,1,,NB-munselle-5020702-0007,4.5,Citrate,0,0,0,0,0,,,,0,0,,,0,0,,0.0862,0,0,100,0,,,,,,,,281723.9,68304.9,12764.7,5822.2,1222.2,356.5,33.9,0,,219504.7,50038.7,8300.2,3785.1,712.9,305.5,17,17,,,,,,,,49.4,43.54,7.04,-41,44,-2,,,,12.3,5.12,82.56,-76,-3,79,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C06,1,,NB-munselle-5020702-0007,5,Citrate,0,0,0,0,0,,,,0,0,,,0,0,,0.095,0,0,100,0,,,,,,,,281091.2,70849.9,13138,6042.8,1459.8,662,84.9,33.9,,220915,48816.9,6925.3,3106.2,848.7,339.5,17,17,,,,,,,,33.8,60.75,5.47,-57,61,-4,,,,46,13.14,40.83,-43,5,37,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C07,1,,NB-munselle-5020702-0007,5.6,Citrate,0,0,0,0,0,,,,0,0,,,0,0,,0.1185,0,0,100,0,,,,,,,,280848.9,69830.3,13222.6,6042.7,1001.5,339.5,84.9,33.9,,277256.2,65503.4,8164.6,3343.9,763.8,220.7,17,17,,,,,,,,12.4,84.15,3.42,-78,84,-6,,,,47.2,5.38,9.17,-41,-3,6,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C08,1,,NB-munselle-5020702-0007,6.2,Citrate,0,0,0,0,0,,,,0,0,,,0,0,,0.1586,0,0,100,0,,,,,,,,285738,71001.7,14139.2,6925.3,1493.7,458.3,0,0,,540811.2,112487.9,16161.9,6026.7,1086.5,356.5,34,34,,,,,,,,2,95.82,2.21,-89,96,-7,,,,27.1,69.68,3.2,-61,62,0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C09,1,,NB-munselle-5020702-0007,5,Histidine,0,0,0,0,0,,,,0,0,,,0,0,,0.0846,0,0,100,0,,,,,,,,284249,70120.2,12526.9,5499.6,1171.2,441.3,17,0,,237465.3,51108.5,7723.1,3598.5,814.7,322.5,33.9,0,,,,,,,,43.9,50.31,5.84,-47,50,-4,,,,69.8,19.27,10.92,-19,11,8,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C10,1,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0,0,0,,,,0,0,,,0,0,,0.0957,0,0,100,0,,,,,,,,291599.8,71461.4,14343.2,7298.9,1901.1,611.1,67.9,17,,261863.1,56982.9,7502.7,2783.8,645,237.6,33.9,33.9,,,,,,,,27.9,67.32,4.78,-63,67,-5,,,,66.2,31.13,3.83,-22,23,0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,C11,1,,NB-munselle-5020702-0007,6.2,Histidine,0,0,0,0,0,,,,0,0,,,0,0,,0.1247,0,0,100,0,,,,,,,,305156.6,76454.7,15277.4,7587.8,1799.3,679,84.9,0,,403775,79818,9675.9,4328.7,1069.4,441.4,34,17,,,,,,,,8,89.38,2.65,-83,89,-7,,,,36.4,62.24,1.39,-52,54,-2,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D02,1,,NB-munselle-5020702-0007,4.5,Acetate,0,150,0,0,0,,,,0,0,,,0,0,,0.0744,,,,,,,,,,,,325465.2,78102.8,14768.4,7367.2,1782.4,679,101.9,17,,274436.6,53909.6,8605.8,3717.3,882.7,390.4,17,17,,,,,,,,50.3,43.34,6.36,-40,43,-3,,,,0,0,100,-89,-8,97,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D03,1,,NB-munselle-5020702-0007,5,Acetate,0,150,0,0,0,,,,0,0,,,0,0,,0.085,,,,,,,,,,,,335001.6,78305.7,15294.5,7078.6,1850.3,696,84.9,50.9,,252964.6,44217.5,6416.2,2851.6,543.2,237.6,0,0,,,,,,,,36.2,58.23,5.62,-54,58,-4,,,,12.3,12.32,75.34,-76,4,72,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D04,1,,NB-munselle-5020702-0007,5.6,Acetate,0,150,0,0,0,,,,0,0,,,0,0,,0.0918,,,,,,,,,,,,348191.7,82142.2,15820.7,7316.2,2291.6,780.9,67.9,34,,291080.5,52162.9,6976.6,3055.4,645,237.6,0,0,,,,,,,,27.3,68.11,4.58,-63,68,-5,,,,45.2,19.69,35.13,-43,12,32,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D05,1,,NB-munselle-5020702-0007,4.5,Citrate,0,150,0,0,0,,,,0,0,,,0,0,,0.0702,,,,,,,,,,,,340177.3,79850,16211,7740.6,1833.3,746.9,50.9,17,,279431.1,54300.8,7977.9,3972,695.9,254.6,17,17,,,,,,,,61.3,30.64,8.04,-29,31,-1,,,,0,0,100,-89,-8,97,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D06,1,,NB-munselle-5020702-0007,5,Citrate,0,150,0,0,0,,,,0,0,,,0,0,,0.0813,,,,,,,,,,,,346169.1,82413.1,15905.5,7604.8,2087.9,797.8,135.8,17,,256835.2,46288.4,7400.7,3293,695.9,254.6,0,0,,,,,,,,41.2,52.15,6.66,-49,52,-3,,,,0,0,100,-89,-8,97,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D07,1,,NB-munselle-5020702-0007,5.6,Citrate,0,150,0,0,0,,,,0,0,,,0,0,,0.0892,,,,,,,,,,,,364027.1,88795.8,15022.8,7876.4,1731.4,577.1,118.8,33.9,,320333.9,56271.9,6263.7,2733,577.1,152.8,0,0,,,,,,,,27,68.68,4.33,-64,69,-5,,,,50.4,14.9,34.76,-38,7,31,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D08,1,,NB-munselle-5020702-0007,6.2,Citrate,0,150,0,0,0,,,,0,0,,,0,0,,0.1112,,,,,,,,,,,,341161.9,82430.2,15820.6,7757.5,1969.1,696,118.8,33.9,,329267.4,64047.3,8368.8,3615.7,933.6,271.6,17,17,,,,,,,,9.8,87.18,3.04,-81,87,-6,,,,47.7,15.82,17.57,-41,8,14,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D09,1,,NB-munselle-5020702-0007,5,Histidine,0,150,0,0,0,,,,0,0,,,0,0,,0.0809,,,,,,,,,,,,348649.7,83415.2,17025.9,9268.4,2410.5,746.9,50.9,0,,260893.5,46458.4,6653.9,3225.1,780.8,407.4,17,0,,,,,,,,42.4,52.03,5.58,-48,52,-4,,,,0,0.76,99.24,-89,-7,96,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D10,1,,NB-munselle-5020702-0007,5.6,Histidine,0,150,0,0,0,,,,0,0,,,0,0,,0.09,,,,,,,,,,,,352655.2,82804,15769.8,8063.1,1867.2,543.2,50.9,17,,267143.5,48445,7349.9,3921.1,1069.4,322.5,17,0,,,,,,,,29.9,65.76,4.39,-61,66,-5,,,,36.5,19.17,44.3,-52,11,41,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,D11,1,,NB-munselle-5020702-0007,6.2,Histidine,0,150,0,0,0,,,,0,0,,,0,0,,0.1054,,,,,,,,,,,,352529.4,85263.6,15854.3,8283.6,2037,628.1,135.8,17,,361014.3,65066.4,8538.6,3768.5,899.7,390.4,0,0,,,,,,,,10.8,86.46,2.73,-80,86,-7,,,,47.6,40.65,11.8,-41,33,8,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,E02,1,,NB-munselle-5020702-0007,7.4,Phosphate,0,0,0,0,0,,,,0,0,,,0,0,,0.4228,0,0,100,,,,,,,,,420198.7,103212.1,22815.3,11509.5,2784,763.9,118.8,17,,6808646.1,5382295.2,2494894.3,1054793.4,9621.6,1671.8,136.5,102.4,,,,,,,,1.3,94.37,4.34,-89,94,-5,,,,0,100,0,-89,92,-3,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,E03,1,,NB-munselle-5020702-0007,6.8,Histidine,0,0,0,0,0,,,,0,0,,,0,0,,0.1712,0,0,100,,,,,,,,,401298.4,98966.6,22254.7,11679.1,2750,899.7,152.8,50.9,,2106679,226832.4,22487.9,7150.6,1138,458.6,51,17,,,,,,,,1.6,95.52,2.86,-89,96,-7,,,,0,100,0,-89,92,-3,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40,10,E04,1,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0,0,0,,,,0,0,,,0,0,,0.0886,0,0,100,,,,,,,,,288455.1,72478.7,14122.3,7264.8,1527.7,492.2,0,0,,252827.1,51991.2,6891.4,2953.5,729.9,305.5,33.9,33.9,,,,,,,,31.7,63.49,4.78,-59,63,-5,,,,60.1,38.97,0.94,-28,31,-2,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,5,0,F09,1,,NB-munselle-5020702-0007,4.6,Acetate,0,0,0,0,0,,,,0,,,,0,,,0.0591,0,0,100,0,,,,,,,,419334.7,105550.9,23035.1,12086.2,3089.5,933.6,186.7,84.9,,350014,81417.8,15074.2,8045.3,2842.6,1877.8,447.9,292.9,,,,,,,,90.6,0,9.38,0,0,0,,,,88.6,8.09,3.36,0,0,0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,-80,0,F10,1,,NB-munselle-5020702-0007,4.5,Citrate,0,0,0,0,0,,,,0,,,,,,,0.0567,0,0,100,0,,,,,,,,,,,,,,,,,469455.6,223448.4,45270.2,19180.9,3666.4,1357.9,0,0,,,,,,,,90.7,0,9.31,0,0,0,,,,89.3,8.48,2.18,0.79,0,-1.18,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204251_A1,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96.1,,,68.01,99.66,,,,55.19,12.59,32.22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204251_A2,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96.1,,,68.13,99.66,,,,54.23,15.13,30.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204251_A3,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.9,,,68.89,99.91,,,,73.14,18.41,8.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204251_A4,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.9,,,68.81,99.91,,,,54.74,15.73,29.53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204251_B1,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96,,,68.97,99.89,,,,70.16,20.32,9.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204251_B2,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96.2,,,68.51,99.75,,,,70.56,20.6,8.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204251_B3,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,96,,,69.1,99.91,,,,75.66,15.9,8.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204251_B4,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,96.2,,,69.82,99.91,,,,67.8,19.81,12.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204251_C1,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96,,,67.75,99.72,,,,55.82,16,28.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204251_C2,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96,,,67.95,99.74,,,,53.51,15.14,31.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204251_C3,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.8,,,67.67,99.64,,,,69.66,19.64,10.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204251_C4,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.9,,,68.2,99.64,,,,52.09,17.17,30.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204251_D1,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,95,,,66.58,99.51,,,,71.55,20.59,7.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204251_D2,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,95.1,,,66.45,99.73,,,,52.01,20.62,27.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204251_D3,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,94.8,,,66.97,99.49,,,,49.26,23.73,27.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204251_D4,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.1,,,67.54,99.42,,,,68.61,23.54,7.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204251_E1,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,95.8,,,67.56,99.72,,,,51.05,18.68,30.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204251_E2,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,95.9,,,68.17,99.62,,,,48.27,21.19,30.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204251_E3,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.7,,,67.65,99.65,,,,46.62,22.79,30.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204251_E4,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,96,,,69.15,99.91,,,,45.89,23.78,30.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204251_F1,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,95.8,,,66.67,99.72,,,,70.51,20.72,8.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204251_F2,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96.1,,,67.59,99.74,,,,71.9,18.08,10.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204251_F3,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.9,,,67.51,99.73,,,,70.56,19.61,9.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204251_F4,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,96,,,67.9,99.63,,,,69.28,21.67,9.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204251_G1,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96.1,,,67.67,99.64,,,,72.15,19.18,8.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204251_G2,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96.1,,,67.95,99.65,,,,70.38,18.62,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204251_G3,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,96.1,,,68.04,99.64,,,,69.51,19.53,10.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204251_G4,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,96.1,,,68.27,99.63,,,,54.43,16.02,29.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204251_H1,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,96.1,,,67.39,99.73,,,,77.74,13.32,8.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204251_H2,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0,7,0,,,,95.7,,,65.65,99.73,,,,76.34,16.41,7.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM,NaCl 50 mM,-,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204251_H3,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.8,,,67.23,99.74,,,,73.27,18.08,8.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204251_H4,NB-mozzicon-5088257-0001,6.5,Histidine,0,50,0.02,7,0,,,,95.6,,,66.31,99.74,,,,74.3,17.15,8.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,NaCl 50 mM PS80,NaCl 50 mM,PS80,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204252_A1,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.9,,,67.67,99.73,,,,53.04,16.58,30.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204252_A2,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.9,,,67.71,99.74,,,,57.89,15.73,26.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204252_A3,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.8,,,68.1,99.64,,,,56.32,17.34,26.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204252_B1,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,96,,,67.02,99.74,,,,72.3,19.22,8.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204252_A4,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.9,,,68.3,99.64,,,,70.17,19.41,10.42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204252_A5,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.3,,,67.65,99.63,,,,70.4,20.55,9.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Control,,0,,5,US-10204252_A6,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.4,,,68.3,99.64,,,,68.92,20,11.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204252_B2,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,96.1,,,67.11,99.75,,,,55.35,13.55,31.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204252_B3,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.7,,,66.92,99.73,,,,73.52,17.47,9.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204252_B4,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.7,,,67.48,99.64,,,,74.91,17.3,7.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204252_B5,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.3,,,67.32,99.64,,,,70.74,18.92,10.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Agitation,,,,5,US-10204252_B6,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.3,,,67.15,99.63,,,,70.32,19.98,9.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204252_C1,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.9,,,67.67,99.72,,,,55.39,14.61,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204252_C2,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.8,,,67.75,99.74,,,,53.85,16.54,29.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204252_C3,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.7,,,67.85,99.64,,,,73.92,16.99,9.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204252_C4,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.7,,,67.64,99.65,,,,74.12,17.21,8.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204252_C5,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.2,,,67.76,99.62,,,,69.06,19.97,10.97,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Freeze Thaw,,,,5,US-10204252_C6,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.2,,,67.96,99.63,,,,69.85,19.41,10.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204252_D1,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,94.4,,,66.28,99.31,,,,50.58,24.66,24.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204252_D2,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,94.7,,,66.63,99.53,,,,68.03,24.48,7.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204252_D3,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,94.5,,,66.76,99.48,,,,47.51,24.74,27.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204252_D4,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,94.8,,,66.9,99.44,,,,62.95,30.53,6.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204252_D5,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,94.3,,,66.89,99.39,,,,63.13,28.43,8.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x,,,,5,US-10204252_D6,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,93.9,,,66.32,99.35,,,,65.4,28.02,6.58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204252_E1,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,93.5,,,63.7,98.95,,,,40.13,33.13,26.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204252_E2,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,94.9,,,63.52,98.58,,,,41.69,26.12,32.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204252_E3,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,93.8,,,64.73,98.49,,,,44.56,29.46,25.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204252_E4,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,93.8,,,65.91,98.81,,,,43.76,24.86,31.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204252_E5,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,93.6,,,65.36,98.28,,,,42.69,30.67,26.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Oxidation,,,,5,US-10204252_E6,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,93.2,,,64.96,97.98,,,,39.08,36.32,24.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204252_F1,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.2,,,66.98,99.72,,,,68.52,22.52,8.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204252_F2,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.3,,,66.86,99.73,,,,69.64,21.75,8.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204252_F3,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.2,,,67.45,99.65,,,,69.08,20.65,10.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204252_F4,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.5,,,67.84,99.66,,,,71.74,19.89,8.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204252_F5,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,94.6,,,66.86,99.72,,,,69.55,21.01,9.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,High pH,,,,5,US-10204252_F6,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,94.8,,,67.55,99.63,,,,69.79,20.67,9.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204252_G1,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.6,,,66.56,99.58,,,,74.32,16.27,9.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204252_G2,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.9,,,67.13,99.58,,,,71,18.76,10.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204252_G3,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.5,,,67.27,99.56,,,,71.31,20.37,8.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204252_G4,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.9,,,67.48,99.55,,,,69.92,21.31,8.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204252_G5,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.2,,,67.52,99.5,,,,71.81,19.26,8.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Low pH,,,,5,US-10204252_G6,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.3,,,67.46,99.51,,,,71.77,18.86,9.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204252_H1,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.9,,,66.94,99.74,,,,73.99,16.68,9.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204252_H2,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,96,,,67.23,99.74,,,,72.59,18.69,8.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204252_H3,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.8,,,67.09,99.73,,,,74.94,17.3,7.76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204252_H4,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0.02,7,0,,,,95.9,,,67.41,99.73,,,,73.34,17.75,8.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204252_H5,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,95.3,,,67.32,99.64,,,,70.23,19.83,9.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
6/30/2023,mozzicon,Tie2,DAB016505_008,mAb,,Light Stress 0.2x CT,,,,5,US-10204252_H6,NB-mozzicon-5088257-0001,6.8,His-Glu-Arg,0,0,0,7,0,,,,93.2,,,68.03,99.2,,,,72.06,18.6,9.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sucrose,-,Sucrose,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,1,1,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0,0,0,,,,97.43,-0.55,0.55,,95.25,-1.8,1.8,0.0014,81.14,11.44,7.43,-6.4,0.6,5.8,6.36,0.64,5.83,68.34743591,84.32386876,,,,,,,,,,,,,,,,,,,,,,,,,96.905,1.584,0.234,,,,,,,98.262,0.11,1.628,0.461,0.1,-0.56,0.461,0.1,0.56,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,2,1,Acetate pH 5.0,NB-walpeter-5075040-0039,5,Acetate,0,0,0,0,0,,,,97.09,-0.89,0.89,,95.61,-1.43,1.43,0.0032,82.8,10.52,6.68,-4.7,-0.3,5.1,4.7,0.28,5.08,70.89762,84.80369688,,,,,,,,,,,,,,,,,,,,,,,,,97.28,2.538,0.183,,,,,,,98.644,0.06,1.296,0.843,0.05,-0.892,0.843,0.05,0.892,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,16,1,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Acetate,0,150,0,0,0,,,,97.45,-0.53,0.53,,96.38,-0.66,0.66,0.0056,54.27,39.74,5.99,-33.2,28.9,4.4,33.23,28.94,4.39,67.50908,84.74658682,,,,,,,,,,,,,,,,,,,,,,,,,96.708,1.585,0.286,,,,,,,97.865,0.81,1.325,0.064,0.8,-0.863,0.064,0.8,0.863,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,6,1,Citrate pH 4.0,NB-walpeter-5075040-0039,4,Citrate,0,0,0,0,0,,,,97.75,-0.23,0.23,,90.76,-6.28,6.28,0.0035,69.37,18.19,12.45,-18.1,7.4,10.9,18.13,7.39,10.85,60.92531,78.82745438,,,,,,,,,,,,,,,,,,,,,,,,,96.761,1.304,0.177,,,,,,,97.96,0.39,1.65,0.159,0.38,-0.538,0.159,0.38,0.538,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,7,1,Citrate pH 5.0,NB-walpeter-5075040-0039,5,Citrate,0,0,0,0,0,,,,97.4,-0.58,0.58,,95.99,-1.05,1.05,0.0029,79.56,13.89,6.55,-7.9,3.1,5,7.94,3.09,4.95,67.35703,85.23141756,,,,,,,,,,,,,,,,,,,,,,,,,97.255,1.236,0.178,,,,,,,98.07,0.18,1.74,0.269,0.17,-0.448,0.269,0.17,0.448,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,18,1,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6,Citrate,0,150,0,0,0,,,,96.64,-1.34,1.34,,96.57,-0.48,0.48,0.0069,37.23,59.31,3.47,-50.3,48.5,1.9,50.27,48.51,1.87,68.47509,86,,,,,,,,,,,,,,,,,,,,,,,,,97.381,1.307,0.149,,,,,,,98.15,0.39,1.47,0.349,0.38,-0.718,0.349,0.38,0.718,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,8,1,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0,0,0,,,,97.16,-0.82,0.82,,96.9,-0.14,0.14,0.004,75.12,16.77,8.11,-12.4,6,6.5,12.38,5.97,6.51,68.98753,86,,,,,,,,,,,,,,,,,,,,,,,,,97.267,1.272,0.153,,,,,,,97.75,0.18,2.07,-0.051,0.17,-0.118,0.051,0.17,0.118,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,3,1,Glutamate pH 4.0,NB-walpeter-5075040-0039,4,Glutamate,0,0,0,0,0,,,,97.6,-0.38,0.38,,93.7,-3.35,3.35,0.0038,74.1,15.39,10.51,-13.4,4.6,8.9,13.4,4.59,8.91,67.72348,81.75832395,,,,,,,,,,,,,,,,,,,,,,,,,97.105,1.321,0.16,,,,,,,98.994,0.12,0.886,1.193,0.11,-1.302,1.193,0.11,1.302,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,4,1,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0,0,0,,,,97.28,-0.7,0.7,,94.62,-2.43,2.43,0.0036,69.98,19.01,11.02,-17.5,8.2,9.4,17.52,8.21,9.42,69.87636,87,,,,,,,,,,,,,,,,,,,,,,,,,97.212,2.586,0.202,,,,,,,98.549,0.159,1.292,0.748,0.149,-0.896,0.748,0.149,0.896,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,5,1,Glutamate pH 5.0,NB-walpeter-5075040-0039,5,Glutamate,0,0,0,0,0,,,,97.29,-0.69,0.69,,95.22,-1.83,1.83,0.0037,74.86,15.7,9.43,-12.6,4.9,7.8,12.64,4.9,7.83,70.77851,87,,,,,,,,,,,,,,,,,,,,,,,,,97.324,2.492,0.183,,,,,,,98.206,0.146,1.648,0.405,0.136,-0.54,0.405,0.136,0.54,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,17,1,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Glutamate,0,150,0,0,0,,,,96.94,-1.04,1.04,,95.73,-1.32,1.32,0.0067,37.43,57.74,4.84,-50.1,46.9,3.2,50.07,46.94,3.24,65.79023,83.3494074,,,,,,,,,,,,,,,,,,,,,,,,,97.421,1.131,0.101,,,,,,,97.012,0.558,2.431,-0.789,0.548,0.243,0.789,0.548,0.243,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,12,1,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0,0,0,,,,96.93,-1.05,1.05,,96.63,-0.42,0.42,0.0055,79.32,12.28,8.39,-8.2,1.5,6.8,8.18,1.48,6.79,69.92788,85.47466342,,,,,,,,,,,,,,,,,,,,,,,,,97.462,1.197,0.173,,,,,,,98.321,0.271,1.408,0.52,0.261,-0.78,0.52,0.261,0.78,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,13,1,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0,0,0,,,,96.63,-1.35,1.35,,96.49,-0.55,0.55,0.0076,78.58,13.74,7.68,-8.9,2.9,6.1,8.92,2.94,6.08,71.40955,90,,,,,,,,,,,,,,,,,,,,,,,,,97.279,1.242,0.171,,,,,,,98.115,0.333,1.551,0.314,0.323,-0.637,0.314,0.323,0.637,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,14,1,Phosphate pH 6.0,NB-walpeter-5075040-0039,6,Phosphate,0,0,0,0,0,,,,97.25,-0.73,0.73,,96.3,-0.74,0.74,0.0078,76.67,15.9,7.44,-10.8,5.1,5.8,10.83,5.1,5.84,70.58512,87,,,,,,,,,,,,,,,,,,,,,,,,,97.105,1.415,0.186,,,,,,,97.664,0.35,1.986,-0.137,0.34,-0.202,0.137,0.34,0.202,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,15,1,Phosphate pH 7.0,NB-walpeter-5075040-0039,7,Phosphate,0,0,0,0,0,,,,96.96,-1.02,1.02,,95.57,-1.47,1.47,0.0069,72.31,19.48,8.21,-15.2,8.7,6.6,15.19,8.68,6.61,70.64557,87,,,,,,,,,,,,,,,,,,,,,,,,,96.077,1.877,0.206,,,,,,,96.78,0.508,2.713,-1.021,0.498,0.525,1.021,0.498,0.525,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,19,1,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7,Phosphate,0,150,0,0,0,,,,96.58,-1.4,1.4,,96.75,-0.29,0.29,0.0044,40.96,57.13,1.91,-46.5,46.3,0.3,46.54,46.33,0.31,68.75246,86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.676,0.033,1.838,-0.125,0.023,-0.35,0.125,0.023,0.35,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,9,1,Succinate pH 4.0,NB-walpeter-5075040-0039,4,Succinate,0,0,0,0,0,,,,97.74,-0.24,0.24,,93.44,-3.61,3.61,0.0027,73.52,15.6,10.89,-14,4.8,9.3,13.98,4.8,9.29,66.99309,82.25193954,,,,,,,,,,,,,,,,,,,,,,,,,97.157,2.677,0.167,,,,,,,98.687,0.249,1.063,0.886,0.239,-1.125,0.886,0.239,1.125,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,10,1,Succinate pH 5.0,NB-walpeter-5075040-0039,5,Succinate,0,0,0,0,0,,,,97.37,-0.61,0.61,,96.19,-0.86,0.86,0.0017,76.57,14.46,8.96,-10.9,3.7,7.4,10.93,3.66,7.36,69.52102,87,,,,,,,,,,,,,,,,,,,,,,,,,97.409,1.241,0.147,,,,,,,97.803,0.24,1.957,0.002,0.23,-0.231,0.002,0.23,0.231,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25,30,11,1,Succinate pH 6.0,NB-walpeter-5075040-0039,6,Succinate,0,0,0,0,0,,,,97.37,-0.61,0.61,,96.64,-0.4,0.4,0.004,84.14,13.9,1.96,-3.4,3.1,0.4,3.36,3.1,0.36,69.93926,87,,,,,,,,,,,,,,,,,,,,,,,,,96.933,1.606,0.224,,,,,,,98.009,0.249,1.741,0.208,0.239,-0.447,0.208,0.239,0.447,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,1,1,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0,0,0,,,,97.71,-0.71,0.71,,,,,0.0038,75.9,19.81,4.29,-8.9,7,1.9,8.9,7.01,1.89,69.33366,86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.03,0.76,3.22,-0.284,0.755,-0.461,0.284,0.755,0.461,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,2,1,Acetate pH 5.0,NB-walpeter-5075040-0039,5,Acetate,0,0,0,0,0,,,,97.68,-0.74,0.74,,,,,0.0061,78.81,17.81,3.37,-6,5,1,5.99,5.01,0.97,71.21933,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.24,0.53,3.22,-0.074,0.525,-0.461,0.074,0.525,0.461,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,3,1,Glutamate pH 4.0,NB-walpeter-5075040-0039,4,Glutamate,0,0,0,0,0,,,,97.58,-0.84,0.84,,,,,0.0063,73.52,20.77,5.71,-11.3,8,3.3,11.28,7.97,3.31,67.70273,81.81545696,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.34,0.92,2.75,0.026,0.915,-0.931,0.026,0.915,0.931,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,4,1,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0,0,0,,,,97.73,-0.69,0.69,,,,,0.0069,76.2,19.37,4.43,-8.6,6.6,2,8.6,6.57,2.03,69.56688,85.40042975,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.12,0.77,3.12,-0.194,0.765,-0.561,0.194,0.765,0.561,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,5,1,Glutamate pH 5.0,NB-walpeter-5075040-0039,5,Glutamate,0,0,0,0,0,,,,97.71,-0.71,0.71,,,,,0.0057,78.1,18.34,3.56,-6.7,5.5,1.2,6.7,5.54,1.16,70.50187,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.95,0.57,3.48,-0.364,0.565,-0.201,0.364,0.565,0.201,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,6,1,Citrate pH 4.0,NB-walpeter-5075040-0039,4,Citrate,0,0,0,0,0,,,,97.27,-1.15,1.15,,,,,0.0065,70.16,22.86,6.99,-14.6,10.1,4.6,14.64,10.06,4.59,61.10062,78.94443132,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.36,1.2,3.45,-0.954,1.195,-0.231,0.954,1.195,0.231,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,7,1,Citrate pH 5.0,NB-walpeter-5075040-0039,5,Citrate,0,0,0,0,0,,,,97.81,-0.61,0.61,,,,,0.0075,75.01,20.83,4.15,-9.8,8,1.8,9.79,8.03,1.75,67.43836,86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.6,0.6,3.8,-0.714,0.595,0.119,0.714,0.595,0.119,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,8,1,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0,0,0,,,,97.51,-0.91,0.91,,,,,0.0039,73.7,22.83,3.47,-11.1,10,1.1,11.1,10.03,1.07,68.74003,87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.11,0.39,3.5,-0.204,0.385,-0.181,0.204,0.385,0.181,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,9,1,Succinate pH 4.0,NB-walpeter-5075040-0039,4,Succinate,0,0,0,0,0,,,,97.41,-1.01,1.01,,,,,0.0055,73.89,20.62,5.48,-10.9,7.8,3.1,10.91,7.82,3.08,66.99896,82.32103161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.36,0.76,2.88,0.046,0.755,-0.801,0.046,0.755,0.801,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,10,1,Succinate pH 5.0,NB-walpeter-5075040-0039,5,Succinate,0,0,0,0,0,,,,97.78,-0.64,0.64,,,,,0.0047,74.72,21.5,3.77,-10.1,8.7,1.4,10.08,8.7,1.37,69.40223,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.94,0.45,3.61,-0.374,0.445,-0.071,0.374,0.445,0.071,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,11,1,Succinate pH 6.0,NB-walpeter-5075040-0039,6,Succinate,0,0,0,0,0,,,,97.59,-0.83,0.83,,,,,0.0054,76.61,20.38,3,-8.2,7.6,0.6,8.19,7.58,0.6,70.28021,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.18,0.38,3.43,-0.134,0.375,-0.251,0.134,0.375,0.251,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,12,1,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0,0,0,,,,97.43,-0.99,0.99,,,,,0.0066,77.28,19.37,3.35,-7.5,6.6,1,7.52,6.57,0.95,69.85283,86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.33,0.48,3.19,0.016,0.475,-0.491,0.016,0.475,0.491,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,13,1,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0,0,0,,,,97.46,-0.96,0.96,,,,,0.0083,77.84,18.6,3.56,-7,5.8,1.2,6.96,5.8,1.16,71.07001,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.26,0.26,3.49,-0.054,0.255,-0.191,0.054,0.255,0.191,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,14,1,Phosphate pH 6.0,NB-walpeter-5075040-0039,6,Phosphate,0,0,0,0,0,,,,97.61,-0.81,0.81,,,,,0.0076,76.68,20.19,3.13,-8.1,7.4,0.7,8.12,7.39,0.73,70.33449,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.82,0.42,3.76,-0.494,0.415,0.079,0.494,0.415,0.079,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,15,1,Phosphate pH 7.0,NB-walpeter-5075040-0039,7,Phosphate,0,0,0,0,0,,,,97.54,-0.88,0.88,,,,,0.0064,68.39,25.93,5.67,-16.4,13.1,3.3,16.41,13.13,3.27,70.0695,87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.63,0.4,3.98,-0.684,0.395,0.299,0.684,0.395,0.299,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,16,1,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Acetate,0,150,0,0,0,,,,97.57,-0.85,0.85,,,,,0.0055,36.59,61.72,1.69,-48.2,48.9,-0.7,48.21,48.92,0.71,66.48062,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.73,0.64,3.63,-0.584,0.635,-0.051,0.584,0.635,0.051,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,17,1,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Glutamate,0,150,0,0,0,,,,97.55,-0.87,0.87,,,,,0.0065,35.17,63.1,1.73,-49.6,50.3,-0.7,49.63,50.3,0.67,65.64906,83.44973716,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.94,0.77,4.3,-1.374,0.765,0.619,1.374,0.765,0.619,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,18,1,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6,Citrate,0,150,0,0,0,,,,97.41,-1.01,1.01,,,,,0.0069,31.44,67.34,1.22,-53.4,54.5,-1.2,53.36,54.54,1.18,68.09826,87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.21,0.62,3.17,-0.104,0.615,-0.511,0.104,0.615,0.511,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25,30,19,1,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7,Phosphate,0,150,0,0,0,,,,97.45,-0.97,0.97,,,,,0.0058,31.69,66.47,1.84,-53.1,53.7,-0.6,53.11,53.67,0.56,68.51927,86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.6,1.17,3.23,-0.714,1.165,-0.451,0.714,1.165,0.451,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,1,1,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0,0,0,,,,97.34,1.46,1.46,,,,,0.0041,71.44,24.47,4.09,-1.7,0.2,1.5,1.66,0.17,1.49,69.14442678,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.9,2.37,3.73,-0.043,2.33,-2.287,0.043,2.33,2.287,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,2,1,Acetate pH 5.0,NB-walpeter-5075040-0039,5,Acetate,0,0,0,0,0,,,,97.02,1.14,1.14,,,,,0.005,71.68,24.54,3.78,-1.4,0.2,1.2,1.42,0.24,1.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.2,0.65,4.14,1.257,0.61,-1.877,1.257,0.61,1.877,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,3,1,Glutamate pH 4.0,NB-walpeter-5075040-0039,4,Glutamate,0,0,0,0,0,,,,97.36,1.48,1.48,,,,,0.0048,70.04,24.52,5.43,-3.1,0.2,2.8,3.06,0.22,2.83,67.54287147,83.55866571,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.47,3.68,2.86,-0.473,3.64,-3.157,0.473,3.64,3.157,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,4,1,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0,0,0,,,,97.12,1.24,1.24,,,,,0.0055,70.45,25.19,4.36,-2.6,0.9,1.8,2.65,0.89,1.76,69.35562335,87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.44,0.87,3.7,1.497,0.83,-2.317,1.497,0.83,2.317,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,5,1,Glutamate pH 5.0,NB-walpeter-5075040-0039,5,Glutamate,0,0,0,0,0,,,,97.21,1.33,1.33,,,,,0.0035,70.61,25.68,3.72,-2.5,1.4,1.1,2.49,1.38,1.12,70.38845686,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.75,1,4.25,0.807,0.96,-1.767,0.807,0.96,1.767,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,6,1,Citrate pH 4.0,NB-walpeter-5075040-0039,4,Citrate,0,0,0,0,0,,,,97.68,1.8,1.8,,,,,0.0036,69.52,24.63,5.85,-3.6,0.3,3.3,3.58,0.33,3.25,60.79894114,81.16082577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.98,1.78,4.24,0.037,1.74,-1.777,0.037,1.74,1.777,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,7,1,Citrate pH 5.0,NB-walpeter-5075040-0039,5,Citrate,0,0,0,0,0,,,,97.4,1.52,1.52,,,,,0.0053,71.05,25.19,3.77,-2.1,0.9,1.2,2.05,0.89,1.17,67.30275451,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.67,1.72,4.61,-0.273,1.68,-1.407,0.273,1.68,1.407,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,8,1,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0,0,0,,,,96.85,0.97,0.97,,,,,0.0064,69.8,26.82,3.38,-3.3,2.5,0.8,3.3,2.52,0.78,68.74277443,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.32,1.42,5.26,-0.623,1.38,-0.757,0.623,1.38,0.757,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,9,1,Succinate pH 4.0,NB-walpeter-5075040-0039,4,Succinate,0,0,0,0,0,,,,97.56,1.68,1.68,,,,,0.0051,67.51,27.28,5.21,-5.6,3,2.6,5.59,2.98,2.61,67.06594589,84.43055977,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.55,1.81,3.64,0.607,1.77,-2.377,0.607,1.77,2.377,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,10,1,Succinate pH 5.0,NB-walpeter-5075040-0039,5,Succinate,0,0,0,0,0,,,,97.21,1.33,1.33,,,,,0.0045,69.1,27.16,3.72,-4,2.9,1.1,4,2.86,1.12,69.15403139,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.68,1.51,4.81,-0.263,1.47,-1.207,0.263,1.47,1.207,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,11,1,Succinate pH 6.0,NB-walpeter-5075040-0039,6,Succinate,0,0,0,0,0,,,,96.8,0.92,0.92,,,,,0.0049,68.98,27.73,3.29,-4.1,3.4,0.7,4.12,3.43,0.69,69.72865739,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.52,3.62,3.86,-1.423,3.58,-2.157,1.423,3.58,2.157,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,12,1,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0,0,0,,,,96.6,0.72,0.72,,,,,0.0056,75.89,21.13,2.98,2.8,-3.2,0.4,2.79,3.17,0.38,69.57070583,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.62,0.93,3.45,1.677,0.89,-2.567,1.677,0.89,2.567,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,13,1,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0,0,0,,,,96.27,0.39,0.39,,,,,0.0074,71.67,24.33,4.01,-1.4,0,1.4,1.43,0.03,1.41,70.73565377,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.97,0.7,4.33,1.027,0.66,-1.687,1.027,0.66,1.687,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,14,1,Phosphate pH 6.0,NB-walpeter-5075040-0039,6,Phosphate,0,0,0,0,0,,,,96.95,1.07,1.07,,,,,0.0072,71.62,25.03,3.35,-1.5,0.7,0.8,1.48,0.73,0.75,70.22723835,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.64,1.09,5.27,-0.303,1.05,-0.747,0.303,1.05,0.747,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,15,1,Phosphate pH 7.0,NB-walpeter-5075040-0039,7,Phosphate,0,0,0,0,0,,,,96.91,1.03,1.03,,,,,0.0058,66.96,27.07,5.96,-6.1,2.8,3.4,6.14,2.77,3.36,70.34676147,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.5,2.8,4.7,-1.443,2.76,-1.317,1.443,2.76,1.317,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,16,1,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Acetate,0,150,0,0,0,,,,97.02,1.14,1.14,,,,,0.0066,32.57,66.25,1.19,-40.5,42,-1.4,40.53,41.95,1.41,66.46567468,86.11640609,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.34,1.98,4.68,-0.603,1.94,-1.337,0.603,1.94,1.337,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,17,1,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Glutamate,0,150,0,0,0,,,,97.3,1.42,1.42,,,,,0.0068,29.91,68.88,1.21,-43.2,44.6,-1.4,43.19,44.58,1.39,65.54175193,85.08930582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.04,1.57,5.39,-0.903,1.53,-0.627,0.903,1.53,0.627,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,18,1,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6,Citrate,0,150,0,0,0,,,,96.69,0.81,0.81,,,,,0.0082,29.77,69.21,1.02,-43.3,44.9,-1.6,43.33,44.91,1.58,68.21492229,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.36,1.72,4.92,-0.583,1.68,-1.097,0.583,1.68,1.097,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25,30,19,1,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7,Phosphate,0,150,0,0,0,,,,96.59,0.71,0.71,,,,,0.0056,27.42,70.9,1.68,-46.7,48.8,-2.1,46.68,48.8,2.12,68.4921336,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.13,1.64,5.23,-0.813,1.6,-0.787,0.813,1.6,0.787,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,1,1,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0,0,0,,,,98.19,0.65,0.65,,,,,0.003,77.54,18.84,3.62,3.4,-3.3,-0.2,3.44,3.26,0.18,69.2545527,82.10241214,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.57,0,2.43,1.185,-0.015,-1.17,1.185,0.015,1.17,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,2,1,Acetate pH 5.0,NB-walpeter-5075040-0039,5,Acetate,0,0,0,0,0,,,,98.07,0.53,0.53,,,,,0.0047,74.45,21.84,3.72,0.4,-0.3,-0.1,0.35,0.26,0.08,70.79934909,83.28610996,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.5,0.05,1.45,2.115,0.035,-2.15,2.115,0.035,2.15,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,3,1,Glutamate pH 4.0,NB-walpeter-5075040-0039,4,Glutamate,0,0,0,0,0,,,,98.02,0.48,0.48,,,,,0.0053,70.16,23.33,6.51,-3.9,1.2,2.7,3.94,1.23,2.71,67.92585223,79.86924857,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.71,1.25,2.03,0.325,1.235,-1.57,0.325,1.235,1.57,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,4,1,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0,0,0,,,,98.12,0.58,0.58,,,,,0.0058,72.12,23.03,4.86,-2,0.9,1.1,1.98,0.93,1.06,69.70809066,82.07925348,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.62,1.8,1.57,0.235,1.785,-2.03,0.235,1.785,2.03,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,5,1,Glutamate pH 5.0,NB-walpeter-5075040-0039,5,Glutamate,0,0,0,0,0,,,,98.34,0.8,0.8,,,,,0.005,77.72,19.23,3.06,3.6,-2.9,-0.7,3.62,2.87,0.74,70.46986227,82.75395634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.71,1.28,2.01,0.325,1.265,-1.59,0.325,1.265,1.59,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,6,1,Citrate pH 4.0,NB-walpeter-5075040-0039,4,Citrate,0,0,0,0,0,,,,97.61,0.07,0.07,,,,,0.0049,69.82,23.44,6.74,-4.3,1.3,2.9,4.28,1.34,2.94,60.90048361,77.17585325,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.56,1.2,2.23,0.175,1.185,-1.37,0.175,1.185,1.37,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,7,1,Citrate pH 5.0,NB-walpeter-5075040-0039,5,Citrate,0,0,0,0,0,,,,98.38,0.84,0.84,,,,,0.0052,76.42,19.73,3.85,2.3,-2.4,0,2.32,2.37,0.05,67.3923395,81.74312684,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.81,1.69,2.5,-0.575,1.675,-1.1,0.575,1.675,1.1,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,8,1,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0,0,0,,,,98.43,0.89,0.89,,,,,0.006,69.18,27.16,3.66,-4.9,5.1,-0.1,4.92,5.06,0.14,68.76021275,82.85631598,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.7,1.49,2.81,-0.685,1.475,-0.79,0.685,1.475,0.79,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,9,1,Succinate pH 4.0,NB-walpeter-5075040-0039,4,Succinate,0,0,0,0,0,,,,97.78,0.24,0.24,,,,,0.0046,70.08,24.19,5.73,-4,2.1,1.9,4.02,2.09,1.93,66.88536993,80.11943129,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.27,1.68,2.05,-0.115,1.665,-1.55,0.115,1.665,1.55,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,10,1,Succinate pH 5.0,NB-walpeter-5075040-0039,5,Succinate,0,0,0,0,0,,,,98.4,0.86,0.86,,,,,0.0026,73.01,23.2,3.79,-1.1,1.1,0,1.09,1.1,0.01,69.48036562,82.57865167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.86,1.49,2.64,-0.525,1.475,-0.96,0.525,1.475,0.96,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,11,1,Succinate pH 6.0,NB-walpeter-5075040-0039,6,Succinate,0,0,0,0,0,,,,98.37,0.83,0.83,,,,,0.0012,65.28,31,3.72,-8.8,8.9,-0.1,8.82,8.9,0.08,70.0486006,83.14555131,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.72,3.44,1.85,-1.665,3.425,-1.75,1.665,3.425,1.75,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,12,1,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0,0,0,,,,98.02,0.48,0.48,,,,,0.0031,75.44,21.21,3.36,1.3,-0.9,-0.4,1.34,0.89,0.44,69.89132675,82.08181823,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.74,0.58,1.68,1.355,0.565,-1.92,1.355,0.565,1.92,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,13,1,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0,0,0,,,,98.29,0.75,0.75,,,,,0.0042,72.55,23.44,4,-1.6,1.3,0.2,1.55,1.34,0.2,71.14691673,83.65004188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.45,1.69,1.86,0.065,1.675,-1.74,0.065,1.675,1.74,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,14,1,Phosphate pH 6.0,NB-walpeter-5075040-0039,6,Phosphate,0,0,0,0,0,,,,98.6,1.06,1.06,,,,,0.0028,75.13,21.66,3.21,1,-0.4,-0.6,1.03,0.44,0.59,70.76990889,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.24,0.63,2.14,0.855,0.615,-1.46,0.855,0.615,1.46,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,15,1,Phosphate pH 7.0,NB-walpeter-5075040-0039,7,Phosphate,0,0,0,0,0,,,,98.31,0.77,0.77,,,,,0.0033,63.44,31.5,5.04,-10.7,9.4,1.2,10.66,9.4,1.24,70.33157163,83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.72,0.67,3.61,-0.665,0.655,0.01,0.665,0.655,0.01,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,16,1,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Acetate,0,150,0,0,0,,,,98.23,0.69,0.69,,,,,0.0024,1.01,98.73,0.26,-73.1,76.6,-3.5,73.09,76.63,3.54,66.58332198,80.79622403,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.32,2.47,2.21,-1.065,2.455,-1.39,1.065,2.455,1.39,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,17,1,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Glutamate,0,150,0,0,0,,,,98.29,0.75,0.75,,,,,0.0035,27.22,71.15,1.63,-46.9,49.1,-2.2,46.88,49.05,2.17,65.80467254,80.25492094,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.01,0.74,3.24,-0.375,0.725,-0.36,0.375,0.725,0.36,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,18,1,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6,Citrate,0,150,0,0,0,,,,98.34,0.8,0.8,,,,,0.0033,27.97,70.83,1.19,-46.1,48.7,-2.6,46.13,48.73,2.61,68.49099698,82.60103997,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.14,1.28,2.57,-0.245,1.265,-1.03,0.245,1.265,1.03,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25,30,19,1,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7,Phosphate,0,150,0,0,0,,,,98.37,0.83,0.83,,,,,-0.0004,26.6,71.86,1.55,-47.5,49.8,-2.3,47.5,49.76,2.25,68.94709907,82.64533277,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.71,1.42,2.86,-0.675,1.405,-0.74,0.675,1.405,0.74,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,24,1,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0042,78.55,14.46,7,-9,3.7,5.4,8.95,3.66,5.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.61,0.36,9.03,-7.191,0.35,6.842,7.191,0.35,6.842,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,21,1,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0024,81.15,12.39,6.46,-6.3,1.6,4.9,6.35,1.59,4.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.64,0.27,11.09,-9.161,0.26,8.902,9.161,0.26,8.902,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,22,1,Acetate pH 5.0,NB-walpeter-5075040-0039,5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0044,81.07,11.2,7.73,-6.4,0.4,6.1,6.43,0.4,6.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.53,0.19,8.28,-6.271,0.18,6.092,6.271,0.18,6.092,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,23,1,Glutamate pH 4.0,NB-walpeter-5075040-0039,4,Glutamate,0,0,0,0,0,,,,,,,,,,,0.004,71,16.88,12.12,-16.5,6.1,10.5,16.5,6.08,10.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.57,0.66,4.76,-3.231,0.65,2.572,3.231,0.65,2.572,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,25,1,Glutamate pH 5.0,NB-walpeter-5075040-0039,5,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0054,78.08,13.51,8.41,-9.4,2.7,6.8,9.42,2.71,6.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.73,0.26,12.01,-10.071,0.25,9.822,10.071,0.25,9.822,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,26,1,Citrate pH 4.0,NB-walpeter-5075040-0039,4,Citrate,0,0,0,0,0,,,,,,,,,,,0.0121,24.61,69.35,6.04,-62.9,58.6,4.4,62.89,58.55,4.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32.13,2.49,65.38,-65.671,2.48,63.192,65.671,2.48,63.192,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,27,1,Citrate pH 5.0,NB-walpeter-5075040-0039,5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0327,51.25,36.47,12.28,-36.3,25.7,10.7,36.25,25.67,10.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,43.39,0.54,56.07,-54.411,0.53,53.882,54.411,0.53,53.882,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,28,1,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0401,48.43,36.39,15.18,-39.1,25.6,13.6,39.07,25.59,13.58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41.98,0.25,57.77,-55.821,0.24,55.582,55.821,0.24,55.582,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,29,1,Succinate pH 4.0,NB-walpeter-5075040-0039,4,Succinate,0,0,0,0,0,,,,,,,,,,,0.0067,64.2,20.6,15.2,-23.3,9.8,13.6,23.3,9.8,13.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.54,0.9,11.54,-10.261,0.89,9.352,10.261,0.89,9.352,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,30,1,Succinate pH 5.0,NB-walpeter-5075040-0039,5,Succinate,0,0,0,0,0,,,,,,,,,,,0.0076,56.18,36.89,6.92,-31.3,26.1,5.3,31.32,26.09,5.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,73.52,0.33,26.15,-24.281,0.32,23.962,24.281,0.32,23.962,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,31,1,Succinate pH 6.0,NB-walpeter-5075040-0039,6,Succinate,0,0,0,0,0,,,,,,,,,,,0.0109,74.35,18.91,6.73,-13.2,8.1,5.1,13.15,8.11,5.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75.15,0.25,24.6,-22.651,0.24,22.412,22.651,0.24,22.412,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,32,1,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0131,77.09,13.63,9.28,-10.4,2.8,7.7,10.41,2.83,7.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.41,0.27,7.32,-5.391,0.26,5.132,5.391,0.26,5.132,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,33,1,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0063,81.5,12.5,6,-6,1.7,4.4,6,1.7,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.53,0.28,9.19,-7.271,0.27,7.002,7.271,0.27,7.002,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,34,1,Phosphate pH 6.0,NB-walpeter-5075040-0039,6,Phosphate,0,0,0,0,0,,,,,,,,,,,0.0091,62.36,30.01,7.63,-25.1,19.2,6,25.14,19.21,6.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75.2,0.29,24.5,-22.601,0.28,22.312,22.601,0.28,22.312,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,35,1,Phosphate pH 7.0,NB-walpeter-5075040-0039,7,Phosphate,0,0,0,0,0,,,,,,,,,,,0.0142,42.38,44.23,13.4,-45.1,33.4,11.8,45.12,33.43,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,61.04,1.02,37.95,-36.761,1.01,35.762,36.761,1.01,35.762,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,36,1,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Acetate,0,150,0,0,0,,,,,,,,,,,0.0278,57.29,37.26,5.45,-30.2,26.5,3.9,30.21,26.46,3.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70.31,0.61,29.08,-27.491,0.6,26.892,27.491,0.6,26.892,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,37,1,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Glutamate,0,150,0,0,0,,,,,,,,,,,0.0114,18.16,73.19,8.64,-69.3,62.4,7,69.34,62.39,7.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30.9,0.92,68.18,-66.901,0.91,65.992,66.901,0.91,65.992,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,38,1,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6,Citrate,0,150,0,0,0,,,,,,,,,,,0.0483,29.98,68.64,1.37,-57.5,57.8,-0.2,57.52,57.84,0.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60.88,0.34,38.79,-36.921,0.33,36.602,36.921,0.33,36.602,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35,30,39,1,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7,Phosphate,0,150,0,0,0,,,,,,,,,,,0.0214,23.22,73.32,3.46,-64.3,62.5,1.9,64.28,62.52,1.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64.88,0.46,34.66,-32.921,0.45,32.472,32.921,0.45,32.472,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,24,1,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0081,68.76,22.61,8.64,-16,9.8,6.2,16.04,9.81,6.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.04,1.3,10.66,-8.274,1.295,6.979,8.274,1.295,6.979,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,21,1,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0049,70.4,23.11,6.49,-14.4,10.3,4.1,14.4,10.31,4.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.79,1.08,13.12,-10.524,1.075,9.439,10.524,1.075,9.439,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,22,1,Acetate pH 5.0,NB-walpeter-5075040-0039,5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0059,77.41,17.91,4.68,-7.4,5.1,2.3,7.39,5.11,2.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.95,0.61,9.45,-6.364,0.605,5.769,6.364,0.605,5.769,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,23,1,Glutamate pH 4.0,NB-walpeter-5075040-0039,4,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0072,62.65,25.25,12.1,-22.2,12.5,9.7,22.15,12.45,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.19,2.24,6.57,-5.124,2.235,2.889,5.124,2.235,2.889,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,25,1,Glutamate pH 5.0,NB-walpeter-5075040-0039,5,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0073,70.78,23.54,5.67,-14,10.7,3.3,14.02,10.74,3.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,84.56,0.87,14.56,-11.754,0.865,10.879,11.754,0.865,10.879,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,26,1,Citrate pH 4.0,NB-walpeter-5075040-0039,4,Citrate,0,0,0,0,0,,,,,,,,,,,0.0175,17.06,79.85,3.1,-67.7,67.1,0.7,67.74,67.05,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30.25,3.04,66.72,-66.064,3.035,63.039,66.064,3.035,63.039,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,27,1,Citrate pH 5.0,NB-walpeter-5075040-0039,5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0495,40.04,47.56,12.4,-44.8,34.8,10,44.76,34.76,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,38.67,0.86,60.48,-57.644,0.855,56.799,57.644,0.855,56.799,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,28,1,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0521,52.53,32.86,14.61,-32.3,20.1,12.2,32.27,20.06,12.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35.46,0.41,64.12,-60.854,0.405,60.439,60.854,0.405,60.439,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,29,1,Succinate pH 4.0,NB-walpeter-5075040-0039,4,Succinate,0,0,0,0,0,,,,,,,,,,,0.0064,64.2,20.6,15.2,-20.6,7.8,12.8,20.6,7.8,12.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.71,2.31,10.97,-9.604,2.305,7.289,9.604,2.305,7.289,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,30,1,Succinate pH 5.0,NB-walpeter-5075040-0039,5,Succinate,0,0,0,0,0,,,,,,,,,,,0.0121,56.18,36.89,6.92,-28.6,24.1,4.5,28.62,24.09,4.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65.39,0.81,33.8,-30.924,0.805,30.119,30.924,0.805,30.119,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,31,1,Succinate pH 6.0,NB-walpeter-5075040-0039,6,Succinate,0,0,0,0,0,,,,,,,,,,,0.0159,74.35,18.91,6.73,-10.5,6.1,4.3,10.45,6.11,4.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,67.72,0.36,31.92,-28.594,0.355,28.239,28.594,0.355,28.239,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,32,1,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0074,78.55,16.95,4.49,-6.3,4.2,2.1,6.25,4.15,2.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.35,0.64,10.01,-6.964,0.635,6.329,6.964,0.635,6.329,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,33,1,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0115,81.5,12.5,6,-3.3,-0.3,3.6,3.3,0.3,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.54,0.35,13.11,-9.774,0.345,9.429,9.774,0.345,9.429,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,34,1,Phosphate pH 6.0,NB-walpeter-5075040-0039,6,Phosphate,0,0,0,0,0,,,,,,,,,,,0.0172,62.36,30.01,7.63,-22.4,17.2,5.2,22.44,17.21,5.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,66.58,0.35,33.06,-29.734,0.345,29.379,29.734,0.345,29.379,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,35,1,Phosphate pH 7.0,NB-walpeter-5075040-0039,7,Phosphate,0,0,0,0,0,,,,,,,,,,,0.0338,42.38,44.23,13.4,-42.4,31.4,11,42.42,31.43,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,52.67,1,46.33,-43.644,0.995,42.649,43.644,0.995,42.649,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,36,1,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Acetate,0,150,0,0,0,,,,,,,,,,,0.052,22.78,44.46,32.76,-62,31.7,30.4,62.02,31.66,30.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,34.29,1.18,64.54,-62.024,1.175,60.859,62.024,1.175,60.859,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,37,1,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Glutamate,0,150,0,0,0,,,,,,,,,,,0.0629,17.58,76.91,5.51,-67.2,64.1,3.1,67.22,64.11,3.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28.97,1.58,69.45,-67.344,1.575,65.769,67.344,1.575,65.769,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,38,1,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6,Citrate,0,150,0,0,0,,,,,,,,,,,0.0281,29.98,68.64,1.37,-54.8,55.8,-1,54.82,55.84,1.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50.88,0.42,48.7,-45.434,0.415,45.019,45.434,0.415,45.019,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35,30,39,1,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7,Phosphate,0,150,0,0,0,,,,,,,,,,,0.0258,23.22,73.32,3.46,-61.6,60.5,1.1,61.58,60.52,1.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57.25,0.52,42.24,-39.064,0.515,38.559,39.064,0.515,38.559,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,21,1,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0041,67.98,24.62,7.4,-5.1,0.3,4.8,5.12,0.32,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.52,0.4,10.09,-4.423,0.36,4.073,4.423,0.36,4.073,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,22,1,Acetate pH 5.0,NB-walpeter-5075040-0039,5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0057,70.71,24.04,5.25,-2.4,-0.3,2.7,2.39,0.26,2.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.3,0.31,8.39,-2.643,0.27,2.373,2.643,0.27,2.373,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,23,1,Glutamate pH 4.0,NB-walpeter-5075040-0039,4,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0063,59.61,27.13,13.25,-13.5,2.8,10.7,13.49,2.83,10.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.27,0.98,7.75,-2.673,0.94,1.733,2.673,0.94,1.733,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,24,1,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0075,66.33,25.1,8.56,-6.8,0.8,6,6.77,0.8,5.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.98,0.47,9.55,-3.963,0.43,3.533,3.963,0.43,3.533,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,25,1,Glutamate pH 5.0,NB-walpeter-5075040-0039,5,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0058,71.01,23.15,5.84,-2.1,-1.2,3.2,2.09,1.15,3.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.11,0.36,11.53,-5.833,0.32,5.513,5.833,0.32,5.513,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,26,1,Citrate pH 4.0,NB-walpeter-5075040-0039,4,Citrate,0,0,0,0,0,,,,,,,,,,,0.0115,16.76,80.25,2.99,-56.3,56,0.4,56.34,55.95,0.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33.76,2.37,63.88,-60.183,2.33,57.863,60.183,2.33,57.863,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,27,1,Citrate pH 5.0,NB-walpeter-5075040-0039,5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0301,45.34,45.88,8.77,-27.8,21.6,6.2,27.76,21.58,6.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42.28,0.61,57.1,-51.663,0.57,51.083,51.663,0.57,51.083,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,28,1,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0336,51.52,36.52,11.96,-21.6,12.2,9.4,21.58,12.22,9.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,39.89,0.34,59.78,-54.053,0.3,53.763,54.053,0.3,53.763,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,29,1,Succinate pH 4.0,NB-walpeter-5075040-0039,4,Succinate,0,0,0,0,0,,,,,,,,,,,0.0052,56.87,31.36,11.76,-16.2,7.1,9.2,16.23,7.06,9.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.21,1.02,11.76,-6.733,0.98,5.743,6.733,0.98,5.743,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,30,1,Succinate pH 5.0,NB-walpeter-5075040-0039,5,Succinate,0,0,0,0,0,,,,,,,,,,,0.0073,71.39,23.89,4.72,-1.7,-0.4,2.1,1.71,0.41,2.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75.32,0.34,24.35,-18.623,0.3,18.333,18.623,0.3,18.333,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,31,1,Succinate pH 6.0,NB-walpeter-5075040-0039,6,Succinate,0,0,0,0,0,,,,,,,,,,,0.0091,55.39,40.95,3.66,-17.7,16.7,1.1,17.71,16.65,1.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,74.5,0.09,25.42,-19.443,0.05,19.403,19.443,0.05,19.403,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,32,1,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0066,73.76,21.62,4.63,0.7,-2.7,2,0.66,2.68,2.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.48,0.36,8.16,-2.463,0.32,2.143,2.463,0.32,2.143,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,33,1,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0095,73.27,19.46,7.27,0.2,-4.8,4.7,0.17,4.84,4.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.64,0.47,9.89,-4.303,0.43,3.873,4.303,0.43,3.873,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,34,1,Phosphate pH 6.0,NB-walpeter-5075040-0039,6,Phosphate,0,0,0,0,0,,,,,,,,,,,0.0248,61.42,33.71,4.87,-11.7,9.4,2.3,11.68,9.41,2.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75.4,0.49,24.11,-18.543,0.45,18.093,18.543,0.45,18.093,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,35,1,Phosphate pH 7.0,NB-walpeter-5075040-0039,7,Phosphate,0,0,0,0,0,,,,,,,,,,,0.0184,58.96,28.69,12.35,-14.1,4.4,9.8,14.14,4.39,9.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,71.71,1.44,26.85,-22.233,1.4,20.833,22.233,1.4,20.833,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,36,1,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Acetate,0,150,0,0,0,,,,,,,,,,,0.0305,21.34,72.33,6.34,-51.8,48,3.7,51.76,48.03,3.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41.22,0.79,57.98,-52.723,0.75,51.963,52.723,0.75,51.963,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,37,1,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Glutamate,0,150,0,0,0,,,,,,,,,,,0.0546,14.42,83.91,1.67,-58.7,59.6,-0.9,58.68,59.61,0.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31.92,1.11,66.98,-62.023,1.07,60.963,62.023,1.07,60.963,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,38,1,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6,Citrate,0,150,0,0,0,,,,,,,,,,,0.0187,31.93,67.8,0.26,-41.2,43.5,-2.3,41.17,43.5,2.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,58.96,0.64,40.41,-34.983,0.6,34.393,34.983,0.6,34.393,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35,30,39,1,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7,Phosphate,0,150,0,0,0,,,,,,,,,,,0.0163,23.26,73.88,2.85,-49.8,49.6,0.3,49.84,49.58,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60.31,0.68,39,-33.633,0.64,32.983,33.633,0.64,32.983,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,21,1,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0045,74.04,18.81,7.15,-0.1,-3.3,3.4,0.06,3.29,3.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.99,0.67,11.34,-8.395,0.655,7.74,8.395,0.655,7.74,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,22,1,Acetate pH 5.0,NB-walpeter-5075040-0039,5,Acetate,0,0,0,0,0,,,,,,,,,,,0.0059,73.35,20.94,5.72,-0.8,-1.2,1.9,0.75,1.16,1.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.59,0.49,8.91,-5.795,0.475,5.31,5.795,0.475,5.31,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,23,1,Glutamate pH 4.0,NB-walpeter-5075040-0039,4,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0067,57.38,27.18,15.43,-16.7,5.1,11.6,16.72,5.08,11.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.88,0.87,7.24,-4.505,0.855,3.64,4.505,0.855,3.64,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,24,1,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0078,64.93,25.16,9.9,-9.2,3.1,6.1,9.17,3.06,6.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.6,0.68,10.72,-7.785,0.665,7.12,7.785,0.665,7.12,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,25,1,Glutamate pH 5.0,NB-walpeter-5075040-0039,5,Glutamate,0,0,0,0,0,,,,,,,,,,,0.0072,70.91,22.25,6.83,-3.2,0.2,3,3.19,0.15,3.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.11,0.59,13.29,-10.275,0.575,9.69,10.275,0.575,9.69,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,26,1,Citrate pH 4.0,NB-walpeter-5075040-0039,4,Citrate,0,0,0,0,0,,,,,,,,,,,0.0135,18.1,77.81,4.08,-56,55.7,0.3,56,55.71,0.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32.6,2.59,64.82,-63.785,2.575,61.22,63.785,2.575,61.22,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,27,1,Citrate pH 5.0,NB-walpeter-5075040-0039,5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0427,59.27,26.02,14.71,-14.8,3.9,10.9,14.83,3.92,10.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,38.27,0.83,60.9,-58.115,0.815,57.3,58.115,0.815,57.3,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,28,1,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,0.0511,43.58,43.55,12.87,-30.5,21.5,9.1,30.52,21.45,9.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,36.48,0.61,62.9,-59.905,0.595,59.3,59.905,0.595,59.3,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,29,1,Succinate pH 4.0,NB-walpeter-5075040-0039,4,Succinate,0,0,0,0,0,,,,,,,,,,,0.0051,57.21,29.27,13.53,-16.9,7.2,9.7,16.89,7.17,9.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.63,1,11.37,-8.755,0.985,7.77,8.755,0.985,7.77,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,30,1,Succinate pH 5.0,NB-walpeter-5075040-0039,5,Succinate,0,0,0,0,0,,,,,,,,,,,0.0086,57.09,38.76,4.15,-17,16.7,0.4,17.01,16.66,0.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,71.16,0.62,28.22,-25.225,0.605,24.62,25.225,0.605,24.62,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,31,1,Succinate pH 6.0,NB-walpeter-5075040-0039,6,Succinate,0,0,0,0,0,,,,,,,,,,,0.0118,62.75,33.12,4.13,-11.4,11,0.3,11.35,11.02,0.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70.59,0.54,28.87,-25.795,0.525,25.27,25.795,0.525,25.27,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,32,1,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.005,76.76,18.1,5.14,2.7,-4,1.3,2.66,4,1.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.22,0.44,8.34,-5.165,0.425,4.74,5.165,0.425,4.74,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,33,1,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,0.0069,74.36,17.93,7.71,0.3,-4.2,3.9,0.26,4.17,3.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.36,0.51,11.12,-8.025,0.495,7.52,8.025,0.495,7.52,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,34,1,Phosphate pH 6.0,NB-walpeter-5075040-0039,6,Phosphate,0,0,0,0,0,,,,,,,,,,,0.0121,66.33,28.17,5.49,-7.8,6.1,1.7,7.77,6.07,1.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,71.39,0.54,28.08,-24.995,0.525,24.48,24.995,0.525,24.48,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,35,1,Phosphate pH 7.0,NB-walpeter-5075040-0039,7,Phosphate,0,0,0,0,0,,,,,,,,,,,0.0303,41.72,39.43,18.86,-32.4,17.3,15.1,32.38,17.33,15.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,55.98,1.14,42.88,-40.405,1.125,39.28,40.405,1.125,39.28,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,36,1,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Acetate,0,150,0,0,0,,,,,,,,,,,0.039,20.76,69.11,10.14,-53.3,47,6.3,53.34,47.01,6.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37.2,0.76,62.04,-59.185,0.745,58.44,59.185,0.745,58.44,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,37,1,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5,Glutamate,0,150,0,0,0,,,,,,,,,,,0.0505,24.42,60.28,15.29,-49.7,38.2,11.5,49.68,38.18,11.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28.93,0.96,70.11,-67.455,0.945,66.51,67.455,0.945,66.51,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,38,1,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6,Citrate,0,150,0,0,0,,,,,,,,,,,0.0238,25.36,61.23,13.41,-48.7,39.1,9.6,48.74,39.13,9.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,53.89,0.52,45.59,-42.495,0.505,41.99,42.495,0.505,41.99,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35,30,39,1,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7,Phosphate,0,150,0,0,0,,,,,,,,,,,0.0191,21.34,66.12,12.55,-52.8,44,8.8,52.76,44.02,8.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,58.83,0.67,40.5,-37.555,0.655,36.9,37.555,0.655,36.9,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,,,,,,NB-walpeter-5075040-0039,,,0,0,0,0,0,,,,,,,,,,,0.0173,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,,,,,,NB-walpeter-5075040-0039,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,,,,,,NB-walpeter-5075040-0039,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,,,,,,NB-walpeter-5075040-0039,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,N/A,-,-,0,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000492_004,ADC,MULTIPLE CONTROL,,,,,20.3,D492_15.8_Start,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,97.2,,,65.67,98.76,,,,43.83,32.7,23.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.04,0,0.96,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000492_005,ADC,MULTIPLE CONTROL,,,,,20.3,D492_His_6.5_9S_0.2x,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,76.9,,,54.99,83.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,49.37,50.62,0,-49.6,50.6,-1,49.6,50.6,1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000492_005,ADC,MULTIPLE CONTROL,,,,,20.3,D492_His_6.5_9S_0.2xCT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,97.1,,,65.72,98.69,,,,41.46,37.94,20.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.72,0,1.28,-0.2,0,0.2,0.2,0,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000492_005,ADC,MULTIPLE CONTROL,,,,,20.3,D492_His_6.5_9S_24H5C_6HRT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,97.1,,,65.76,98.7,,,,44.57,32.83,22.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0,0.88,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000492_005,ADC,MULTIPLE CONTROL,,,,,20.3,D492_His_6.5_9S_6HRT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,97.2,,,65.76,98.69,,,,43.67,34.54,21.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.19,0,0.81,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000492_005,ADC,MULTIPLE CONTROL,,,0,,20.3,D492_His_6.5_9S_CT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,97.2,,,65.48,98.76,,,,43.05,32.63,24.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.96,0,1.04,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000492_005,ADC,MULTIPLE CONTROL,,,,,20.3,D492_His_6.5_9S_FT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,97.2,,,65.65,98.79,,,,43.74,33.19,23.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.21,0,0.79,0.2,0,-0.2,0.2,0,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000674_004,ADC,MULTIPLE CONTROL,,,,,21.1,D674_16.6_Start,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,89,,,60.19,93.28,,,,42.83,31.37,25.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.01,0.08,2.91,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000674_005,ADC,MULTIPLE CONTROL,,,,,21.1,D674_His_6.5_9S_0.2x,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,68,,,37.36,64.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,54.6,10.43,34.97,-42.6,10.3,32.2,42.6,10.3,32.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000674_005,ADC,MULTIPLE CONTROL,,,,,21.1,D674_His_6.5_9S_0.2xCT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,89.4,,,60.24,93.47,,,,35.27,51.28,13.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.07,0.09,2.84,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000674_005,ADC,MULTIPLE CONTROL,,,,,21.1,D674_His_6.5_9S_24H5C_6HRT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,88.8,,,59.96,93.45,,,,40.94,31.19,27.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.06,0.09,2.85,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000674_005,ADC,MULTIPLE CONTROL,,,,,21.1,D674_His_6.5_9S_6HRT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,89,,,59.98,93.24,,,,41.95,29.51,28.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.08,0.09,2.82,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000674_005,ADC,MULTIPLE CONTROL,,,0,,21.1,D674_His_6.5_9S_CT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,88.9,,,59.67,93.38,,,,43.38,26.14,30.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.16,0.1,2.74,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000674_005,ADC,MULTIPLE CONTROL,,,,,21.1,D674_His_6.5_9S_FT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,88.6,,,60.03,93.19,,,,42.04,27.5,30.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.03,0.09,2.88,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000706_004,ADC,MULTIPLE CONTROL,,,,,21.6,D706_16.8_Start,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.5,,,66.32,98.77,,,,41.52,33.22,25.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.6,0,0.4,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000706_005,ADC,MULTIPLE CONTROL,,,,,21.6,D706_His_6.5_9S_0.2x,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,76.5,,,54.44,83.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,49.92,11.63,38.45,-49.6,11.6,38,49.6,11.6,38,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000706_005,ADC,MULTIPLE CONTROL,,,,,21.6,D706_His_6.5_9S_0.2xCT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.4,,,66.01,98.97,,,,40,38.81,21.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.57,0,0.43,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000706_005,ADC,MULTIPLE CONTROL,,,,,21.6,D706_His_6.5_9S_24H5C_6HRT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.5,,,65.87,98.95,,,,41.62,32.21,26.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.62,0,0.38,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000706_005,ADC,MULTIPLE CONTROL,,,,,21.6,D706_His_6.5_9S_6HRT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.7,,,65.96,98.9,,,,42.51,31.68,25.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.57,0.04,0.39,0,0,-0.1,0,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000706_005,ADC,MULTIPLE CONTROL,,,0,,21.6,D706_His_6.5_9S_CT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.4,,,66.05,98.98,,,,41.8,31.08,27.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
3/1/2023,aujer,Trop2,DCC000706_005,ADC,MULTIPLE CONTROL,,,,,21.6,D706_His_6.5_9S_FT,NB-aujer-5081594-0002,6.5,Histidine,0,0,0.02,9,0,,,,96.5,,,65.95,98.94,,,,42.37,31.59,26.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.61,0,0.39,0.1,0,-0.1,0.1,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15079.3,1865.3,0,15079.3,0,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2817.3,635,0,2817.3,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,-,,Trop2_MMAE_Cit_5.5_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4391.7,820,0,4391.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3651,939.3,13.3,3651,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3651,939.3,13.3,3651,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.0_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2248.7,489.3,0,2248.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2275,383.7,0,2275,0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3928.5,1349.5,59.5,3908.5,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1045,450,0,1045,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582,145.3,13.3,568.7,13.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,383.3,0,1587.3,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3756.7,674.7,13.3,3743.7,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1164,423.3,13.3,1164,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1693,529,26.7,1679.7,13.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,-,,Trop2_PNU_Cit_6.0_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1693,529,26.7,1679.7,13.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926,171.7,0,926,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926,238,0,926,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2447.3,595.3,52.7,2447.3,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,397,132.3,13.3,397,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0,1097.7,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9894.3,608.7,13.3,9894.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4788.7,542.3,39.7,4775.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5846.7,476,0,5846.7,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.0_7.5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30410.3,4206.3,26.3,30410.3,0,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10674.7,754,13.3,10661.3,13.3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5542.3,423.3,13.3,5542.3,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2949.7,820,79.3,2949.7,0,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4153.3,436.3,0,4153.3,0,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1508,317.3,13.3,1508,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,608.7,145.7,13.3,608.7,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582,53,0,582,0,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12156,2116.3,13.3,12156,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1666.7,343.7,13.3,1653.7,13.3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4391.7,820,0,4391.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,886.3,238,0,886.3,0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1825.3,502.7,13.3,1825.3,0,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3426,727.3,13.3,3412.7,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25516,5211.3,26.7,25516,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.0_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3783,674.7,0,3783,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.0_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4285.3,714.3,39.7,4272.3,13.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.0_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9404.7,1547.7,40,9391.3,13.3,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2275,383.7,0,2275,0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2288.7,396.7,26.3,2275.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2910,886.3,0,2910,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7288,1084.7,39.7,7288,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17698.3,2791,40,17685,13.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5092.3,1521.3,39.7,5066,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2209,568.7,26.7,2209,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,-,,Trop2_PNU_Cit_6.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,952.3,211.7,13.3,952.3,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,-,,Trop2_PNU_His_5.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0,1097.7,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3307,370.3,0,3307,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2354.7,198,39.7,2341.3,13.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,-,,Trop2_PNU_His_6.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1561,304.3,26.7,1547.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4312,846.3,39.7,4312,0,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1164,476.3,26.7,1164,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,807,225,13.3,807,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1071.3,291.3,13.3,1071.3,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12156,2116.3,13.3,12156,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3505.3,833.3,0,3505.3,0,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25516,5211.3,26.7,25516,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1640,463,0,1640,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,-,,Trop2_MMAE_His_6.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17698.3,2791,40,17685,13.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2024,608.3,0,2024,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53,1561,26.7,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2777.7,529,0,2777.7,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1296.3,264.3,13.3,1296.3,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10595.3,595.3,0,10595.3,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,979,224.7,0,979,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,-,,Trop2_PNU_His_6.0_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,979,224.7,0,979,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1561,304.3,26.7,1547.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,370.3,132.3,26.7,357.3,13.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997.3,370.3,13.3,1984,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2724.7,317.3,13.3,2724.7,0,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1494.7,383.7,26.3,1481.7,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4695.7,1296,66,4695.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7314.7,1984.3,105.7,7301.7,13.3,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1177,225,26.7,1164,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,675,145.3,26.7,675,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_6.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3426,727.3,13.3,3412.7,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.0_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4285.3,714.3,39.7,4272.3,13.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.0_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9404.7,1547.7,40,9391.3,13.3,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_6.0_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2738,926,39.7,2724.7,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.0_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,370.3,132.3,26.7,357.3,13.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.0_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1494.7,383.7,26.3,1481.7,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.0_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9894.3,608.7,13.3,9894.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.5_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9312.3,740.7,26.7,9299,13.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1561,304.3,26.7,1547.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_5.5_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2182.7,436.7,0,2182.7,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_5.5_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15079.3,1865.3,0,15079.3,0,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_6.0_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3558,621.7,39.7,3544.7,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_6.0_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,886.3,238,0,886.3,0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.0_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2248.7,489.3,0,2248.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.0_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3783,674.7,0,3783,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.0_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10595.3,595.3,0,10595.3,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.5_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6389,224.7,13.3,6389,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.5_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4788.7,542.3,39.7,4775.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.0_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_5.5_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1045,450,0,1045,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_5.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_6.0_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3558,621.7,39.7,3544.7,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,-,,Trop2_MMAE_Cit_6.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3426,727.3,13.3,3412.7,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,992,225,0,992,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6389,224.7,13.3,6389,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9312.3,740.7,26.7,9299,13.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.0_5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9590,793.7,0,9590,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1957.7,436.7,26.3,1944.3,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_53_Start,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,207063.5,24980,198,207024,0,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2182.7,436.7,0,2182.7,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4338.7,648.3,13.3,4338.7,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2910,886.3,0,2910,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_5.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5965.7,754,26.7,5939.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,-,,Trop2_PNU_Cit_5.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5965.7,754,26.7,5939.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.0_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53,1561,26.7,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1018.7,317.3,13.3,1018.7,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1018.7,198.3,13.3,1018.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1137.3,277.7,13.3,1137.3,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,-,,Trop2_MMAE_His_5.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8399.3,1402,26.7,8399.3,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8254,3492,119,8254,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_Cit_6.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926,171.7,0,926,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_6.5_5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4510.3,436.7,13.3,4497.3,13.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_2M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3148.3,569,0,3148.3,0,2.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_6.0_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1825.3,502.7,13.3,1825.3,0,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_6.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17698.3,2791,40,17685,13.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_5.5_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,383.3,0,1587.3,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.5_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926,238,0,926,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.5_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,397,132.3,13.3,397,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_5.5_5S_3w5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1296.3,264.3,13.3,1296.3,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.5_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5846.7,476,0,5846.7,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.0_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5092.3,1521.3,39.7,5066,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.5_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2447.3,595.3,52.7,2447.3,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_6.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3651,939.3,13.3,3651,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.5_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997.3,370.3,13.3,1984,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_6.0_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3716.7,436.3,0,3716.7,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.0_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3307,370.3,0,3307,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_5.5_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,992,225,0,992,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.0_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53,1561,26.7,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.0_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1164,423.3,13.3,1164,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.5_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1018.7,317.3,13.3,1018.7,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_5.5_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1018.7,198.3,13.3,1018.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_5.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8399.3,1402,26.7,8399.3,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_6.0_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3716.7,436.3,0,3716.7,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_His_5.5_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2142.5,516,20,2142.5,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_17.5_Start,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,410555.5,126528,10595,409484,20,11.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,,,Trop2_MMAE_Cit_5.5_7.5S_2M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6124.3,1362.3,185,6071.3,0,3.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000363_035,ADC,,,,,-,,Trop2_MMAE_His_5.5_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2142.5,516,20,2142.5,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,aujer,Trop2,DCC000770_035,ADC,,,,,,,Trop2_PNU_His_5.5_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582.3,39.7,0,582.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_5.5_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4391.7,820,0,4391.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.5_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2724.7,317.3,13.3,2724.7,0,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_5.5_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582,145.3,13.3,568.7,13.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.0_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1693,529,26.7,1679.7,13.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_5.5_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582.3,39.7,0,582.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_6.0_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3505.3,833.3,0,3505.3,0,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_5.5_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2024,608.3,0,2024,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.5_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1640,463,0,1640,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_6.0_7.5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2288.7,396.7,26.3,2275.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_6.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2910,886.3,0,2910,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.0_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3756.7,674.7,13.3,3743.7,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926,171.7,0,926,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_53_Start,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,207063.5,24980,198,207024,0,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_5.5_7.5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1666.7,343.7,13.3,1653.7,13.3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.5_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4338.7,648.3,13.3,4338.7,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_17.5_Start,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,410555.5,126528,10595,409484,20,11.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_5.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0,1097.7,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.0_5S_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2354.7,198,39.7,2341.3,13.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_5.5_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,952.3,211.7,13.3,952.3,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.0_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4695.7,1296,66,4695.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_5.5_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12156,2116.3,13.3,12156,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_Cit_5.5_7.5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2817.3,635,0,2817.3,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.0_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25516,5211.3,26.7,25516,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.5_7.5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2275,383.7,0,2275,0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.0_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,979,224.7,0,979,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_6.0_7.5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7288,1084.7,39.7,7288,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.5_5S_1M25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2209,568.7,26.7,2209,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_1A,ADC,,,,,,,Trop2_A_His_5.0_7.5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8399.3,1402,26.7,8399.3,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_5.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5965.7,754,26.7,5939.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_5.5_5S_1M5C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2777.7,529,0,2777.7,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_Cit_6.5_5S_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.5_5S_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8254,3492,119,8254,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,penglei5,Trop2,DCC_2B,ADC,,,,,,,Trop2_B_His_6.5_5S_1M40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_5.5S_2w25C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0,9,0,,,,91.2,-4,4,65.98,99.56,-0.4,0.4,,55.4,35.6,9,-8.6,8.9,-0.2,8.6,8.9,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.5,3.44,5.06,0.8,-0.8,0,0.8,0.8,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_5.5S_2w40C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0,9,0,,,,88.6,-6.6,6.6,63.84,98.78,-1.2,1.2,,29.5,62.8,7.7,-34.5,36.1,-1.5,34.5,36.1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.52,9.13,4.36,-4.2,4.9,-0.7,4.2,4.9,0.7,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Cit_5.5S_4w5C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0,9,0,,,,88.7,-6.5,6.5,66.23,99.98,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.18,3.16,5.66,0.5,-1,0.6,0.5,1,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_5.5S_T0,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0,9,0,,,,95.2,0,0,66.43,100,0,0,,64.03,26.73,9.24,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.7,4.2,5.1,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_5.5_2w25C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0,0,0,,,,91.2,-4,4,66.06,99.59,-0.4,0.4,,46.23,46.55,7.22,-6.8,6.8,-0.1,6.8,6.8,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.6,3.17,5.23,0.9,-1.1,0.1,0.9,1.1,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_5.5_2w40C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0,0,0,,,,88.7,-6.5,6.5,63.62,98.67,-1.3,1.3,,27.05,66.89,6.06,-25.9,27.2,-1.2,25.9,27.2,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.67,9.45,4.88,-5,5.2,-0.2,5,5.2,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Cit_5.5_4w5C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0,0,0,,,,89.2,-6,6,66.27,99.96,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.3,2.97,5.74,0.6,-1.3,0.7,0.6,1.3,0.7,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_5.5_T0,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0,0,0,,,,95.2,0,0,66.72,100,0,0,,52.98,39.74,7.28,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.65,4.27,5.09,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_5S_2w25C,NB-penglei5-5060234-0005,5,Citrate,0,0,0,9,0,,,,91.6,-3.7,3.7,65.8,99.32,0.4,0.4,,54.94,37.07,7.99,-11.9,13.5,-1.7,11.9,13.5,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.99,2.87,5.14,1.2,-1.2,0,1.2,1.2,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_5S_2w40C,NB-penglei5-5060234-0005,5,Citrate,0,0,0,9,0,,,,88.3,-7,7,63.46,98.49,-0.4,0.4,,30.7,60,9.2,-36.1,36.5,-0.5,36.1,36.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.27,9.9,4.83,-5.5,5.8,-0.3,5.5,5.8,0.3,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Cit_5S_4w5C,NB-penglei5-5060234-0005,5,Citrate,0,0,0,9,0,,,,89.1,-6.2,6.2,66.39,99.94,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.3,2.69,6.01,0.5,-1.4,0.9,0.5,1.4,0.9,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_5S_T0,NB-penglei5-5060234-0005,5,Citrate,0,0,0,9,0,,,,95.3,0,0,65.92,98.9,0,0,,66.8,23.54,9.66,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.79,4.1,5.11,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_5_2w25C,NB-penglei5-5060234-0005,5,Citrate,0,0,0,0,0,,,,91.6,-3.6,3.6,65.71,99.26,-0.7,0.7,,43.4,49.81,6.79,-13.6,15.2,-1.6,13.6,15.2,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.78,2.82,5.4,0.9,-1.3,0.4,0.9,1.3,0.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_5_2w40C,NB-penglei5-5060234-0005,5,Citrate,0,0,0,0,0,,,,88.6,-6.6,6.6,63.25,98.64,-1.4,1.4,,32.05,62.45,5.51,-25,27.8,-2.9,25,27.8,2.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.12,11.26,5.62,-7.7,7.2,0.6,7.7,7.2,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Cit_5_4w5C,NB-penglei5-5060234-0005,5,Citrate,0,0,0,0,0,,,,89.1,-6.1,6.1,66.29,99.94,-0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.39,2.51,6.1,0.5,-1.6,1,0.5,1.6,1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_5_T0,NB-penglei5-5060234-0005,5,Citrate,0,0,0,0,0,,,,95.2,0,0,66.85,100,0,0,,57,34.62,8.38,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.85,4.1,5.05,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_6S_2w25C,NB-penglei5-5060234-0005,6,Citrate,0,0,0,9,0,,,,90.8,-4.3,4.3,66.01,99.58,-0.4,0.4,,61.89,29.61,8.5,-1,1.8,-0.8,1,1.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.05,4.04,4.91,0.2,-0.1,-0.2,0.2,0.1,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_6S_2w40C,NB-penglei5-5060234-0005,6,Citrate,0,0,0,9,0,,,,89,-6.1,6.1,63.96,98.94,-1.1,1.1,,30.7,60.8,8.5,-32.1,32.9,-0.8,32.1,32.9,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.32,8.45,4.23,-3.5,4.3,-0.8,3.5,4.3,0.8,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Cit_6S_4w5C,NB-penglei5-5060234-0005,6,Citrate,0,0,0,9,0,,,,89.3,-5.8,5.8,66.29,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.79,3.82,5.39,0,-0.3,0.3,0,0.3,0.3,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_6S_T0,NB-penglei5-5060234-0005,6,Citrate,0,0,0,9,0,,,,95.1,0,0,66.8,100,0,0,,62.84,27.86,9.29,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.8,4.12,5.08,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_6_2w25C,NB-penglei5-5060234-0005,6,Citrate,0,0,0,0,0,,,,90.8,-4.2,4.2,66.04,99.65,-0.3,0.3,,44.8,48.45,6.74,-5.8,5.9,-0.1,5.8,5.9,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.24,3.67,5.09,0.3,-0.4,0.1,0.3,0.4,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_6_2w40C,NB-penglei5-5060234-0005,6,Citrate,0,0,0,0,0,,,,89.2,-5.8,5.8,63.92,98.88,-1.1,1.1,,26.51,67.9,5.59,-24.1,25.3,-1.2,24.1,25.3,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.38,8.99,4.63,-4.6,5,-0.4,4.6,5,0.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Cit_6_4w5C,NB-penglei5-5060234-0005,6,Citrate,0,0,0,0,0,,,,89.4,-5.6,5.6,66.49,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.34,3.42,5.24,0.4,-0.6,0.2,0.4,0.6,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_6_T0,NB-penglei5-5060234-0005,6,Citrate,0,0,0,0,0,,,,95,0,0,66.93,100,0,0,,50.63,42.56,6.82,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.96,4.04,5,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Glu_4_2w25C,NB-penglei5-5060234-0005,4,Glutamate,0,0,0,0,0,,,,91.4,-3.7,3.7,66.39,99.6,-0.4,0.4,,55.85,36.45,7.71,-7.6,9.3,-1.7,7.6,9.3,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.88,4.22,3.9,1.5,-0.5,-1,1.5,0.5,1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Glu_4_2w40C,NB-penglei5-5060234-0005,4,Glutamate,0,0,0,0,0,,,,85.4,-9.7,9.7,57.99,94.68,-5.3,5.3,,34.26,59.08,6.66,-29.2,31.9,-2.8,29.2,31.9,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,79.84,17.8,2.36,-10.6,13.1,-2.5,10.6,13.1,2.5,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Glu_4_4w5C,NB-penglei5-5060234-0005,4,Glutamate,0,0,0,0,0,,,,89.5,-5.6,5.6,66.47,99.96,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Glu_4_T0,NB-penglei5-5060234-0005,4,Glutamate,0,0,0,0,0,,,,95.1,0,0,68.31,100,0,0,,63.43,27.15,9.42,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.41,4.71,4.88,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Glu_5S_2w25C,NB-penglei5-5060234-0005,5,Glutamate,0,0,0,9,0,,,,91.4,-3.8,3.8,66.45,99.63,-0.4,0.4,,65.45,25.23,9.32,-2.2,2.6,-0.4,2.2,2.6,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.59,4.15,4.25,0.7,0,-0.7,0.7,0,0.7,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Glu_5S_2w40C,NB-penglei5-5060234-0005,5,Glutamate,0,0,0,9,0,,,,89,-6.2,6.2,65.05,99.04,-1,1,,41.27,45.43,13.3,-26.4,22.8,3.6,26.4,22.8,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.23,9.21,3.56,-3.6,5,-1.4,3.6,5,1.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Glu_5S_4w5C,NB-penglei5-5060234-0005,5,Glutamate,0,0,0,9,0,,,,89.3,-5.9,5.9,66.57,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.87,3.16,4.98,1,-1,0,1,1,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Glu_5S_T0,NB-penglei5-5060234-0005,5,Glutamate,0,0,0,9,0,,,,95.2,0,0,67.02,100,0,0,,67.65,22.66,9.69,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.87,4.19,4.94,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Glu_5_2w25C,NB-penglei5-5060234-0005,5,Glutamate,0,0,0,0,0,,,,91.4,-3.6,3.6,66.41,99.65,-0.3,0.3,,60.24,31.53,8.24,-3.4,4.1,-0.6,3.4,4.1,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.24,4.36,4.4,0.4,0.2,-0.6,0.4,0.2,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Glu_5_2w40C,NB-penglei5-5060234-0005,5,Glutamate,0,0,0,0,0,,,,89,-6,6,64.39,99.1,-0.9,0.9,,42.3,48.16,9.54,-21.4,20.7,0.7,21.4,20.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.9,10.53,3.57,-4.9,6.4,-1.5,4.9,6.4,1.5,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Glu_5_4w5C,NB-penglei5-5060234-0005,5,Glutamate,0,0,0,0,0,,,,89.2,-5.8,5.8,66.54,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.3,3.54,5.16,0.5,-0.6,0.1,0.5,0.6,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Glu_5_T0,NB-penglei5-5060234-0005,5,Glutamate,0,0,0,0,0,,,,95,0,0,67.13,100,0,0,,63.69,27.47,8.84,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.83,4.13,5.04,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_His_5.5S_2w25C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0,9,0,,,,91.3,-3.8,3.8,65.87,99.29,-0.7,0.7,,64.63,27.37,7.99,-3.1,4.4,-1.2,3.1,4.4,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.41,4.38,4.21,0.7,0.1,-0.8,0.7,0.1,0.8,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_His_5.5S_2w40C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0,9,0,,,,88.8,-6.3,6.3,64.45,98.75,-1.2,1.2,,41.2,43.7,15.1,-26.6,20.7,5.9,26.6,20.7,5.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.62,8.79,3.59,-3.1,4.5,-1.4,3.1,4.5,1.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_His_5.5S_4w5C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0,9,0,,,,89,-6.1,6.1,66.4,99.93,-0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.93,4.19,4.88,0.2,-0.1,-0.1,0.2,0.1,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_His_5.5S_T0,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0,9,0,,,,95.1,0,0,68.46,100,0,0,,67.75,23.01,9.24,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.73,4.26,5.01,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_His_5.5_2w25C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0,0,0,,,,91.5,-3.5,3.5,66.12,99.35,-0.6,0.6,,61.33,30.36,8.3,-3.3,4.3,-1,3.3,4.3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.12,4.43,4.45,0.7,-0.1,-0.6,0.7,0.1,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_His_5.5_2w40C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0,0,0,,,,88.6,-6.4,6.4,64.66,98.75,-1.2,1.2,,45.62,44.72,9.66,-19,18.6,0.4,19,18.6,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.71,9.6,3.69,-3.7,5.1,-1.4,3.7,5.1,1.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_His_5.5_4w5C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0,0,0,,,,89.2,-5.8,5.8,66.6,99.94,-0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.18,3.74,5.08,0.7,-0.8,0,0.7,0.8,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_His_5.5_T0,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0,0,0,,,,95,0,0,67.21,100,0,0,,64.64,26.08,9.28,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.44,4.51,5.05,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_His_6S_2w25C,NB-penglei5-5060234-0005,6,Histidine,0,0,0,9,0,,,,91.1,-3.9,3.9,66.44,99.59,-0.4,0.4,,59.19,32.48,8.32,-9.2,10.3,-1.1,9.2,10.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.58,4.18,4.23,0.5,0.3,-0.8,0.5,0.3,0.8,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_His_6S_2w40C,NB-penglei5-5060234-0005,6,Histidine,0,0,0,9,0,,,,88.8,-6.2,6.2,64.68,99.11,-0.9,0.9,,39.2,49.5,11.3,-29.2,27.3,1.8,29.2,27.3,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.08,8.35,3.57,-3,4.5,-1.5,3,4.5,1.5,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_His_6S_4w5C,NB-penglei5-5060234-0005,6,Histidine,0,0,0,9,0,,,,88.9,-6.1,6.1,66.59,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.03,4.11,4.86,0,0.3,-0.2,0,0.3,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_His_6S_T0,NB-penglei5-5060234-0005,6,Histidine,0,0,0,9,0,,,,95,0,0,66.86,100,0,0,,68.38,22.16,9.46,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.08,3.84,5.08,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_His_6_2w25C,NB-penglei5-5060234-0005,6,Histidine,0,0,0,0,0,,,,91.1,-3.8,3.8,66.49,99.63,-0.4,0.4,,59.49,33.11,7.39,-5.1,6.2,-1.1,5.1,6.2,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.48,4.28,4.24,1,-0.2,-0.8,1,0.2,0.8,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_His_6_2w40C,NB-penglei5-5060234-0005,6,Histidine,0,0,0,0,0,,,,88.9,-6,6,64.57,98.96,-1,1,,41.01,49.53,9.46,-23.5,22.6,1,23.5,22.6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.6,9.74,3.66,-3.9,5.3,-1.4,3.9,5.3,1.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_His_6_4w5C,NB-penglei5-5060234-0005,6,Histidine,0,0,0,0,0,,,,89.4,-5.5,5.5,66.64,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.71,4.29,5.01,0.2,-0.2,0,0.2,0.2,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_His_6_T0,NB-penglei5-5060234-0005,6,Histidine,0,0,0,0,0,,,,94.9,0,0,67.12,100,0,0,,64.55,26.94,8.51,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.52,4.44,5.04,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_His_7_2w25C,NB-penglei5-5060234-0005,7,Histidine,0,0,0,0,0,,,,90.8,-4,4,65.88,99.45,-0.5,0.5,,62.61,22.06,15.33,0.7,5.2,-5.8,0.7,5.2,5.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.3,3.75,0.94,4.7,-0.8,-4,4.7,0.8,4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_His_7_2w40C,NB-penglei5-5060234-0005,7,Histidine,0,0,0,0,0,,,,89.7,-5.1,5.1,63.96,98.63,-1.4,1.4,,57.18,29.84,12.98,-4.8,12.9,-8.2,4.8,12.9,8.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.36,3.71,3.93,1.8,-0.8,-1,1.8,0.8,1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_His_7_4w5C,NB-penglei5-5060234-0005,7,Histidine,0,0,0,0,0,,,,89.7,-5.1,5.1,66.43,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.59,3.5,1.91,4,-1,-3,4,1,3,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_His_7_T0,NB-penglei5-5060234-0005,7,Histidine,0,0,0,0,0,,,,94.8,0,0,67.5,100,0,0,,61.93,16.9,21.17,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.58,4.53,4.89,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Succ_5.5S_2w25C,NB-penglei5-5060234-0005,5.5,Succinate,0,0,0,9,0,,,,91.3,-3.9,3.9,65.67,99.5,-0.5,0.5,,59.1,31.5,9.5,-2.6,2.5,0.2,2.6,2.5,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.71,4.27,5.01,-0.2,0.3,-0.1,0.2,0.3,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Succ_5.5S_2w40C,NB-penglei5-5060234-0005,5.5,Succinate,0,0,0,9,0,,,,88.9,-6.3,6.3,63.41,98.66,-1.3,1.3,,32.6,58.2,9.2,-29.1,29.2,-0.1,29.1,29.2,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.09,9.43,4.48,-4.8,5.4,-0.6,4.8,5.4,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Succ_5.5S_4w5C,NB-penglei5-5060234-0005,5.5,Succinate,0,0,0,9,0,,,,88.5,-6.7,6.7,66.27,99.95,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.11,3.3,5.58,0.2,-0.7,0.5,0.2,0.7,0.5,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Succ_5.5S_T0,NB-penglei5-5060234-0005,5.5,Succinate,0,0,0,9,0,,,,95.2,0,0,66.45,100,0,0,,61.7,29.04,9.26,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.88,4.01,5.11,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Succ_6S_2w25C,NB-penglei5-5060234-0005,6,Succinate,0,0,0,9,0,,,,90.8,-4.2,4.2,66.27,99.72,-0.3,0.3,,57.94,33.33,8.73,-8.6,9.3,-0.7,8.6,9.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.69,3.53,4.78,0.7,-0.5,-0.2,0.7,0.5,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Succ_6S_2w40C,NB-penglei5-5060234-0005,6,Succinate,0,0,0,9,0,,,,89.1,-5.9,5.9,63.84,98.87,-1.1,1.1,,33.8,57.6,8.5,-32.8,33.6,-1,32.8,33.6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.43,8.39,4.18,-3.5,4.4,-0.9,3.5,4.4,0.9,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,28,,,Trop2_PNU_Succ_6S_4w5C,NB-penglei5-5060234-0005,6,Succinate,0,0,0,9,0,,,,89,-6,6,66.36,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.9,4.02,5.08,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Succ_6S_T0,NB-penglei5-5060234-0005,6,Succinate,0,0,0,9,0,,,,95,0,0,66.85,100,0,0,,66.55,23.99,9.46,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.95,4.02,5.03,0,0,0,0,0,0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_012,Fab,MULTIPLE CONTROL,,-80,0,,9.8,Anti_MMAE_Fab_ST,NB-ramapa-5084681-0001,6,Histidine,0,0,0,9,0,,,,99.2,,,52.22,99.59,,,,87.61,8.53,3.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0,2.18,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,,,,10.5,Anti_MMAE_Fab_48h5C_6hRT,NB-ramapa-5084681-0001,6,Histidine,0,0,0.02,9,0,,,,98.9,,,51.97,99.63,,,,86.75,9.82,3.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.72,0,2.28,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,25,2,,10.5,Anti_MMAE_Fab_48hRT,NB-ramapa-5084681-0001,6,Histidine,0,0,0.02,9,0,,,,98.9,,,52.06,99.58,,,,87.1,9.54,3.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.73,0,2.27,-0.1,0,0.1,0.1,0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,25,0.25,,10.5,Anti_MMAE_Fab_6hRT,NB-ramapa-5084681-0001,6,Histidine,0,0,0.02,9,0,,,,99,,,51.87,99.31,,,,87.48,9.15,3.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.76,0,2.24,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,-80,0,,10.5,Anti_MMAE_Fab_CT,NB-ramapa-5084681-0001,6,Histidine,0,0,0.02,9,0,,,,99.1,,,52.12,99.57,,,,87.68,9.09,3.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.81,0,2.19,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,Freeze Thaw,,,,10.5,Anti_MMAE_Fab_FT,NB-ramapa-5084681-0001,6,Histidine,0,0,0.02,9,0,,,,98.9,,,52.14,99.52,,,,86.89,9.61,3.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.75,0,2.25,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,Light stress 0.2 x,,,,10.5,Anti_MMAE_Fab_LT_0.2x,NB-ramapa-5084681-0001,6,Histidine,0,0,0.02,9,0,,,,98,,,51.77,99.34,,,,83.42,12.21,4.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.12,0,2.88,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,Light stress 0.2 x,,,,10.5,Anti_MMAE_Fab_LT_0.2x_CT,NB-ramapa-5084681-0001,6,Histidine,0,0,0.02,9,0,,,,98.8,,,52,99.61,,,,86.25,10.04,3.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.77,0,2.23,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,52.2,Trop2_MMAE_Cit_5.5_7.5S_1M40C,NB-ramapa-5085740-0001,5.5,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.94,3.96,6.1,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,51.3,Trop2_MMAE_Cit_6.0_7.5S_1M40C,NB-ramapa-5085740-0001,6,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.06,7.02,4.91,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,51.8,Trop2_MMAE_His_5.0_7.5S_1M40C,NB-ramapa-5085740-0001,5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.92,8.46,5.62,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,51.6,Trop2_MMAE_His_5.5_7.5S_1M40C,NB-ramapa-5085740-0001,5.5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.18,4.82,3.01,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,53,Trop2_MMAE_His_6.0_7.5S_1M40C,NB-ramapa-5085740-0001,6,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.06,4.28,2.66,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.7,Trop2_PNU_Cit_5.5_5S_1M40C,NB-ramapa-5085740-0001,5.5,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.18,5.9,5.92,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.8,Trop2_PNU_Cit_6.0_5S_1M40C,NB-ramapa-5085740-0001,6,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.03,5.04,5.93,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.2,Trop2_PNU_Cit_6.5_5S_1M40C,NB-ramapa-5085740-0001,6.5,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.4,2.88,4.73,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.9,Trop2_PNU_His_5.5_5S_1M40C,NB-ramapa-5085740-0001,5.5,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.89,4.39,2.72,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.6,Trop2_PNU_His_6.0_5S_1M40C,NB-ramapa-5085740-0001,6,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.21,7.92,4.86,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.7,Trop2_PNU_His_6.5_5S_1M40C,NB-ramapa-5085740-0001,6.5,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.13,6.44,4.44,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Glu_4_2w25C,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,97.8,1.6,1.6,75.34,99.22,-0.1,0.1,,58.58,23.83,17.59,-2.5,2.7,-0.1,2.5,2.7,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0,0.84,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Glu_4_2w40C,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,97.4,1.2,1.2,73.01,98.99,-0.3,0.3,,54.6,25.08,20.32,-6.5,3.9,2.6,6.5,3.9,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.57,0.78,0.65,-0.6,0.8,-0.2,0.6,0.8,0.2,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Glu_4_T0,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,96.2,0,0,75.18,99.27,0,0,,61.11,21.16,17.72,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0,0.86,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Glu_5_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,97.9,1.6,1.6,76.17,100,0.3,0.3,,57.68,28.92,13.41,-2.2,5.6,-3.4,2.2,5.6,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0,0.85,-0.1,0,0.1,0.1,0,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Glu_5_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,98.4,2.1,2.1,73.91,99.63,-0.1,0.1,,53.89,32.92,13.2,-6,9.6,-3.6,6,9.6,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.01,0.24,0.75,-0.2,0.2,0,0.2,0.2,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,97.9,1.4,1.4,76.18,100,0.3,0.3,,63.18,26.53,10.3,3.4,3.3,-6.7,3.4,3.3,6.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0,0.86,-0.1,0,0.1,0.1,0,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,98.1,1.6,1.6,74.02,99.82,0.1,0.1,,52.23,34.1,13.67,-7.6,10.9,-3.3,7.6,10.9,3.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.62,0.61,0.76,-0.6,0.6,0,0.6,0.6,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Glu_5_S_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,96.5,0,0,75.64,99.71,0,0,,59.81,23.21,16.98,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.2,0,0.8,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Glu_5_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,96.3,0,0,75.71,99.71,0,0,,59.86,23.37,16.77,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.21,0,0.79,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_His_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,97.9,1.6,1.6,75.56,99.74,0.3,0.3,,58.24,26.25,15.5,-2.4,3.9,-1.5,2.4,3.9,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0,0.75,0.1,0,-0.1,0.1,0,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_His_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,98.3,2,2,73.33,99.24,-0.2,0.2,,53.11,32.19,14.7,-7.6,9.9,-2.3,7.6,9.9,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.95,0.3,0.75,-0.2,0.3,-0.1,0.2,0.3,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_His_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,97.8,1.5,1.5,75.6,99.69,0.4,0.4,,58.87,25.63,15.5,-0.9,1.5,-0.6,0.9,1.5,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.2,0,0.8,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_His_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,98.3,2,2,73.49,99.28,0,0,,51.51,34.43,14.06,-8.2,10.3,-2,8.2,10.3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.18,0.19,0.63,0,0.2,-0.2,0,0.2,0.2,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_His_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,96.3,0,0,74.86,99.29,0,0,,59.76,24.14,16.1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_His_5.5_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,96.3,0,0,75.23,99.4,0,0,,60.68,22.31,17.01,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0,0.87,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_His_5.5_T_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,97.9,1.5,1.5,75.47,99.69,0.3,0.3,,58.11,26.79,15.1,-0.2,2.6,-2.4,0.2,2.6,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_His_5.5_T_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,98.3,1.9,1.9,73.5,99.29,-0.1,0.1,,51.53,32.93,15.55,-6.8,8.8,-1.9,6.8,8.8,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.11,0.12,0.77,0,0.1,-0.1,0,0.1,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_His_5.5_T_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,96.4,0,0,75.44,99.38,0,0,,58.35,24.15,17.49,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0,0.87,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_His_6_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,98,1.6,1.6,75.81,99.86,0.4,0.4,,51.36,37.39,11.25,-4.6,9,-4.5,4.6,9,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_His_6_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,97.3,0.9,0.9,73.56,99.43,-0.1,0.1,,42.82,45.89,11.28,-13.1,17.5,-4.4,13.1,17.5,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.97,0.23,0.8,-0.2,0.2,-0.1,0.2,0.2,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_His_6_S_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,97.9,1.5,1.5,75.78,99.7,0.1,0.1,,50.61,35.96,13.43,-2.9,5.1,-2.2,2.9,5.1,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_His_6_S_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,97.4,1,1,73.86,99.54,-0.1,0.1,,40.11,48.7,11.2,-13.4,17.8,-4.5,13.4,17.8,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0.33,0.76,-0.2,0.3,-0.1,0.2,0.3,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_His_6_S_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,96.4,0,0,75.42,99.58,0,0,,53.48,30.87,15.65,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_His_6_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,96.4,0,0,75.47,99.49,0,0,,55.92,28.37,15.72,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0,0.87,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_His_7_2w25C,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,98,1.4,1.4,76.28,100,0.3,0.3,,52.37,32.12,15.51,-6.4,8.6,-2.2,6.4,8.6,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.18,0,0.82,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_His_7_2w40C,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,97.7,1.1,1.1,73.53,99.8,0.1,0.1,,46.16,39.09,14.76,-12.6,15.6,-2.9,12.6,15.6,2.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.32,0.91,0.77,-0.8,0.9,-0.1,0.8,0.9,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_His_7_T0,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,96.6,0,0,75.81,99.74,0,0,,58.8,23.54,17.66,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0,0.86,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Succ_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,98,1.6,1.6,75.76,100,0.5,0.5,,53.63,31.73,14.64,-2.5,2.4,0.1,2.5,2.4,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0,0.87,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Succ_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,97.8,1.4,1.4,73.42,99.42,-0.1,0.1,,47.35,40.37,12.28,-8.8,11.1,-2.3,8.8,11.1,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.78,0.41,0.81,-0.3,0.4,-0.1,0.3,0.4,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Succ_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,98,1.8,1.8,76.01,100,0.6,0.6,,55.67,28.81,15.51,-2,4.6,-2.6,2,4.6,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0,0.86,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Succ_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,97.7,1.5,1.5,73.58,99.59,0.2,0.2,,45.78,40.05,14.17,-11.9,15.8,-3.9,11.9,15.8,3.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.62,0.59,0.78,-0.6,0.6,0,0.6,0.6,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Succ_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,96.2,0,0,75.23,99.41,0,0,,57.68,24.22,18.1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.19,0,0.81,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Succ_5.5_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,96.4,0,0,75.26,99.45,0,0,,56.15,29.31,14.54,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Succ_5_2w25C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,97.9,1.6,1.6,75.19,99.66,0.4,0.4,,60.57,29.38,10.06,1.2,4.6,-5.8,1.2,4.6,5.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0,0.86,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Succ_5_2w40C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,98.3,2,2,73.2,99.1,-0.2,0.2,,50.66,35.73,13.61,-8.7,10.9,-2.2,8.7,10.9,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.49,0.75,0.76,-0.7,0.8,-0.1,0.7,0.8,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Succ_5_S_2w25C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,97.9,1.6,1.6,75.35,99.67,0.3,0.3,,63.18,26.2,10.62,3.3,3.5,-6.8,3.3,3.5,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0,0.86,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Succ_5_S_2w40C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,98.2,1.9,1.9,73.19,99.12,-0.3,0.3,,50.16,35.04,14.8,-9.7,12.3,-2.6,9.7,12.3,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.57,0.66,0.77,-0.6,0.7,-0.1,0.6,0.7,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Succ_5_S_T0,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,96.3,0,0,75.12,99.4,0,0,,59.88,22.71,17.41,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0,0.85,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Succ_5_T0,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,96.3,0,0,75.27,99.34,0,0,,59.33,24.8,15.86,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0,0.84,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Succ_6_2w25C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,98,1.5,1.5,76.16,100,0.3,0.3,,56.81,35.84,7.35,3.2,3.7,-6.8,3.2,3.7,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0,0.9,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Succ_6_2w40C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,97.9,1.4,1.4,73.93,99.65,0,0,,37.05,53.06,9.89,-16.6,20.9,-4.3,16.6,20.9,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.78,0.35,0.87,-0.3,0.4,0,0.3,0.4,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25,14,,,D238_Succ_6_S_2w25C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,98,1.6,1.6,76.17,100,0.3,0.3,,52.36,33.91,13.73,-3.7,5.4,-1.7,3.7,5.4,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0,0.87,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40,14,,,D238_Succ_6_S_2w40C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,97.7,1.3,1.3,73.74,99.64,-0.1,0.1,,38.97,50.82,10.21,-17.1,22.3,-5.2,17.1,22.3,5.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.51,0.68,0.8,-0.7,0.7,0,0.7,0.7,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Succ_6_S_T0,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,96.4,0,0,75.75,99.7,0,0,,56.07,28.49,15.44,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.17,0,0.83,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5,0,,,D238_Succ_6_T0,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,96.5,0,0,75.79,99.73,0,0,,53.62,32.18,14.19,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0,0.9,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Glu_4_2w25C,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,97.6,1.5,1.5,76.26,99.02,-0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.94,0,1.06,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Glu_4_2w40C,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,96.6,0.5,0.5,73.09,98.57,-0.7,0.7,,51.7,23.74,24.56,-11.1,7.5,3.6,11.1,7.5,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.73,0.56,0.72,-0.2,0.6,-0.4,0.2,0.6,0.4,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Glu_4_T0,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,96.1,0,0,76.15,99.31,0,0,,62.77,16.27,20.96,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.92,0,1.08,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Glu_5_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,98.1,1.9,1.9,76.5,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0,1.09,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Glu_5_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,97.7,1.5,1.5,74.34,99.45,-0.2,0.2,,58.99,21.12,19.88,-0.8,0.5,0.3,0.8,0.5,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.41,0.6,0.99,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,97,0.8,0.8,77.32,100,2.1,2.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.9,0,1.1,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,97.7,1.5,1.5,74.43,99.54,1.6,1.6,,50.24,30.16,19.6,-5.9,7.3,-1.4,5.9,7.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.46,0.56,0.98,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Glu_5_S_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,96.2,0,0,74.21,97.89,0,0,,56.17,22.85,20.98,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0,1.18,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Glu_5_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,96.2,0,0,76.37,99.7,0,0,,59.81,20.66,19.53,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.79,0,1.21,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_His_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,98,1.9,1.9,76.35,99.15,0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.92,0,1.08,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_His_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,97.4,1.3,1.3,74.14,99.17,0.2,0.2,,58.81,22.52,18.67,-8.5,8,0.5,8.5,8,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.44,0.6,0.96,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_His_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,98.1,2.1,2.1,76.87,99.31,0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0,1.07,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_His_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,97.7,1.7,1.7,73.9,99.1,0,0,,56.63,22.77,20.61,1.8,-2.2,0.4,1.8,-2.2,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.5,0.53,0.97,-0.3,0.5,-0.2,0.3,0.5,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_His_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,96,0,0,75.8,99.05,0,0,,54.87,24.96,20.17,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.83,0,1.17,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_His_5.5_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,96.1,0,0,75.74,99.02,0,0,,67.26,14.53,18.21,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.8,0,1.2,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_His_5.5_T_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,98.1,2,2,76.6,99.27,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.92,0,1.08,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_His_5.5_T_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,96.6,0.5,0.5,74.09,99.18,-0.1,0.1,,54.42,24.51,21.07,-2,2,0.1,2,2,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.4,0.6,0.99,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_His_5.5_T_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,96.1,0,0,75.95,99.26,0,0,,56.43,22.56,21.02,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.78,0,1.22,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_His_6_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,98.1,1.9,1.9,76.55,100,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0,1.09,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_His_6_S_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,96.2,0,0,76.02,99.3,0,0,,69.93,7.93,22.14,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0,1.18,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_His_6_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,98,1.8,1.8,74.18,99.4,0.1,0.1,,57.43,22.53,20.04,-6.1,6.3,-0.2,6.1,6.3,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.87,0.15,0.98,0.1,0.2,-0.2,0.1,0.2,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_His_6_S_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,98.1,1.9,1.9,75.78,99.68,0.4,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.92,0,1.08,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_His_6_S_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,97.8,1.6,1.6,74.22,99.35,0.1,0.1,,51.37,30.81,17.83,-18.6,22.9,-4.3,18.6,22.9,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.75,0.29,0.96,-0.1,0.3,-0.2,0.1,0.3,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_His_6_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,96.2,0,0,76.02,99.34,0,0,,63.49,16.22,20.29,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.8,0,1.2,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_His_7_2w25C,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,98.2,1.8,1.8,76.01,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0,1.09,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_His_7_2w40C,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,97.7,1.3,1.3,74.34,99.74,0,0,,61.93,23.66,14.41,-5,3.2,1.8,5,3.2,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.25,0.62,1.13,-0.6,0.6,0,0.6,0.6,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_His_7_T0,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,96.4,0,0,76.3,99.71,0,0,,66.89,20.5,12.61,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.83,0,1.17,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Succ_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,98.2,2,2,77,100,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.86,0,1.14,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Succ_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,97.6,1.4,1.4,74.11,99.35,0.1,0.1,,55.43,27.69,16.88,-2.7,4.6,-1.9,2.7,4.6,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.34,0.58,1.08,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Succ_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,98.1,1.9,1.9,77.22,100,0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.9,0,1.1,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Succ_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,97.4,1.2,1.2,74.13,99.4,-0.1,0.1,,48.95,32.36,18.69,-7.3,9.3,-2,7.3,9.3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.49,0.5,1.01,-0.3,0.5,-0.2,0.3,0.5,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Succ_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,96.2,0,0,76.05,99.45,0,0,,56.25,23.03,20.72,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.81,0,1.19,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Succ_5.5_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,96.2,0,0,75.92,99.27,0,0,,58.12,23.1,18.78,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.76,0,1.24,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Succ_5_2w25C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,98.2,2.1,2.1,76.42,98.92,-0.4,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.9,0,1.1,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Succ_5_2w40C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,97.1,1,1,73.77,98.92,-0.4,0.4,,56.2,26.86,16.94,-3.2,5.3,-2.1,3.2,5.3,2.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.43,0.67,0.9,-0.4,0.7,-0.3,0.4,0.7,0.3,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Succ_5_S_2w25C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,98.2,2.1,2.1,76.55,98.98,0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0,1.09,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Succ_5_S_2w40C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,97.4,1.3,1.3,73.8,99.04,0.1,0.1,,52.05,32.16,15.79,-0.4,5.6,-5.2,0.4,5.6,5.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.41,0.6,0.99,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Succ_5_S_T0,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,96.1,0,0,75.42,98.93,0,0,,52.47,26.58,20.95,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0,1.18,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Succ_5_T0,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,96.1,0,0,76.06,99.33,0,0,,59.42,21.57,19.02,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.79,0,1.21,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Succ_6_2w25C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,98.2,2,2,77.58,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.83,0,1.17,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Succ_6_2w40C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,97.8,1.6,1.6,74.27,99.59,-0.1,0.1,,58.87,23.82,17.31,1.8,-0.4,-1.3,1.8,-0.4,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.54,0.26,1.2,-0.2,0.3,-0.1,0.2,0.3,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25,14,,,D250_Succ_6_S_2w25C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,98.1,1.8,1.8,74.98,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0,1.07,0.1,0,-0.1,0.1,0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40,14,,,D250_Succ_6_S_2w40C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,97.8,1.5,1.5,74.1,99.45,-0.2,0.2,,48.36,32.2,19.43,-9.1,9.7,-0.6,9.1,9.7,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.46,0.5,1.04,-0.4,0.5,-0.1,0.4,0.5,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Succ_6_S_T0,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,96.3,0,0,76.14,99.69,0,0,,57.45,22.51,20.04,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0,1.18,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5,0,,,D250_Succ_6_T0,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,96.2,0,0,76.37,99.73,0,0,,57.09,24.27,18.64,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.75,0,1.25,0,0,0,0,0,0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,,L133_DCC712_Photo,NB-penglei5-5060234-0003,6,Histidine,0,0,0,8,0,,,,99.7,-0.2,0.2,73.34,99.97,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.67,0,3.33,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,,L133_DCC712_Photo_CT,NB-penglei5-5060234-0003,6,Histidine,0,0,0,8,0,,,,99.9,0,0,75.2,99.95,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.87,0,1.13,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_Glu_4_2w25C,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,0,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_Glu_4_2w40C,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,97.4,-1.5,1.5,71.82,99.31,-0.3,0.3,,51.44,28.02,20.53,-6.2,3.3,2.9,6.2,3.3,2.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.28,0,0.72,0.3,0,-0.3,0.3,0,0.3,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_Glu_4_T0,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,98.9,0,0,74.42,99.55,0,0,,57.62,24.73,17.65,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.98,0,1.02,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_Glu_5_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.97,0,0.03,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_Glu_5_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,98.9,-0.3,0.3,73.15,99.78,0.1,0.1,,56.99,25.22,17.79,-4.1,2.4,1.6,4.1,2.4,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0,0.84,0.2,0,-0.2,0.2,0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,98.5,-0.8,0.8,73.01,99.74,0,0,,,,,-4.3,6.1,-1.8,4.3,39.3,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_Glu_5_S_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,99.3,0,0,74.69,99.64,-0.1,0.1,,,,,-2.1,1.7,0.4,2.1,34.9,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_Glu_5_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,99.2,0,0,74.76,99.77,0.1,0.1,,61.06,22.78,16.16,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.98,0,1.02,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_His_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.94,0,0.06,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_His_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,98.4,-0.6,0.6,72.95,99.74,0.1,0.1,,57.18,24.84,17.97,-3.9,4,-0.1,3.9,4,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.21,0,0.79,0.3,0,-0.3,0.3,0,0.3,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_His_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.92,0,0.08,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_His_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,98.6,-0.4,0.4,72.92,99.69,0.2,0.2,,54.86,26.96,18.19,0.3,-0.9,0.6,0.3,-0.9,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0,0.75,0.3,0,-0.3,0.3,0,0.3,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_His_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,99,0,0,74.57,99.53,0,0,,54.57,27.82,17.61,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0,1.07,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_His_5.5_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,99,0,0,74.65,99.56,0,0,,61.09,20.86,18.04,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.95,0,1.05,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_His_5.5_T_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.9,0,0.1,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_His_5.5_T_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,98.8,-0.2,0.2,72.88,99.64,0,0,,58.74,26.13,15.14,0.2,1.8,-2,0.2,1.8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.19,0,0.81,0.2,0,-0.2,0.2,0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_His_5.5_T_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,99,0,0,74.48,99.56,0,0,,58.52,24.34,17.14,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.95,0,1.05,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_His_6_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.98,0,0.02,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_His_6_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,98.8,-0.4,0.4,73.09,99.65,0.1,0.1,,56.83,26.96,16.21,-7.4,7.9,-0.4,7.4,7.9,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.49,0,0.51,0.5,0,-0.5,0.5,0,0.5,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_His_6_S_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_His_6_S_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,98.5,-0.7,0.7,73.03,99.69,0.1,0.1,,,,,-3.8,3.8,0,3.8,35,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_His_6_S_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,99.2,0,0,74.71,99.62,0,0,,,,,-2.7,2.7,0,2.7,33.9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_His_6_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,99.1,-0.1,0.1,74.62,99.59,0,0,,64.27,19.1,16.64,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.97,0,1.03,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_His_7_2w25C,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.94,0,0.06,0.9,0,-0.9,0.9,0,0.9,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_His_7_2w40C,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,98.5,-0.7,0.7,73.04,99.7,0,0,,51.8,35.59,12.61,-8.3,12.7,-4.4,8.3,12.7,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,0,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_His_7_T0,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,99.2,0,0,74.63,99.68,0,0,,60.08,22.91,17.01,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.03,0,0.97,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_Succinate_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.91,0,0.09,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_Succinate_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,98.3,-0.7,0.7,72.75,99.67,0,0,,47.08,34.84,18.08,-8.2,9.4,-1.2,8.2,9.4,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0,0.84,0.2,0,-0.2,0.2,0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_Succinate_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,99,0,0,74.61,99.71,0,0,,55.3,25.46,19.24,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0,1.07,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_Succinate_5_S_2w25C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,0,1,0,-1,1,0,1,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_Succinate_5_S_2w40C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,98.6,-0.2,0.2,72.49,99.59,0.1,0.1,,47.03,36.23,16.75,-5.5,7.8,-2.3,5.5,7.8,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.31,0,0.69,0.3,0,-0.3,0.3,0,0.3,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_Succinate_5_S_T0,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,98.8,0,0,74.34,99.53,0,0,,52.5,28.43,19.08,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.97,0,1.03,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_Succinate_6_S_2w25C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.63,0,0.37,0.7,0,-0.7,0.7,0,0.7,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_Succinate_6_S_2w40C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,98.4,-0.7,0.7,72.8,99.7,0,0,,48.21,35.44,16.35,-6.7,9,-2.3,6.7,9,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0,0.87,0.2,0,-0.2,0.2,0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_Succinate_6_S_T0,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,99.1,0,0,74.6,99.69,0,0,,54.89,26.42,18.69,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0,1.07,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,,D238_L830_LT_0.2x,NB-penglei5-5060234-0003,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.09,0,1.91,-1,0,1,1,0,1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,,D238_L830_LT_CT,NB-penglei5-5060234-0003,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0,0.91,0,0,0,0,0,0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,,D250_L177_LT_0.2x,NB-penglei5-5060234-0003,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.05,0.23,2.72,,,,,,,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,,D250_L177_LT_CT,NB-penglei5-5060234-0003,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.72,0,1.28,,,,,,,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.77,0,0.23,0.8,0,-0.8,0.8,0,0.8,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,98.5,-0.8,0.8,73.01,99.74,0,0,,50.21,34.59,15.2,-3.8,7.8,-4,3.8,7.8,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.17,0,0.83,0.2,0,-0.2,0.2,0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_Glu_5_S_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,99.3,0,0,74.69,99.64,-0.1,0.1,,53.99,26.84,19.17,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0,1.07,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25,14,,,L133_His_6_S_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.94,0,0.06,0.8,0,-0.8,0.8,0,0.8,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40,14,,,L133_His_6_S_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,98.5,-0.7,0.7,73.03,99.69,0.1,0.1,,52,29.7,18.4,-2,1.8,0.3,2,1.8,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,0,0.8,0,-0.8,0.8,0,0.8,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5,0,,,L133_His_6_S_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,99.2,0,0,74.71,99.62,0,0,,53.95,27.92,18.13,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0,0.84,0,0,0,0,0,0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Glu_5_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,97.6,1.7,1.7,76.22,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0,0.9,0.1,0,-0.1,0.1,0,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Glu_4_2w25C,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,97.6,1.7,1.7,75.32,99.3,-0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0,0.91,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Glu_4_2w40C,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,97.2,1.3,1.3,72.98,98.71,-0.7,0.7,,53.71,21.6,24.69,-7.5,3.1,4.4,7.5,3.1,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.27,0.84,0.89,-0.8,0.8,0,0.8,0.8,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Glu_4_T0,NB-penglei5-5060234-0003,4,Glutamate,0,0,0,0,0,,,,95.9,0,0,75.47,99.37,0,0,,61.23,18.5,20.26,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.06,0,0.94,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Glu_5_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,98.2,2.3,2.3,73.89,99.37,-0.3,0.3,,54.32,24.28,21.4,-9.1,6.5,2.6,9.1,6.5,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.77,0.42,0.8,-0.3,0.4,-0.2,0.3,0.4,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,97.6,1.5,1.5,76.27,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0,0.91,-0.1,0,0.2,0.1,0,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,97.9,1.8,1.8,73.85,99.25,-0.4,0.4,,53.13,25.53,21.34,-4.5,2.1,2.4,4.5,2.1,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.79,0.46,0.75,-0.4,0.5,0,0.4,0.5,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Glu_5_S_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,7,0,,,,96.1,0,0,75.73,99.71,0,0,,57.6,23.48,18.93,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.24,0,0.76,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Glu_5_T0,NB-penglei5-5060234-0003,5,Glutamate,0,0,0,0,0,,,,95.9,0,0,75.72,99.68,0,0,,63.47,17.77,18.76,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.04,0,0.96,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_His_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,97.1,1.3,1.3,75.41,99.84,0.4,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0,0.91,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_His_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,98.1,2.3,2.3,73.66,99.12,-0.3,0.3,,57.95,19.91,22.14,-6.8,6.4,0.3,6.8,6.4,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.76,0.43,0.82,-0.3,0.4,-0.1,0.3,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_His_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,97.4,1.6,1.6,75.52,99.79,0.9,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0,0.9,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_His_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,97.9,2.1,2.1,73.66,99.27,0.4,0.4,,54.44,25.56,20,-0.9,2.2,-1.3,0.9,2.2,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.74,0.44,0.81,-0.4,0.4,-0.1,0.4,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_His_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,7,0,,,,95.8,0,0,74.02,98.93,0,0,,55.33,23.37,21.3,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_His_5.5_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,0,,,,95.8,0,0,75.46,99.42,0,0,,64.73,13.46,21.82,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.05,0,0.95,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_His_5.5_T_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,97.5,1.7,1.7,75.63,100,0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0,0.9,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_His_5.5_T_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,98.2,2.4,2.4,73.67,99.1,-0.4,0.4,,58.49,23.34,18.17,0.8,0.3,-1.1,0.8,0.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0.39,0.8,-0.2,0.4,-0.1,0.2,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_His_5.5_T_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0,0,7,,,,95.8,0,0,75.17,99.51,0,0,,57.67,23.03,19.3,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.07,0,0.93,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_His_6_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,97.5,1.6,1.6,76.13,100,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.08,0,0.92,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_His_6_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,98.1,2.2,2.2,74.18,99.51,0.1,0.1,,55.95,23.02,21.03,-2.2,3.6,-1.4,2.2,3.6,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.78,0.38,0.84,-0.3,0.4,-0.1,0.3,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_His_6_S_2w25C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,97.4,1.5,1.5,76.06,100,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0,0.9,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_His_6_S_2w40C,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,97.9,2,2,74.04,99.45,0.2,0.2,,49.76,30.52,19.72,-8.7,7.3,1.4,8.7,7.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.76,0.44,0.79,-0.3,0.4,-0.1,0.3,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_His_6_S_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,7,0,,,,95.9,0,0,75.44,99.34,0,0,,58.47,23.22,18.31,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0,0.91,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_His_6_T0,NB-penglei5-5060234-0003,6,Histidine,0,0,0,0,0,,,,95.9,0,0,75.63,99.44,0,0,,58.14,19.45,22.42,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.05,0,0.95,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_His_7_2w25C,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,97.5,1.5,1.5,76.36,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.11,0,0.89,0.1,0,-0.1,0.1,0,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_His_7_2w40C,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,98,2,2,73.97,99.81,0.1,0.1,,47.34,24.29,28.37,-11,2.3,8.7,11,2.3,8.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.76,0.45,0.79,-0.2,0.4,-0.2,0.2,0.4,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_His_7_T0,NB-penglei5-5060234-0003,7,Histidine,0,0,0,0,0,,,,96,0,0,76.11,99.71,0,0,,58.37,22,19.64,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.98,0,1.02,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,,D159_L190_LT_0.2x,NB-penglei5-5060234-0003,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.95,0,2.05,-0.9,0,0.9,0.9,0,0.9,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,Light stress 0.2 x,,,,,D159_L190_LT_CT,NB-penglei5-5060234-0003,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.88,0,1.12,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Succ_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,97.6,1.8,1.8,75.44,100,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.07,0,0.93,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Succ_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,98.2,2.4,2.4,73.77,99.18,-0.2,0.2,,53.64,27,19.36,-7.9,7.9,0,7.9,7.9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.68,0.43,0.89,-0.4,0.4,0,0.4,0.4,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Succ_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,97.6,1.8,1.8,76.26,100,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.08,0,0.92,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Succ_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,97.9,2.1,2.1,73.7,99.35,0.1,0.1,,49.62,29.97,20.41,-6.1,8.1,-2,6.1,8.1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.7,0.45,0.85,-0.4,0.4,0,0.4,0.4,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Succ_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,7,0,,,,95.8,0,0,75.31,99.32,0,0,,55.71,21.88,22.41,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Succ_5.5_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0,0,0,,,,95.8,0,0,75.48,99.41,0,0,,61.55,19.11,19.34,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.07,0,0.93,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Succ_5_2w25C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,97.5,1.8,1.8,75.36,99.27,0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.08,0,0.92,-0.2,0,0.2,0.2,0,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Succ_5_2w40C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,97.8,2.1,2.1,73.52,99.09,-0.1,0.1,,57.49,22.67,19.84,-2.8,2.7,0.1,2.8,2.7,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.65,0.52,0.83,-0.6,0.5,0.1,0.6,0.5,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Succ_5_S_2w25C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,97.5,1.7,1.7,75.43,99.84,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0,0.9,-0.2,0,0.2,0.2,0,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Succ_5_S_2w40C,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,98.1,2.3,2.3,73.24,98.9,-0.3,0.3,,45.16,33.54,21.29,-11.7,11.9,-0.2,11.7,11.9,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.59,0.56,0.85,-0.7,0.6,0.1,0.7,0.6,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Succ_5_S_T0,NB-penglei5-5060234-0003,5,Succinate,0,0,0,7,0,,,,95.8,0,0,75.16,99.19,0,0,,56.81,21.67,21.52,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0,0.75,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Succ_5_T0,NB-penglei5-5060234-0003,5,Succinate,0,0,0,0,0,,,,95.7,0,0,75.26,99.24,0,0,,60.25,19.98,19.77,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0,0.75,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Succ_6_2w25C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,97.7,2,2,77.6,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.05,0,0.95,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Succ_6_2w40C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,98.2,2.5,2.5,73.95,99.63,-0.1,0.1,,57.42,24.61,17.97,0.3,1.1,-1.4,0.3,1.1,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.64,0.4,0.96,-0.4,0.4,0,0.4,0.4,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25,14,,,D159_Succ_6_S_2w25C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,97.6,1.6,1.6,76.43,100,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.07,0,0.93,-0.2,0,0.2,0.2,0,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40,14,,,D159_Succ_6_S_2w40C,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,97.9,1.9,1.9,73.82,99.62,-0.1,0.1,,47.43,33.47,19.1,-6,9.2,-3.1,6,9.2,3.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.7,0.44,0.87,-0.5,0.4,0.1,0.5,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Succ_6_S_T0,NB-penglei5-5060234-0003,6,Succinate,0,0,0,7,0,,,,96,0,0,75.83,99.68,0,0,,53.47,24.28,22.24,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.23,0,0.77,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5,0,,,D159_Succ_6_T0,NB-penglei5-5060234-0003,6,Succinate,0,0,0,0,0,,,,95.7,0,0,75.84,99.7,0,0,,57.11,23.56,19.33,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.01,0,0.99,0,0,0,0,0,0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,-80,0,,53,Trop2_MMAE_53_Start,NB-aujer-5078398-0002,6,Histidine,0,0,0,7.5,0,,,,94.8,0,0,68.72,98.77,0,0,,58.69,14.89,26.42,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.91,3.07,1.02,0,0,0,0,0,0,,,,,,,,,,Sucrose,-,Sucrose,0,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,52.2,Trop2_MMAE_Cit_5.5_7.5S_1M25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.4,0.2,0.2,67.89,99.71,1,1,,59.98,14.18,25.85,-0.2,1.1,-0.9,0.2,1.1,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.93,3.98,1.09,-1.3,1.1,0.2,1.3,1.1,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,52.2,Trop2_MMAE_Cit_5.5_7.5S_1M40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,91.5,-2.7,2.7,65.05,97.18,-1.5,1.5,,42.26,37.66,20.08,-17.9,24.6,-6.7,17.9,24.6,6.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.94,3.96,6.1,-6.3,1.1,5.2,6.3,1.1,5.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,52.2,Trop2_MMAE_Cit_5.5_7.5S_1M5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.8,0.6,0.6,67.74,99.71,1,1,,58.61,13.98,27.41,-1.5,0.9,0.6,1.5,0.9,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.23,3.85,0.92,-1,1,0,1,1,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,60,,52.2,Trop2_MMAE_Cit_5.5_7.5S_2M25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,95.7,1.5,1.5,70.04,98.94,0.2,0.2,,56.19,17.35,26.46,-3.9,4.3,-0.3,3.9,4.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.62,4.08,1.29,-1.6,1.2,0.4,1.6,1.2,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,52.2,Trop2_MMAE_Cit_5.5_7.5S_2M5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.9,0.7,0.7,70.32,99.19,0.5,0.5,,57.97,14.58,27.45,-2.2,1.5,0.7,2.2,1.5,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.08,3.9,1.01,-1.1,1,0.1,1.1,1,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,52.2,Trop2_MMAE_Cit_5.5_7.5S_2w25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.4,0.2,0.2,71.08,98.61,-0.1,0.1,,58.95,14.01,27.04,-1.2,0.9,0.2,1.2,0.9,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.61,3.31,1.08,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,52.2,Trop2_MMAE_Cit_5.5_7.5S_2w40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,92.5,-1.7,1.7,69.04,96.49,-2.2,2.2,,45.6,31.02,23.38,-14.5,17.9,-3.4,14.5,17.9,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.14,2.8,7.06,-6.1,-0.1,6.2,6.1,0.1,6.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_T0,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.2,0,0,69.46,98.72,0,0,,60.13,13.09,26.79,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.22,2.9,0.89,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_T0_25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_T0_40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,51.3,Trop2_MMAE_Cit_6.0_7.5S_1M25C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,94.4,0.1,0.1,67.86,99.7,0.6,0.6,,58.15,16.48,25.38,-1.5,3,-1.5,1.5,3,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.72,3.93,1.36,-1,0.6,0.4,1,0.6,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,51.3,Trop2_MMAE_Cit_6.0_7.5S_1M40C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,91.7,-2.6,2.6,65.19,97.28,-1.8,1.8,,33.46,51.15,15.39,-26.2,37.7,-11.5,26.2,37.7,11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.77,4.02,4.21,-4,0.7,3.2,4,0.7,3.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,51.3,Trop2_MMAE_Cit_6.0_7.5S_1M5C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,94.5,0.2,0.2,66.22,99.72,0.6,0.6,,59.84,14.22,25.94,0.2,0.8,-0.9,0.2,0.8,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.73,4.2,1.07,-1,0.9,0.1,1,0.9,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,60,,51.3,Trop2_MMAE_Cit_6.0_7.5S_2M25C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,95.4,1.1,1.1,70,99.13,0,0,,52.7,22.39,24.91,-7,8.9,-2,7,8.9,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.07,4.37,1.56,-1.7,1.1,0.6,1.7,1.1,0.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,51.3,Trop2_MMAE_Cit_6.0_7.5S_2M5C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,95.3,1,1,70.34,99.24,0.1,0.1,,58.05,15.15,26.8,-1.6,1.7,-0.1,1.6,1.7,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.06,3.74,1.2,-0.7,0.4,0.2,0.7,0.4,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,51.3,Trop2_MMAE_Cit_6.0_7.5S_2w25C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,94.4,0.1,0.1,70.68,98.8,-0.3,0.3,,58.56,15.15,26.29,-1.1,1.7,-0.6,1.1,1.7,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.85,2.84,1.3,0.1,-0.5,0.3,0.1,0.5,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,51.3,Trop2_MMAE_Cit_6.0_7.5S_2w40C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,91.5,-2.8,2.8,68.85,96.44,-2.7,2.7,,36.9,45.28,17.82,-22.8,31.8,-9,22.8,31.8,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.52,2.93,4.55,-3.2,-0.4,3.6,3.2,0.4,3.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_T0,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,94.3,0,0,68.76,99.09,0,0,,59.67,13.46,26.87,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.74,3.3,0.96,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_T0_25C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_T0_40C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,51.8,Trop2_MMAE_His_5.0_7.5S_1M25C,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,94.4,0.2,0.2,67.77,99.58,1.1,1.1,,60.13,13.44,26.42,0.1,0.7,-0.8,0.1,0.7,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.58,4.53,0.88,-1.3,1.2,0.1,1.3,1.2,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,51.8,Trop2_MMAE_His_5.0_7.5S_1M40C,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,91.2,-3,3,63.33,96.46,-2,2,,46.55,29.68,23.77,-13.5,16.9,-3.4,13.5,16.9,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.1,5.03,4.87,-5.8,1.7,4.1,5.8,1.7,4.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,51.8,Trop2_MMAE_His_5.0_7.5S_1M5C,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,94.7,0.5,0.5,67.07,99.55,1.1,1.1,,59.1,13.45,27.45,-0.9,0.7,0.2,0.9,0.7,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.84,4.38,0.78,-1,1,0,1,1,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,51.8,Trop2_MMAE_His_5.0_7.5S_2M5C,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,94.9,0.7,0.7,68.65,97.99,-0.5,0.5,,58.82,13.81,27.37,-1.2,1,0.2,1.2,1,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.5,3.64,0.86,-0.4,0.3,0.1,0.4,0.3,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,51.8,Trop2_MMAE_His_5.0_7.5S_2w25C,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,94.4,0.2,0.2,70.31,98.46,0,0,,59.65,13.26,27.09,-0.4,0.5,-0.1,0.4,0.5,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.7,3.4,0.9,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,51.8,Trop2_MMAE_His_5.0_7.5S_2w40C,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,92.2,-2,2,66.91,96.86,-1.6,1.6,,50.4,24.05,25.55,-9.6,11.3,-1.6,9.6,11.3,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.45,2.69,4.85,-3.4,-0.6,4.1,3.4,0.6,4.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,51.8,Trop2_MMAE_His_5.0_7.5S_T0,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,94.2,0,0,68.83,98.46,0,0,,60.03,12.77,27.2,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.89,3.33,0.78,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,51.8,Trop2_MMAE_His_5.0_7.5S_T0_25C,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,51.8,Trop2_MMAE_His_5.0_7.5S_T0_40C,NB-aujer-5078398-0002,5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,51.6,Trop2_MMAE_His_5.5_7.5S_1M25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.3,0.2,0.2,67.71,99.67,1.1,1.1,,57.35,16.1,26.55,-1.2,2,-0.7,1.2,2,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.59,4.39,1.02,-1,0.9,0.2,1,0.9,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,51.6,Trop2_MMAE_His_5.5_7.5S_1M40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,91.3,-2.8,2.8,64.97,97.14,-1.5,1.5,,40.06,40.05,19.89,-18.5,25.9,-7.4,18.5,25.9,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.18,4.82,3.01,-3.4,1.3,2.2,3.4,1.3,2.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,51.6,Trop2_MMAE_His_5.5_7.5S_1M5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.6,0.5,0.5,67.61,99.56,1,1,,60.23,13.39,26.38,1.6,-0.7,-0.9,1.6,-0.7,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.1,4,0.89,-0.5,0.5,0,0.5,0.5,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,60,,51.6,Trop2_MMAE_His_5.5_7.5S_2M25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.9,0.8,0.8,69.82,98.62,0,0,,55.65,18.46,25.89,-3,4.3,-1.4,3,4.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.85,3.96,1.19,-0.8,0.4,0.3,0.8,0.4,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,51.6,Trop2_MMAE_His_5.5_7.5S_2M5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.9,0.8,0.8,69.4,98.58,0,0,,57.83,14.84,27.34,-0.8,0.7,0.1,0.8,0.7,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.52,3.47,1.01,-0.1,0,0.2,0.1,0,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,51.6,Trop2_MMAE_His_5.5_7.5S_2w25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.4,0.3,0.3,70.83,98.66,0.1,0.1,,59.16,14.44,26.39,0.6,0.3,-0.9,0.6,0.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.59,3.38,1.03,0,-0.1,0.2,0,0.1,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,51.6,Trop2_MMAE_His_5.5_7.5S_2w40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,92.2,-1.9,1.9,68.85,97.49,-1.1,1.1,,46.94,31.14,21.92,-11.7,17,-5.4,11.7,17,5.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.11,3.51,3.37,-2.5,0,2.5,2.5,0,2.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,51.6,Trop2_MMAE_His_5.5_7.5S_T0,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.1,0,0,69.94,98.61,0,0,,58.6,14.12,27.29,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.63,3.52,0.85,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,51.6,Trop2_MMAE_His_5.5_7.5S_T0_25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,51.6,Trop2_MMAE_His_5.5_7.5S_T0_40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,53,Trop2_MMAE_His_6.0_7.5S_1M25C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,94.5,0.5,0.5,68.74,99.67,1,1,,55.66,20.49,23.86,-2.9,6,-3.1,2.9,6,3.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.55,3.25,1.2,-0.7,0.4,0.3,0.7,0.4,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,53,Trop2_MMAE_His_6.0_7.5S_1M40C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,91.2,-2.8,2.8,65.47,97.62,-1.1,1.1,,33.9,50.4,15.7,-24.6,35.9,-11.2,24.6,35.9,11.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.06,4.28,2.66,-3.2,1.4,1.8,3.2,1.4,1.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,53,Trop2_MMAE_His_6.0_7.5S_1M5C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,94.3,0.3,0.3,67.24,99.6,0.9,0.9,,58.19,15.87,25.93,-0.4,1.4,-1,0.4,1.4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.81,4.19,0.99,-1.4,1.3,0.1,1.4,1.3,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,60,,53,Trop2_MMAE_His_6.0_7.5S_2M25C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,95.8,1.8,1.8,70.14,98.84,0.1,0.1,,47.47,29.76,22.77,-11.1,15.3,-4.2,11.1,15.3,4.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.06,4.61,1.34,-2.2,1.8,0.4,2.2,1.8,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,53,Trop2_MMAE_His_6.0_7.5S_2M5C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,94.8,0.8,0.8,69.99,98.93,0.2,0.2,,57.79,17.15,25.06,-0.8,2.6,-1.9,0.8,2.6,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.89,4,1.12,-1.4,1.2,0.2,1.4,1.2,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,53,Trop2_MMAE_His_6.0_7.5S_2w25C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,94.4,0.4,0.4,71.19,98.72,0,0,,57.22,18.08,24.7,-1.3,3.6,-2.2,1.3,3.6,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.67,3.2,1.13,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,53,Trop2_MMAE_His_6.0_7.5S_2w40C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,92.2,-1.8,1.8,69.69,96.98,-1.7,1.7,,40.88,40.81,18.3,-17.7,26.3,-8.6,17.7,26.3,8.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.57,3.41,3.02,-2.7,0.6,2.1,2.7,0.6,2.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,53,Trop2_MMAE_His_6.0_7.5S_T0,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,94,0,0,70.34,98.68,0,0,,58.55,14.51,26.94,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.25,2.85,0.9,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,53,Trop2_MMAE_His_6.0_7.5S_T0_25C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,53,Trop2_MMAE_His_6.0_7.5S_T0_40C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,-80,0,,17.5,Trop2_PNU_17.5_Start,NB-aujer-5078398-0002,6,Histidine,0,0,0,7.5,0,,,,94.4,0,0,66.09,98.75,0,0,,55.7,19.87,24.43,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.19,3.04,1.77,0,0,0,0,0,0,,,,,,,,,,Sucrose,-,Sucrose,0,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,10.7,Trop2_PNU_Cit_5.5_5S_1M25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,95.4,0.8,0.8,63.97,99.7,1,1,,42.9,36.52,20.58,-13.7,18.1,-4.3,13.7,18.1,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.83,1.86,3.32,-0.5,-1,1.5,0.5,1,1.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.7,Trop2_PNU_Cit_5.5_5S_1M40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,92.4,-2.2,2.2,59.53,97.25,-1.4,1.4,,10.47,82.32,7.21,-46.2,63.9,-17.7,46.2,63.9,17.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.55,3.77,4.68,-3.8,0.9,2.9,3.8,0.9,2.9,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,10.7,Trop2_PNU_Cit_5.5_5S_1M5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,95.2,0.6,0.6,63.68,99.7,1,1,,54.04,21.68,24.27,-2.6,3.2,-0.6,2.6,3.2,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.6,1.85,2.55,0.2,-1,0.7,0.2,1,0.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,10.7,Trop2_PNU_Cit_5.5_5S_2M25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,95.7,1.1,1.1,64.99,98.78,0.1,0.1,,33.79,49.3,16.91,-22.8,30.8,-8,22.8,30.8,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.45,1.97,3.58,-0.9,-0.9,1.8,0.9,0.9,1.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,10.7,Trop2_PNU_Cit_5.5_5S_2M5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,95.7,1.1,1.1,65.74,98.95,0.3,0.3,,50.53,26.73,22.74,-6.1,8.3,-2.2,6.1,8.3,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95,2.19,2.81,-0.4,-0.6,1,0.4,0.6,1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,10.7,Trop2_PNU_Cit_5.5_5S_2w25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,94.7,0.1,0.1,67.11,98.33,-0.4,0.4,,46.54,30.51,22.95,-10.1,12.1,-1.9,10.1,12.1,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.79,2.24,2.97,-0.6,-0.6,1.2,0.6,0.6,1.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,10.7,Trop2_PNU_Cit_5.5_5S_2w40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,92.9,-1.7,1.7,63.2,96.5,-2.2,2.2,,16.45,76.95,6.6,-40.2,58.5,-18.3,40.2,58.5,18.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.97,3.05,4.99,-3.4,0.2,3.2,3.4,0.2,3.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,10.7,Trop2_PNU_Cit_5.5_5S_3w5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,94.7,0.1,0.1,65.96,98.82,0.1,0.1,,55.53,19.82,24.65,-1.1,1.4,-0.2,1.1,1.4,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.01,2.5,2.49,-0.3,-0.3,0.7,0.3,0.3,0.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,10.7,Trop2_PNU_Cit_5.5_5S_T0,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,94.6,0,0,66.18,98.72,0,0,,56.64,18.45,24.9,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.36,2.83,1.81,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,10.7,Trop2_PNU_Cit_5.5_5S_T0_25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,10.7,Trop2_PNU_Cit_5.5_5S_T0_40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,10.8,Trop2_PNU_Cit_6.0_5S_1M25C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,95.2,0.5,0.5,63.86,99.7,0.8,0.8,,44.67,34.24,21.09,-12.3,16.4,-4,12.3,16.4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.68,1.38,2.94,0.5,-1.6,1.1,0.5,1.6,1.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.8,Trop2_PNU_Cit_6.0_5S_1M40C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,92.4,-2.3,2.3,59.92,97.36,-1.5,1.5,,14.99,74.24,10.77,-42,56.4,-14.4,42,56.4,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.21,3.19,4.6,-1.8,0,1.8,1.8,0,1.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,10.8,Trop2_PNU_Cit_6.0_5S_1M5C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,95.3,0.6,0.6,63.6,99.74,0.8,0.8,,57.3,20.29,22.41,0.3,2.4,-2.7,0.3,2.4,2.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.9,1.79,2.3,0.8,-1.2,0.4,0.8,1.2,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,10.8,Trop2_PNU_Cit_6.0_5S_2M25C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,95.7,1,1,65.03,98.79,-0.1,0.1,,35.98,46.54,17.47,-21,28.6,-7.7,21,28.6,7.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.6,1.95,3.45,-0.6,-1,1.6,0.6,1,1.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,10.8,Trop2_PNU_Cit_6.0_5S_2M5C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,95.5,0.8,0.8,65.69,99.19,0.3,0.3,,49.72,26.24,24.04,-7.2,8.3,-1.1,7.2,8.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.87,2.47,2.66,-0.3,-0.5,0.8,0.3,0.5,0.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,10.8,Trop2_PNU_Cit_6.0_5S_2w25C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,94.7,0,0,67.11,98.56,-0.3,0.3,,49.02,28.05,22.93,-7.9,10.2,-2.2,7.9,10.2,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.44,2.65,2.9,-0.7,-0.4,1,0.7,0.4,1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,10.8,Trop2_PNU_Cit_6.0_5S_2w40C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,93.1,-1.6,1.6,62.45,96,-2.9,2.9,,15.83,69.87,14.3,-41.1,52,-10.8,41.1,52,10.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.25,3.19,4.56,-2.9,0.2,2.7,2.9,0.2,2.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,10.8,Trop2_PNU_Cit_6.0_5S_3w5C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,94.6,-0.1,0.1,66.28,98.77,-0.1,0.1,,56.67,18.56,24.78,-0.3,0.7,-0.3,0.3,0.7,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.77,2.77,2.46,-0.4,-0.2,0.6,0.4,0.2,0.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,10.8,Trop2_PNU_Cit_6.0_5S_T0,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,94.7,0,0,64.56,98.91,0,0,,56.97,17.89,25.13,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.15,3,1.85,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,10.8,Trop2_PNU_Cit_6.0_5S_T0_25C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,10.8,Trop2_PNU_Cit_6.0_5S_T0_40C,NB-aujer-5078398-0002,6,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,10.2,Trop2_PNU_Cit_6.5_5S_1M25C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,95.5,0.9,0.9,63.43,99.67,0.6,0.6,,40.12,42.31,17.57,-16.1,23.3,-7.1,16.1,23.3,7.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.32,1.84,2.85,0.4,-1.2,0.8,0.4,1.2,0.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.2,Trop2_PNU_Cit_6.5_5S_1M40C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,91.9,-2.7,2.7,59.39,97.41,-1.7,1.7,,13.21,81.71,5.07,-43,62.7,-19.6,43,62.7,19.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.4,2.88,4.73,-1.5,-0.3,1.8,1.5,0.3,1.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,10.2,Trop2_PNU_Cit_6.5_5S_1M5C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,95.3,0.7,0.7,63.47,99.71,0.6,0.6,,54.34,22.12,23.54,-1.9,3.1,-1.2,1.9,3.1,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.32,2.16,2.53,0.4,-0.8,0.5,0.4,0.8,0.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,10.2,Trop2_PNU_Cit_6.5_5S_2M25C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,95.7,1.1,1.1,64.74,98.88,-0.2,0.2,,30.59,54.77,14.64,-25.7,35.7,-10.1,25.7,35.7,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.32,2.35,3.33,-0.6,-0.6,1.3,0.6,0.6,1.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,10.2,Trop2_PNU_Cit_6.5_5S_2M5C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,95.4,0.8,0.8,65.33,99.06,0,0,,46.43,30.31,23.25,-9.8,11.3,-1.5,9.8,11.3,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.77,2.59,2.65,-0.2,-0.4,0.6,0.2,0.4,0.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,10.2,Trop2_PNU_Cit_6.5_5S_2w25C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,94.7,0.1,0.1,65.71,99.02,-0.1,0.1,,43.95,33.82,22.23,-12.3,14.8,-2.5,12.3,14.8,2.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.04,2.98,2.98,-0.9,0,0.9,0.9,0,0.9,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,10.2,Trop2_PNU_Cit_6.5_5S_2w40C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,92.9,-1.7,1.7,61.66,95.48,-3.6,3.6,,16.43,77.42,6.15,-39.8,58.4,-18.6,39.8,58.4,18.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.62,1.65,4.75,-1.3,-1.4,2.7,1.3,1.4,2.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,10.2,Trop2_PNU_Cit_6.5_5S_3w5C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,93.9,-0.7,0.7,65.41,99.17,0.1,0.1,,54.6,20.6,24.8,-1.6,1.6,0.1,1.6,1.6,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.6,2.93,2.47,-0.4,-0.1,0.4,0.4,0.1,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,10.2,Trop2_PNU_Cit_6.5_5S_T0,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,94.6,0,0,66.56,99.09,0,0,,56.25,19.03,24.72,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.95,3,2.05,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,10.2,Trop2_PNU_Cit_6.5_5S_T0_25C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,10.2,Trop2_PNU_Cit_6.5_5S_T0_40C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,10.9,Trop2_PNU_His_5.5_5S_1M25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,95.2,1,1,63.63,99.71,0.9,0.9,,52.07,26.87,21.06,-5.3,9.7,-4.3,5.3,9.7,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.74,1.7,1.56,1.6,-1.8,0.2,1.6,1.8,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.9,Trop2_PNU_His_5.5_5S_1M40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,91.6,-2.6,2.6,60.93,97.87,-0.9,0.9,,18.71,71.4,9.9,-38.7,54.2,-15.5,38.7,54.2,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.89,4.39,2.72,-2.2,0.8,1.4,2.2,0.8,1.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,10.9,Trop2_PNU_His_5.5_5S_1M5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,95.3,1.1,1.1,63.67,99.68,0.9,0.9,,57.86,18.56,23.59,0.5,1.4,-1.8,0.5,1.4,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.87,1.78,1.35,1.8,-1.8,0,1.8,1.8,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,10.9,Trop2_PNU_His_5.5_5S_2w40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,92.3,-1.9,1.9,64.05,96.69,-2.1,2.1,,27.48,60.2,12.32,-29.9,43,-13.1,29.9,43,13.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.06,4.58,2.37,-2.1,1,1,2.1,1,1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,10.9,Trop2_PNU_His_5.5_5S_2M25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,95.4,1.2,1.2,65.47,98.91,0.1,0.1,,45.2,33.92,20.88,-12.2,16.7,-4.5,12.2,16.7,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.74,2.53,1.73,0.6,-1,0.4,0.6,1,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,10.9,Trop2_PNU_His_5.5_5S_2M5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,95.4,1.2,1.2,65.61,98.97,0.2,0.2,,54.83,20.22,24.96,-2.6,3,-0.4,2.6,3,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.76,2.81,1.43,0.6,-0.7,0.1,0.6,0.7,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,10.9,Trop2_PNU_His_5.5_5S_2w25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,94.7,0.5,0.5,65.5,96.91,-1.9,1.9,,55.43,20.28,24.29,-2,3.1,-1.1,2,3.1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.04,3.47,1.48,-0.1,-0.1,0.1,0.1,0.1,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,10.9,Trop2_PNU_His_5.5_5S_3w5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,94.6,0.4,0.4,65.87,98.78,0,0,,57.09,18.15,24.76,-0.3,0.9,-0.6,0.3,0.9,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.42,3.12,1.46,0.3,-0.4,0.1,0.3,0.4,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,10.9,Trop2_PNU_His_5.5_5S_T0,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,94.2,0,0,66,98.81,0,0,,57.4,17.2,25.4,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.12,3.54,1.34,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,10.9,Trop2_PNU_His_5.5_5S_T0_25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,10.9,Trop2_PNU_His_5.5_5S_T0_40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,10.6,Trop2_PNU_His_6.0_5S_1M25C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,95.1,0.2,0.2,63.71,99.69,0.8,0.8,,44.88,34.88,20.23,-10.5,14.9,-4.4,10.5,14.9,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.74,2.39,1.87,0.8,-1.2,0.3,0.8,1.2,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.6,Trop2_PNU_His_6.0_5S_1M40C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,91.7,-3.2,3.2,60.65,98.02,-0.9,0.9,,15.01,78.16,6.82,-40.4,58.2,-17.8,40.4,58.2,17.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.33,4.11,3.56,-2.2,0.5,1.7,2.2,0.5,1.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,10.6,Trop2_PNU_His_6.0_5S_1M5C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,95.6,0.7,0.7,63.63,99.71,0.8,0.8,,50.92,26.35,22.74,-4.5,6.4,-1.9,4.5,6.4,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.72,1.66,1.62,1.8,-1.9,0.1,1.8,1.9,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,10.6,Trop2_PNU_His_6.0_5S_2M25C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,95.3,0.4,0.4,65.2,98.88,0,0,,34.67,48.03,17.29,-20.8,28.1,-7.3,20.8,28.1,7.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.11,2.83,2.07,0.2,-0.8,0.5,0.2,0.8,0.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,10.6,Trop2_PNU_His_6.0_5S_2M5C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,95.6,0.7,0.7,65.57,98.87,0,0,,48.16,29.93,21.91,-7.3,10,-2.7,7.3,10,2.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.76,2.55,1.68,0.9,-1,0.1,0.9,1,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,10.6,Trop2_PNU_His_6.0_5S_2w25C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,94.5,-0.4,0.4,67.42,98.51,-0.4,0.4,,47.48,30.23,22.29,-7.9,10.3,-2.3,7.9,10.3,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.54,3.67,1.79,-0.3,0.1,0.3,0.3,0.1,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,10.6,Trop2_PNU_His_6.0_5S_2w40C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,92,-2.9,2.9,63.21,96.52,-2.4,2.4,,20.9,69.59,9.52,-34.5,49.6,-15.1,34.5,49.6,15.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.56,4.24,3.2,-2.3,0.7,1.7,2.3,0.7,1.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,10.6,Trop2_PNU_His_6.0_5S_3w5C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,94.5,-0.4,0.4,66.85,98.74,-0.2,0.2,,54.32,22.2,23.48,-1.1,2.2,-1.1,1.1,2.2,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.72,3.51,1.78,-0.2,-0.1,0.2,0.2,0.1,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,10.6,Trop2_PNU_His_6.0_5S_T0,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,94.9,0,0,65.05,98.93,0,0,,55.42,19.97,24.61,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.89,3.58,1.53,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,10.6,Trop2_PNU_His_6.0_5S_T0_25C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,10.6,Trop2_PNU_His_6.0_5S_T0_40C,NB-aujer-5078398-0002,6,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,10.7,Trop2_PNU_His_6.5_5S_1M25C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,95.2,0.6,0.6,63.64,99.71,0.8,0.8,,32.04,53.12,14.84,-23.1,31.9,-8.9,23.1,31.9,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.62,3.29,2.09,-0.3,-0.2,0.5,0.3,0.2,0.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,10.7,Trop2_PNU_His_6.5_5S_1M40C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,91.9,-2.7,2.7,59.93,97.6,-1.3,1.3,,12.7,81.68,5.62,-42.4,60.5,-18.1,42.4,60.5,18.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.78,2.95,3.26,-1.1,-0.5,1.7,1.1,0.5,1.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,10.7,Trop2_PNU_His_6.5_5S_1M5C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,95.4,0.8,0.8,63.67,99.71,0.8,0.8,,45.26,33.84,20.9,-9.9,12.7,-2.8,9.9,12.7,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.02,2.17,1.81,1.1,-1.3,0.2,1.1,1.3,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,10.7,Trop2_PNU_His_6.5_5S_2M25C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,95.4,0.8,0.8,65.19,98.93,0,0,,25.14,63.18,11.68,-30,42,-12,30,42,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.18,2.6,2.23,0.3,-0.9,0.6,0.3,0.9,0.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,10.7,Trop2_PNU_His_6.5_5S_2M5C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,95.6,1,1,65.52,98.89,0,0,,38.79,42.31,18.9,-16.3,21.1,-4.8,16.3,21.1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.89,2.29,1.82,1,-1.2,0.2,1,1.2,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,10.7,Trop2_PNU_His_6.5_5S_2w25C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,94.6,0,0,67.46,98.43,-0.5,0.5,,38.29,43.84,17.88,-16.8,22.7,-5.8,16.8,22.7,5.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.42,3.58,2,-0.5,0.1,0.4,0.5,0.1,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,10.7,Trop2_PNU_His_6.5_5S_2w40C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,91.6,-3,3,63.42,96.45,-2.4,2.4,,14.21,76.7,9.1,-40.9,55.5,-14.6,40.9,55.5,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.83,3.08,3.09,-1.1,-0.4,1.5,1.1,0.4,1.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,10.7,Trop2_PNU_His_6.5_5S_3w5C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,94.3,-0.3,0.3,66.22,99,0.1,0.1,,45.43,32.82,21.75,-9.7,11.6,-1.9,9.7,11.6,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.11,3,1.89,0.2,-0.5,0.3,0.2,0.5,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,10.7,Trop2_PNU_His_6.5_5S_T0,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,94.6,0,0,65.17,98.93,0,0,,55.13,21.17,23.7,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.92,3.49,1.6,0,0,0,0,0,0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,10.7,Trop2_PNU_His_6.5_5S_T0_25C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,10.7,Trop2_PNU_His_6.5_5S_T0_40C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_002%PO188_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,002%PO188,002%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64.12,0.92,34.95,-33.5,0.1,33.4,33.5,0.1,33.4,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_002%PO188_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,002%PO188,002%PO188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.58,0.83,1.58,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_002%PS20_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,002%PS20,002%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65.9,0.97,33.13,-31.7,0.1,31.6,31.7,0.1,31.6,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_002%PS20_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,002%PS20,002%PS20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.59,0.83,1.58,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_002%PS80_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,002%PS80,002%PS80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65.69,0.88,33.43,-31.9,0,31.9,31.9,0,31.9,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_002%PS80_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,002%PS80,002%PS80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.6,0.86,1.55,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_005%MoNi_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,005%MoNi,005%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64.66,0.96,34.38,-32.9,0.1,32.8,32.9,0.1,32.8,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_005%MoNi_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,005%MoNi,005%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.59,0.86,1.55,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_05%MoNI_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,05%MoNI,05%MoNI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63.2,1,35.8,-34.3,0.1,34.2,34.3,0.1,34.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_05%MoNI_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,05%MoNI,05%MoNI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.52,0.88,1.6,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_1%HPbCD_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%HPbCD,1%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64.82,0.95,34.22,-32.9,0.2,32.7,32.9,0.2,32.7,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_1%HPbCD_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%HPbCD,1%HPbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.72,0.79,1.49,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_1%HPgCD_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%HPgCD,1%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64.93,0.96,34.11,-32.7,0.1,32.6,32.7,0.1,32.6,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_1%HPgCD_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%HPgCD,1%HPgCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,0.85,1.52,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_1%MoNi_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64.07,1.01,34.92,-33.6,0.2,33.5,33.6,0.2,33.5,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_1%MoNi_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%MoNi,1%MoNi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.69,0.86,1.45,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_1%SBEbCD_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%SBEbCD,1%SBEbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32.22,1.61,66.17,-65.2,0.7,64.5,65.2,0.7,64.5,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_1%SBEbCD_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%SBEbCD,1%SBEbCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.44,0.91,1.65,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2-PNU_1%gCD_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%gCD,1%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,66.46,0.96,32.58,-31.3,0.1,31.2,31.3,0.1,31.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2-PNU_1%gCD_RT_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,1%gCD,1%gCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.77,0.85,1.39,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Stirring,25,0,,5,Trop2-PNU_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.46,0.84,1.69,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Stirring,25,0,,5,Trop2-PNU_t0.5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.46,0.89,1.64,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Stirring,25,2,,5,Trop2-PNU_t2,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.54,0.78,1.69,0.1,-0.1,0,0.1,0.1,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Stirring,25,4,,5,Trop2-PNU_t4,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.56,0.8,1.64,0.1,-0.1,0,0.1,0.1,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Stirring,25,5,,5,Trop2-PNU_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.59,0.78,1.64,0.1,-0.1,0,0.1,0.1,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,5,Trop2_PNU_ctrl_60C_t5,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65.46,0.88,33.66,-32.1,0.1,32.1,32.1,0.1,32.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25,0,,5,Trop2_PNU_ctrl_t0,NB-knoxbrow-5090913-0001,6,10 mM Histidine,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.58,0.83,1.58,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,-80,0,,,Trop2_MMAE_53_Start,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.8,0,0,68.72,98.77,0,0,,58.69,14.89,26.42,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,207063.5,24980,198,207024,0,4.1,,,,,,,,,,95.91,3.07,1.02,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_MMAE_Cit_5.5_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.4,0.2,0.2,67.89,99.71,1,1,,59.98,14.18,25.85,-0.2,1.1,-0.9,0.2,1.1,0.9,,,,,,,,,,,,,,,,,,,,,15079.3,1865.3,0,15079.3,0,2,,,,,,,,,,94.93,3.98,1.09,-1.3,1.1,0.2,1.3,1.1,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_MMAE_Cit_5.5_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,91.5,-2.7,2.7,65.05,97.18,-1.5,1.5,,42.26,37.66,20.08,-17.9,24.6,-6.7,17.9,24.6,6.7,,,,,,,,,,,,,,,,,,,,,12156,2116.3,13.3,12156,0,2.3,,,,,,,,,,89.94,3.96,6.1,-6.3,1.1,5.2,6.3,1.1,5.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_MMAE_Cit_5.5_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.8,0.6,0.6,67.74,99.71,1,1,,58.61,13.98,27.41,-1.5,0.9,0.6,1.5,0.9,0.6,,,,,,,,,,,,,,,,,,,,,2817.3,635,0,2817.3,0,2.3,,,,,,,,,,95.23,3.85,0.92,-1,1,0,1,1,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_MMAE_Cit_5.5_7.5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,95.7,1.5,1.5,70.04,98.94,0.2,0.2,,56.19,17.35,26.46,-3.9,4.3,-0.3,3.9,4.3,0.3,,,,,,,,,,,,,,,,,,,,,6124.3,1362.3,185,6071.3,0,3.7,,,,,,,,,,94.62,4.08,1.29,-1.6,1.2,0.4,1.6,1.2,0.4,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_MMAE_Cit_5.5_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.9,0.7,0.7,70.32,99.19,0.5,0.5,,57.97,14.58,27.45,-2.2,1.5,0.7,2.2,1.5,0.7,,,,,,,,,,,,,,,,,,,,,3148.3,569,0,3148.3,0,2.7,,,,,,,,,,95.08,3.9,1.01,-1.1,1,0.1,1.1,1,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_MMAE_Cit_5.5_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.4,0.2,0.2,71.08,98.61,-0.1,0.1,,58.95,14.01,27.04,-1.2,0.9,0.2,1.2,0.9,0.2,,,,,,,,,,,,,,,,,,,,,1666.7,343.7,13.3,1653.7,13.3,1,,,,,,,,,,95.61,3.31,1.08,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_MMAE_Cit_5.5_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,92.5,-1.7,1.7,69.04,96.49,-2.2,2.2,,45.6,31.02,23.38,-14.5,17.9,-3.4,14.5,17.9,3.4,,,,,,,,,,,,,,,,,,,,,2182.7,436.7,0,2182.7,0,1.4,,,,,,,,,,90.14,2.8,7.06,-6.1,-0.1,6.2,6.1,0.1,6.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_MMAE_Cit_5.5_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.2,0,0,69.46,98.72,0,0,,60.13,13.09,26.79,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,4391.7,820,0,4391.7,0,1.2,,,,,,,,,,96.22,2.9,0.89,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_MMAE_Cit_6.0_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.4,0.1,0.1,67.86,99.7,0.6,0.6,,58.15,16.48,25.38,-1.5,3,-1.5,1.5,3,1.5,,,,,,,,,,,,,,,,,,,,,3558,621.7,39.7,3544.7,0,1.4,,,,,,,,,,94.72,3.93,1.36,-1,0.6,0.4,1,0.6,0.4,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_MMAE_Cit_6.0_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,91.7,-2.6,2.6,65.19,97.28,-1.8,1.8,,33.46,51.15,15.39,-26.2,37.7,-11.5,26.2,37.7,11.5,,,,,,,,,,,,,,,,,,,,,3651,939.3,13.3,3651,0,2.3,,,,,,,,,,91.77,4.02,4.21,-4,0.7,3.2,4,0.7,3.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_MMAE_Cit_6.0_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.5,0.2,0.2,66.22,99.72,0.6,0.6,,59.84,14.22,25.94,0.2,0.8,-0.9,0.2,0.8,0.9,,,,,,,,,,,,,,,,,,,,,886.3,238,0,886.3,0,1.7,,,,,,,,,,94.73,4.2,1.07,-1,0.9,0.1,1,0.9,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_MMAE_Cit_6.0_7.5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,95.4,1.1,1.1,70,99.13,0,0,,52.7,22.39,24.91,-7,8.9,-2,7,8.9,2,,,,,,,,,,,,,,,,,,,,,7314.7,1984.3,105.7,7301.7,13.3,3.6,,,,,,,,,,94.07,4.37,1.56,-1.7,1.1,0.6,1.7,1.1,0.6,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_MMAE_Cit_6.0_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,95.3,1,1,70.34,99.24,0.1,0.1,,58.05,15.15,26.8,-1.6,1.7,-0.1,1.6,1.7,0.1,,,,,,,,,,,,,,,,,,,,,2949.7,820,79.3,2949.7,0,3,,,,,,,,,,95.06,3.74,1.2,-0.7,0.4,0.2,0.7,0.4,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_MMAE_Cit_6.0_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.4,0.1,0.1,70.68,98.8,-0.3,0.3,,58.56,15.15,26.29,-1.1,1.7,-0.6,1.1,1.7,0.6,,,,,,,,,,,,,,,,,,,,,1825.3,502.7,13.3,1825.3,0,2.2,,,,,,,,,,95.85,2.84,1.3,0.1,-0.5,0.3,0.1,0.5,0.3,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_MMAE_Cit_6.0_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,91.5,-2.8,2.8,68.85,96.44,-2.7,2.7,,36.9,45.28,17.82,-22.8,31.8,-9,22.8,31.8,9,,,,,,,,,,,,,,,,,,,,,3505.3,833.3,0,3505.3,0,1.5,,,,,,,,,,92.52,2.93,4.55,-3.2,-0.4,3.6,3.2,0.4,3.6,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_MMAE_Cit_6.0_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.3,0,0,68.76,99.09,0,0,,59.67,13.46,26.87,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,3426,727.3,13.3,3412.7,0,1.3,,,,,,,,,,95.74,3.3,0.96,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_MMAE_His_5.0_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,94.4,0.2,0.2,67.77,99.58,1.1,1.1,,60.13,13.44,26.42,0.1,0.7,-0.8,0.1,0.7,0.8,,,,,,,,,,,,,,,,,,,,,2248.7,489.3,0,2248.7,0,0.4,,,,,,,,,,94.58,4.53,0.88,-1.3,1.2,0.1,1.3,1.2,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_MMAE_His_5.0_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,91.2,-3,3,63.33,96.46,-2,2,,46.55,29.68,23.77,-13.5,16.9,-3.4,13.5,16.9,3.4,,,,,,,,,,,,,,,,,,,,,25516,5211.3,26.7,25516,0,1,,,,,,,,,,90.1,5.03,4.87,-5.8,1.7,4.1,5.8,1.7,4.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_MMAE_His_5.0_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,94.7,0.5,0.5,67.07,99.55,1.1,1.1,,59.1,13.45,27.45,-0.9,0.7,0.2,0.9,0.7,0.2,,,,,,,,,,,,,,,,,,,,,3783,674.7,0,3783,0,0.4,,,,,,,,,,94.84,4.38,0.78,-1,1,0,1,1,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_MMAE_His_5.0_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,94.9,0.7,0.7,68.65,97.99,-0.5,0.5,,58.82,13.81,27.37,-1.2,1,0.2,1.2,1,0.2,,,,,,,,,,,,,,,,,,,,,30410.3,4206.3,26.3,30410.3,0,1.9,,,,,,,,,,95.5,3.64,0.86,-0.4,0.3,0.1,0.4,0.3,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_MMAE_His_5.0_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,94.4,0.2,0.2,70.31,98.46,0,0,,59.65,13.26,27.09,-0.4,0.5,-0.1,0.4,0.5,0.1,,,,,,,,,,,,,,,,,,,,,4285.3,714.3,39.7,4272.3,13.3,1.3,,,,,,,,,,95.7,3.4,0.9,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_MMAE_His_5.0_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,92.2,-2,2,66.91,96.86,-1.6,1.6,,50.4,24.05,25.55,-9.6,11.3,-1.6,9.6,11.3,1.6,,,,,,,,,,,,,,,,,,,,,9404.7,1547.7,40,9391.3,13.3,2.8,,,,,,,,,,92.45,2.69,4.85,-3.4,-0.6,4.1,3.4,0.6,4.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_MMAE_His_5.0_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,94.2,0,0,68.83,98.46,0,0,,60.03,12.77,27.2,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,8399.3,1402,26.7,8399.3,0,1.3,,,,,,,,,,95.89,3.33,0.78,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_MMAE_His_5.5_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.3,0.2,0.2,67.71,99.67,1.1,1.1,,57.35,16.1,26.55,-1.2,2,-0.7,1.2,2,0.7,,,,,,,,,,,,,,,,,,,,,1640,463,0,1640,0,0.9,,,,,,,,,,94.59,4.39,1.02,-1,0.9,0.2,1,0.9,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_MMAE_His_5.5_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,91.3,-2.8,2.8,64.97,97.14,-1.5,1.5,,40.06,40.05,19.89,-18.5,25.9,-7.4,18.5,25.9,7.4,,,,,,,,,,,,,,,,,,,,,2275,383.7,0,2275,0,1.7,,,,,,,,,,92.18,4.82,3.01,-3.4,1.3,2.2,3.4,1.3,2.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_MMAE_His_5.5_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.6,0.5,0.5,67.61,99.56,1,1,,60.23,13.39,26.38,1.6,-0.7,-0.9,1.6,-0.7,0.9,,,,,,,,,,,,,,,,,,,,,1997.3,370.3,13.3,1984,0,0.7,,,,,,,,,,95.1,4,0.89,-0.5,0.5,0,0.5,0.5,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_MMAE_His_5.5_7.5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.9,0.8,0.8,69.82,98.62,0,0,,55.65,18.46,25.89,-3,4.3,-1.4,3,4.3,1.4,,,,,,,,,,,,,,,,,,,,,4312,846.3,39.7,4312,0,2,,,,,,,,,,94.85,3.96,1.19,-0.8,0.4,0.3,0.8,0.4,0.3,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_MMAE_His_5.5_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.9,0.8,0.8,69.4,98.58,0,0,,57.83,14.84,27.34,-0.8,0.7,0.1,0.8,0.7,0.1,,,,,,,,,,,,,,,,,,,,,4153.3,436.3,0,4153.3,0,1.9,,,,,,,,,,95.52,3.47,1.01,-0.1,0,0.2,0.1,0,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_MMAE_His_5.5_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.4,0.3,0.3,70.83,98.66,0.1,0.1,,59.16,14.44,26.39,0.6,0.3,-0.9,0.6,0.3,0.9,,,,,,,,,,,,,,,,,,,,,2724.7,317.3,13.3,2724.7,0,2.4,,,,,,,,,,95.59,3.38,1.03,0,-0.1,0.2,0,0.1,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_MMAE_His_5.5_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,92.2,-1.9,1.9,68.85,97.49,-1.1,1.1,,46.94,31.14,21.92,-11.7,17,-5.4,11.7,17,5.4,,,,,,,,,,,,,,,,,,,,,4338.7,648.3,13.3,4338.7,0,1,,,,,,,,,,93.11,3.51,3.37,-2.5,0,2.5,2.5,0,2.5,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_MMAE_His_5.5_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.1,0,0,69.94,98.61,0,0,,58.6,14.12,27.29,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,2142.5,516,20,2142.5,0,1.3,,,,,,,,,,95.63,3.52,0.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_MMAE_His_6.0_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.5,0.5,0.5,68.74,99.67,1,1,,55.66,20.49,23.86,-2.9,6,-3.1,2.9,6,3.1,,,,,,,,,,,,,,,,,,,,,2288.7,396.7,26.3,2275.3,13.3,1.1,,,,,,,,,,95.55,3.25,1.2,-0.7,0.4,0.3,0.7,0.4,0.3,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_MMAE_His_6.0_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,91.2,-2.8,2.8,65.47,97.62,-1.1,1.1,,33.9,50.4,15.7,-24.6,35.9,-11.2,24.6,35.9,11.2,,,,,,,,,,,,,,,,,,,,,2910,886.3,0,2910,0,0.8,,,,,,,,,,93.06,4.28,2.66,-3.2,1.4,1.8,3.2,1.4,1.8,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_MMAE_His_6.0_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.3,0.3,0.3,67.24,99.6,0.9,0.9,,58.19,15.87,25.93,-0.4,1.4,-1,0.4,1.4,1,,,,,,,,,,,,,,,,,,,,,3716.7,436.3,0,3716.7,0,0.7,,,,,,,,,,94.81,4.19,0.99,-1.4,1.3,0.1,1.4,1.3,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_MMAE_His_6.0_7.5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,95.8,1.8,1.8,70.14,98.84,0.1,0.1,,47.47,29.76,22.77,-11.1,15.3,-4.2,11.1,15.3,4.2,,,,,,,,,,,,,,,,,,,,,1177,225,26.7,1164,0,1.4,,,,,,,,,,94.06,4.61,1.34,-2.2,1.8,0.4,2.2,1.8,0.4,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_MMAE_His_6.0_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.8,0.8,0.8,69.99,98.93,0.2,0.2,,57.79,17.15,25.06,-0.8,2.6,-1.9,0.8,2.6,1.9,,,,,,,,,,,,,,,,,,,,,582,53,0,582,0,1.8,,,,,,,,,,94.89,4,1.12,-1.4,1.2,0.2,1.4,1.2,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_MMAE_His_6.0_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.4,0.4,0.4,71.19,98.72,0,0,,57.22,18.08,24.7,-1.3,3.6,-2.2,1.3,3.6,2.2,,,,,,,,,,,,,,,,,,,,,3928.5,1349.5,59.5,3908.5,0,1.3,,,,,,,,,,95.67,3.2,1.13,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_MMAE_His_6.0_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,92.2,-1.8,1.8,69.69,96.98,-1.7,1.7,,40.88,40.81,18.3,-17.7,26.3,-8.6,17.7,26.3,8.6,,,,,,,,,,,,,,,,,,,,,7288,1084.7,39.7,7288,0,0.6,,,,,,,,,,93.57,3.41,3.02,-2.7,0.6,2.1,2.7,0.6,2.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_MMAE_His_6.0_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94,0,0,70.34,98.68,0,0,,58.55,14.51,26.94,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,17698.3,2791,40,17685,13.3,1.4,,,,,,,,,,96.25,2.85,0.9,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,-80,0,,,Trop2_PNU_17.5_Start,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.4,0,0,66.09,98.75,0,0,,55.7,19.87,24.43,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,410555.5,126528,10595,409484,20,11.2,,,,,,,,,,95.19,3.04,1.77,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_PNU_Cit_5.5_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,95.4,0.8,0.8,63.97,99.7,1,1,,42.9,36.52,20.58,-13.7,18.1,-4.3,13.7,18.1,4.3,,,,,,,,,,,,,,,,,,,,,1045,450,0,1045,0,0.5,,,,,,,,,,94.83,1.86,3.32,-0.5,-1,1.5,0.5,1,1.5,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_PNU_Cit_5.5_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,92.4,-2.2,2.2,59.53,97.25,-1.4,1.4,,10.47,82.32,7.21,-46.2,63.9,-17.7,46.2,63.9,17.7,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0,0.2,,,,,,,,,,93.04,3.62,3.35,-2.3,0.8,1.5,2.3,0.8,1.5,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_PNU_Cit_5.5_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,95.2,0.6,0.6,63.68,99.7,1,1,,54.04,21.68,24.27,-2.6,3.2,-0.6,2.6,3.2,0.6,,,,,,,,,,,,,,,,,,,,,992,225,0,992,0,0.4,,,,,,,,,,95.6,1.85,2.55,0.2,-1,0.7,0.2,1,0.7,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_PNU_Cit_5.5_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,95.7,1.1,1.1,64.99,98.78,0.1,0.1,,33.79,49.3,16.91,-22.8,30.8,-8,22.8,30.8,8,,,,,,,,,,,,,,,,,,,,,675,145.3,26.7,675,0,0.8,,,,,,,,,,94.45,1.97,3.58,-0.9,-0.9,1.8,0.9,0.9,1.8,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_PNU_Cit_5.5_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,95.7,1.1,1.1,65.74,98.95,0.3,0.3,,50.53,26.73,22.74,-6.1,8.3,-2.2,6.1,8.3,2.2,,,,,,,,,,,,,,,,,,,,,1508,317.3,13.3,1508,0,0.9,,,,,,,,,,95,2.19,2.81,-0.4,-0.6,1,0.4,0.6,1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_5.5_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.7,0.1,0.1,67.11,98.33,-0.4,0.4,,46.54,30.51,22.95,-10.1,12.1,-1.9,10.1,12.1,1.9,,,,,,,,,,,,,,,,,,,,,582,145.3,13.3,568.7,13.3,0.7,,,,,,,,,,94.79,2.24,2.97,-0.6,-0.6,1.2,0.6,0.6,1.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_5.5_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,92.9,-1.7,1.7,63.2,96.5,-2.2,2.2,,16.45,76.95,6.6,-40.2,58.5,-18.3,40.2,58.5,18.3,,,,,,,,,,,,,,,,,,,,,2024,608.3,0,2024,0,0.2,,,,,,,,,,91.97,3.05,4.99,-3.4,0.2,3.2,3.4,0.2,3.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_PNU_Cit_5.5_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.7,0.1,0.1,65.96,98.82,0.1,0.1,,55.53,19.82,24.65,-1.1,1.4,-0.2,1.1,1.4,0.2,,,,,,,,,,,,,,,,,,,,,1587.3,383.3,0,1587.3,0,1.1,,,,,,,,,,95.01,2.5,2.49,-0.3,-0.3,0.7,0.3,0.3,0.7,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_5.5_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.6,0,0,66.18,98.72,0,0,,56.64,18.45,24.9,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,5965.7,754,26.7,5939.3,13.3,1.1,,,,,,,,,,95.36,2.83,1.81,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_PNU_Cit_6.0_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,95.2,0.5,0.5,63.86,99.7,0.8,0.8,,44.67,34.24,21.09,-12.3,16.4,-4,12.3,16.4,4,,,,,,,,,,,,,,,,,,,,,3756.7,674.7,13.3,3743.7,0,0.3,,,,,,,,,,95.68,1.38,2.94,0.5,-1.6,1.1,0.5,1.6,1.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_PNU_Cit_6.0_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,92.4,-2.3,2.3,59.92,97.36,-1.5,1.5,,14.99,74.24,10.77,-42,56.4,-14.4,42,56.4,14.4,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53,1561,26.7,0.8,,,,,,,,,,93.39,2.98,3.63,-1.8,0,1.8,1.8,0,1.8,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_PNU_Cit_6.0_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,95.3,0.6,0.6,63.6,99.74,0.8,0.8,,57.3,20.29,22.41,0.3,2.4,-2.7,0.3,2.4,2.7,,,,,,,,,,,,,,,,,,,,,1164,423.3,13.3,1164,0,0.6,,,,,,,,,,95.9,1.79,2.3,0.8,-1.2,0.4,0.8,1.2,0.4,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_PNU_Cit_6.0_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,95.7,1,1,65.03,98.79,-0.1,0.1,,35.98,46.54,17.47,-21,28.6,-7.7,21,28.6,7.7,,,,,,,,,,,,,,,,,,,,,1164,476.3,26.7,1164,0,0.9,,,,,,,,,,94.6,1.95,3.45,-0.6,-1,1.6,0.6,1,1.6,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_PNU_Cit_6.0_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,95.5,0.8,0.8,65.69,99.19,0.3,0.3,,49.72,26.24,24.04,-7.2,8.3,-1.1,7.2,8.3,1.1,,,,,,,,,,,,,,,,,,,,,807,225,13.3,807,0,1.4,,,,,,,,,,94.87,2.47,2.66,-0.3,-0.5,0.8,0.3,0.5,0.8,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_6.0_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.7,0,0,67.11,98.56,-0.3,0.3,,49.02,28.05,22.93,-7.9,10.2,-2.2,7.9,10.2,2.2,,,,,,,,,,,,,,,,,,,,,370.3,132.3,26.7,357.3,13.3,0.7,,,,,,,,,,94.44,2.65,2.9,-0.7,-0.4,1,0.7,0.4,1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_6.0_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,93.1,-1.6,1.6,62.45,96,-2.9,2.9,,15.83,69.87,14.3,-41.1,52,-10.8,41.1,52,10.8,,,,,,,,,,,,,,,,,,,,,5092.3,1521.3,39.7,5066,0,0.3,,,,,,,,,,92.25,3.19,4.56,-2.9,0.2,2.7,2.9,0.2,2.7,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_PNU_Cit_6.0_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.6,-0.1,0.1,66.28,98.77,-0.1,0.1,,56.67,18.56,24.78,-0.3,0.7,-0.3,0.3,0.7,0.3,,,,,,,,,,,,,,,,,,,,,1494.7,383.7,26.3,1481.7,0,0.9,,,,,,,,,,94.77,2.77,2.46,-0.4,-0.2,0.6,0.4,0.2,0.6,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_6.0_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.7,0,0,64.56,98.91,0,0,,56.97,17.89,25.13,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1693,529,26.7,1679.7,13.3,0.8,,,,,,,,,,95.15,3,1.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_PNU_Cit_6.5_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,95.5,0.9,0.9,63.43,99.67,0.6,0.6,,40.12,42.31,17.57,-16.1,23.3,-7.1,16.1,23.3,7.1,,,,,,,,,,,,,,,,,,,,,2209,568.7,26.7,2209,0,0.3,,,,,,,,,,95.32,1.84,2.85,0.4,-1.2,0.8,0.4,1.2,0.8,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_PNU_Cit_6.5_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,91.9,-2.7,2.7,59.39,97.41,-1.7,1.7,,13.21,81.71,5.07,-43,62.7,-19.6,43,62.7,19.6,,,,,,,,,,,,,,,,,,,,,926,171.7,0,926,0,0.4,,,,,,,,,,93.45,2.67,3.88,-1.5,-0.3,1.8,1.5,0.3,1.8,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_PNU_Cit_6.5_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,95.3,0.7,0.7,63.47,99.71,0.6,0.6,,54.34,22.12,23.54,-1.9,3.1,-1.2,1.9,3.1,1.2,,,,,,,,,,,,,,,,,,,,,1018.7,317.3,13.3,1018.7,0,0.5,,,,,,,,,,95.32,2.16,2.53,0.4,-0.8,0.5,0.4,0.8,0.5,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_PNU_Cit_6.5_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,95.7,1.1,1.1,64.74,98.88,-0.2,0.2,,30.59,54.77,14.64,-25.7,35.7,-10.1,25.7,35.7,10.1,,,,,,,,,,,,,,,,,,,,,1957.7,436.7,26.3,1944.3,0,0.8,,,,,,,,,,94.32,2.35,3.33,-0.6,-0.6,1.3,0.6,0.6,1.3,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_PNU_Cit_6.5_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,95.4,0.8,0.8,65.33,99.06,0,0,,46.43,30.31,23.25,-9.8,11.3,-1.5,9.8,11.3,1.5,,,,,,,,,,,,,,,,,,,,,1071.3,291.3,13.3,1071.3,0,0.7,,,,,,,,,,94.77,2.59,2.65,-0.2,-0.4,0.6,0.2,0.4,0.6,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_Cit_6.5_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,94.7,0.1,0.1,65.71,99.02,-0.1,0.1,,43.95,33.82,22.23,-12.3,14.8,-2.5,12.3,14.8,2.5,,,,,,,,,,,,,,,,,,,,,926,238,0,926,0,0.6,,,,,,,,,,94.04,2.98,2.98,-0.9,0,0.9,0.9,0,0.9,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_Cit_6.5_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,92.9,-1.7,1.7,61.66,95.48,-3.6,3.6,,16.43,77.42,6.15,-39.8,58.4,-18.6,39.8,58.4,18.6,,,,,,,,,,,,,,,,,,,,,2447.3,595.3,52.7,2447.3,0,0.3,,,,,,,,,,93.62,1.65,4.75,-1.3,-1.4,2.7,1.3,1.4,2.7,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_PNU_Cit_6.5_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,93.9,-0.7,0.7,65.41,99.17,0.1,0.1,,54.6,20.6,24.8,-1.6,1.6,0.1,1.6,1.6,0.1,,,,,,,,,,,,,,,,,,,,,397,132.3,13.3,397,0,0.6,,,,,,,,,,94.6,2.93,2.47,-0.4,-0.1,0.4,0.4,0.1,0.4,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_Cit_6.5_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,94.6,0,0,66.56,99.09,0,0,,56.25,19.03,24.72,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0,0.9,,,,,,,,,,94.95,3,2.05,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_PNU_His_5.5_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,95.2,1,1,63.63,99.71,0.9,0.9,,52.07,26.87,21.06,-5.3,9.7,-4.3,5.3,9.7,4.3,,,,,,,,,,,,,,,,,,,,,1018.7,198.3,13.3,1018.7,0,0.4,,,,,,,,,,96.74,1.7,1.56,1.6,-1.8,0.2,1.6,1.8,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_PNU_His_5.5_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,91.6,-2.6,2.6,60.93,97.87,-0.9,0.9,,18.71,71.4,9.9,-38.7,54.2,-15.5,38.7,54.2,15.5,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582,0,0.6,,,,,,,,,,92.89,4.39,2.72,-2.2,0.8,1.4,2.2,0.8,1.4,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_PNU_His_5.5_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,95.3,1.1,1.1,63.67,99.68,0.9,0.9,,57.86,18.56,23.59,0.5,1.4,-1.8,0.5,1.4,1.8,,,,,,,,,,,,,,,,,,,,,2777.7,529,0,2777.7,0,0.7,,,,,,,,,,96.87,1.78,1.35,1.8,-1.8,0,1.8,1.8,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_PNU_His_5.5_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,95.4,1.2,1.2,65.47,98.91,0.1,0.1,,45.2,33.92,20.88,-12.2,16.7,-4.5,12.2,16.7,4.5,,,,,,,,,,,,,,,,,,,,,608.7,145.7,13.3,608.7,0,0.8,,,,,,,,,,95.74,2.53,1.73,0.6,-1,0.4,0.6,1,0.4,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_PNU_His_5.5_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,95.4,1.2,1.2,65.61,98.97,0.2,0.2,,54.83,20.22,24.96,-2.6,3,-0.4,2.6,3,0.4,,,,,,,,,,,,,,,,,,,,,1137.3,277.7,13.3,1137.3,0,1.2,,,,,,,,,,95.76,2.81,1.43,0.6,-0.7,0.1,0.6,0.7,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_His_5.5_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.7,0.5,0.5,65.5,96.91,-1.9,1.9,,55.43,20.28,24.29,-2,3.1,-1.1,2,3.1,1.1,,,,,,,,,,,,,,,,,,,,,582.3,39.7,0,582.3,0,0.6,,,,,,,,,,95.04,3.47,1.48,-0.1,-0.1,0.1,0.1,0.1,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_His_5.5_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,92.3,-1.9,1.9,64.05,96.69,-2.1,2.1,,27.48,60.2,12.32,-29.9,43,-13.1,29.9,43,13.1,,,,,,,,,,,,,,,,,,,,,952.3,211.7,13.3,952.3,0,0.2,,,,,,,,,,93.06,4.58,2.37,-2.1,1,1,2.1,1,1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_PNU_His_5.5_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.6,0.4,0.4,65.87,98.78,0,0,,57.09,18.15,24.76,-0.3,0.9,-0.6,0.3,0.9,0.6,,,,,,,,,,,,,,,,,,,,,1296.3,264.3,13.3,1296.3,0,1.1,,,,,,,,,,95.42,3.12,1.46,0.3,-0.4,0.1,0.3,0.4,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_His_5.5_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.2,0,0,66,98.81,0,0,,57.4,17.2,25.4,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0,1097.7,0,0.8,,,,,,,,,,95.12,3.54,1.34,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_PNU_His_6.0_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,95.1,0.2,0.2,63.71,99.69,0.8,0.8,,44.88,34.88,20.23,-10.5,14.9,-4.4,10.5,14.9,4.4,,,,,,,,,,,,,,,,,,,,,3307,370.3,0,3307,0,0.6,,,,,,,,,,95.74,2.39,1.87,0.8,-1.2,0.3,0.8,1.2,0.3,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_PNU_His_6.0_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,91.7,-3.2,3.2,60.65,98.02,-0.9,0.9,,15.01,78.16,6.82,-40.4,58.2,-17.8,40.4,58.2,17.8,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0,0.5,,,,,,,,,,92.74,4.07,3.19,-2.2,0.5,1.7,2.2,0.5,1.7,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_PNU_His_6.0_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,95.6,0.7,0.7,63.63,99.71,0.8,0.8,,50.92,26.35,22.74,-4.5,6.4,-1.9,4.5,6.4,1.9,,,,,,,,,,,,,,,,,,,,,10595.3,595.3,0,10595.3,0,0.7,,,,,,,,,,96.72,1.66,1.62,1.8,-1.9,0.1,1.8,1.9,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_PNU_His_6.0_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,95.3,0.4,0.4,65.2,98.88,0,0,,34.67,48.03,17.29,-20.8,28.1,-7.3,20.8,28.1,7.3,,,,,,,,,,,,,,,,,,,,,5542.3,423.3,13.3,5542.3,0,1.3,,,,,,,,,,95.11,2.83,2.07,0.2,-0.8,0.5,0.2,0.8,0.5,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_PNU_His_6.0_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,95.6,0.7,0.7,65.57,98.87,0,0,,48.16,29.93,21.91,-7.3,10,-2.7,7.3,10,2.7,,,,,,,,,,,,,,,,,,,,,9590,793.7,0,9590,0,1.2,,,,,,,,,,95.76,2.55,1.68,0.9,-1,0.1,0.9,1,0.1,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_His_6.0_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.5,-0.4,0.4,67.42,98.51,-0.4,0.4,,47.48,30.23,22.29,-7.9,10.3,-2.3,7.9,10.3,2.3,,,,,,,,,,,,,,,,,,,,,2354.7,198,39.7,2341.3,13.3,0.9,,,,,,,,,,94.54,3.67,1.79,-0.3,0.1,0.3,0.3,0.1,0.3,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_His_6.0_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,92,-2.9,2.9,63.21,96.52,-2.4,2.4,,20.9,69.59,9.52,-34.5,49.6,-15.1,34.5,49.6,15.1,,,,,,,,,,,,,,,,,,,,,4695.7,1296,66,4695.7,0,0.4,,,,,,,,,,92.56,4.24,3.2,-2.3,0.7,1.7,2.3,0.7,1.7,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_PNU_His_6.0_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.5,-0.4,0.4,66.85,98.74,-0.2,0.2,,54.32,22.2,23.48,-1.1,2.2,-1.1,1.1,2.2,1.1,,,,,,,,,,,,,,,,,,,,,9894.3,608.7,13.3,9894.3,0,0.5,,,,,,,,,,94.72,3.51,1.78,-0.2,-0.1,0.2,0.2,0.1,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_His_6.0_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.9,0,0,65.05,98.93,0,0,,55.42,19.97,24.61,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,979,224.7,0,979,0,1.1,,,,,,,,,,94.89,3.58,1.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_PNU_His_6.5_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,95.2,0.6,0.6,63.64,99.71,0.8,0.8,,32.04,53.12,14.84,-23.1,31.9,-8.9,23.1,31.9,8.9,,,,,,,,,,,,,,,,,,,,,6389,224.7,13.3,6389,0,1,,,,,,,,,,94.62,3.29,2.09,-0.3,-0.2,0.5,0.3,0.2,0.5,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_PNU_His_6.5_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,91.9,-2.7,2.7,59.93,97.6,-1.3,1.3,,12.7,81.68,5.62,-42.4,60.5,-18.1,42.4,60.5,18.1,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0,0.4,,,,,,,,,,94.19,2.9,2.91,-0.7,-0.6,1.3,0.7,0.6,1.3,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_PNU_His_6.5_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,95.4,0.8,0.8,63.67,99.71,0.8,0.8,,45.26,33.84,20.9,-9.9,12.7,-2.8,9.9,12.7,2.8,,,,,,,,,,,,,,,,,,,,,4788.7,542.3,39.7,4775.3,0,0.5,,,,,,,,,,96.02,2.17,1.81,1.1,-1.3,0.2,1.1,1.3,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_PNU_His_6.5_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,95.4,0.8,0.8,65.19,98.93,0,0,,25.14,63.18,11.68,-30,42,-12,30,42,12,,,,,,,,,,,,,,,,,,,,,4510.3,436.7,13.3,4497.3,13.3,1.3,,,,,,,,,,95.18,2.6,2.23,0.3,-0.9,0.6,0.3,0.9,0.6,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_PNU_His_6.5_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,95.6,1,1,65.52,98.89,0,0,,38.79,42.31,18.9,-16.3,21.1,-4.8,16.3,21.1,4.8,,,,,,,,,,,,,,,,,,,,,10674.7,754,13.3,10661.3,13.3,1,,,,,,,,,,95.89,2.29,1.82,1,-1.2,0.2,1,1.2,0.2,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_PNU_His_6.5_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,94.6,0,0,67.46,98.43,-0.5,0.5,,38.29,43.84,17.88,-16.8,22.7,-5.8,16.8,22.7,5.8,,,,,,,,,,,,,,,,,,,,,5846.7,476,0,5846.7,0,1,,,,,,,,,,94.42,3.58,2,-0.5,0.1,0.4,0.5,0.1,0.4,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_PNU_His_6.5_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,91.6,-3,3,63.42,96.45,-2.4,2.4,,14.21,76.7,9.1,-40.9,55.5,-14.6,40.9,55.5,14.6,,,,,,,,,,,,,,,,,,,,,8254,3492,119,8254,0,0.4,,,,,,,,,,93.83,3.08,3.09,-1.1,-0.4,1.5,1.1,0.4,1.5,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_PNU_His_6.5_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,94.3,-0.3,0.3,66.22,99,0.1,0.1,,45.43,32.82,21.75,-9.7,11.6,-1.9,9.7,11.6,1.9,,,,,,,,,,,,,,,,,,,,,9312.3,740.7,26.7,9299,13.3,0.9,,,,,,,,,,95.11,3,1.89,0.2,-0.5,0.3,0.2,0.5,0.3,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_PNU_His_6.5_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,94.6,0,0,65.17,98.93,0,0,,55.13,21.17,23.7,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1561,304.3,26.7,1547.7,0,1.2,,,,,,,,,,94.92,3.49,1.6,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_MMAE_Cit_5.5_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.2,0,0,69.46,98.72,0,0,,60.13,13.09,26.79,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,4391.7,0,0,4391.7,0,1.2,,,,0,,,,,,96.22,2.9,0.89,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_MMAE_Cit_6.0_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.3,0,0,68.76,99.09,0,0,,59.67,13.46,26.87,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,3426,13.3,13.3,3412.7,0,1.3,,,,0,,,,,,95.74,3.3,0.96,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_MMAE_His_5.0_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,94.2,0,0,68.83,98.46,0,0,,60.03,12.77,27.2,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,8399.3,26.7,26.7,8399.3,0,1.3,,,,0,,,,,,95.89,3.33,0.78,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_MMAE_His_5.5_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.1,0,0,69.94,98.61,0,0,,58.6,14.12,27.29,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,2142.5,20,20,2142.5,0,1.3,,,,0,,,,,,95.63,3.52,0.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_MMAE_His_6.0_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94,0,0,70.34,98.68,0,0,,58.55,14.51,26.94,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,17698.3,40,40,17685,13.3,1.4,,,,0,,,,,,96.25,2.85,0.9,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_PNU_Cit_5.5_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.6,0,0,66.18,98.72,0,0,,56.64,18.45,24.9,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,5965.7,26.7,26.7,5939.3,13.3,1.1,,,,0,,,,,,95.36,2.83,1.81,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_PNU_Cit_6.0_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.7,0,0,64.56,98.91,0,0,,56.97,17.89,25.13,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1693,26.7,26.7,1679.7,13.3,0.8,,,,0,,,,,,95.15,3,1.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_PNU_Cit_6.5_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,94.6,0,0,66.56,99.09,0,0,,56.25,19.03,24.72,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1481.3,26.7,26.7,1481.3,0,0.9,,,,0,,,,,,94.95,3,2.05,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_PNU_His_5.5_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.2,0,0,66,98.81,0,0,,57.4,17.2,25.4,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1097.7,0,0,1097.7,0,0.8,,,,0,,,,,,95.12,3.54,1.34,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_PNU_His_6.0_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.9,0,0,65.05,98.93,0,0,,55.42,19.97,24.61,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,979,0,0,979,0,1.1,,,,0,,,,,,94.89,3.58,1.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_PNU_His_6.5_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,94.6,0,0,65.17,98.93,0,0,,55.13,21.17,23.7,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1561,26.7,26.7,1547.7,0,1.2,,,,0,,,,,,94.92,3.49,1.6,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_MMAE_Cit_5.5_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.2,0,0,69.46,98.72,0,0,,60.13,13.09,26.79,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,4391.7,0,0,4391.7,0,1.2,,,,0,,,,,,96.22,2.9,0.89,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_MMAE_Cit_6.0_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.3,0,0,68.76,99.09,0,0,,59.67,13.46,26.87,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,3426,13.3,13.3,3412.7,0,1.3,,,,0,,,,,,95.74,3.3,0.96,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_MMAE_His_5.0_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5,Histidine,0,0,0,0,0,,,,94.2,0,0,68.83,98.46,0,0,,60.03,12.77,27.2,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,8399.3,26.7,26.7,8399.3,0,1.3,,,,0,,,,,,95.89,3.33,0.78,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_MMAE_His_5.5_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.1,0,0,69.94,98.61,0,0,,58.6,14.12,27.29,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,2142.5,20,20,2142.5,0,1.3,,,,0,,,,,,95.63,3.52,0.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_MMAE_His_6.0_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94,0,0,70.34,98.68,0,0,,58.55,14.51,26.94,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,17698.3,40,40,17685,13.3,1.4,,,,0,,,,,,96.25,2.85,0.9,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_PNU_Cit_5.5_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0,0,0,,,,94.6,0,0,66.18,98.72,0,0,,56.64,18.45,24.9,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,5965.7,26.7,26.7,5939.3,13.3,1.1,,,,0,,,,,,95.36,2.83,1.81,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_PNU_Cit_6.0_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Citrate,0,0,0,0,0,,,,94.7,0,0,64.56,98.91,0,0,,56.97,17.89,25.13,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1693,26.7,26.7,1679.7,13.3,0.8,,,,0,,,,,,95.15,3,1.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_PNU_Cit_6.5_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0,0,0,,,,94.6,0,0,66.56,99.09,0,0,,56.25,19.03,24.72,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1481.3,26.7,26.7,1481.3,0,0.9,,,,0,,,,,,94.95,3,2.05,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_PNU_His_5.5_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0,0,0,,,,94.2,0,0,66,98.81,0,0,,57.4,17.2,25.4,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1097.7,0,0,1097.7,0,0.8,,,,0,,,,,,95.12,3.54,1.34,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_PNU_His_6.0_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6,Histidine,0,0,0,0,0,,,,94.9,0,0,65.05,98.93,0,0,,55.42,19.97,24.61,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,979,0,0,979,0,1.1,,,,0,,,,,,94.89,3.58,1.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_PNU_His_6.5_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0,0,0,,,,94.6,0,0,65.17,98.93,0,0,,55.13,21.17,23.7,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1561,26.7,26.7,1547.7,0,1.2,,,,0,,,,,,94.92,3.49,1.6,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_012,Fab,MULTIPLE CONTROL,,-80,0,,,Anti_MMAE_Fab_ST,NB-ramapa-5084681-0001,6,Histidine,0,0,0,0,0,,,,99.2,,,52.22,99.59,,,,87.61,8.53,3.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0,2.18,,,,,,,DAB0156292_012,DAB0156292,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,,,,,Anti_MMAE_Fab_48h5C_6hRT,NB-ramapa-5084681-0001,6,Histidine,0,0,0,0,0,,,,98.9,,,51.97,99.63,,,,86.75,9.82,3.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.72,0,2.28,-0.1,0,0.1,0.1,0,0.1,DAB0156292_013,DAB0156292,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,25,2,,,Anti_MMAE_Fab_48hRT,NB-ramapa-5084681-0001,6,Histidine,0,0,0,0,0,,,,98.9,,,52.06,99.58,,,,87.1,9.54,3.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.73,0,2.27,-0.1,0,0.1,0.1,0,0.1,DAB0156292_013,DAB0156292,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,25,0.25,,,Anti_MMAE_Fab_6hRT,NB-ramapa-5084681-0001,6,Histidine,0,0,0,0,0,,,,99,,,51.87,99.31,,,,87.48,9.15,3.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.76,0,2.24,0,0,0,0,0,0,DAB0156292_013,DAB0156292,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,-80,0,,,Anti_MMAE_Fab_CT,NB-ramapa-5084681-0001,6,Histidine,0,0,0,0,0,,,,99.1,,,52.12,99.57,,,,87.68,9.09,3.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.81,0,2.19,0,0,0,0,0,0,DAB0156292_013,DAB0156292,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,Freeze Thaw,,,,,Anti_MMAE_Fab_FT,NB-ramapa-5084681-0001,6,Histidine,0,0,0,0,0,,,,98.9,,,52.14,99.52,,,,86.89,9.61,3.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.75,0,2.25,,,,,,,DAB0156292_013,DAB0156292,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,Light stress 0.2 x,,,,,Anti_MMAE_Fab_LT_0.2x,NB-ramapa-5084681-0001,6,Histidine,0,0,0,0,0,,,,98,,,51.77,99.34,,,,83.42,12.21,4.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.12,0,2.88,,,,,,,DAB0156292_013,DAB0156292,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,Light stress 0.2 x,,,,,Anti_MMAE_Fab_LT_0.2x_CT,NB-ramapa-5084681-0001,6,Histidine,0,0,0,0,0,,,,98.8,,,52,99.61,,,,86.25,10.04,3.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.77,0,2.23,,,,,,,DAB0156292_013,DAB0156292,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,-80,0,,,Trop2_A_53_Start,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94.8,0,0,68.72,98.77,0,0,,58.69,14.89,26.42,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,207063.5,24980,198,207024,0,4.1,,,,,,,,,,95.91,3.07,1.02,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_A_Cit_5.5_7.5S_1M25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,94.4,0.2,0.2,67.89,99.71,1,1,,59.98,14.18,25.85,-0.2,1.1,-0.9,0.2,1.1,0.9,,,,,,,,,,,,,,,,,,,,,15079.3,1865.3,0,15079.3,0,2,,,,,,,,,,94.93,3.98,1.09,-1.3,1.1,0.2,1.3,1.1,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_A_Cit_5.5_7.5S_1M40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,91.5,-2.7,2.7,65.05,97.18,-1.5,1.5,,42.26,37.66,20.08,-17.9,24.6,-6.7,17.9,24.6,6.7,,,,,,,,,,,,,,,,,,,,,12156,2116.3,13.3,12156,0,2.3,,,,,,,,,,89.94,3.96,6.1,-6.3,1.1,5.2,6.3,1.1,5.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_A_Cit_5.5_7.5S_1M5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,94.8,0.6,0.6,67.74,99.71,1,1,,58.61,13.98,27.41,-1.5,0.9,0.6,1.5,0.9,0.6,,,,,,,,,,,,,,,,,,,,,2817.3,635,0,2817.3,0,2.3,,,,,,,,,,95.23,3.85,0.92,-1,1,0,1,1,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_A_Cit_5.5_7.5S_2M25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.62,4.08,1.29,-1.6,1.2,0.4,1.6,1.2,0.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_A_Cit_5.5_7.5S_2M5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.08,3.9,1.01,-1.1,1,0.1,1.1,1,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_A_Cit_5.5_7.5S_2w25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,94.4,0.2,0.2,71.08,98.61,-0.1,0.1,,58.95,14.01,27.04,-1.2,0.9,0.2,1.2,0.9,0.2,,,,,,,,,,,,,,,,,,,,,1666.7,343.7,13.3,1653.7,13.3,1,,,,,,,,,,95.61,3.31,1.08,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_A_Cit_5.5_7.5S_2w40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,92.5,-1.7,1.7,69.04,96.49,-2.2,2.2,,45.6,31.02,23.38,-14.5,17.9,-3.4,14.5,17.9,3.4,,,,,,,,,,,,,,,,,,,,,2182.7,436.7,0,2182.7,0,1.4,,,,,,,,,,90.14,2.8,7.06,-6.1,-0.1,6.2,6.1,0.1,6.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_A_Cit_5.5_7.5S_T0,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,94.2,0,0,69.46,98.72,0,0,,60.13,13.09,26.79,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,4391.7,820,0,4391.7,0,1.2,,,,,,,,,,96.22,2.9,0.89,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_A_Cit_5.5_7.5S_T0_25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_A_Cit_5.5_7.5S_T0_40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_A_Cit_6.0_7.5S_1M25C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,94.4,0.1,0.1,67.86,99.7,0.6,0.6,,58.15,16.48,25.38,-1.5,3,-1.5,1.5,3,1.5,,,,,,,,,,,,,,,,,,,,,3558,621.7,39.7,3544.7,0,1.4,,,,,,,,,,94.72,3.93,1.36,-1,0.6,0.4,1,0.6,0.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_A_Cit_6.0_7.5S_1M40C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,91.7,-2.6,2.6,65.19,97.28,-1.8,1.8,,33.46,51.15,15.39,-26.2,37.7,-11.5,26.2,37.7,11.5,,,,,,,,,,,,,,,,,,,,,3651,939.3,13.3,3651,0,2.3,,,,,,,,,,91.77,4.02,4.21,-4,0.7,3.2,4,0.7,3.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_A_Cit_6.0_7.5S_1M5C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,94.5,0.2,0.2,66.22,99.72,0.6,0.6,,59.84,14.22,25.94,0.2,0.8,-0.9,0.2,0.8,0.9,,,,,,,,,,,,,,,,,,,,,886.3,238,0,886.3,0,1.7,,,,,,,,,,94.73,4.2,1.07,-1,0.9,0.1,1,0.9,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_A_Cit_6.0_7.5S_2M25C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.07,4.37,1.56,-1.7,1.1,0.6,1.7,1.1,0.6,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_A_Cit_6.0_7.5S_2M5C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.06,3.74,1.2,-0.7,0.4,0.2,0.7,0.4,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_A_Cit_6.0_7.5S_2w25C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,94.4,0.1,0.1,70.68,98.8,-0.3,0.3,,58.56,15.15,26.29,-1.1,1.7,-0.6,1.1,1.7,0.6,,,,,,,,,,,,,,,,,,,,,1825.3,502.7,13.3,1825.3,0,2.2,,,,,,,,,,95.85,2.84,1.3,0.1,-0.5,0.3,0.1,0.5,0.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_A_Cit_6.0_7.5S_2w40C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,91.5,-2.8,2.8,68.85,96.44,-2.7,2.7,,36.9,45.28,17.82,-22.8,31.8,-9,22.8,31.8,9,,,,,,,,,,,,,,,,,,,,,3505.3,833.3,0,3505.3,0,1.5,,,,,,,,,,92.52,2.93,4.55,-3.2,-0.4,3.6,3.2,0.4,3.6,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_A_Cit_6.0_7.5S_T0,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,94.3,0,0,68.76,99.09,0,0,,59.67,13.46,26.87,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,3426,727.3,13.3,3412.7,0,1.3,,,,,,,,,,95.74,3.3,0.96,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_A_Cit_6.0_7.5S_T0_25C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_A_Cit_6.0_7.5S_T0_40C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_A_His_5.0_7.5S_1M25C,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,94.4,0.2,0.2,67.77,99.58,1.1,1.1,,60.13,13.44,26.42,0.1,0.7,-0.8,0.1,0.7,0.8,,,,,,,,,,,,,,,,,,,,,2248.7,489.3,0,2248.7,0,0.4,,,,,,,,,,94.58,4.53,0.88,-1.3,1.2,0.1,1.3,1.2,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_A_His_5.0_7.5S_1M40C,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,91.2,-3,3,63.33,96.46,-2,2,,46.55,29.68,23.77,-13.5,16.9,-3.4,13.5,16.9,3.4,,,,,,,,,,,,,,,,,,,,,25516,5211.3,26.7,25516,0,1,,,,,,,,,,90.1,5.03,4.87,-5.8,1.7,4.1,5.8,1.7,4.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_A_His_5.0_7.5S_1M5C,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,94.7,0.5,0.5,67.07,99.55,1.1,1.1,,59.1,13.45,27.45,-0.9,0.7,0.2,0.9,0.7,0.2,,,,,,,,,,,,,,,,,,,,,3783,674.7,0,3783,0,0.4,,,,,,,,,,94.84,4.38,0.78,-1,1,0,1,1,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_A_His_5.0_7.5S_2M5C,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.5,3.64,0.86,-0.4,0.3,0.1,0.4,0.3,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_A_His_5.0_7.5S_2w25C,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,94.4,0.2,0.2,70.31,98.46,0,0,,59.65,13.26,27.09,-0.4,0.5,-0.1,0.4,0.5,0.1,,,,,,,,,,,,,,,,,,,,,4285.3,714.3,39.7,4272.3,13.3,1.3,,,,,,,,,,95.7,3.4,0.9,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_A_His_5.0_7.5S_2w40C,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,92.2,-2,2,66.91,96.86,-1.6,1.6,,50.4,24.05,25.55,-9.6,11.3,-1.6,9.6,11.3,1.6,,,,,,,,,,,,,,,,,,,,,9404.7,1547.7,40,9391.3,13.3,2.8,,,,,,,,,,92.45,2.69,4.85,-3.4,-0.6,4.1,3.4,0.6,4.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_A_His_5.0_7.5S_T0,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,94.2,0,0,68.83,98.46,0,0,,60.03,12.77,27.2,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,8399.3,1402,26.7,8399.3,0,1.3,,,,,,,,,,95.89,3.33,0.78,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_A_His_5.0_7.5S_T0_25C,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_A_His_5.0_7.5S_T0_40C,NB-penglei5-5065175-0003,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_A_His_5.5_7.5S_1M25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,94.3,0.2,0.2,67.71,99.67,1.1,1.1,,44.8,50.19,5.01,-13.8,36.1,-22.3,13.8,36.1,22.3,,,,,,,,,,,,,,,,,,,,,1640,463,0,1640,0,0.9,,,,,,,,,,94.59,4.39,1.02,-1,0.9,0.2,1,0.9,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_A_His_5.5_7.5S_1M40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,91.3,-2.8,2.8,64.97,97.14,-1.5,1.5,,28.9,68.35,2.74,-29.7,54.2,-24.5,29.7,54.2,24.5,,,,,,,,,,,,,,,,,,,,,2275,383.7,0,2275,0,1.7,,,,,,,,,,92.18,4.82,3.01,-3.4,1.3,2.2,3.4,1.3,2.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_A_His_5.5_7.5S_1M5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,94.6,0.5,0.5,67.61,99.56,1,1,,60.23,13.39,26.38,1.6,-0.7,-0.9,1.6,-0.7,0.9,,,,,,,,,,,,,,,,,,,,,1997.3,370.3,13.3,1984,0,0.7,,,,,,,,,,95.1,4,0.89,-0.5,0.5,0,0.5,0.5,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_A_His_5.5_7.5S_2M25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.85,3.96,1.19,-0.8,0.4,0.3,0.8,0.4,0.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_A_His_5.5_7.5S_2M5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.52,3.47,1.01,-0.1,0,0.2,0.1,0,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_A_His_5.5_7.5S_2w25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,94.4,0.3,0.3,70.83,98.66,0.1,0.1,,59.16,14.44,26.39,0.6,0.3,-0.9,0.6,0.3,0.9,,,,,,,,,,,,,,,,,,,,,2724.7,317.3,13.3,2724.7,0,2.4,,,,,,,,,,95.59,3.38,1.03,0,-0.1,0.2,0,0.1,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_A_His_5.5_7.5S_2w40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,92.2,-1.9,1.9,68.85,97.49,-1.1,1.1,,46.94,31.14,21.92,-11.7,17,-5.4,11.7,17,5.4,,,,,,,,,,,,,,,,,,,,,4338.7,648.3,13.3,4338.7,0,1,,,,,,,,,,93.11,3.51,3.37,-2.5,0,2.5,2.5,0,2.5,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_A_His_5.5_7.5S_T0,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,94.1,0,0,69.94,98.61,0,0,,58.6,14.12,27.29,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.63,3.52,0.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_A_His_5.5_7.5S_T0_25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_A_His_5.5_7.5S_T0_40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_A_His_6.0_7.5S_1M25C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94.5,0.5,0.5,68.74,99.67,1,1,,55.66,20.49,23.86,-2.9,6,-3.1,2.9,6,3.1,,,,,,,,,,,,,,,,,,,,,2288.7,396.7,26.3,2275.3,13.3,1.1,,,,,,,,,,95.55,3.25,1.2,-0.7,0.4,0.3,0.7,0.4,0.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_A_His_6.0_7.5S_1M40C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,91.2,-2.8,2.8,65.47,97.62,-1.1,1.1,,33.9,50.4,15.7,-24.6,35.9,-11.2,24.6,35.9,11.2,,,,,,,,,,,,,,,,,,,,,2910,886.3,0,2910,0,0.8,,,,,,,,,,93.06,4.28,2.66,-3.2,1.4,1.8,3.2,1.4,1.8,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_A_His_6.0_7.5S_1M5C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94.3,0.3,0.3,67.24,99.6,0.9,0.9,,58.19,15.87,25.93,-0.4,1.4,-1,0.4,1.4,1,,,,,,,,,,,,,,,,,,,,,3716.7,436.3,0,3716.7,0,0.7,,,,,,,,,,94.81,4.19,0.99,-1.4,1.3,0.1,1.4,1.3,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_A_His_6.0_7.5S_2M25C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.06,4.61,1.34,-2.2,1.8,0.4,2.2,1.8,0.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_A_His_6.0_7.5S_2M5C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.89,4,1.12,-1.4,1.2,0.2,1.4,1.2,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_A_His_6.0_7.5S_2w25C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94.4,0.4,0.4,71.19,98.72,0,0,,57.22,18.08,24.7,-1.3,3.6,-2.2,1.3,3.6,2.2,,,,,,,,,,,,,,,,,,,,,2738,926,39.7,2724.7,0,1.1,,,,,,,,,,95.67,3.2,1.13,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_A_His_6.0_7.5S_2w40C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,92.2,-1.8,1.8,69.69,96.98,-1.7,1.7,,40.88,40.81,18.3,-17.7,26.3,-8.6,17.7,26.3,8.6,,,,,,,,,,,,,,,,,,,,,7288,1084.7,39.7,7288,0,0.6,,,,,,,,,,93.57,3.41,3.02,-2.7,0.6,2.1,2.7,0.6,2.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_A_His_6.0_7.5S_T0,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94,0,0,70.34,98.68,0,0,,58.55,14.51,26.94,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,17698.3,2791,40,17685,13.3,1.4,,,,,,,,,,96.25,2.85,0.9,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_A_His_6.0_7.5S_T0_25C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_A_His_6.0_7.5S_T0_40C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,-80,0,,,Trop2_B_17.5_Start,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94.4,0,0,66.09,98.75,0,0,,55.7,19.87,24.43,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,410555.5,126528,10595,409484,20,11.2,,,,,,,,,,95.19,3.04,1.77,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_B_Cit_5.5_5S_1M25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,95.4,0.8,0.8,63.97,99.7,1,1,,42.9,36.52,20.58,-13.7,18.1,-4.3,13.7,18.1,4.3,,,,,,,,,,,,,,,,,,,,,1045,450,0,1045,0,0.5,,,,,,,,,,94.83,1.86,3.32,-0.5,-1,1.5,0.5,1,1.5,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_B_Cit_5.5_5S_1M40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,92.4,-2.2,2.2,59.53,97.25,-1.4,1.4,,10.47,82.32,7.21,-46.2,63.9,-17.7,46.2,63.9,17.7,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0,0.2,,,,,,,,,,91.55,3.77,4.68,-2.3,0.8,1.5,2.3,0.8,1.5,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_B_Cit_5.5_5S_1M5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,95.2,0.6,0.6,63.68,99.7,1,1,,54.04,21.68,24.27,-2.6,3.2,-0.6,2.6,3.2,0.6,,,,,,,,,,,,,,,,,,,,,992,225,0,992,0,0.4,,,,,,,,,,95.6,1.85,2.55,0.2,-1,0.7,0.2,1,0.7,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_B_Cit_5.5_5S_2M25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.45,1.97,3.58,-0.9,-0.9,1.8,0.9,0.9,1.8,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_B_Cit_5.5_5S_2M5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95,2.19,2.81,-0.4,-0.6,1,0.4,0.6,1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_B_Cit_5.5_5S_2w25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,94.7,0.1,0.1,67.11,98.33,-0.4,0.4,,46.54,30.51,22.95,-10.1,12.1,-1.9,10.1,12.1,1.9,,,,,,,,,,,,,,,,,,,,,582,145.3,13.3,568.7,13.3,0.7,,,,,,,,,,94.79,2.24,2.97,-0.6,-0.6,1.2,0.6,0.6,1.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_B_Cit_5.5_5S_2w40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,92.9,-1.7,1.7,63.2,96.5,-2.2,2.2,,16.45,76.95,6.6,-40.2,58.5,-18.3,40.2,58.5,18.3,,,,,,,,,,,,,,,,,,,,,2024,608.3,0,2024,0,0.2,,,,,,,,,,91.97,3.05,4.99,-3.4,0.2,3.2,3.4,0.2,3.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_B_Cit_5.5_5S_3w5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,94.7,0.1,0.1,65.96,98.82,0.1,0.1,,55.53,19.82,24.65,-1.1,1.4,-0.2,1.1,1.4,0.2,,,,,,,,,,,,,,,,,,,,,1587.3,383.3,0,1587.3,0,1.1,,,,,,,,,,95.01,2.5,2.49,-0.3,-0.3,0.7,0.3,0.3,0.7,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_B_Cit_5.5_5S_T0,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,94.6,0,0,66.18,98.72,0,0,,56.64,18.45,24.9,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,5965.7,754,26.7,5939.3,13.3,1.1,,,,,,,,,,95.36,2.83,1.81,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_B_Cit_5.5_5S_T0_25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_B_Cit_5.5_5S_T0_40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_B_Cit_6.0_5S_1M25C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,95.2,0.5,0.5,63.86,99.7,0.8,0.8,,44.67,34.24,21.09,-12.3,16.4,-4,12.3,16.4,4,,,,,,,,,,,,,,,,,,,,,3756.7,674.7,13.3,3743.7,0,0.3,,,,,,,,,,95.68,1.38,2.94,0.5,-1.6,1.1,0.5,1.6,1.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_B_Cit_6.0_5S_1M40C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,92.4,-2.3,2.3,59.92,97.36,-1.5,1.5,,14.99,74.24,10.77,-42,56.4,-14.4,42,56.4,14.4,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53,1561,26.7,0.8,,,,,,,,,,92.21,3.19,4.6,-2.9,0.2,2.7,2.9,0.2,2.7,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_B_Cit_6.0_5S_1M5C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,95.3,0.6,0.6,63.6,99.74,0.8,0.8,,57.3,20.29,22.41,0.3,2.4,-2.7,0.3,2.4,2.7,,,,,,,,,,,,,,,,,,,,,1164,423.3,13.3,1164,0,0.6,,,,,,,,,,95.9,1.79,2.3,0.8,-1.2,0.4,0.8,1.2,0.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_B_Cit_6.0_5S_2M25C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.6,1.95,3.45,-0.6,-1,1.6,0.6,1,1.6,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_B_Cit_6.0_5S_2M5C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.87,2.47,2.66,-0.3,-0.5,0.8,0.3,0.5,0.8,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_B_Cit_6.0_5S_2w25C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,94.7,0,0,67.11,98.56,-0.3,0.3,,49.02,28.05,22.93,-7.9,10.2,-2.2,7.9,10.2,2.2,,,,,,,,,,,,,,,,,,,,,370.3,132.3,26.7,357.3,13.3,0.7,,,,,,,,,,94.44,2.65,2.9,-0.7,-0.4,1,0.7,0.4,1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_B_Cit_6.0_5S_2w40C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,93.1,-1.6,1.6,62.45,96,-2.9,2.9,,15.83,69.87,14.3,-41.1,52,-10.8,41.1,52,10.8,,,,,,,,,,,,,,,,,,,,,5092.3,1521.3,39.7,5066,0,0.3,,,,,,,,,,92.25,3.19,4.56,-2.9,0.2,2.7,2.9,0.2,2.7,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_B_Cit_6.0_5S_3w5C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,94.6,-0.1,0.1,66.28,98.77,-0.1,0.1,,56.67,18.56,24.78,-0.3,0.7,-0.3,0.3,0.7,0.3,,,,,,,,,,,,,,,,,,,,,1494.7,383.7,26.3,1481.7,0,0.9,,,,,,,,,,94.77,2.77,2.46,-0.4,-0.2,0.6,0.4,0.2,0.6,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_B_Cit_6.0_5S_T0,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,94.7,0,0,64.56,98.91,0,0,,56.97,17.89,25.13,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1693,529,26.7,1679.7,13.3,0.8,,,,,,,,,,95.15,3,1.85,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_B_Cit_6.0_5S_T0_25C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_B_Cit_6.0_5S_T0_40C,NB-penglei5-5065175-0003,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_B_Cit_6.5_5S_1M25C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,95.5,0.9,0.9,63.43,99.67,0.6,0.6,,40.12,42.31,17.57,-16.1,23.3,-7.1,16.1,23.3,7.1,,,,,,,,,,,,,,,,,,,,,2209,568.7,26.7,2209,0,0.3,,,,,,,,,,95.32,1.84,2.85,0.4,-1.2,0.8,0.4,1.2,0.8,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_B_Cit_6.5_5S_1M40C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,91.9,-2.7,2.7,59.39,97.41,-1.7,1.7,,13.21,81.71,5.07,-43,62.7,-19.6,43,62.7,19.6,,,,,,,,,,,,,,,,,,,,,926,171.7,0,926,0,0.4,,,,,,,,,,93.45,2.67,3.88,-2.5,-0.1,2.7,2.5,0.1,2.7,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_B_Cit_6.5_5S_1M5C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,95.3,0.7,0.7,63.47,99.71,0.6,0.6,,54.34,22.12,23.54,-1.9,3.1,-1.2,1.9,3.1,1.2,,,,,,,,,,,,,,,,,,,,,1018.7,317.3,13.3,1018.7,0,0.5,,,,,,,,,,95.32,2.16,2.53,0.4,-0.8,0.5,0.4,0.8,0.5,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_B_Cit_6.5_5S_2M25C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.32,2.35,3.33,-0.6,-0.6,1.3,0.6,0.6,1.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_B_Cit_6.5_5S_2M5C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.77,2.59,2.65,-0.2,-0.4,0.6,0.2,0.4,0.6,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_B_Cit_6.5_5S_2w25C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,94.7,0.1,0.1,65.71,99.02,-0.1,0.1,,43.95,33.82,22.23,-12.3,14.8,-2.5,12.3,14.8,2.5,,,,,,,,,,,,,,,,,,,,,926,238,0,926,0,0.6,,,,,,,,,,94.04,2.98,2.98,-0.9,0,0.9,0.9,0,0.9,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_B_Cit_6.5_5S_2w40C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,92.9,-1.7,1.7,61.66,95.48,-3.6,3.6,,16.43,77.42,6.15,-39.8,58.4,-18.6,39.8,58.4,18.6,,,,,,,,,,,,,,,,,,,,,2447.3,595.3,52.7,2447.3,0,0.3,,,,,,,,,,93.62,1.65,4.75,-1.3,-1.4,2.7,1.3,1.4,2.7,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_B_Cit_6.5_5S_3w5C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,93.9,-0.7,0.7,65.41,99.17,0.1,0.1,,54.6,20.6,24.8,-1.6,1.6,0.1,1.6,1.6,0.1,,,,,,,,,,,,,,,,,,,,,397,132.3,13.3,397,0,0.6,,,,,,,,,,94.6,2.93,2.47,-0.4,-0.1,0.4,0.4,0.1,0.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_B_Cit_6.5_5S_T0,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,94.6,0,0,66.56,99.09,0,0,,56.25,19.03,24.72,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0,0.9,,,,,,,,,,94.95,3,2.05,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_B_Cit_6.5_5S_T0_25C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_B_Cit_6.5_5S_T0_40C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_B_His_5.5_5S_1M25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,95.2,1,1,63.63,99.71,0.9,0.9,,52.07,26.87,21.06,-5.3,9.7,-4.3,5.3,9.7,4.3,,,,,,,,,,,,,,,,,,,,,1018.7,198.3,13.3,1018.7,0,0.4,,,,,,,,,,96.74,1.7,1.56,1.6,-1.8,0.2,1.6,1.8,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_B_His_5.5_5S_1M40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,91.6,-2.6,2.6,60.93,97.87,-0.9,0.9,,18.71,71.4,9.9,-38.7,54.2,-15.5,38.7,54.2,15.5,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582,0,0.6,,,,,,,,,,92.89,4.39,2.72,-2.2,0.8,1.4,2.2,0.8,1.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_B_His_5.5_5S_1M5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,95.3,1.1,1.1,63.67,99.68,0.9,0.9,,57.86,18.56,23.59,0.5,1.4,-1.8,0.5,1.4,1.8,,,,,,,,,,,,,,,,,,,,,2777.7,529,0,2777.7,0,0.7,,,,,,,,,,96.87,1.78,1.35,1.8,-1.8,0,1.8,1.8,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_B_His_5.5_5S_2M25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.74,2.53,1.73,0.6,-1,0.4,0.6,1,0.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_B_His_5.5_5S_2M5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.76,2.81,1.43,0.6,-0.7,0.1,0.6,0.7,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_B_His_5.5_5S_2w25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,94.7,0.5,0.5,65.5,96.91,-1.9,1.9,,55.43,20.28,24.29,-2,3.1,-1.1,2,3.1,1.1,,,,,,,,,,,,,,,,,,,,,582.3,39.7,0,582.3,0,0.6,,,,,,,,,,95.04,3.47,1.48,-0.1,-0.1,0.1,0.1,0.1,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_B_His_5.5_5S_2w40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,92.3,-1.9,1.9,64.05,96.69,-2.1,2.1,,27.48,60.2,12.32,-29.9,43,-13.1,29.9,43,13.1,,,,,,,,,,,,,,,,,,,,,952.3,211.7,13.3,952.3,0,0.2,,,,,,,,,,93.06,4.58,2.37,-2.1,1,1,2.1,1,1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_B_His_5.5_5S_3w5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,94.6,0.4,0.4,65.87,98.78,0,0,,57.09,18.15,24.76,-0.3,0.9,-0.6,0.3,0.9,0.6,,,,,,,,,,,,,,,,,,,,,1296.3,264.3,13.3,1296.3,0,1.1,,,,,,,,,,95.42,3.12,1.46,0.3,-0.4,0.1,0.3,0.4,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_B_His_5.5_5S_T0,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,94.2,0,0,66,98.81,0,0,,57.4,17.2,25.4,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0,1097.7,0,0.8,,,,,,,,,,95.12,3.54,1.34,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_B_His_5.5_5S_T0_25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_B_His_5.5_5S_T0_40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_B_His_6.0_5S_1M25C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,95.1,0.2,0.2,63.71,99.69,0.8,0.8,,44.88,34.88,20.23,-10.5,14.9,-4.4,10.5,14.9,4.4,,,,,,,,,,,,,,,,,,,,,3307,370.3,0,3307,0,0.6,,,,,,,,,,95.74,2.39,1.87,0.8,-1.2,0.3,0.8,1.2,0.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_B_His_6.0_5S_1M40C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,91.7,-3.2,3.2,60.65,98.02,-0.9,0.9,,15.01,78.16,6.82,-40.4,58.2,-17.8,40.4,58.2,17.8,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0,0.5,,,,,,,,,,92.33,4.11,3.56,-2.6,0.5,2,2.6,0.5,2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_B_His_6.0_5S_1M5C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,95.6,0.7,0.7,63.63,99.71,0.8,0.8,,50.92,26.35,22.74,-4.5,6.4,-1.9,4.5,6.4,1.9,,,,,,,,,,,,,,,,,,,,,10595.3,595.3,0,10595.3,0,0.7,,,,,,,,,,96.72,1.66,1.62,1.8,-1.9,0.1,1.8,1.9,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_B_His_6.0_5S_2M25C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.11,2.83,2.07,0.2,-0.8,0.5,0.2,0.8,0.5,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_B_His_6.0_5S_2M5C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.76,2.55,1.68,0.9,-1,0.1,0.9,1,0.1,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_B_His_6.0_5S_2w25C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94.5,-0.4,0.4,67.42,98.51,-0.4,0.4,,47.48,30.23,22.29,-7.9,10.3,-2.3,7.9,10.3,2.3,,,,,,,,,,,,,,,,,,,,,2354.7,198,39.7,2341.3,13.3,0.9,,,,,,,,,,94.54,3.67,1.79,-0.3,0.1,0.3,0.3,0.1,0.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_B_His_6.0_5S_2w40C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,92,-2.9,2.9,63.21,96.52,-2.4,2.4,,20.9,69.59,9.52,-34.5,49.6,-15.1,34.5,49.6,15.1,,,,,,,,,,,,,,,,,,,,,4695.7,1296,66,4695.7,0,0.4,,,,,,,,,,92.56,4.24,3.2,-2.3,0.7,1.7,2.3,0.7,1.7,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_B_His_6.0_5S_3w5C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94.5,-0.4,0.4,66.85,98.74,-0.2,0.2,,54.32,22.2,23.48,-1.1,2.2,-1.1,1.1,2.2,1.1,,,,,,,,,,,,,,,,,,,,,9894.3,608.7,13.3,9894.3,0,0.5,,,,,,,,,,94.72,3.51,1.78,-0.2,-0.1,0.2,0.2,0.1,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_B_His_6.0_5S_T0,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,94.9,0,0,65.05,98.93,0,0,,55.42,19.97,24.61,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,979,224.7,0,979,0,1.1,,,,,,,,,,94.89,3.58,1.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_B_His_6.0_5S_T0_25C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_B_His_6.0_5S_T0_40C,NB-penglei5-5065175-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,30,,,Trop2_B_His_6.5_5S_1M25C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,95.2,0.6,0.6,63.64,99.71,0.8,0.8,,32.04,53.12,14.84,-23.1,31.9,-8.9,23.1,31.9,8.9,,,,,,,,,,,,,,,,,,,,,6389,224.7,13.3,6389,0,1,,,,,,,,,,94.62,3.29,2.09,-0.3,-0.2,0.5,0.3,0.2,0.5,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,30,,,Trop2_B_His_6.5_5S_1M40C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,91.9,-2.7,2.7,59.93,97.6,-1.3,1.3,,12.7,81.68,5.62,-42.4,60.5,-18.1,42.4,60.5,18.1,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0,0.4,,,,,,,,,,93.78,2.95,3.26,-1.1,-0.5,1.7,1.1,0.5,1.7,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,30,,,Trop2_B_His_6.5_5S_1M5C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,95.4,0.8,0.8,63.67,99.71,0.8,0.8,,45.26,33.84,20.9,-9.9,12.7,-2.8,9.9,12.7,2.8,,,,,,,,,,,,,,,,,,,,,4788.7,542.3,39.7,4775.3,0,0.5,,,,,,,,,,96.02,2.17,1.81,1.1,-1.3,0.2,1.1,1.3,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,60,,,Trop2_B_His_6.5_5S_2M25C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.18,2.6,2.23,0.3,-0.9,0.6,0.3,0.9,0.6,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,60,,,Trop2_B_His_6.5_5S_2M5C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.89,2.29,1.82,1,-1.2,0.2,1,1.2,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,14,,,Trop2_B_His_6.5_5S_2w25C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,94.6,0,0,67.46,98.43,-0.5,0.5,,38.29,43.84,17.88,-16.8,22.7,-5.8,16.8,22.7,5.8,,,,,,,,,,,,,,,,,,,,,5846.7,476,0,5846.7,0,1,,,,,,,,,,94.42,3.58,2,-0.5,0.1,0.4,0.5,0.1,0.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,14,,,Trop2_B_His_6.5_5S_2w40C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,91.6,-3,3,63.42,96.45,-2.4,2.4,,14.21,76.7,9.1,-40.9,55.5,-14.6,40.9,55.5,14.6,,,,,,,,,,,,,,,,,,,,,8254,3492,119,8254,0,0.4,,,,,,,,,,93.83,3.08,3.09,-1.1,-0.4,1.5,1.1,0.4,1.5,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,21,,,Trop2_B_His_6.5_5S_3w5C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,94.3,-0.3,0.3,66.22,99,0.1,0.1,,45.43,32.82,21.75,-9.7,11.6,-1.9,9.7,11.6,1.9,,,,,,,,,,,,,,,,,,,,,9312.3,740.7,26.7,9299,13.3,0.9,,,,,,,,,,95.11,3,1.89,0.2,-0.5,0.3,0.2,0.5,0.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5,0,,,Trop2_B_His_6.5_5S_T0,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,94.6,0,0,65.17,98.93,0,0,,55.13,21.17,23.7,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,1561,304.3,26.7,1547.7,0,1.2,,,,,,,,,,94.92,3.49,1.6,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25,0,,,Trop2_B_His_6.5_5S_T0_25C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40,0,,,Trop2_B_His_6.5_5S_T0_40C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,-80,0,,,Trop2_MMAE_53_Start,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,207063.5,24980,198,207024,0,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,30,,,Trop2_MMAE_Cit_5.5_7.5S_1M25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15079.3,1865.3,0,15079.3,0,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,14,,,Trop2_MMAE_Cit_6.0_7.5S_2w40C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3505.3,833.3,0,3505.3,0,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,30,,,Trop2_MMAE_His_5.0_7.5S_1M40C,NB-ramapa-5085300-0003-0001,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25516,5211.3,26.7,25516,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,30,,,Trop2_MMAE_His_5.0_7.5S_1M5C,NB-ramapa-5085300-0003-0001,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3783,674.7,0,3783,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,14,,,Trop2_MMAE_His_5.0_7.5S_2w40C,NB-ramapa-5085300-0003-0001,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9404.7,1547.7,40,9391.3,13.3,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,14,,,Trop2_MMAE_His_5.5_7.5S_2w40C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4338.7,648.3,13.3,4338.7,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,30,,,Trop2_MMAE_His_6.0_7.5S_1M40C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2910,886.3,0,2910,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,14,,,Trop2_MMAE_His_6.0_7.5S_2w40C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7288,1084.7,39.7,7288,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,0,,,Trop2_MMAE_His_6.0_7.5S_T0,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17698.3,2791,40,17685,13.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,-80,0,,,Trop2_PNU_17.5_Start,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,410555.5,126528,10595,409484,20,11.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,30,,,Trop2_PNU_Cit_5.5_5S_1M25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1045,450,0,1045,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,30,,,Trop2_PNU_Cit_5.5_5S_1M40C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,14,,,Trop2_PNU_Cit_5.5_5S_2w25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582,145.3,13.3,568.7,13.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,21,,,Trop2_PNU_Cit_5.5_5S_3w5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,383.3,0,1587.3,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,30,,,Trop2_PNU_Cit_6.0_5S_1M5C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1164,423.3,13.3,1164,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,21,,,Trop2_PNU_Cit_6.5_5S_3w5C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,397,132.3,13.3,397,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,0,,,Trop2_PNU_Cit_6.5_5S_T0,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,30,,,Trop2_PNU_His_5.5_5S_1M25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1018.7,198.3,13.3,1018.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,30,,,Trop2_PNU_His_5.5_5S_1M40C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,14,,,Trop2_PNU_His_5.5_5S_2w40C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,952.3,211.7,13.3,952.3,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,0,,,Trop2_PNU_His_5.5_5S_T0,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0,1097.7,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,30,,,Trop2_PNU_His_6.0_5S_1M40C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,21,,,Trop2_PNU_His_6.0_5S_3w5C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9894.3,608.7,13.3,9894.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,0,,,Trop2_PNU_His_6.0_5S_T0,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,979,224.7,0,979,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,30,,,Trop2_PNU_His_6.5_5S_1M25C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6389,224.7,13.3,6389,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,14,,,Trop2_PNU_His_6.5_5S_2w25C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5846.7,476,0,5846.7,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,60,,,Trop2_MMAE_Cit_5.5_7.5S_2M25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6124.3,1362.3,185,6071.3,0,3.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,60,,,Trop2_PNU_Cit_6.5_5S_2M25C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1957.7,436.7,26.3,1944.3,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,60,,,Trop2_MMAE_His_6.0_7.5S_2M25C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1177,225,26.7,1164,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,60,,,Trop2_PNU_Cit_5.5_5S_2M5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1508,317.3,13.3,1508,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,60,,,Trop2_PNU_His_5.5_5S_2M5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1137.3,277.7,13.3,1137.3,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,60,,,Trop2_PNU_Cit_6.0_5S_2M5C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,807,225,13.3,807,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,60,,,Trop2_MMAE_His_6.0_7.5S_2M5C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582,53,0,582,0,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,60,,,Trop2_PNU_Cit_5.5_5S_2M25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,675,145.3,26.7,675,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,30,,,Trop2_MMAE_Cit_5.5_7.5S_1M5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2817.3,635,0,2817.3,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,30,,,Trop2_MMAE_Cit_6.0_7.5S_1M5C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,886.3,238,0,886.3,0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,30,,,Trop2_MMAE_His_5.0_7.5S_1M25C,NB-ramapa-5085300-0003-0001,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2248.7,489.3,0,2248.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,30,,,Trop2_MMAE_His_5.5_7.5S_1M5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997.3,370.3,13.3,1984,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,30,,,Trop2_MMAE_His_6.0_7.5S_1M5C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3716.7,436.3,0,3716.7,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,14,,,Trop2_PNU_Cit_5.5_5S_2w40C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2024,608.3,0,2024,0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,14,,,Trop2_PNU_Cit_6.0_5S_2w25C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,370.3,132.3,26.7,357.3,13.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,21,,,Trop2_PNU_Cit_6.0_5S_3w5C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1494.7,383.7,26.3,1481.7,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,30,,,Trop2_PNU_Cit_6.5_5S_1M25C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2209,568.7,26.7,2209,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,30,,,Trop2_PNU_Cit_6.5_5S_1M40C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926,171.7,0,926,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,14,,,Trop2_PNU_Cit_6.5_5S_2w40C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2447.3,595.3,52.7,2447.3,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,30,,,Trop2_PNU_His_6.0_5S_1M25C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3307,370.3,0,3307,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,60,,,Trop2_MMAE_His_5.0_7.5S_2M5C,NB-ramapa-5085300-0003-0001,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30410.3,4206.3,26.3,30410.3,0,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,60,,,Trop2_PNU_His_6.5_5S_2M5C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10674.7,754,13.3,10661.3,13.3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,60,,,Trop2_PNU_His_6.5_5S_2M25C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4510.3,436.7,13.3,4497.3,13.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,60,,,Trop2_MMAE_His_5.5_7.5S_2M25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4312,846.3,39.7,4312,0,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,60,,,Trop2_PNU_His_6.0_5S_2M25C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5542.3,423.3,13.3,5542.3,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,60,,,Trop2_PNU_His_5.5_5S_2M25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,608.7,145.7,13.3,608.7,0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,0,,,Trop2_MMAE_His_5.5_7.5S_T0,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2142.5,516,20,2142.5,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,30,,,Trop2_MMAE_Cit_5.5_7.5S_1M40C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12156,2116.3,13.3,12156,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,14,,,Trop2_MMAE_Cit_5.5_7.5S_2w25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1666.7,343.7,13.3,1653.7,13.3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,14,,,Trop2_MMAE_Cit_6.0_7.5S_2w25C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1825.3,502.7,13.3,1825.3,0,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,14,,,Trop2_MMAE_His_5.0_7.5S_2w25C,NB-ramapa-5085300-0003-0001,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4285.3,714.3,39.7,4272.3,13.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,30,,,Trop2_PNU_Cit_6.0_5S_1M25C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3756.7,674.7,13.3,3743.7,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,14,,,Trop2_PNU_His_5.5_5S_2w25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582.3,39.7,0,582.3,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,14,,,Trop2_PNU_His_6.0_5S_2w25C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2354.7,198,39.7,2341.3,13.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,14,,,Trop2_PNU_His_6.0_5S_2w40C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4695.7,1296,66,4695.7,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,60,,,Trop2_MMAE_Cit_6.0_7.5S_2M25C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7314.7,1984.3,105.7,7301.7,13.3,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,30,,,Trop2_MMAE_Cit_6.0_7.5S_1M25C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3558,621.7,39.7,3544.7,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,0,,,Trop2_MMAE_Cit_6.0_7.5S_T0,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3426,727.3,13.3,3412.7,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,30,,,Trop2_MMAE_His_5.5_7.5S_1M25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1640,463,0,1640,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,14,,,Trop2_MMAE_His_6.0_7.5S_2w25C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3928.5,1349.5,59.5,3908.5,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,0,,,Trop2_PNU_Cit_5.5_5S_T0,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5965.7,754,26.7,5939.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,0,,,Trop2_PNU_Cit_6.0_5S_T0,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1693,529,26.7,1679.7,13.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,30,,,Trop2_PNU_His_5.5_5S_1M5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2777.7,529,0,2777.7,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,30,,,Trop2_PNU_His_6.5_5S_1M40C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,30,,,Trop2_PNU_His_6.5_5S_1M5C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4788.7,542.3,39.7,4775.3,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,21,,,Trop2_PNU_His_6.5_5S_3w5C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9312.3,740.7,26.7,9299,13.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,60,,,Trop2_MMAE_His_5.5_7.5S_2M5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4153.3,436.3,0,4153.3,0,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,60,,,Trop2_MMAE_Cit_5.5_7.5S_2M5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3148.3,569,0,3148.3,0,2.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,30,,,Trop2_MMAE_Cit_6.0_7.5S_1M40C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3651,939.3,13.3,3651,0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,30,,,Trop2_MMAE_His_6.0_7.5S_1M25C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2288.7,396.7,26.3,2275.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,30,,,Trop2_PNU_Cit_6.0_5S_1M40C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53,1561,26.7,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,21,,,Trop2_PNU_His_5.5_5S_3w5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1296.3,264.3,13.3,1296.3,0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,60,,,Trop2_PNU_His_6.0_5S_2M5C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9590,793.7,0,9590,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,60,,,Trop2_MMAE_Cit_6.0_7.5S_2M5C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2949.7,820,79.3,2949.7,0,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,60,,,Trop2_PNU_Cit_6.5_5S_2M5C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1071.3,291.3,13.3,1071.3,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,30,,,Trop2_MMAE_His_5.5_7.5S_1M40C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2275,383.7,0,2275,0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,30,,,Trop2_PNU_Cit_5.5_5S_1M5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,992,225,0,992,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25,14,,,Trop2_MMAE_His_5.5_7.5S_2w25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2724.7,317.3,13.3,2724.7,0,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,14,,,Trop2_PNU_Cit_6.5_5S_2w25C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926,238,0,926,0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25,60,,,Trop2_PNU_Cit_6.0_5S_2M25C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1164,476.3,26.7,1164,0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,14,,,Trop2_PNU_Cit_6.0_5S_2w40C,NB-ramapa-5085300-0003-0001,6,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5092.3,1521.3,39.7,5066,0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,30,,,Trop2_PNU_Cit_6.5_5S_1M5C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1018.7,317.3,13.3,1018.7,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,30,,,Trop2_PNU_His_6.0_5S_1M5C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10595.3,595.3,0,10595.3,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5,0,,,Trop2_PNU_His_6.5_5S_T0,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1561,304.3,26.7,1547.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40,14,,,Trop2_MMAE_Cit_5.5_7.5S_2w40C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2182.7,436.7,0,2182.7,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,0,,,Trop2_MMAE_His_5.0_7.5S_T0,NB-ramapa-5085300-0003-0001,5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8399.3,1402,26.7,8399.3,0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5,0,,,Trop2_MMAE_Cit_5.5_7.5S_T0,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4391.7,820,0,4391.7,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40,14,,,Trop2_PNU_His_6.5_5S_2w40C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8254,3492,119,8254,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,ramapa,,,,,,,,,,VLS231_Start_0.2x,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11865,4921,794,11508,159,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,,,,,,,,,VLS231_0.2%Pyr_0.2x,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5357,1429,40,5317,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,Trab,,,,,,,,Trop2-Trabectedin_Start_CT,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14127,4127,238,14127,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,,,,,,,,,VLS231_CT,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3254,913,79,3214,40,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000141_007,,,,,,,,VLS231_CT,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3254,913,79,3214,40,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000706_005,,,,,,,,D62_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25952,6151,40,25913,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000706_005,,,,,,,,D62_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11667,1944,159,11667,0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000674_005,,,,,,,,D63_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13492,1349,0,13492,0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,Trab,,,,,,,,Trop2-Trabectedin_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75198,17698,198,75119,40,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,Trab,,,,,,,,Trop2-Trabectedin_1%SBEbCD_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2976,913,79,2937,40,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,,,,,,,,,Trop2-Trabectedin_Start_0.2x,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26984,7817,317,26944,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,Trab,,,,,,,,Trop2-Trabectedin_0.2%Pyr_0.2x,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24921,6984,238,24881,40,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DAB015692_013,,,,,,,,Anti-MMAE_Fab_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,252976,94603,675,252937,0,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,,,,,,,,,Trop2-Trabectedin_Start_CT,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14127,4127,238,14127,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000141_007,,,,,,,,VLS231_0.2%Pyr_0.2x,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5357,1429,40,5317,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DAB015692_013,,,,,,,,Anti-MMAE_Fab_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83214,32302,437,83135,0,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000492_005,,,,,,,,D64_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13333,2262,40,13333,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,,,,,,,,,Trop2-Trabectedin_T0,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75198,17698,198,75119,40,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,Trab,,,,,,,,Trop2-Trabectedin_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9127,2817,159,9087,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,Trab,,,,,,,,Trop2-Trabectedin_0.5%MoNi_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5873,1032,79,5833,0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000492_005,,,,,,,,D64_2w25C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21706,7659,40,21706,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000141_007,,,,,,,,VLS231_Start_0.2x,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11865,4921,794,11508,159,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,Trab,,,,,,,,Trop2-Trabectedin_Start_0.2x,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26984,7817,317,26944,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,,,,,,,,,Trop2-Trabectedin_0.2%Pyr_0.2x,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24921,6984,238,24881,40,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,ramapa,,DCC000674_005,,,,,,,,D63_2w40C,NB-ramapa-5085300-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21508,4405,238,21508,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,0,0,0,0,,,,100,0.09,,,98.09,-1.91,,0.0412,42,42.24,15.75,-24.2,,,,,,60.2,,511651,33463.8,2258.1,696.1,135.8,34,0,0,,57281.3,23268.9,9708.1,6771.9,2732.5,831.6,33.9,17,,,,,,,,92.5,0.96,6.53,-2.7,0.79,1.9,,,,96.1,0.91,3.03,-1.17,-0.13,1.3,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,0,0,0,0,,,,100,0.09,,,99.64,-0.36,,0.0446,39.9,48,12.09,-26.3,,,,,,63.8,,106050.9,3089.2,662,356.4,118.8,33.9,0,0,,102888.3,22166.3,8146.9,5499.1,2087.6,611,17,0,,,,,,,,92,1.07,6.89,-3.2,0.9,2.26,,,,96.7,0.82,2.45,-0.51,-0.22,0.72,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,0,0,0,0,,,,100,0.09,,,99.33,-0.67,,0.0448,35.7,54.31,10.03,-30.6,,,,,,64.8,,13747.4,2138.5,339.4,135.8,0,0,0,0,,43296,16496.9,5583.8,3886.6,1459.6,424.3,17,0,,,,,,,,91.9,1.17,6.92,-3.3,1,2.29,,,,96.7,0.88,2.46,-0.57,-0.16,0.73,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,0,0,0,0,,,,99.83,-0.08,,,100,0,,0.0453,36.6,53.78,9.64,-29.6,,,,,,63.6,,73373.8,2681.7,475.2,169.7,17,17,0,0,,35523.4,10047.7,3852.8,2308.3,645,169.7,0,0,,,,,,,,87.7,1.02,11.25,-7.5,0.85,6.62,,,,96.5,0.83,2.71,-0.77,-0.21,0.98,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,0,0,0,0,,,,94.66,-5.25,,,97.19,-2.81,,0.0441,29.7,63.81,6.48,-36.5,,,,,,64,,168741.8,3140.3,390.4,305.5,33.9,0,0,0,,46573,4667.5,1748.2,1154.1,322.5,152.8,17,17,,,,,,,,86.4,1,12.63,-8.8,0.83,8,,,,96.1,0.85,3.03,-1.12,-0.19,1.3,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,0,0,0,0,,,,100,0.09,,,99.2,-0.8,,0.0438,23.3,71.41,5.31,-42.9,,,,,,63,,204254.7,4260.6,458.3,152.8,17,0,0,0,,20281.7,3886.6,1459.6,865.6,237.6,50.9,0,0,,,,,,,,85.1,1.12,13.76,-10.1,0.95,9.13,,,,96.1,0.82,3.1,-1.15,-0.22,1.37,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,0,0,0,0,,,,100,0.09,,,96.13,-3.87,,0.0479,,,,,,,,,,56,,11099.7,2087.6,424.3,220.6,50.9,17,0,0,,45502.2,17922.5,6126.9,3767.8,1239,186.7,0,0,,,,,,,,93.5,0.79,5.71,-1.7,0.62,1.08,,,,87.3,1.84,10.89,-9.96,0.8,9.16,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,0,0,0,0,,,,99.86,-0.05,,,96.84,-3.16,,0.047,,,,,,,,,,59.8,,20248,2274.3,577.1,271.6,135.8,50.9,0,0,,51782.4,20197,6177.9,4056.4,1239,390.4,17,17,,,,,,,,93.1,0.94,6,-2.1,0.77,1.37,,,,95.6,0.88,3.55,-1.66,-0.16,1.82,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,0,0,0,0,,,,100,0.09,,,99.42,-0.58,,0.0512,,,,,,,,,,63.2,,16513.9,1442.6,186.7,101.8,33.9,0,0,0,,51443.4,19060,8350.4,5363.3,2257.3,729.8,17,17,,,,,,,,92.6,1.01,6.44,-2.6,0.84,1.81,,,,96.5,0.9,2.56,-0.69,-0.14,0.83,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,B11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,0,0,0,0,,,,100,0.09,,,99.74,-0.26,,0.0474,,,,,,,,,,65.6,,101704.3,6059.5,950.5,441.3,135.8,33.9,17,17,,62814.5,18364,6941.7,4480.7,1680.3,661.9,17,0,,,,,,,,92.6,1.02,6.37,-2.6,0.85,1.74,,,,97,0.74,2.25,-0.23,-0.3,0.52,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,50,0,0,0,,,,100,0.09,,,99.84,-0.16,,0.0437,59.4,25.27,15.32,-6.8,,,,,,56.6,,30682.8,7895.7,916.9,509.4,152.8,101.9,17,0,,148581.1,47694,17499.1,11320.9,4090.5,1714.3,67.9,17,,,,,,,,86.9,1.02,12.05,-8.3,0.85,7.42,,,,93.2,0.91,5.91,-4.04,-0.13,4.18,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,50,0,0,0,,,,100,0.09,,,99.92,-0.08,,0.0445,67.5,24.57,7.89,1.3,,,,,,62.2,,20044.9,2596.8,475.2,288.5,135.8,84.9,67.9,67.9,,180862.7,72032.8,33351.6,22964.3,7807.5,2512,50.9,0,,,,,,,,86.1,0.93,13,-9.1,0.76,8.37,,,,96.1,0.92,3.01,-1.16,-0.12,1.28,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,50,0,0,0,,,,98.93,-0.98,,,99.93,-0.07,,0.0456,18.8,75.27,5.9,-47.4,,,,,,63.6,,35319.6,2766.5,492.2,305.5,50.9,33.9,0,0,,67990.9,16225.5,5295.3,2919.2,628,305.5,50.9,17,,,,,,,,86.2,0.87,12.88,-9,0.7,8.25,,,,96.4,0.81,2.78,-0.82,-0.23,1.05,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,50,0,0,0,,,,100,0.09,,,99.89,-0.11,,0.0464,20.1,74.4,5.54,-46.2,,,,,,63.6,,23642.2,1866.9,305.5,186.7,67.9,0,0,0,,101325.1,28768.2,8859.6,5142.6,1391.7,390.4,67.9,0,,,,,,,,82.8,0.93,16.27,-12.4,0.76,11.64,,,,95.7,0.83,3.44,-1.51,-0.21,1.71,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,50,0,0,0,,,,100,0.09,,,99.91,-0.09,,0.0456,18.4,77.05,4.58,-47.9,,,,,,65,,43941.6,2308.3,254.6,152.8,0,0,0,0,,51970.3,15377.2,5193.6,3241.8,1120.2,407.3,50.9,17,,,,,,,,82,1,16.97,-13.2,0.83,12.34,,,,96,0.81,3.19,-1.23,-0.23,1.46,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,50,0,0,0,,,,99.16,-0.75,,,99.9,-0.1,,0.0458,81.8,14.98,3.26,15.5,,,,,,66.6,,60067.5,1782.2,288.5,203.7,50.9,17,0,0,,26493.4,8469.1,3360.5,2291.2,729.8,186.7,0,0,,,,,,,,82,1.01,16.96,-13.2,0.84,12.33,,,,96,0.78,3.21,-1.22,-0.26,1.48,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,50,0,0,0,,,,100,0.09,,,96.54,-3.46,,0.1783,,,,,,,,,,55,,17413.7,2104.6,424.3,254.6,17,0,0,0,,7743831.5,4842057.6,352063.2,34567.2,4988.3,1403,116.9,39,,,,,,,,90.4,0.57,8.99,-4.8,0.4,4.36,,,,78.7,1.33,19.99,-18.55,0.29,18.26,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,50,0,0,0,,,,100,0.09,,,99.4,-0.6,,0.0492,,,,,,,,,,58.8,,12491.4,2172.4,475.2,271.6,118.8,33.9,0,0,,331604.9,53250.3,15684.8,9081.6,1782.4,560.2,67.9,0,,,,,,,,88.2,0.86,10.94,-7,0.69,6.31,,,,94.1,0.89,5.06,-3.17,-0.15,3.33,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,50,0,0,0,,,,100,0.09,,,99.91,-0.09,,0.0533,,,,,,,,,,62.8,,26001.4,2681.6,611,373.4,135.8,50.9,0,0,,153810.2,49900.9,20520.5,12882.6,4124.5,1442.7,84.9,0,,,,,,,,84,0.97,15.02,-11.2,0.8,10.39,,,,96.5,0.79,2.7,-0.71,-0.25,0.97,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D04,1,,NB-ferguhei-5069961-0003,6.2,Acetate,0,150,0,0,0,,,,100,0.09,,,99.94,-0.06,,0.0465,,,,,,,,,,63.2,,27512.3,2393.1,356.4,186.7,84.9,17,17,0,,170203.9,43314.7,10913.6,5346.5,729.8,152.8,17,0,,,,,,,,76.1,0.85,23.04,-19.1,0.68,18.41,,,,96.1,0.75,3.15,-1.13,-0.29,1.42,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,C11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,50,0,0,0,,,,99.7,-0.21,,,98.76,-1.24,,0.0497,,,,,,,,,,63.8,,53107.4,3275.7,645,220.6,33.9,0,0,0,,222360.9,94555.6,41855,27037.7,9436.9,2834.5,271.6,50.9,,,,,,,,84.3,0.92,14.79,-10.9,0.75,10.16,,,,96.8,0.73,2.48,-0.44,-0.31,0.75,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D02,1,,NB-ferguhei-5069961-0003,5,Acetate,0,150,0,0,0,,,,100,0.09,,,99.91,-0.09,,0.239,,,,,,,,,,56,,38341.7,10132.8,3428.5,2257.4,933.5,373.4,33.9,17,,2499026,1663957.4,916950.7,629930.4,181217,42477.5,3463.4,135.8,,,,,,,,82.7,1.37,15.89,-12.5,1.2,11.26,,,,93.6,0.81,5.6,-3.64,-0.23,3.87,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D03,1,,NB-ferguhei-5069961-0003,5.6,Acetate,0,150,0,0,0,,,,100,0.09,,,99.95,-0.05,,0.0496,,,,,,,,,,61.2,,22403.2,3004.1,509.2,254.6,135.8,50.9,33.9,33.9,,60695.1,21946,7841.5,4294.1,746.8,135.8,50.9,17,,,,,,,,76.1,0.9,22.96,-19.1,0.73,18.33,,,,95.5,0.86,3.65,-1.75,-0.18,1.92,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D05,1,,NB-ferguhei-5069961-0003,5.6,Citrate,0,150,0,0,0,,,,100,0.09,,,99.91,-0.09,,0.0467,,,,,,,,,,61.8,,22352.4,2172.4,407.3,152.7,50.9,33.9,0,0,,177947.2,51921.1,14087.8,7128.7,746.8,84.9,0,0,,,,,,,,77.1,0.76,22.11,-18.1,0.59,17.48,,,,94.8,0.88,4.34,-2.45,-0.16,2.61,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D06,1,,NB-ferguhei-5069961-0003,6.2,Citrate,0,150,0,0,0,,,,100,0.09,,,99.94,-0.06,,0.0455,,,,,,,,,,65,,29090.8,2698.6,543.1,373.4,118.8,33.9,0,0,,65480.2,17125.3,6093.2,3666.1,712.8,220.6,33.9,0,,,,,,,,76.7,0.85,22.48,-18.5,0.68,17.85,,,,95.7,0.81,3.45,-1.5,-0.23,1.72,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D07,1,,NB-ferguhei-5069961-0003,6.8,Citrate,0,150,0,0,0,,,,100,0.09,,,99.91,-0.09,,0.0433,,,,,,,,,,61.8,,37458.3,2783.5,645,356.4,84.9,50.9,0,0,,75003.5,26053.5,10574.1,6483.7,1680.3,611,0,0,,,,,,,,76.1,0.93,22.96,-19.1,0.76,18.33,,,,95.8,0.78,3.43,-1.44,-0.26,1.7,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D08,1,,NB-ferguhei-5069961-0003,5,Histidine,0,150,0,0,0,,,,78.27,-21.64,,,95.92,-4.08,,0.5758,,,,,,,,,,52.4,,18737.5,2970.2,577.1,390.4,169.7,50.9,0,0,,1634007.2,1359270.9,819812.7,551526.4,113808.7,23220,118.8,0,,,,,,,,82,3.18,14.84,-13.2,3.01,10.21,,,,0,0,0,-97.23,-1.04,-1.73,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D09,1,,NB-ferguhei-5069961-0003,5.6,Histidine,0,150,0,0,0,,,,98.96,-0.95,,,99.72,-0.28,,0.0638,,,,,,,,,,58.6,,24558.8,4141.2,1052.3,644.9,203.7,152.8,67.9,17,,1016609.7,353107.4,58585.3,21984.3,3157.6,526.3,17,0,,,,,,,,79.5,0.84,19.67,-15.7,0.67,15.04,,,,94.7,0.79,4.55,-2.57,-0.25,2.82,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D10,1,,NB-ferguhei-5069961-0003,6.2,Histidine,0,150,0,0,0,,,,100,0.09,,,99.93,-0.07,,0.0538,,,,,,,,,,62,,32807.2,3683,814.7,441.3,169.7,33.9,0,0,,115959.5,40480.6,14376.1,8045.2,1901,526.2,17,0,,,,,,,,73.6,0.92,25.47,-21.6,0.75,20.84,,,,96.1,0.83,3.03,-1.09,-0.21,1.3,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50,10,D11,1,,NB-ferguhei-5069961-0003,6.8,Histidine,0,150,0,0,0,,,,100,0.09,,,99.94,-0.06,,0.0508,,,,,,,,,,64.2,,28564.2,3173.8,678.9,373.4,101.8,33.9,0,0,,93060.2,32790.9,12169.3,7145.4,2155.5,628,67.9,0,,,,,,,,73.9,1,25.12,-21.3,0.83,20.49,,,,96.4,0.73,2.85,-0.81,-0.31,1.12,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,5,0,H11,1.246265823,,NB-ferguhei-5069961-0003,6,Water,0,0,0,0,0,,,,99.91,0,,,100,0,,0.0413,66.2,17.25,16.53,0,,,,,,62.8,,498233.3,84858.4,390.5,152.8,34,17,0,0,,110956.3,13294.4,3022.2,1748.8,594.3,220.7,50.9,17,,,,,,,,95.2,0.17,4.63,0,0,0,,,,97.2,1.04,1.73,0,0,0,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,N/A,-,-,0,Protein Formulation Characterization Summary
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,1.61,Trop2-Trabectedin_0.2%Pyr_0.2x,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,1.61,Trop2-Trabectedin_Start_0.2x,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,1.61,Trop2-Trabectedin_Start_CT,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
5/22/2023,ramapa,,,,,,,,,1.61,Trop2-Trabectedin_T0,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,5,VLS231_0.2%Pyr_0.2x,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
5/22/2023,ramapa,,,,,,,,,5,VLS231_CT,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,5,VLS231_Start_0.2x,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_Glu_4_2w40C,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,98,-0.9,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.74,1.07,0.2,-0.9,1.1,-0.2,0.9,1.1,0.2,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_Glu_4_T0,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,98.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.6,0,0.4,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_Glu_5_2w40C,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,98.5,-0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.95,0.43,0.63,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_Glu_5_T0,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,99,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.54,0,0.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_His_5.5S_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,9,0,,,,98.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.85,0.17,0.98,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_His_5.5S_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,96.5,-1.6,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.43,0,0.57,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_His_5.5T_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,9,,,,97.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.02,0.21,0.77,,,,,,,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_His_5.5T_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,98.9,0.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.41,0,0.59,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_His_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,98.3,0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.38,0.43,1.19,-1,0.4,0.6,1,0.4,0.6,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_His_5.5_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,98.9,0.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.38,0,0.62,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_His_6_2w40C,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,98.3,-0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.68,0.34,0.98,-0.6,0.3,0.2,0.6,0.3,0.2,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_His_6_T0,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,98.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.26,0,0.74,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_His_7_2w40C,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,98,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0.5,1.68,-1.2,0.5,0.7,1.2,0.5,0.7,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_His_7_T0,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,98.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.04,0,0.96,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_Succi_5.5S_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,9,0,,,,98.2,-0.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.91,0.2,3.89,-3.3,0.2,3.1,3.3,0.2,3.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_Succi_5.5S_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,99,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0,0.75,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_Succi_5.5T_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,9,,,,98.3,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.6,0.39,4,-3.5,0.4,3.1,3.5,0.4,3.1,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_Succi_5.5T_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,9,0,,,,99,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.17,0,0.83,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_Succi_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,98.2,-0.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.44,0.38,5.17,-4.8,0.4,4.4,4.8,0.4,4.4,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_Succi_5.5_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,9,,,,99,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0,0.88,0,0,0,0,0,0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_Succi_5_2w40C,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,0,,,,98.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.43,0.45,4.11,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_Succi_5_T0,NB-penglei5-5065175-0002,5,Succinate,0,0,0,9,0,,,,99,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.34,0,0.66,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40,14,,,En_Succi_6_2w40C,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,0,,,,98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.46,0.51,7.03,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5,0,,,En_Succi_6_T0,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,9,,,,99,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.87,0,1.13,0,0,0,0,0,0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Glu_4S_T0,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,93.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.99,0,2.01,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Glu_4_2w40C,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,93.5,-0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.48,4.94,1.57,-4.5,4.9,-0.4,4.5,4.9,0.4,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Glu_5S_2w40C,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,9,0,,,,94.8,0.9,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.91,0.36,1.73,0,0.4,-0.3,0,0.4,0.3,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Glu_5S_T0,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,9,0,,,,93.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.94,0,2.06,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Glu_5T_2w40C,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,9,,,,94.6,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0.39,1.79,-0.1,0.4,-0.3,0.1,0.4,0.3,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Glu_5T_T0,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,9,,,,93.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.92,0,2.08,0,0,0,0,0,0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Glu_5_2w40C,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,94.8,1.1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.71,0.31,1.98,-0.2,0.3,-0.1,0.2,0.3,0.1,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Glu_5_T0,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,93.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.87,0,2.13,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_His_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,94.5,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0.33,1.85,0,0.3,-0.3,0,0.3,0.3,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_His_5.5_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,93.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.86,0,2.14,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_His_6_2w40C,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,92.8,-1.2,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.72,0.31,1.97,0,0.3,-0.3,0,0.3,0.3,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_His_6_T0,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,94,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.71,0,2.29,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_His_7_2w40C,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,95.3,1.1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.19,0.35,2.47,-0.5,0.4,0.1,0.5,0.4,0.1,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_His_7_T0,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,94.2,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.66,0,2.34,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Sccin_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,95,1.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.83,0.38,2.79,-0.8,0.4,0.4,0.8,0.4,0.4,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Sccin_5.5_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,93.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,0,2.38,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Succi_5S_2w40C,NB-penglei5-5065175-0002,5,Succinate,0,0,0,9,0,,,,94.6,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.25,0.49,2.26,-0.7,0.5,0.2,0.7,0.5,0.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Succi_5S_T0,NB-penglei5-5065175-0002,5,Succinate,0,0,0,9,0,,,,93.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.91,0,2.09,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Succi_5T_2w40C,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,9,,,,94.3,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.87,0.48,2.65,-0.8,0.5,0.3,0.8,0.5,0.3,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Succi_5T_T0,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,9,,,,93.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.68,0,2.32,0,0,0,0,0,0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Succi_5_2w40C,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,0,,,,94.3,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.81,0.46,2.73,-0.8,0.5,0.3,0.8,0.5,0.3,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Succi_5_T0,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,0,,,,93.6,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.57,0,2.43,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40,14,,,ROR1_Succi_6_2w40C,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,0,,,,95,1.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.86,0.32,2.82,-0.7,0.3,0.4,0.7,0.3,0.4,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5,0,,,ROR1_Succi_6_T0,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,0,,,,93.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.54,0,2.46,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Glu_4,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,99.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Glu_4_2w40C,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,99.2,-0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.47,0.66,1.86,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Glu_5,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,99.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,0,2.38,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Glu_5S,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,9,0,,,,99.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,0,2.38,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Glu_5S_2w40,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,9,0,,,,99.5,-0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.82,0.35,3.83,-1.8,0.4,1.5,1.8,0.4,1.5,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Glu_5T,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,9,,,,99.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.58,0,2.42,0,0,0,0,0,0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Glu_5T_2w40,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,9,,,,99.4,-0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.96,0.42,3.61,-1.6,0.4,1.2,1.6,0.4,1.2,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Glu_5_2w40,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,99.5,-0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.87,0.31,3.82,-1.8,0.3,1.4,1.8,0.3,1.4,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_His_5.5,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.53,0,2.47,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_His_5.5_2w40,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,99.1,-0.9,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.48,0.36,4.16,-2,0.4,1.7,2,0.4,1.7,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_His_6,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.53,0,2.47,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_His_6_2w40,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,99.8,-0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.22,0.39,4.39,-2.3,0.4,1.9,2.3,0.4,1.9,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_His_7,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.61,0,2.39,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_His_7_2w40,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,98.8,-1.2,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.02,0.42,4.56,-2.6,0.4,2.2,2.6,0.4,2.2,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Sccin_5.5,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.31,0,2.69,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Sccin_5.5_2w40,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,99.7,-0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.51,0.52,6.96,-4.8,0.5,4.3,4.8,0.5,4.3,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Succi_5,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,0,,,,99.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.38,0,2.62,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Succi_5S,NB-penglei5-5065175-0002,5,Succinate,0,0,0,9,0,,,,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.38,0,2.62,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Succi_5S_2w40,NB-penglei5-5065175-0002,5,Succinate,0,0,0,9,0,,,,99.3,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.81,0.47,10.72,-8.6,0.5,8.1,8.6,0.5,8.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Succi_5T,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,9,,,,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.35,0,2.65,0,0,0,0,0,0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Succi_5T_2w40,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,9,,,,99.3,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.07,0.54,10.39,-8.3,0.5,7.7,8.3,0.5,7.7,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Succi_5_2w40,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,0,,,,99.1,-0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.48,0.41,13.11,-10.9,0.4,10.5,10.9,0.4,10.5,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5,0,,,101_Succi_6,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,0,,,,100,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.27,0,2.73,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40,14,,,101_Succi_6_2w40,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,0,,,,99.3,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.92,0.59,5.49,-3.3,0.6,2.8,3.3,0.6,2.8,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Glu_4_,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Glu_4_25C2w,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.59,2.58,4.83,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Glu_4_2w40C,NB-penglei5-5065175-0002,4,Glutamate,0,0,0,0,0,,,,95.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.47,5.31,5.22,,,,,,,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Glu_5S_25C2w,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.24,2.77,7.99,-2.1,0.4,1.7,2.1,0.4,1.7,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Glu_5S_2w40C,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,9,0,,,,95.8,-1.1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.81,3.72,9.46,-4.5,1.4,3.2,4.5,1.4,3.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Glu_5S_T0,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,9,0,,,,96.9,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.35,2.36,6.29,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Glu_5T_25C2w,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.59,2.53,7.88,-8.1,-2.1,1.6,8.1,2.1,1.6,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Glu_5T_2w40C,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,9,,,,95.9,-1.7,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.71,3.99,9.3,-11,-0.6,3,11,0.6,3,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Glu_5T_T0,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,9,,,,97.6,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.68,4.64,6.31,0,0,0,0,0,0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Glu_5_25C2w,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.76,2.78,9.46,-3.6,0.5,3.1,3.6,0.5,3.1,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Glu_5_2w40C,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,95.8,-1.8,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.18,3.91,10.91,-6.2,1.7,4.5,6.2,1.7,4.5,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Glu_5_T0,NB-penglei5-5065175-0002,5,Glutamate,0,0,0,0,0,,,,97.6,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.34,2.26,6.4,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_His_5.5_25C2w,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,84.12,2.33,13.55,-6.2,-0.3,6.5,6.2,0.3,6.5,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_His_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,95.5,-1.2,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.4,3.75,9.85,-3.9,1.2,2.8,3.9,1.2,2.8,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_His_5.5_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0,0,0,,,,96.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.34,2.6,7.06,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_His_6_25C2w,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,79.67,2.09,18.24,-10.4,-0.3,10.7,10.4,0.3,10.7,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_His_6_2w40C,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,95.3,-1.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.81,3.76,8.43,-2.3,1.4,0.9,2.3,1.4,0.9,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_His_6_T0,NB-penglei5-5065175-0002,6,Histidine,0,0,0,0,0,,,,96.6,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.09,2.38,7.53,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_His_7_25C2w,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,79.64,2.34,18.02,-12.2,-0.5,12.7,12.2,0.5,12.7,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_His_7_2w40C,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,94.6,-2.4,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.58,4.87,3.55,-0.3,2.1,-1.8,0.3,2.1,1.8,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_His_7_T0,NB-penglei5-5065175-0002,7,Histidine,0,0,0,0,0,,,,97,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.87,2.81,5.32,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Sccin_5.5_25C2w,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.83,2.54,10.64,-10.8,-2.2,5.7,10.8,2.2,5.7,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Sccin_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,95.4,-2.6,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.34,5.13,9.53,-12.3,0.4,4.6,12.3,0.4,4.6,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Sccin_5.5_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0,0,0,,,,98,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,4.76,4.94,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Succi_5S_25C2w,NB-penglei5-5065175-0002,5,Succinate,0,0,0,9,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.19,2.4,9.41,-9.6,-2.1,2.7,9.6,2.1,2.7,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Succi_5S_2w40C,NB-penglei5-5065175-0002,5,Succinate,0,0,0,9,0,,,,96.2,-0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.27,3.86,12.87,-14.5,-0.6,6.2,14.5,0.6,6.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Succi_5S_T0,NB-penglei5-5065175-0002,5,Succinate,0,0,0,9,0,,,,96.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.75,4.5,6.69,0,0,0,0,0,0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Succi_5T_25C2w,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.86,2,10.14,-3,-0.3,3.4,3,0.3,3.4,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Succi_5T_2w40C,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,9,,,,96.3,-0.4,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.51,4.07,12.42,-7.4,1.7,5.6,7.4,1.7,5.6,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Succi_5T_T0,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,9,,,,96.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.9,2.33,6.77,0,0,0,0,0,0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Succi_5_25C2w,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.28,2.32,10.4,-10.8,-1.6,3.5,10.8,1.6,3.5,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Succi_5_2w40C,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,0,,,,95.4,-1.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.56,4.34,12.1,-14.5,0.4,5.2,14.5,0.4,5.2,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Succi_5_T0,NB-penglei5-5065175-0002,5,Succinate,0,0,0,0,0,,,,96.7,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.03,3.94,6.86,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25,14,,,231_Succi_6_25C2w,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.16,2.59,11.24,-11.2,-2.6,7.1,11.2,2.6,7.1,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40,14,,,231_Succi_6_2w40C,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,0,,,,96.4,-1.6,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.27,4.77,7.95,-10.1,-0.4,3.8,10.1,0.4,3.8,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5,0,,,231_Succi_6_T0,NB-penglei5-5065175-0002,6,Succinate,0,0,0,0,0,,,,98,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.4,5.2,4.15,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,1,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,-80,0,H03,1,,NB-munselle-5020702-0004-0004,5.5,Frozen,0,0,0,0,0,,,,99,,,,99.9,0,,0.0405,84,9.97,5.99,,,,,,,64.2,,121353.9,59794.4,11711.1,4633.5,967.4,305.5,17,17,,319782.3,155613.8,34422.4,15768.5,3903.9,1816.2,50.9,0,,,,,,,,90.5,4.9,4.56,0,0,0,,,,91.4,8.6,0,0.66,,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,5,0,H02,1,,NB-munselle-5020702-0004-0004,5.2,Acetate,0,0,0,0,0,,,,99,,,,99.9,0,,0.0386,84.4,9.53,6.03,,,,,,,66,,7858,2817.3,560.1,373.4,67.9,50.9,0,0,,11388.1,5431,322.5,169.7,0,0,0,0,,,,,,,,91.1,5.46,3.49,0,0,0,,,,90.7,9.26,0,0,-9.83,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,150,0,0,0,,,,98,-1,,,99.9,0,,0.0427,,,,,,,,,,61.4,,16242.2,3632,1205,797.7,271.6,101.8,0,0,,16377.9,3122.8,611,254.6,50.9,33.9,0,0,,,,,,,,80.6,15.5,3.94,-10,10,0,,,,90,9.89,0.1,-1,1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,150,0,0,0,,,,98,-1,,,99.9,0,,0.0445,,,,,,,,,,60.6,,17684.8,5804.4,1816,1052.3,441.3,237.6,67.9,33.9,,20553.2,3716.9,475.2,305.5,50.9,17,0,0,,,,,,,,83.2,12.38,4.39,-8,7,1,,,,90.2,9.55,0.24,-1,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,150,0,0,0,,,,98,-1,,,99.9,0,,0.0433,,,,,,,,,,56.6,,15563.2,3411.4,882.5,424.3,169.7,118.8,17,17,,12134.9,2291.2,475.2,237.6,135.8,50.9,0,0,,,,,,,,80.8,15.27,3.93,-10,10,0,,,,90.4,9.38,0.18,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,150,0,0,0,,,,98,-1,,,99.8,-0.1,,0.0435,,,,,,,,,,53.4,,18194.1,4192.1,1239,644.9,220.6,101.8,33.9,0,,30821.4,5227.4,984.4,526.1,135.8,33.9,17,0,,,,,,,,78.2,18.04,3.72,-13,13,0,,,,88.9,8.24,2.85,-2,-1,3,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,150,0,0,0,,,,95,-5,,,100,0.1,,0.0419,,,,,,,,,,61.8,,10318.9,2325.2,339.4,237.6,84.9,17,0,0,,24813.2,3649,678.9,441.3,169.7,101.8,17,0,,,,,,,,79.9,15.96,4.19,-11,11,1,,,,91,8.76,0.2,0,-1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,150,0,0,0,,,,97,-2,,,100,0.1,,0.0417,,,,,,,,,,59.4,,20705.8,4972.8,1018.3,644.9,169.7,50.9,0,0,,59149.2,9657.4,1340.8,729.8,220.6,84.9,17,0,,,,,,,,81.2,14.59,4.18,-10,9,1,,,,90.9,8.93,0.16,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,150,0,0,0,,,,83,-17,,,99.9,0,,0.0429,,,,,,,,,,61.2,,9707.9,2562.8,441.3,237.6,84.9,33.9,0,0,,17040,2749.5,577.1,288.5,33.9,0,0,0,,,,,,,,81.5,13.53,4.95,-10,8,1,,,,91.2,8.57,0.2,0,-1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,150,0,0,0,,,,86,-13,,,99.9,-0.1,,0.0432,,,,,,,,,,59.6,,8740.6,1849.9,475.2,288.5,101.8,33.9,0,0,,12389.5,1765.1,203.7,84.9,0,0,0,0,,,,,,,,81,14.14,4.83,-10,9,1,,,,90.7,9.17,0.13,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,150,0,0,0,,,,99,-1,,,99.9,-0.1,,0.043,,,,,,,,,,56.6,,13730.3,1968.7,475.2,220.6,67.9,17,0,0,,17498.1,2681.6,458.2,220.6,33.9,17,0,0,,,,,,,,79.6,16.49,3.88,-11,11,0,,,,90.8,8.7,0.46,0,-1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,D02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,150,0,0,0,,,,98,-2,,,99.4,-0.5,,0.0427,,,,,,,,,,55,,345313.9,8776.3,899.7,288.6,17,17,17,17,,40597.4,4905,916.5,373.4,101.8,50.9,17,17,,,,,,,,76.8,19.61,3.6,-14,14,0,,,,79.5,7.48,12.98,-11,-2,13,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,50,0,0,0,,,,98,-2,,,99.9,0,,0.0423,67.6,22.74,9.64,,,,,,,61.4,,13577.5,4107.2,882.5,526.1,152.7,101.8,17,17,,27376.1,7009.5,1748.1,950.4,203.7,33.9,0,0,,,,,,,,82,13.78,4.21,-9,8,1,,,,90.9,8.64,0.44,0,-1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,50,0,0,0,,,,99,0,,,99.9,0,,0.044,70.7,19.56,9.73,,,,,,,,,11812.4,5193.4,644.9,322.5,152.7,67.9,17,0,,14290.4,2376.1,220.6,67.9,33.9,17,17,17,,,,,,,,83.2,12.67,4.17,-8,7,1,,,,91,8.92,0.11,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,50,0,0,0,,,,99,-1,,,99.8,-0.1,,0.0433,71.6,18.9,9.51,,,,,,,59,,11829.5,3852.6,509.2,288.5,67.9,33.9,0,0,,16140.3,3139.8,577,271.6,67.9,33.9,0,0,,,,,,,,81.9,14.46,3.7,-9,9,0,,,,90.9,9.12,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,50,0,0,0,,,,99,0,,,99.8,-0.1,,0.0436,69.6,20.32,10.06,,,,,,,56,,7009.4,1799,356.4,220.6,67.9,17,0,0,,18805,3275.6,339.4,135.8,33.9,0,0,0,,,,,,,,80.7,15.97,3.3,-10,11,0,,,,90.4,9.56,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,50,0,0,0,,,,89,-10,,,99.9,0,,0.0442,61.9,28.03,10.07,,,,,,,60,,14494.1,4226,628,322.5,101.8,67.9,0,0,,17583,3055,509.2,237.6,118.8,101.8,17,0,,,,,,,,82.3,13.7,4.04,-9,8,1,,,,91.5,8.47,0.08,1,-1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,50,0,0,0,,,,94,-5,,,99.9,0,,0.0431,63.4,26.53,10.12,,,,,,,59.6,,12525.3,3699.9,322.5,220.6,67.9,17,0,0,,25899.6,5414.1,1103.2,543.1,84.9,17,0,0,,,,,,,,81.9,14.37,3.76,-9,9,0,,,,91.5,8.52,0,1,-1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,50,0,0,0,,,,91,-9,,,99.9,0,,0.0448,67.2,22.3,10.46,,,,,,,60.2,,10539.5,4005.4,220.6,152.7,17,0,0,0,,13356.9,1816,356.4,169.7,50.9,50.9,50.9,33.9,,,,,,,,83.5,12.77,3.73,-8,7,0,,,,91,8.98,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,50,0,0,0,,,,90,-9,,,99.9,0,,0.0443,66.9,21.98,11.16,,,,,,,60.8,,6398.4,1476.6,169.7,84.9,17,17,0,0,,14884.4,2393,339.4,186.7,33.9,17,0,0,,,,,,,,82.2,14.08,3.68,-9,9,0,,,,90.8,9.18,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,50,0,0,0,,,,98,-1,,,99.9,-0.1,,0.0428,66.6,22.55,10.84,,,,,,,59,,7552.5,1357.8,135.8,101.8,50.9,0,0,0,,12627.1,2104.5,271.6,135.8,33.9,17,0,0,,,,,,,,81,15.12,3.85,-10,10,0,,,,90.4,9.61,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,C02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,50,0,0,0,,,,98,-1,,,99.9,0,,0.0406,66,23.06,10.92,,,,,,,,,5431,1035.3,101.8,67.9,0,0,0,0,,35913.1,6687,1561.4,933.5,288.5,118.8,33.9,33.9,,,,,,,,79.1,17.17,3.69,-12,12,0,,,,90.2,9.82,0,-1,1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,0,0,0,0,,,,97,-3,,,99.9,0,,0.0424,67.1,23.85,9.1,,,,,,,63.4,,30821.2,18126.1,2834.3,1340.8,407.3,169.7,17,0,,45502.3,5838.4,1001.4,543.1,135.8,50.9,33.9,0,,,,,,,,82.4,13.74,3.89,-9,8,0,,,,90.7,9.31,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,0,0,0,0,,,,99,0,,,99.9,0,,0.0433,69.6,20.66,9.72,,,,,,,64.8,,53445.3,17175.8,2647.7,1374.7,475.2,254.6,33.9,33.9,,40377,3598.1,390.4,186.7,101.8,50.9,0,0,,,,,,,,84.2,11.85,3.93,-7,6,0,,,,90.7,9.27,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,0,0,0,0,,,,99,0,,,99.8,-0.1,,0.0432,71.7,18.92,9.42,,,,,,,63.6,,16547.6,8961.2,1934.8,899.5,237.6,67.9,0,0,,13339.9,1900.9,271.6,67.9,0,0,0,0,,,,,,,,83.9,12.37,3.76,-7,7,0,,,,90.5,9.52,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,0,0,0,0,,,,99,0,,,99.8,-0.1,,0.0435,71,18.66,10.33,,,,,,,62.2,,11931.3,5465,1340.8,831.6,373.4,169.7,0,0,,14782.6,2274.2,254.6,101.8,50.9,0,0,0,,,,,,,,83,13.05,3.99,-8,8,1,,,,90.6,9.36,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,0,0,0,0,,,,0,,,,99.9,0,,0.0425,63,27.23,9.81,,,,,,,59.6,,17379.3,6347.5,1408.7,780.7,237.6,118.8,0,0,,38051.7,6687.1,1035.3,441.3,203.7,33.9,0,0,,,,,,,,80.5,14.88,4.59,-11,9,1,,,,91.5,8.53,0,1,-1,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,0,0,0,0,,,,0,,,,99.9,0,,0.0415,64.9,25.51,9.58,,,,,,,60,,15546.4,4022.4,1272.9,729.8,254.6,135.8,0,0,,38849.2,4514.6,661.9,288.5,0,0,0,0,,,,,,,,82.2,13.32,4.47,-9,8,1,,,,91,8.96,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,0,0,0,0,,,,89,-10,,,100,0,,0.0426,66.1,22.7,11.18,,,,,,,62.4,,30176.3,9657.1,1425.7,865.6,305.5,169.7,17,0,,25084.7,3615.1,288.5,33.9,0,0,0,0,,,,,,,,82.9,12.82,4.29,-8,7,1,,,,90.7,9.35,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,0,0,0,0,,,,89,-11,,,100,-0.1,,0.0431,68,21.95,10.03,,,,,,,63.2,,13611.5,6313.6,1629.3,882.5,271.6,84.9,17,17,,96219.6,3768,220.6,101.8,17,0,0,0,,,,,,,,83.1,12.66,4.26,-8,7,1,,,,90.6,9.36,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,0,0,0,0,,,,99,0,,,100,0,,0.0414,70.3,20.15,9.58,,,,,,,64.2,,11557.9,4412.7,1629.3,1001.3,373.4,135.8,0,0,,12151.9,1985.7,203.7,50.9,33.9,17,0,0,,,,,,,,82.6,13.16,4.26,-8,8,1,,,,90.7,9.3,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40,12,B02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,0,0,0,0,,,,100,0,,,100,-0.1,,0.0404,67.8,20.7,11.51,,,,,,,62.8,,44637.4,6381.6,1544.5,780.7,271.6,135.8,0,0,,9538.2,1731.1,135.8,67.9,0,0,0,0,,,,,,,,82.3,13.44,4.22,-9,8,1,,,,90.7,9.29,0,0,0,0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,-80,0,H08,1,,NB-munselle-5020702-0004-0004,5.5,Frozen,0,0,0,0,0,,,,0,,,,0,0,,0.0393,81.3,10.13,8.59,,,,,,,65,,189451.3,49293.7,12272.5,5075.3,1103.3,390.4,0,0,,225433.7,105367.6,25561.2,12644.8,3055.1,1069.3,84.9,17,,,,,,,,91.7,5.56,2.73,-1,0,0,,,,89.3,10.53,0.17,-0.87,,0.17,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,5,0,H07,1,,NB-munselle-5020702-0004-0004,5.2,Acetate,0,0,0,0,0,,,,0,,,,0,0,,0.0388,80.7,10.7,8.63,,,,,,,65.2,,153655.7,3734.5,763.9,390.4,17,17,0,0,,15020.1,6737.8,797.7,322.5,101.8,33.9,0,0,,,,,,,,92.4,5.02,2.57,0,0,0,,,,90.2,9.83,0,0,-9.83,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,150,0,0,0,,,,0,,,,0,,,0.0426,,,,,,,,,,62.4,,1569113.5,5163.7,2021.3,1189,356.7,84.9,0,0,,29039.3,7552.6,1391.7,661.9,101.8,17,0,0,,,,,,,,82,14.91,3.11,-10,10,1,,,,86.8,13.02,0.14,-3,3,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,150,0,0,0,,,,0,,,,0,,,0.0435,,,,,,,,,,59.8,,1473434.2,6693.1,1953.6,1104.2,339.8,135.9,0,0,,26900.6,6466.3,1510.5,628,169.7,101.8,17,0,,,,,,,,85.7,11.46,2.88,-7,6,0,,,,86.8,13.08,0.14,-3,3,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,150,0,0,0,,,,0,,,,0,,,0.0435,,,,,,,,,,55.8,,997552.1,7642.8,2734.4,1715.4,764.3,305.7,34,0,,31313.7,8944.4,2461,1527.5,594,169.7,17,0,,,,,,,,82.8,14.42,2.74,-10,9,0,,,,87,13.03,0,-3,3,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,150,0,0,0,,,,0,,,,0,,,0.0438,,,,,,,,,,54,,826576.9,5179.3,1579.3,984.9,373.6,135.8,17,0,,22318.2,4158.1,848.6,407.3,118.8,67.9,0,0,,,,,,,,81.9,14.87,3.2,-10,10,1,,,,86.1,11.64,2.24,-4,2,2,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,150,0,0,0,,,,0,,,,0,,,0.0429,,,,,,,,,,61.4,,783649.8,6622.8,1664.2,764.2,203.8,101.9,0,0,,5583.7,1629.3,543.1,237.6,118.8,50.9,0,0,,,,,,,,81.4,15.27,3.33,-11,10,1,,,,90,9.98,0,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,150,0,0,0,,,,0,,,,0,,,0.042,,,,,,,,,,59.6,,611231.4,3820.5,611.3,373.6,67.9,34,0,0,,12219.8,2800.4,509.2,271.6,67.9,0,0,0,,,,,,,,81.9,14.64,3.43,-10,10,1,,,,90.2,9.85,0,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,150,0,0,0,,,,0,,,,0,,,0.0434,,,,,,,,,,60.8,,3435267,118029,1071.9,734.5,337.5,139,19.9,0,,26323.7,5566.8,1069.2,509.2,135.8,17,0,0,,,,,,,,82.5,14,3.52,-10,9,1,,,,90.1,9.9,0,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,150,0,0,0,,,,0,,,,0,,,0.0426,,,,,,,,,,59.6,,3304926.5,101102.3,904.6,404.2,173.2,77,0,0,,11948.2,2613.7,475.2,305.5,67.9,33.9,0,0,,,,,,,,82.9,13.99,3.13,-10,9,1,,,,90,9.99,0.03,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,150,0,0,0,,,,0,,,,0,,,0.0417,,,,,,,,,,56.6,,3231777.3,93996.7,548.4,378.2,75.6,18.9,0,0,,9266.7,1917.8,305.5,169.7,50.9,17,0,0,,,,,,,,82.1,14.39,3.47,-10,9,1,,,,89.6,10.1,0.25,-1,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,G02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,150,0,0,0,,,,0,,,,0,,,0.0413,,,,,,,,,,51.8,,2794300,17722.4,696.7,475.8,220.9,51,0,0,,14867.4,2766.4,628,322.5,67.9,33.9,0,0,,,,,,,,81.5,15.04,3.44,-11,10,1,,,,76,8.12,15.93,-14,-2,16,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,50,0,0,0,,,,0,,,,0,,,0.0434,65.1,22.69,12.2,,,,,,,61.4,,326977.9,7486.9,2393.8,1477,679.1,237.7,0,0,,40936.8,10336,2647.7,1527.5,373.4,118.8,0,0,,,,,,,,81,15.91,3.12,-11,11,1,,,,89.5,10.47,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,50,0,0,0,,,,0,,,,0,,,0.0445,68.7,18.86,12.45,,,,,,,61.2,,416518.6,7317.2,1273.3,662.1,203.7,67.9,0,0,,17600,3071.9,560.1,356.4,135.8,84.9,17,0,,,,,,,,83.1,13.55,3.33,-9,9,1,,,,89.6,10.43,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,50,0,0,0,,,,0,,,,0,,,0.0441,68.7,18.75,12.51,,,,,,,58.8,,143758.9,6874.8,2189.7,1375,560.2,220.7,0,0,,24202.1,6551.2,1340.8,746.8,288.5,84.9,17,0,,,,,,,,82.5,14.41,3.15,-10,9,1,,,,89,11.05,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,50,0,0,0,,,,0,,,,0,,,0.0443,67.4,19.38,13.2,,,,,,,56.6,,166526.2,3955.2,1018.5,628.1,237.7,17,0,0,,18041.2,4327.8,814.7,322.5,84.9,33.9,0,0,,,,,,,,81.8,14.87,3.35,-11,10,1,,,,89.1,10.92,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,50,0,0,0,,,,0,,,,0,,,0.0444,63.1,25.08,11.79,,,,,,,61.6,,271593.1,6994.4,1392.1,713,237.7,101.9,17,0,,31109.9,6737.9,1340.8,611,135.8,50.9,0,0,,,,,,,,80.8,15.93,3.29,-12,11,1,,,,90.3,9.58,0.15,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,50,0,0,0,,,,0,,,,0,,,0.0442,64.5,24.69,10.84,,,,,,,59.4,,221333,5585.1,1476.9,848.8,288.6,101.9,34,0,,18295.7,4820,1323.8,882.5,322.5,152.7,0,0,,,,,,,,81.8,14.73,3.48,-11,10,1,,,,89.9,9.98,0.1,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,50,0,0,0,,,,0,,,,0,,,0.0435,66.3,21.31,12.43,,,,,,,61.2,,181606.4,5703.8,526.2,288.6,135.8,50.9,0,0,,16445.8,3682.9,746.8,356.4,101.8,33.9,17,17,,,,,,,,82.9,13.68,3.4,-9,9,1,,,,89.9,10.08,0,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,50,0,0,0,,,,0,,,,0,,,0.0435,66.9,20.71,12.42,,,,,,,60,,152827.3,2597.2,645.1,407.4,135.8,0,0,0,,14748.6,2902.2,441.3,305.5,50.9,17,0,0,,,,,,,,82.8,13.97,3.2,-10,9,1,,,,89.7,10.26,0,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,50,0,0,0,,,,0,,,,0,,,0.0423,66.2,21.29,12.54,,,,,,,59.4,,143369.2,1578.7,271.6,169.7,67.9,17,0,0,,10251.1,1442.6,288.5,169.7,84.9,50.9,33.9,17,,,,,,,,81.3,15.59,3.12,-11,11,1,,,,89.4,10.64,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,F02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,50,0,0,0,,,,0,,,,0,,,0.0415,65.7,20.38,13.97,,,,,,,56.4,,134066,2512.3,831.8,611.1,288.6,33.9,0,0,,18940.8,3479.3,729.8,373.4,186.7,33.9,0,0,,,,,,,,81.6,15.32,3.13,-11,10,1,,,,89.6,10.39,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,0,0,0,0,,,,0,,,,0,,,0.0433,63.1,25.12,11.8,,,,,,,63.6,,813469.2,15011.4,2411.3,1511.3,458.5,135.8,0,0,,20994.4,2342.1,475.2,186.7,67.9,17,0,0,,,,,,,,81.5,15.38,3.11,-11,10,1,,,,89.6,10.45,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,0,0,0,0,,,,0,,,,0,,,0.0444,67.5,20.48,12.03,,,,,,,64.6,,151603.5,11695.8,2631.1,1476.8,390.4,152.8,0,0,,6534.2,1154.1,271.6,152.7,67.9,33.9,0,0,,,,,,,,84.4,12.37,3.29,-8,7,1,,,,89.3,10.68,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,0,0,0,0,,,,0,,,,0,,,0.0434,68.3,19.27,12.39,,,,,,,62.4,,45435.5,8842.7,2053.7,1188.1,390.4,169.7,0,0,,9130.9,1849.9,305.5,186.7,17,17,0,0,,,,,,,,82.7,14.11,3.23,-10,9,1,,,,89.1,10.86,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,0,0,0,0,,,,0,,,,0,,,0.043,68.7,18.24,13.09,,,,,,,62.4,,19450.4,4412.8,1663.3,1035.3,492.2,254.6,0,0,,6551.2,1272.9,322.5,152.7,84.9,50.9,17,0,,,,,,,,83.2,13.91,2.85,-9,9,0,,,,88.9,11.06,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,0,0,0,0,,,,0,,,,0,,,0.0437,62.1,26.55,11.37,,,,,,,61.4,,43027,3462.5,1256,831.7,305.5,169.7,0,0,,9164.8,1459.6,339.4,186.7,50.9,0,0,0,,,,,,,,80.8,16.04,3.12,-12,11,1,,,,90.1,9.82,0.11,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,0,0,0,0,,,,0,,,,0,,,0.0416,63.2,25.44,11.41,,,,,,,59.6,,25849.3,3547.3,1459.6,899.5,407.3,203.7,0,0,,7314.9,1374.7,407.3,203.7,101.8,101.8,33.9,33.9,,,,,,,,82.6,14.17,3.28,-10,9,1,,,,89.8,10.23,0,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,0,0,0,0,,,,0,,,,0,,,0.0477,66,21.51,12.47,,,,,,,63.6,,38986.4,7909.3,1884,984.4,322.5,118.8,0,0,,1400899.6,55054.1,968.2,322.7,67.9,0,0,0,,,,,,,,83.1,13.94,2.97,-9,9,0,,,,89.9,10.09,0,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,0,0,0,0,,,,0,,,,0,,,0.0425,66.8,20.81,12.38,,,,,,,63.6,,12355.6,5278.3,1765.1,1137.1,458.2,220.6,0,0,,6839.7,1782.1,611,356.4,84.9,17,0,0,,,,,,,,83.3,13.63,3.05,-9,9,0,,,,89.6,10.38,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,0,0,0,0,,,,0,,,,0,,,0.0433,67.5,19.97,12.55,,,,,,,63.8,,160213.2,8486.8,2002.9,1171.2,407.4,254.6,0,0,,10149.2,2274.2,577,254.6,50.9,17,0,0,,,,,,,,83.1,13.94,2.99,-9,9,0,,,,89.7,10.26,0,0,0,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40,12,E02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,0,0,0,0,,,,0,,,,0,,,0.0408,67.5,19.94,12.55,,,,,,,63.2,,32111.7,3360.5,1374.8,950.5,288.5,152.8,17,17,,9792.8,1799,424.3,237.6,84.9,33.9,17,17,,,,,,,,82.7,14.33,2.93,-10,9,0,,,,89.5,10.49,0,-1,1,0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,-80,0,H03,0.4,,NB-munselle-5020702-0004-0004,4.5,Frozen,0,0,0,0,0,,,,100,,,,99.7,-0.3,,0.0392,82.7,11.74,5.52,,,,,,,63.6,,55312.2,22165.6,3547.2,1408.7,220.6,101.8,0,0,,285195.9,131132.7,30687,16039.4,4531.8,1850,118.8,84.9,,,,,,,,94.1,4.61,1.26,2,-2,2,,,,89.7,10.35,0,-0.22,,,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,5,0,H02,0.4,,NB-munselle-5020702-0004-0004,5.2,Acetate,0,0,0,0,0,,,,100,,,,100,0,,0.0391,84.1,10.87,5.07,,,,,,,64.4,,8282.3,3241.6,322.5,169.7,17,0,0,0,,5787.4,1629.3,305.5,169.7,17,0,0,0,,,,,,,,92.2,6.22,1.55,0,0,0,,,,89.9,10.13,0,0,-9.83,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D11,0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,150,0,0,0,,,,100,0,,,99.8,-0.2,,0.0435,,,,,,,,,,61.2,,6398.4,1951.8,458.2,186.7,17,0,0,0,,26086,5804.4,1154.1,661.9,254.6,118.8,0,0,,,,,,,,83,15.37,1.63,-9,9,0,,,,89.3,10.73,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D10,0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,150,0,0,0,,,,100,0,,,99.7,-0.3,,0.0442,,,,,,,,,,59.6,,7858,2036.6,237.6,118.8,17,0,0,0,,18703.1,4514.5,899.5,492.2,186.7,50.9,17,17,,,,,,,,84,14.02,2.01,-8,8,0,,,,88.6,11.45,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D09,0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,150,0,0,0,,,,100,0,,,99.7,-0.3,,0.0444,,,,,,,,,,57,,5515.9,1001.3,101.8,50.9,33.9,0,0,0,,61050.3,17906,6144.1,4141.3,1951.8,1018.4,543.1,543.1,,,,,,,,82.5,15.83,1.71,-10,10,0,,,,88.9,11.06,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D08,0,,NB-munselle-5020702-0004-0004,5,Histidine,0,150,0,0,0,,,,100,0,,,99.7,-0.3,,0.0438,,,,,,,,,,53.8,,5431,1323.8,356.4,271.6,169.7,67.9,17,17,,17243.5,3767.8,780.7,390.4,169.7,50.9,0,0,,,,,,,,80.2,18.22,1.63,-12,12,0,,,,85.3,10.06,4.66,-5,0,5,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D07,0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,150,0,0,0,,,,100,0,,,99.8,-0.2,,0.0423,,,,,,,,,,61.2,,7807.1,1222,67.9,17,0,0,0,0,,18703.2,2579.7,356.4,203.7,84.9,17,0,0,,,,,,,,82.5,15.94,1.6,-10,10,0,,,,89.4,10.65,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D06,0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,150,0,0,0,,,,100,0,,,99.7,-0.3,,0.0422,,,,,,,,,,58.8,,6924.5,1544.4,288.5,84.9,33.9,17,0,0,,16598.7,3105.9,644.9,169.7,50.9,0,0,0,,,,,,,,83.2,15.44,1.33,-9,9,0,,,,89.7,10.31,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D05,0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,150,0,0,0,,,,100,0,,,98.3,-1.7,,0.043,,,,,,,,,,61.2,,4667.3,848.6,220.6,118.8,67.9,50.9,0,0,,18567.3,4514.5,916.5,475.2,118.8,17,0,0,,,,,,,,85.1,13.14,1.73,-7,7,0,,,,89.8,10.16,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D04,0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,150,0,0,0,,,,100,0,,,99.8,-0.2,,0.0436,,,,,,,,,,60.2,,5872.3,1188,271.6,152.7,67.9,33.9,0,0,,19161.3,3071.9,543.1,237.6,67.9,0,0,0,,,,,,,,83.5,15.13,1.36,-9,9,0,,,,89.7,10.28,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D03,0,,NB-munselle-5020702-0004-0004,5,Acetate,0,150,0,0,0,,,,100,0,,,99.7,-0.3,,0.0421,,,,,,,,,,56.6,,7688.3,1476.6,356.4,237.6,84.9,17,17,0,,18465.5,2783.4,441.3,254.6,67.9,0,0,0,,,,,,,,81.8,16.72,1.47,-10,11,0,,,,89,10.18,0.85,-1,0,1,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,D02,0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,150,0,0,0,,,,100,0,,,99.7,-0.3,,0.0421,,,,,,,,,,50,,5566.8,1323.8,237.6,135.8,0,0,0,0,,21368,3615.1,543.1,288.5,67.9,50.9,17,0,,,,,,,,78.5,20.11,1.44,-14,14,0,,,,67.9,8.1,23.96,-22,-2,24,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C11,0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,50,0,0,0,,,,100,0,,,99.8,-0.2,,0.0429,64.9,26.47,8.68,,,,,,,60.4,,10420.9,356.4,152.7,84.9,33.9,17,0,0,,27443.9,4175.1,950.4,611,254.6,84.9,17,0,,,,,,,,82.7,15.5,1.8,-10,9,0,,,,89.8,10.17,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C10,0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,50,0,0,0,,,,100,0,,,99.4,-0.6,,0.0426,69.2,22.19,8.62,,,,,,,61.4,,7145.2,1578.4,152.7,84.9,17,17,0,0,,54242.9,14358.4,4022.4,2444,950.4,424.3,0,0,,,,,,,,85.2,13.27,1.53,-7,7,0,,,,89.4,10.6,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C09,0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,50,0,0,0,,,,100,0,,,99.7,-0.3,,0.0438,69.9,20.85,9.21,,,,,,,58.2,,7586.4,1510.5,186.7,84.9,33.9,17,0,0,,27647.5,4480.6,628,356.4,152.7,101.8,33.9,0,,,,,,,,83.8,14.89,1.31,-8,9,0,,,,89.6,10.45,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C08,0,,NB-munselle-5020702-0004-0004,5,Histidine,0,50,0,0,0,,,,100,0,,,99.3,-0.7,,0.044,69.5,20.94,9.59,,,,,,,,,8401.1,1289.9,254.6,152.7,33.9,17,0,0,,32400.2,6653.2,1425.7,678.9,237.6,50.9,33.9,17,,,,,,,,83.6,15.01,1.38,-9,9,0,,,,89.1,10.89,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C07,0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,50,0,0,0,,,,97,-3,,,99.8,-0.2,,0.0449,62,29.34,8.63,,,,,,,59.8,,8044.7,1544.4,373.4,169.7,67.9,17,0,0,,22131.6,3988.4,526.1,288.5,152.7,17,17,17,,,,,,,,83.3,14.97,1.73,-9,9,0,,,,89.8,10.03,0.13,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C06,0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,50,0,0,0,,,,100,0,,,99.7,-0.3,,0.0432,62.7,29.24,8.02,,,,,,,60.4,,7620.4,2036.6,186.7,118.8,0,0,0,0,,33571,6008.2,1357.8,611,220.6,50.9,0,0,,,,,,,,83.2,15.25,1.54,-9,9,0,,,,89.8,10.22,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C05,0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,50,0,0,0,,,,100,0,,,99.8,-0.2,,0.0441,66.4,24.52,9.12,,,,,,,60,,5889.3,1493.5,67.9,33.9,0,0,0,0,,15257.9,2104.5,288.5,152.7,33.9,17,0,0,,,,,,,,84.9,13.5,1.65,-7,7,0,,,,89.5,10.51,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C04,0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,50,0,0,0,,,,100,0,,,99.7,-0.3,,0.0442,66.8,23.81,9.4,,,,,,,58.4,,4650.3,882.5,186.7,118.8,33.9,0,0,0,,24117.2,4039.3,695.9,322.5,84.9,33.9,17,0,,,,,,,,84.6,14.18,1.18,-8,8,0,,,,89.8,10.16,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C03,0,,NB-munselle-5020702-0004-0004,5,Acetate,0,50,0,0,0,,,,100,0,,,99.6,-0.4,,0.0428,66.8,24.06,9.17,,,,,,,58.2,,5295.2,933.5,101.8,67.9,17,17,0,0,,11031.8,1968.7,356.4,237.6,135.8,84.9,50.9,17,,,,,,,,83.5,15.34,1.19,-9,9,0,,,,89.1,10.92,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,C02,0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,50,0,0,0,,,,100,0,,,99.1,-0.9,,0.041,65.4,24.91,9.74,,,,,,,54.4,,5549.8,1069.2,118.8,50.9,17,0,0,0,,22114.5,3360.5,560.1,220.6,50.9,17,0,0,,,,,,,,81.5,17.31,1.22,-11,11,0,,,,89.1,10.95,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B11,0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,0,0,0,0,,,,100,0,,,99.6,-0.4,,0.0417,62.4,29.21,8.37,,,,,,,63.4,,19008.6,6126.9,237.6,84.9,33.9,0,0,0,,137382.8,8418.8,1561.6,899.6,458.3,237.6,17,0,,,,,,,,83,15.65,1.34,-9,9,0,,,,89.1,10.94,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B10,0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,0,0,0,0,,,,100,0,,,99.7,-0.3,,0.0434,67.1,24.15,8.75,,,,,,,,,18193.9,10522.6,356.4,101.8,50.9,50.9,0,0,,26646.3,4599.5,780.7,305.5,135.8,50.9,0,0,,,,,,,,86,12.77,1.27,-6,7,0,,,,89.1,10.91,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B09,0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,0,0,0,0,,,,100,0,,,99.3,-0.7,,0.0432,70.4,21.09,8.48,,,,,,,63.8,,10115.2,4565.4,695.8,271.6,67.9,33.9,0,0,,18499.4,4293.9,865.6,509.2,84.9,33.9,0,0,,,,,,,,85.4,13.59,1.02,-7,7,-1,,,,88.9,11.1,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B08,0,,NB-munselle-5020702-0004-0004,5,Histidine,0,0,0,0,0,,,,100,0,,,99.2,-0.8,,0.0441,69.4,21.76,8.81,,,,,,,60.6,,10166.2,3360.4,628,288.5,67.9,33.9,0,0,,21299.8,4056.3,594,203.7,33.9,0,0,0,,,,,,,,84.8,14.12,1.1,-7,8,0,,,,89.1,10.86,0,-1,1,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B07,0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,0,0,0,0,,,,98,-2,,,99.6,-0.4,,0.0431,60.8,30.79,8.41,,,,,,,60.8,,10369.9,3462.3,492.2,339.4,33.9,17,0,0,,42006,8231.5,1578.4,746.8,169.7,33.9,0,0,,,,,,,,83.3,15.45,1.23,-9,9,0,,,,90,9.96,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B06,0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,0,0,0,0,,,,100,0,,,99.5,-0.5,,0.0423,64.4,27.65,7.96,,,,,,,59.6,,7094.3,1816,339.4,169.7,67.9,17,0,0,,41056.4,6076.1,746.8,305.5,33.9,17,0,0,,,,,,,,83.7,15.07,1.25,-9,9,0,,,,89.7,10.33,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B05,0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,0,0,0,0,,,,100,0,,,100,-0.4,,0.0435,66,24.29,9.67,,,,,,,61.2,,21910.9,5566.8,560.1,169.7,0,0,0,0,,142459.1,30908.9,8147.3,5193.9,2987.3,1952,950.5,695.9,,,,,,,,85.8,13.13,1.1,-6,7,0,,,,89.7,10.27,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B04,0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,0,0,0,0,,,,100,0,,,100,-0.4,,0.0431,66.8,23.62,9.61,,,,,,,62.4,,7959.8,2919.2,407.3,118.8,17,17,0,0,,32892,6534.3,2223.3,1629.3,1035.3,560.1,101.8,17,,,,,,,,84.4,14.42,1.15,-8,8,0,,,,89.9,10.09,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B03,0,,NB-munselle-5020702-0004-0004,5,Acetate,0,0,0,0,0,,,,100,0,,,100,-0.3,,0.0419,67.8,22.87,9.34,,,,,,,64.2,,6924.5,2410,594,254.6,33.9,0,0,0,,28462,4989.8,831.6,322.5,135.8,17,0,0,,,,,,,,84.4,14.39,1.23,-8,8,0,,,,90.1,9.93,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40,12,B02,0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,0,0,0,0,,,,100,0,,,100,-0.3,,0.0413,68,22.31,9.67,,,,,,,62.4,,4837,1765.1,628,271.5,67.9,17,0,0,,27647.6,4243,661.9,305.5,101.8,17,0,0,,,,,,,,83.8,15.12,1.07,-8,9,0,,,,89.6,10.43,0,0,0,0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,-80,0,H08,1,,NB-munselle-5020702-0004-0004,5.5,Frozen,0,0,0,0,0,,,,100,,,,99.8,0,,0.0398,84.9,10.43,4.68,,,,,,,63.8,,82196.2,34046.2,6211.8,2647.7,475.2,118.8,17,17,,70265.2,24236.4,3937.6,1782.1,458.3,203.7,0,0,,,,,,,,95.9,2.68,1.43,1,-1,1,,,,91.2,8.81,0,1.02,,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,5,0,H07,1,,NB-munselle-5020702-0004-0004,5.2,Acetate,0,0,0,0,0,,,,100,,,,99.8,0,,0.0414,84.8,10.44,4.8,,,,,,,66.2,,149999.3,21506.1,1273.1,560.1,203.7,101.8,17,17,,1976647.8,20572.7,475.7,220.8,118.9,51,17,0,,,,,,,,95.1,3.39,1.5,0,0,0,,,,91.3,8.67,0,1.16,-9.57,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,150,0,0,0,,,,99,-1,,,99.8,0,,0.0423,,,,,,,,,,62,,16598.7,3309.6,967.4,543.1,220.6,101.8,33.9,17,,53903.8,12084.2,3920.6,2240.3,865.6,407.3,33.9,0,,,,,,,,82.7,15.62,1.64,-12,12,0,,,,89.2,10.85,0,-2,2,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,150,0,0,0,,,,99,-1,,,99.2,-0.6,,0.0435,,,,,,,,,,,,6788.8,1849.9,577,271.6,118.8,33.9,0,0,,19721.5,4226,933.5,458.2,237.6,67.9,0,0,,,,,,,,86.4,12.15,1.5,-9,9,0,,,,90,10.03,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,150,0,0,0,,,,99,-1,,,99.6,-0.1,,0.0435,,,,,,,,,,57.2,,7993.8,1917.8,458.2,322.5,152.7,101.8,0,0,,48184.3,5006.8,712.8,390.4,186.7,67.9,17,0,,,,,,,,83.7,14.87,1.41,-11,11,0,,,,89.5,10.36,0.14,-2,2,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,150,0,0,0,,,,99,-1,,,99.5,-0.3,,0.0444,,,,,,,,,,54.2,,7501.6,1629.3,339.4,169.7,101.8,67.9,0,0,,28020.9,4921.9,933.5,644.9,254.6,84.9,33.9,17,,,,,,,,82.6,16.17,1.26,-13,13,0,,,,88.2,8.58,3.2,-3,0,3,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,150,0,0,0,,,,95,-5,,,97.3,-2.4,,0.0427,,,,,,,,,,,,7722.3,1510.5,271.6,152.7,17,0,0,0,,18940.8,2715.5,424.3,322.5,50.9,17,17,17,,,,,,,,82.7,15.88,1.43,-12,12,0,,,,90.6,9.27,0.16,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,150,0,0,0,,,,99,-1,,,100,0.2,,0.0418,,,,,,,,,,59.6,,10098.3,1833,288.5,203.7,33.9,17,0,0,,49151.6,7433.8,1069.3,492.2,101.8,50.9,17,0,,,,,,,,83.1,15.39,1.53,-12,12,0,,,,90.4,9.59,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,150,0,0,0,,,,88,-12,,,99.8,0,,0.0443,,,,,,,,,,61.8,,6415.4,1306.8,220.6,67.9,0,0,0,0,,25967.2,4412.7,865.6,475.2,254.6,84.9,0,0,,,,,,,,83.8,14.86,1.39,-11,11,0,,,,90.6,9.41,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,150,0,0,0,,,,87,-13,,,99.8,0,,0.0429,,,,,,,,,,59.8,,6042,1255.9,288.5,254.6,101.8,33.9,0,0,,16972,2783.4,729.8,373.4,135.8,50.9,0,0,,,,,,,,84,14.65,1.38,-11,11,0,,,,90.8,9.2,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,150,0,0,0,,,,99,-1,,,100,0.2,,0.0421,,,,,,,,,,56.6,,12440.4,2766.4,661.9,509.2,118.8,50.9,17,0,,40088.2,8282.4,1968.8,1069.2,441.3,135.8,50.9,0,,,,,,,,82.8,15.81,1.39,-12,12,0,,,,90.3,9.2,0.54,-1,1,1,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,G02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,150,0,0,0,,,,99,-1,,,100,0.2,,0.041,,,,,,,,,,51.2,,7756.2,1951.8,526.1,390.4,152.7,84.9,0,0,,51377.3,4701.5,1306.9,882.6,237.6,67.9,0,0,,,,,,,,81.5,17.09,1.44,-14,14,0,,,,73.3,7.28,19.43,-18,-1,19,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,50,0,0,0,,,,99,-1,,,99.8,0,,0.0401,68.2,23.31,8.52,,,,,,,61.4,,11507,3190.7,780.7,407.3,169.7,50.9,0,0,,51561.7,11710.8,2817.4,1663.3,543.1,254.6,33.9,0,,,,,,,,82.8,15.73,1.47,-12,12,0,,,,90.1,9.66,0.25,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,50,0,0,0,,,,99,-1,,,99.8,0,,0.046,73.5,18.21,8.32,,,,,,,61.2,,9113.9,2121.5,594,322.5,50.9,33.9,17,0,,40970.7,7315,1900.9,1035.3,458.2,186.7,17,0,,,,,,,,85.8,12.7,1.49,-9,9,0,,,,89.9,10.15,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,50,0,0,0,,,,100,0,,,99.6,-0.2,,0.0433,74.7,16.98,8.32,,,,,,,59.6,,7518.5,1646.3,271.6,186.7,84.9,17,0,0,,42447.1,7790.2,1799,1103.2,356.4,118.8,0,0,,,,,,,,83.3,15.33,1.36,-12,12,0,,,,89.4,10.65,0,-2,2,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,50,0,0,0,,,,100,0,,,99.3,-0.5,,0.0448,72.1,19.19,8.72,,,,,,,57.4,,11863.4,2936.1,543.1,322.5,50.9,17,0,0,,44688.1,8367.4,2053.7,1239,373.4,186.7,33.9,0,,,,,,,,83.8,14.88,1.32,-11,11,0,,,,89.3,10.67,0,-2,2,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,50,0,0,0,,,,95,-5,,,99.7,-0.1,,0.0447,64.9,26.86,8.21,,,,,,,62,,14477.1,2291.2,390.4,203.7,50.9,0,0,0,,44195.6,8044.8,1646.3,746.8,271.6,118.8,0,0,,,,,,,,82.2,16.06,1.75,-13,13,0,,,,90.6,9.42,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,50,0,0,0,,,,98,-2,,,99.7,0,,0.0438,66.1,26.34,7.56,,,,,,,60.6,,11710.7,2053.6,475.2,169.7,50.9,0,0,0,,36201.5,7993.9,2206.4,1137.1,390.4,203.7,0,0,,,,,,,,82.7,15.87,1.48,-12,12,0,,,,90,10.05,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,50,0,0,0,,,,87,-13,,,99.8,0,,0.0434,68.8,22.38,8.85,,,,,,,61.4,,6449.4,1035.3,169.7,135.8,0,0,0,0,,19331.1,3207.7,712.8,373.4,101.8,33.9,0,0,,,,,,,,84.1,14.28,1.58,-11,11,0,,,,90.7,9.3,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,50,0,0,0,,,,93,-7,,,99.8,0,,0.0431,69.1,22.05,8.84,,,,,,,61.2,,5838.4,1255.9,288.5,118.8,50.9,17,0,0,,17905.5,2664.6,373.4,118.8,17,17,0,0,,,,,,,,83.9,14.78,1.35,-11,11,0,,,,90.7,9.32,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,50,0,0,0,,,,99,-1,,,99.8,0,,0.0418,67.6,23.23,9.16,,,,,,,59.4,,7145.2,1357.8,186.7,135.8,17,0,0,0,,12576.2,2325.2,271.6,169.7,84.9,17,0,0,,,,,,,,82.6,16.07,1.33,-13,13,0,,,,90.1,9.89,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,F02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,50,0,0,0,,,,99,-1,,,99.8,0,,0.0412,67.9,22.94,9.18,,,,,,,54.6,,5787.4,1748.1,390.4,220.6,118.8,17,0,0,,12966.6,2579.7,611,356.4,84.9,17,0,0,,,,,,,,81.6,17.04,1.36,-14,14,0,,,,89.9,10.14,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E11,1,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,0,0,0,0,,,,99,-1,,,99.8,0,,0.0429,69.3,22.38,8.3,,,,,,,63.6,,20060.9,2919.2,526.1,288.5,67.9,33.9,0,0,,38543.7,6194.8,1476.6,865.6,237.6,118.8,17,0,,,,,,,,83.6,15.08,1.29,-11,12,0,,,,89.2,10.69,0.1,-2,2,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E10,1,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,0,0,0,0,,,,98,-2,,,99.8,0,,0.0436,72.6,18.84,8.58,,,,,,,63.8,,12898.7,3428.3,899.5,509.2,203.7,169.7,0,0,,23998.4,5346.2,1188,763.7,203.7,50.9,0,0,,,,,,,,86.5,12.4,1.14,-9,9,0,,,,89.7,10.35,0,-2,2,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E09,1,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,0,0,0,0,,,,100,0,,,99.4,-0.4,,0.044,74.6,17.13,8.32,,,,,,,62.8,,10929.9,4056.3,1527.5,950.4,220.6,101.8,33.9,0,,18754,3835.7,678.9,356.4,84.9,17,0,0,,,,,,,,84.5,14.29,1.19,-11,11,0,,,,89.8,10.22,0,-2,2,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E08,1,,NB-munselle-5020702-0004-0004,5,Histidine,0,0,0,0,0,,,,100,0,,,99.4,-0.4,,0.0431,73.5,17.67,8.81,,,,,,,62.6,,9368.5,3105.9,950.4,526.1,203.7,118.8,0,0,,13187.2,2953.1,492.2,322.5,135.8,84.9,17,0,,,,,,,,84.5,14.07,1.42,-11,11,0,,,,90.1,9.88,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E07,1,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,0,0,0,0,,,,96,-4,,,99.8,0,,0.0429,64.3,27.19,8.54,,,,,,,61.4,,7518.5,2511.8,1035.3,644.9,305.5,152.7,0,0,,28105.9,4786.1,797.7,390.4,118.8,50.9,17,0,,,,,,,,83.8,14.74,1.44,-11,11,0,,,,91.1,8.62,0.24,0,0,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E06,1,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,0,0,0,0,,,,97,-3,,,99.7,-0.1,,0.0412,66.6,25.62,7.76,,,,,,,60,,9504.3,2562.8,950.4,560.1,220.6,84.9,0,0,,25644.8,4395.8,1035.3,560.1,50.9,17,0,0,,,,,,,,83.2,15.48,1.36,-12,12,0,,,,91,8.74,0.29,0,0,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E05,1,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,0,0,0,0,,,,89,-11,,,99.8,0,,0.0423,68.2,21.98,9.85,,,,,,,63.6,,17124.7,5991.1,1934.8,1018.3,322.5,135.8,17,0,,28818.5,5923.2,2019.7,1171.1,339.4,101.8,0,0,,,,,,,,85.7,12.83,1.49,-9,9,0,,,,91.1,8.87,0,0,0,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E04,1,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,0,0,0,0,,,,99,-1,,,99.8,0,,0.0429,68.8,21.78,9.44,,,,,,,64,,12881.7,4158.1,1137.1,577,220.6,101.8,33.9,0,,20043.9,2359.1,254.6,135.8,33.9,17,0,0,,,,,,,,84.7,13.93,1.42,-10,11,0,,,,91,9.04,0,0,0,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E03,1,,NB-munselle-5020702-0004-0004,5,Acetate,0,0,0,0,0,,,,100,0,,,99.7,-0.1,,0.0422,68.6,21.53,9.84,,,,,,,63,,13696.3,4412.7,916.5,526.1,237.6,101.8,0,0,,21079.3,3886.6,746.8,407.3,67.9,0,0,0,,,,,,,,84.6,14.17,1.27,-11,11,0,,,,90.6,9.45,0,-1,1,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40,12,E02,1,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,0,0,0,0,,,,100,0,,,99.8,0,,0.0405,68.5,21.63,9.87,,,,,,,63.2,,12338.6,4158.1,1510.5,797.7,254.6,135.8,0,0,,14171.6,2817.3,475.2,271.6,101.8,50.9,0,0,,,,,,,,82.6,15.93,1.45,-12,13,0,,,,90.9,9.06,0,0,0,0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,N/A,-,-,2,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_01,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_02,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_03,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_04,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_M_01,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_M_02,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_M_03,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_M_05,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_M_06,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B20_M_07,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,4,,,B50_01,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B50_02,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B50_03,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,B50_04,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,BSM_01,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,BSM_02,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,BSM_03,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,BSM_04,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,BSM_05,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,BSM_06,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,BSM_07,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
11/1/2023,ramapa,,,,,,,,,,BSM_08,NB-ramapa-5088245-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
,,,,,,,,,,,,NB-walpeter-5068643-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Protein Formulation Characterization Summary
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,Trop2-Trabectedin_0.2%Pyr_0.2x,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,Trop2-Trabectedin_Start_0.2x,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,Trop2-Trabectedin_Start_CT,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,,,,,,Trop2-Trabectedin_T0,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,VLS231_0.2%Pyr_0.2x,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,,,,,,VLS231_CT,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,VLS231_Start_0.2x,NB-GANVEER-5049416-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,tBHP,25,1,,,1_US-10204186,NB-mozzicon-5088257-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,tBHP,25,1,,,2_US-10204186,NB-mozzicon-5088257-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,tBHP,25,1,,,3_US-10204186,NB-mozzicon-5088257-0003,6.8,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,High pH,25,7,,,4_US-10204186,NB-mozzicon-5088257-0003,11,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,AAPH,25,0.25,,,5_US-10204186,NB-mozzicon-5088257-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,AAPH,25,0.25,,,6_US-10204186,NB-mozzicon-5088257-0003,6.8,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,tBHP,25,1,,,A_US-10204186,NB-mozzicon-5088257-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,tBPH,25,1,,,B_US-10204186,NB-mozzicon-5088257-0003,6.8,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,Control,5,0,,,CT_US-10204186,NB-mozzicon-5088257-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,UV/Vis 0.2x,25,,,,C_US-10204186,NB-mozzicon-5088257-0003,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
10/6/2023,mozzicon,,,,,UV/Vis 0.2x,25,,,,D_US-10204186,NB-mozzicon-5088257-0003,6.8,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,Trop2-Trabectedin_0.2%Pyr_0.2x,NB-ramapa-5085300-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,Trop2-Trabectedin_Start_0.2x,NB-ramapa-5085300-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,Trop2-Trabectedin_Start_CT,NB-ramapa-5085300-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,,,,,,Trop2-Trabectedin_T0,NB-ramapa-5085300-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,VLS231_0.2%Pyr_0.2x,NB-ramapa-5085300-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,,,,,,VLS231_CT,NB-ramapa-5085300-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
5/22/2023,ramapa,,,,,Light stress 0.2 x,,,,,VLS231_Start_0.2x,NB-ramapa-5085300-0002,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,50,1,,,Trop2-PNU_1d50C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2281.5,952,119,2261.5,0,0.3,,,,,,,,,,98.71,0.11,1.18,0.1,-0.1,0,0.1,0.1,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,1,,,Trop2-PNU_1d60C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1627,536,39.5,1627,0,0.2,,,,,,,,,,93.4,0.17,6.43,-5.2,0,5.3,5.2,0,5.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,70,1,,,Trop2-PNU_1d70C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7183,2738,99,7123,0,0.4,,,,,,,,,,73.28,0.19,26.53,-25.3,0,25.4,25.3,0,25.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,50,3,,,Trop2-PNU_3d50C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6250,2063.5,99.5,6250,0,1,,,,,,,,,,98.55,0.09,1.37,-0.1,-0.1,0.2,0.1,0.1,0.2,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,3,,,Trop2-PNU_3d60C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1091.5,258,0,1091.5,0,0.3,,,,,,,,,,88.87,0.38,10.76,-9.7,0.2,9.6,9.7,0.2,9.6,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,70,3,,,Trop2-PNU_3d70C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5992,1786,20,5992,0,0.2,,,,,,,,,,62.92,0.61,36.47,-35.7,0.4,35.3,35.7,0.4,35.3,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,50,5,,,Trop2-PNU_5d50C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1925,535.5,0,1925,0,0.2,,,,,,,,,,98.33,0.15,1.52,-0.3,-0.1,0.4,0.3,0.1,0.4,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60,5,,,Trop2-PNU_5d60C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3134.5,1309.5,139,3095,0,0.3,,,,,,,,,,84.28,0.58,15.14,-14.3,0.4,14,14.3,0.4,14,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,70,5,,,Trop2-PNU_5d70C,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,932.5,397,20,932.5,0,0.2,,,,,,,,,,58.43,1.36,40.21,-40.2,1.1,39,40.2,1.1,39,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,,0,,,Trop2-PNU_CT,NB-ramapa-5085300-0003-0001,6,Histidine,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1686.5,833.5,119,1666.5,0,0.2,,,,,,,,,,98.61,0.22,1.17,0,0,0,0,0,0,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,ramapa,,,,,,,,,,VLS231_CT,NB-ramapa-5085300-0003-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3254,913,79,3214,40,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,ramapa,,,,,,,,,,Trop2-Trabectedin_T0,NB-ramapa-5085300-0003-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75198,17698,198,75119,40,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,ramapa,,,,,,,,,,Trop2-Trabectedin_Start_0.2x,NB-ramapa-5085300-0003-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26984,7817,317,26944,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,ramapa,,,,,,,,,,Trop2-Trabectedin_0.2%Pyr_0.2x,NB-ramapa-5085300-0003-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24921,6984,238,24881,40,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,ramapa,,,,,,,,,,VLS231_0.2%Pyr_0.2x,NB-ramapa-5085300-0003-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5357,1429,40,5317,0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,ramapa,,,,,,,,,,VLS231_Start_0.2x,NB-ramapa-5085300-0003-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11865,4921,794,11508,159,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,ramapa,,,,,,,,,,Trop2-Trabectedin_Start_CT,NB-ramapa-5085300-0003-0001,,,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14127,4127,238,14127,0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,N/A,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
